data_2rog_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rog _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.09 165.33 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -133.95 141.86 47.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.3 tp -122.65 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.521 1.529 . . . . 0.0 108.978 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -87.15 136.76 32.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.4 133.13 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 125.557 1.543 . . . . 0.0 107.236 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -145.13 163.77 33.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.48 -123.37 5.56 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.245 1.402 . . . . 0.0 113.949 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -68.0 83.03 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 129.658 3.183 . . . . 0.0 111.341 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.98 78.69 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.786 2.434 . . . . 0.0 111.06 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -137.79 161.83 35.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.981 1.712 . . . . 0.0 109.241 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.31 -57.83 4.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.995 1.718 . . . . 0.0 112.805 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -60.47 -19.1 55.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.7 m -63.26 -34.05 76.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.85 1.205 . . . . 0.0 109.667 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.23 -39.12 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.374 1.069 . . . . 0.0 109.734 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 48.6 tpp -62.16 -47.2 85.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.55 -52.32 66.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.124 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.47 -43.52 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.716 1.144 . . . . 0.0 113.092 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.9 t -60.68 -44.49 96.44 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.295 1.861 . . . . 0.0 110.002 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -69.23 -48.3 62.34 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.657 -0.652 . . . . 0.0 111.678 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.15 73.27 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.602 0.761 . . . . 0.0 111.288 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -73.13 -52.13 15.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.708 0.686 . . . . 0.0 110.076 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -69.38 -3.7 15.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -53.56 -40.67 65.78 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.589 0.756 . . . . 0.0 111.039 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.22 136.52 37.89 Favored Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.44 115.06 3.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 106.79 -2.042 . . . . 0.0 106.79 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.88 -92.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.759 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 t -64.75 -57.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 66.22 -31.6 0.16 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.278 2.231 . . . . 0.0 112.444 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -101.2 102.76 13.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.577 1.951 . . . . 0.0 106.374 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.36 127.12 37.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.548 1.139 . . . . 0.0 108.008 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.06 144.84 51.33 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.437 1.495 . . . . 0.0 111.911 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.12 143.04 42.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.729 1.612 . . . . 0.0 107.314 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -77.5 137.28 38.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 109.175 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.34 -48.09 44.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -80.76 -20.97 41.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.77 161.63 32.42 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.075 1.307 . . . . 0.0 109.485 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.21 36.16 3.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -104.26 141.62 35.97 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 120.372 -1.664 . . . . 0.0 107.583 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.22 146.06 51.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 108.562 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.93 144.31 50.73 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.015 1.726 . . . . 0.0 106.703 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.37 141.29 42.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.535 0.734 . . . . 0.0 110.909 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.13 104.19 8.39 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.446 1.117 . . . . 0.0 109.179 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.83 41.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 126.436 1.969 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -117.38 12.72 14.34 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.71 156.27 30.9 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.216 0.916 . . . . 0.0 110.436 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.31 154.93 81.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 113.24 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.7 -51.63 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.14 2.56 . . . . 0.0 109.213 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -55.48 -40.33 71.52 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.128 -1.415 . . . . 0.0 111.074 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.24 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 120.136 1.335 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -70.01 -53.13 19.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.29 0.636 . . . . 0.0 110.666 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.8 t -52.51 -54.96 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.942 0.897 . . . . 0.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.32 -47.42 86.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.121 1.369 . . . . 0.0 110.421 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.75 -45.34 74.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.638 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.86 -32.71 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 119.06 0.845 . . . . 0.0 111.274 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -56.45 -39.16 72.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 112.227 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.83 -34.15 62.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -16.89 61.47 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.398 0.545 . . . . 0.0 112.218 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.29 0.16 47.26 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.544 1.068 . . . . 0.0 110.96 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -78.83 172.27 13.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.377 1.071 . . . . 0.0 109.519 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.35 149.19 39.74 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.57 170.01 23.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.493 1.139 . . . . 0.0 111.694 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -158.04 127.6 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.62 142.12 14.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -125.64 94.8 4.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 177.475 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptt? . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.278 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -91.92 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.716 1.143 . . . . 0.0 110.106 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -127.75 141.08 51.69 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.7 tp -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -86.75 133.98 33.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 100.639 -3.837 . . . . 0.0 100.639 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.43 118.85 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -127.58 145.66 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.94 -176.39 41.47 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.45 -22.8 66.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.905 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -123.18 154.64 38.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.116 1.366 . . . . 0.0 108.152 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 p -133.36 -5.51 2.97 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.664 1.186 . . . . 0.0 113.22 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -115.8 -67.92 0.96 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.406 1.082 . . . . 0.0 111.115 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 -20.54 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.818 -1.176 . . . . 0.0 113.447 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -59.75 -27.67 66.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.771 1.229 . . . . 0.0 112.049 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 m -52.5 -29.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 119.094 0.861 . . . . 0.0 112.865 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 9.9 tpt -67.57 -50.73 57.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.19 74.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.865 0.866 . . . . 0.0 110.374 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -56.27 -55.03 20.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 110.912 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.3 m -68.33 -36.33 79.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.471 1.032 . . . . 0.0 111.222 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HZ3' ' CD ' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -60.98 -47.75 84.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.26 -49.53 75.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.516 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.38 -28.11 64.86 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.831 1.196 . . . . 0.0 112.303 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -58.27 -29.97 66.22 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.488 -0.758 . . . . 0.0 109.58 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -60.9 -16.95 47.79 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 117.258 -1.354 . . . . 0.0 112.83 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.46 92.07 1.7 Allowed Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 119.516 1.053 . . . . 0.0 108.817 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.67 117.16 4.99 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 105.878 -2.393 . . . . 0.0 105.878 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.27 -10.46 5.04 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.002 -1.443 . . . . 0.0 113.117 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.8 t -85.53 -56.93 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 120.166 1.983 . . . . 0.0 106.551 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 63.8 -19.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -130.04 114.49 15.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.829 2.104 . . . . 0.0 110.778 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.6 m -140.09 144.36 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.802 1.241 . . . . 0.0 109.737 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.01 144.75 32.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.957 1.303 . . . . 0.0 109.49 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.46 129.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -76.65 132.52 39.44 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.773 1.229 . . . . 0.0 111.243 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.2 mt -73.56 -48.61 31.57 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.2 1.0 . . . . 0.0 112.749 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.01 -31.61 69.37 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -135.68 161.62 35.03 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.632 1.106 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.59 43.22 1.33 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.236 1.398 . . . . 0.0 112.794 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -104.71 152.51 22.43 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.54 151.85 38.79 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.962 1.305 . . . . 0.0 108.387 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.41 144.6 47.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.091 1.756 . . . . 0.0 107.433 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -138.26 116.19 12.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.89 104.83 13.82 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.13 162.65 12.19 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 t -75.05 31.8 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.234 1.814 . . . . 0.0 112.321 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.71 149.77 8.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.946 1.298 . . . . 0.0 112.447 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.73 131.07 46.48 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.694 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -49.74 -61.81 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.605 2.87 . . . . 0.0 113.634 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -58.02 -23.16 53.05 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.868 -1.063 . . . . 0.0 112.633 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.76 -39.65 66.64 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.382 1.446 . . . . 0.0 109.334 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.09 -48.71 67.37 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.33 -55.86 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.068 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.51 -29.86 71.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.472 -0.775 . . . . 0.0 111.865 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.01 82.8 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.742 1.156 . . . . 0.0 108.726 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.17 -36.89 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.783 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.15 -36.43 72.99 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.234 1.014 . . . . 0.0 113.258 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.53 -15.3 49.92 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.233 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.51 ' CD ' ' HZ3' ' A' ' 20' ' ' LYS . 37.3 mt-10 -107.31 8.71 29.92 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.087 1.312 . . . . 0.0 111.833 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.63 38.39 9.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.46 152.16 43.66 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.99 152.17 19.54 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.6 159.28 42.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.637 0.586 . . . . 0.0 110.867 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -153.59 117.19 4.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.04 168.3 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 124.398 1.079 . . . . 0.0 108.471 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -69.7 -176.05 0.98 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.721 0.808 . . . . 0.0 110.947 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.877 1.671 . . . . 0.0 108.925 -179.613 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.7 165.33 12.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.893 0.854 . . . . 0.0 108.989 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -133.92 123.25 24.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 tp -97.13 111.76 23.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.663 1.185 . . . . 0.0 108.39 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 134.94 33.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.97 164.75 31.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -147.17 139.29 24.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.05 -152.11 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 mmt -63.57 157.68 23.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.027 0.442 . . . . 0.0 110.328 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -57.61 -80.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.714 2.005 . . . . 0.0 113.926 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 p -146.43 132.53 19.32 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.74 1.216 . . . . 0.0 110.148 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -172.15 -173.47 1.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.851 1.261 . . . . 0.0 109.61 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -56.67 -13.91 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.772 2.029 . . . . 0.0 113.111 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.0 m -52.94 -28.89 25.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.341 1.457 . . . . 0.0 110.958 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.34 -42.11 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.21 0.914 . . . . 0.0 109.089 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.3 mmm -63.01 -40.55 98.11 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.399 -0.813 . . . . 0.0 110.625 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.08 -52.88 44.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.495 1.118 . . . . 0.0 110.416 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.18 -40.94 86.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-O 117.696 -1.145 . . . . 0.0 110.278 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.9 m -59.36 -43.57 92.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.808 1.64 . . . . 0.0 108.839 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -64.3 -37.9 89.14 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.907 -1.121 . . . . 0.0 110.757 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -44.97 68.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.508 0.723 . . . . 0.0 110.668 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -32.27 31.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.835 2.454 . . . . 0.0 109.635 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -53.08 -23.26 7.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.081 1.353 . . . . 0.0 112.715 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.29 -12.62 1.69 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.921 1.289 . . . . 0.0 114.472 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.5 m -53.78 152.54 9.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.828 0.74 . . . . 0.0 110.851 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.26 32.27 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.101 3.201 . . . . 0.0 111.514 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.91 91.66 1.61 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 p -112.89 -36.22 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.533 0.733 . . . . 0.0 111.328 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 67.15 -36.91 0.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.67 2.788 . . . . 0.0 113.733 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -104.86 106.61 17.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.1 144.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -143.72 140.76 30.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.52 141.64 45.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -89.08 131.7 35.12 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -72.32 -48.5 41.61 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.275 0.63 . . . . 0.0 110.947 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -82.49 -9.88 59.24 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -135.15 159.6 41.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.696 1.589 . . . . 0.0 111.734 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 59.84 4.74 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.12 138.6 22.88 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 118.566 1.183 . . . . 0.0 110.594 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.55 155.6 48.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.428 1.891 . . . . 0.0 110.268 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.16 142.73 46.65 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 126.553 1.941 . . . . 0.0 107.514 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.32 131.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.87 105.39 8.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.31 -155.39 26.16 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.699 -0.626 . . . . 0.0 111.8 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 t -89.3 -6.53 56.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.997 1.319 . . . . 0.0 114.066 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.66 123.7 10.64 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.447 1.021 . . . . 0.0 112.766 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.69 153.8 95.42 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 125.694 1.598 . . . . 0.0 108.737 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 -46.47 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.297 1.998 . . . . 0.0 109.944 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -58.45 -28.09 64.99 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.118 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.55 -51.19 64.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.21 -40.64 86.45 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.457 0.703 . . . . 0.0 111.18 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.36 -51.79 59.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.04 -30.46 70.99 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.167 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.99 77.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.893 0.77 . . . . 0.0 110.309 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -88.39 -32.57 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.211 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.85 -30.56 71.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.197 0.999 . . . . 0.0 110.882 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.61 -19.55 64.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.296 0.953 . . . . 0.0 108.864 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -97.63 3.5 50.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.581 1.553 . . . . 0.0 109.605 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.85 86.53 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.778 2.132 . . . . 0.0 114.293 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -74.07 166.35 23.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.241 2.021 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -117.72 129.26 55.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 116.403 -1.76 . . . . 0.0 107.752 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.57 160.38 42.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 121.835 2.107 . . . . 0.0 114.355 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.25 163.68 39.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.64 2.376 . . . . 0.0 107.394 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.5 154.76 16.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.781 -1.199 . . . . 0.0 109.228 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -119.42 108.14 14.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 C-N-CA 124.534 1.134 . . . . 0.0 110.952 -178.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.84 165.51 12.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.387 1.475 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 118.0 22.55 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.079 1.752 . . . . 0.0 106.39 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tt -137.4 147.58 45.54 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.275 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -123.81 139.69 53.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.826 1.194 . . . . 0.0 110.42 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.95 138.0 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.576 1.151 . . . . 0.0 110.253 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.25 110.54 3.72 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.359 1.076 . . . . 0.0 111.413 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.0 -48.33 1.25 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 124.665 1.126 . . . . 0.0 113.077 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 7.3 tpt -160.78 159.56 30.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.559 1.18 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -82.51 79.0 9.07 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -149.95 138.17 20.45 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -60.42 -37.86 82.23 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -57.85 -26.98 62.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.996 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -60.01 -36.11 76.53 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.439 1.018 . . . . 0.0 110.745 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.75 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.1 mtt -65.15 -40.82 94.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.881 -0.512 . . . . 0.0 110.982 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.17 -51.28 68.45 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.415 1.086 . . . . 0.0 111.206 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.09 -37.86 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 117.972 -1.013 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 m -60.13 -50.65 72.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.924 1.238 . . . . 0.0 108.122 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -54.14 -43.13 70.27 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.133 0.973 . . . . 0.0 111.13 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.96 59.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.069 0.948 . . . . 0.0 110.088 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 mt -56.67 -34.38 67.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.223 1.409 . . . . 0.0 112.047 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -63.55 -6.08 4.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.725 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -22.61 61.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 120.314 1.416 . . . . 0.0 111.706 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.11 95.75 13.67 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.03 45.27 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.095 3.196 . . . . 0.0 112.618 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.93 17.46 5.18 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.725 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 -57.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 119.402 1.601 . . . . 0.0 107.401 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 70.02 -53.26 0.63 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.089 2.155 . . . . 0.0 113.158 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -95.87 103.32 15.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.454 1.025 . . . . 0.0 109.073 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.78 134.09 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.507 1.123 . . . . 0.0 108.965 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -142.76 142.11 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 t -134.48 143.3 38.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 125.249 1.42 . . . . 0.0 109.391 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.45 145.0 35.29 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.0 -47.33 46.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.084 -1.01 . . . . 0.0 112.289 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -77.42 -24.18 50.45 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -133.23 147.86 51.99 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.891 1.223 . . . . 0.0 108.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.64 25.11 1.44 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.426 -1.208 . . . . 0.0 113.763 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -90.28 143.55 26.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.433 2.116 . . . . 0.0 108.237 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.05 162.69 34.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.3 1.04 . . . . 0.0 112.193 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.2 140.97 52.39 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.033 2.133 . . . . 0.0 106.445 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.57 146.33 27.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.134 0.968 . . . . 0.0 108.666 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -139.01 120.21 14.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.84 170.36 21.76 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 p -75.73 6.53 4.8 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.81 133.71 47.71 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.254 -0.904 . . . . 0.0 111.438 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.0 142.48 79.55 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.188 0.995 . . . . 0.0 111.165 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.2 -43.07 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.866 2.377 . . . . 0.0 113.889 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -56.65 -40.7 75.93 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.652 0.781 . . . . 0.0 111.235 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.3 95.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.941 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.08 -50.55 70.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.839 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.48 -48.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.691 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -65.93 -31.92 73.13 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.639 1.109 . . . . 0.0 111.291 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.4 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.568 0.622 . . . . 0.0 109.933 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 m -74.57 -33.18 31.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -56.55 -26.08 53.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.044 1.738 . . . . 0.0 114.627 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.56 -29.17 67.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.377 0.99 . . . . 0.0 112.398 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.07 4.37 17.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.857 -0.527 . . . . 0.0 111.707 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.1 45.24 83.93 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -123.68 150.72 43.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.525 1.53 . . . . 0.0 108.314 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 153.91 36.67 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.266 0.555 . . . . 0.0 110.36 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.11 26.45 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -152.89 158.14 41.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.97 152.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 120.865 -1.147 . . . . 0.0 109.03 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -137.95 85.53 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 pp -146.71 165.83 28.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.454 0.701 . . . . 0.0 110.679 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -112.07 104.56 12.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.578 1.18 . . . . 0.0 111.353 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 tt -98.88 148.32 24.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.869 2.068 . . . . 0.0 108.343 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -129.35 140.31 51.42 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.791 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.55 142.34 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.68 122.86 18.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.199 1.8 . . . . 0.0 110.234 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.33 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.2 mtt -142.48 132.57 24.56 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 m -74.82 81.57 2.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.787 0.835 . . . . 0.0 110.308 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -151.54 173.7 14.3 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.162 1.785 . . . . 0.0 108.134 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -67.36 -31.26 71.39 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.826 0.851 . . . . 0.0 112.244 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -61.08 -31.66 71.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.389 0.995 . . . . 0.0 111.686 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.3 t -62.49 -50.57 70.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -52.4 -50.13 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.245 1.418 . . . . 0.0 108.587 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 65.6 mtp -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.051 0.541 . . . . 0.0 110.219 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.53 64.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 m -64.05 -48.6 85.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.092 0.86 . . . . 0.0 111.182 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -63.38 -41.64 98.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.416 1.007 . . . . 0.0 110.118 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -64.33 -30.65 71.69 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.938 -1.727 . . . . 0.0 110.261 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.68 -51.43 41.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.034 0.834 . . . . 0.0 109.456 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.54 -33.82 76.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.892 0.477 . . . . 0.0 110.715 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -61.74 -7.23 3.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.109 0.964 . . . . 0.0 111.888 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HE3' ' CB ' ' A' ' 54' ' ' ALA . 0.6 OUTLIER -57.86 -33.23 68.47 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.589 1.54 . . . . 0.0 109.687 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.0 158.35 41.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.59 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.017 2.478 . . . . 0.0 111.371 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 74.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 105.633 -2.987 . . . . 0.0 105.633 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.16 -34.89 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.27 0.628 . . . . 0.0 110.605 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -176.41 -78.64 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.973 2.509 . . . . 0.0 106.416 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -155.72 151.41 27.31 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.082 1.31 . . . . 0.0 110.984 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.8 135.91 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 125.914 1.686 . . . . 0.0 106.799 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -143.27 140.7 30.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.78 131.48 42.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.49 1.116 . . . . 0.0 109.009 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 p -106.14 117.9 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.629 0.728 . . . . 0.0 110.931 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -18.37 61.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.077 0.951 . . . . 0.0 113.457 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -78.38 -15.53 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 112.958 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -137.26 -15.82 1.44 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.09 12.83 83.77 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.4 1.0 . . . . 0.0 112.749 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -93.29 146.74 23.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.868 1.334 . . . . 0.0 108.421 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.83 114.78 16.96 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.962 2.105 . . . . 0.0 109.168 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.89 134.2 34.34 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.25 131.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.798 1.285 . . . . 0.0 112.006 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -123.92 145.48 49.1 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 127.226 2.211 . . . . 0.0 108.581 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.6 177.17 15.44 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 126.246 1.879 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.3 p -66.21 5.14 0.57 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.482 2.313 . . . . 0.0 113.595 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.54 140.45 56.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.929 -1.107 . . . . 0.0 108.315 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.94 129.53 39.45 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -58.34 -31.2 93.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.752 1.635 . . . . 0.0 112.268 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -57.06 -46.49 82.42 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.814 1.188 . . . . 0.0 110.487 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.86 76.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.619 0.768 . . . . 0.0 110.753 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 118.886 -0.578 . . . . 0.0 111.389 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.13 -52.95 52.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -60.67 -33.64 73.13 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.545 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.42 ' CB ' ' HE3' ' A' ' 24' ' ' LYS . . . -60.49 -50.89 71.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.428 1.467 . . . . 0.0 110.082 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.84 -32.45 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.34 -44.61 71.27 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.033 1.333 . . . . 0.0 109.879 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.38 -23.44 66.32 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.784 0.834 . . . . 0.0 109.802 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.67 -14.67 62.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.801 1.24 . . . . 0.0 108.921 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.57 30.0 5.73 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 128.01 2.719 . . . . 0.0 115.518 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.49 175.33 9.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.207 2.003 . . . . 0.0 112.574 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -100.06 134.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.32 160.9 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -149.41 164.64 34.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.54 158.53 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 121.582 -0.699 . . . . 0.0 111.065 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -162.39 166.91 24.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.57 2.748 . . . . 0.0 106.045 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 178.352 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.94 166.45 14.41 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.571 0.748 . . . . 0.0 110.537 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -130.07 128.45 41.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.94 122.04 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -93.21 133.95 35.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.6 t -132.22 113.0 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -134.0 166.12 23.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.303 0.573 . . . . 0.0 109.833 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.0 170.63 43.39 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -83.68 0.6 46.34 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.047 -0.678 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 t -77.58 177.61 7.93 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.089 0.956 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -83.43 -164.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.421 1.888 . . . . 0.0 112.235 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.24 -2.15 0.91 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.287 1.835 . . . . 0.0 113.294 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -62.11 -13.63 28.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.531 -1.356 . . . . 0.0 111.904 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.03 -38.91 80.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.04 -1.457 . . . . 0.0 113.224 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.59 -52.06 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 120.571 1.532 . . . . 0.0 110.6 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.7 ttp -67.88 -47.03 69.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.163 -0.335 . . . . 0.0 111.326 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.71 63.64 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.478 0.711 . . . . 0.0 111.681 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.2 -39.89 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.0 m -61.7 -43.88 98.0 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.218 1.372 . . . . 0.0 109.329 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -56.31 -51.36 68.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.361 0.982 . . . . 0.0 109.091 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.47 69.76 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.89 0.744 . . . . 0.0 111.259 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.8 -30.51 70.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.221 1.408 . . . . 0.0 112.442 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -79.53 -4.28 50.67 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.86 -1.15 . . . . 0.0 112.02 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -36.99 85.79 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.33 1.423 . . . . 0.0 111.455 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.9 148.15 84.01 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.115 0.87 . . . . 0.0 109.4 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.02 -48.57 3.54 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.099 1.866 . . . . 0.0 112.916 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.55 69.92 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.4 -10.48 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.884 0.874 . . . . 0.0 111.938 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.14 163.87 28.26 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.837 -1.165 . . . . 0.0 112.327 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -103.62 134.69 46.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.76 144.18 37.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -144.24 143.13 30.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.251 1.02 . . . . 0.0 111.283 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.5 134.23 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 109.59 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.3 t -72.2 143.17 48.96 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 110.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.4 -28.84 62.22 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -81.67 -27.59 33.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.184 2.194 . . . . 0.0 115.621 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -145.87 160.22 42.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.698 0.799 . . . . 0.0 109.248 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.94 33.88 2.38 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.858 0.742 . . . . 0.0 111.871 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -90.73 125.67 35.76 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 125.014 1.326 . . . . 0.0 107.964 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.38 120.1 37.76 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.791 1.236 . . . . 0.0 109.559 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.13 134.77 34.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.29 132.39 66.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -136.13 105.5 6.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.673 1.189 . . . . 0.0 111.275 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.2 -148.08 11.78 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -121.3 7.87 10.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.844 1.258 . . . . 0.0 111.825 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.31 138.47 57.65 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.511 -0.743 . . . . 0.0 109.075 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.28 148.29 93.62 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.596 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.67 -44.56 10.52 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.591 1.527 . . . . 0.0 110.309 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -55.95 -29.65 60.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -48.44 48.58 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.385 0.993 . . . . 0.0 108.953 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.59 -47.75 68.84 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.258 1.023 . . . . 0.0 110.502 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.28 -52.07 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -60.2 -43.31 96.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 116.533 -1.698 . . . . 0.0 110.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.88 -46.56 67.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.59 1.086 . . . . 0.0 111.465 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 m -73.05 -32.4 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.43 -0.794 . . . . 0.0 111.13 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -68.32 -20.34 64.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.596 1.558 . . . . 0.0 112.544 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -63.49 -11.64 25.43 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.6 5.21 11.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.14 64.09 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 116.387 1.315 . . . . 0.0 116.387 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -74.32 175.96 7.15 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.655 1.728 . . . . 0.0 108.225 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -103.45 124.18 48.25 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.29 120.27 36.48 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.233 1.013 . . . . 0.0 110.183 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -135.64 106.93 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.631 0.772 . . . . 0.0 111.033 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.59 156.48 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.612 -0.68 . . . . 0.0 110.185 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.21 90.9 3.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.301 -1.333 . . . . 0.0 109.659 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 13.0 ptp . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.56 166.57 26.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.32 1.848 . . . . 0.0 109.139 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -122.81 115.19 21.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.655 1.582 . . . . 0.0 107.639 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.38 148.7 43.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.316 1.046 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -124.05 138.57 54.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.63 143.49 40.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.243 1.417 . . . . 0.0 107.776 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -151.38 161.55 42.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.31 -36.86 0.1 Allowed Glycine 0 CA--C 1.521 0.409 0 O-C-N 120.959 -1.088 . . . . 0.0 113.191 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.7 mmt -147.57 3.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.832 1.316 . . . . 0.0 114.201 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.0 p 57.43 5.57 0.31 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 m -73.07 147.58 44.85 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.354 -1.466 . . . . 0.0 111.941 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.18 -23.56 67.49 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.875 0.369 . . . . 0.0 111.978 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -81.08 -4.45 55.29 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.966 -1.084 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 p -57.0 -28.27 62.29 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.08 1.309 . . . . 0.0 111.822 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -54.28 -35.72 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.222 1.409 . . . . 0.0 111.093 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.59 -50.06 70.94 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.95 67.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.08 -49.17 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.967 0.803 . . . . 0.0 110.464 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -54.76 -53.94 48.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.413 1.006 . . . . 0.0 110.002 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -65.19 -33.15 75.33 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.796 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.19 -44.92 74.77 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.256 1.389 . . . . 0.0 108.936 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.68 -30.25 71.26 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.92 0.888 . . . . 0.0 109.137 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -70.44 -14.28 62.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -53.7 -46.52 70.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.646 1.566 . . . . 0.0 110.108 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.13 122.82 84.77 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.07 158.1 42.11 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.662 1.575 . . . . 0.0 109.42 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.31 -70.13 0.21 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-O 117.922 -1.488 . . . . 0.0 116.216 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.07 -57.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.181 1.491 . . . . 0.0 112.555 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 54.86 -26.6 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -96.28 104.63 16.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.026 1.731 . . . . 0.0 110.593 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.26 119.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -110.7 116.88 32.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.8 125.47 54.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.521 1.128 . . . . 0.0 110.405 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.7 t -71.9 132.9 45.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.775 0.798 . . . . 0.0 108.903 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.68 -38.61 64.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.381 1.072 . . . . 0.0 110.604 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -78.52 -46.33 19.8 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -107.81 171.37 7.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.09 0.556 . . . . 0.0 110.432 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.19 15.99 56.87 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.925 -0.931 . . . . 0.0 111.753 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.67 135.45 33.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 118.874 1.337 . . . . 0.0 110.189 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.73 114.7 17.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.997 2.119 . . . . 0.0 107.728 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -77.62 145.46 36.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.9 p -129.48 138.19 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -117.55 104.56 11.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.64 -166.51 37.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.698 2.094 . . . . 0.0 108.524 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -117.47 -2.18 11.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.11 1.764 . . . . 0.0 113.727 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.27 131.65 28.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.453 1.024 . . . . 0.0 112.014 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.56 126.74 31.11 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 126.527 1.931 . . . . 0.0 110.589 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.0 -33.49 98.8 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.491 1.46 . . . . 0.0 112.782 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -61.34 -30.34 70.46 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.134 1.334 . . . . 0.0 111.33 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.93 -44.8 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.48 0.712 . . . . 0.0 110.245 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.74 -53.96 38.96 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.37 -43.49 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.05 -42.32 89.68 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.073 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.69 -41.37 66.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -80.82 -33.66 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.971 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -69.39 -20.92 63.81 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.361 1.464 . . . . 0.0 111.898 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.86 -32.25 71.78 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.945 1.298 . . . . 0.0 108.911 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -75.94 -19.12 59.02 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.21 56.61 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.239 1.876 . . . . 0.0 112.313 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.5 155.66 33.6 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -88.27 150.23 23.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.963 -1.086 . . . . 0.0 109.146 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.75 158.12 43.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -145.7 150.38 36.18 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.675 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.4 147.58 22.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.86 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -146.88 170.73 16.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.182 1.793 . . . . 0.0 109.211 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.12 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.54 ' H1 ' ' CD ' ' A' ' 43' ' ' GLU . 18.0 ptt? . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.2 165.53 13.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.36 148.79 49.53 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.08 145.7 44.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -99.41 132.93 44.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.855 1.262 . . . . 0.0 107.678 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.8 t -126.76 102.11 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -119.74 168.39 11.12 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.112 0.869 . . . . 0.0 112.112 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.16 12.65 0.04 OUTLIER Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.134 2.302 . . . . 0.0 112.326 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.4 ttt 65.35 90.74 0.09 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.925 2.09 . . . . 0.0 109.608 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 m 57.11 80.49 0.16 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.145 1.778 . . . . 0.0 112.075 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 69.0 m -55.27 127.63 30.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.718 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -71.25 -175.82 1.31 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.676 1.19 . . . . 0.0 108.694 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -48.7 -23.14 0.93 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.594 1.558 . . . . 0.0 113.357 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 t -53.96 -28.26 36.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.071 1.348 . . . . 0.0 110.217 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.15 -36.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 119.041 0.837 . . . . 0.0 109.966 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.3 ttm -66.86 -43.31 83.94 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.808 -1.182 . . . . 0.0 109.703 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.95 -52.64 64.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.668 0.787 . . . . 0.0 110.037 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.33 -41.79 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -60.89 -48.7 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.915 -1.116 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -64.22 -37.52 87.75 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 121.731 -0.606 . . . . 0.0 111.68 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.11 -47.53 67.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.346 1.058 . . . . 0.0 109.597 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.5 mt -57.48 -37.65 73.25 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.568 0.747 . . . . 0.0 109.181 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -68.91 -13.07 62.2 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.16 -0.963 . . . . 0.0 112.913 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -73.48 -21.08 60.52 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.538 1.517 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.8 m -52.31 142.06 30.27 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.65 94.04 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.173 3.249 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.16 -74.02 0.37 Allowed Glycine 0 C--N 1.332 0.353 0 O-C-N 121.411 -0.805 . . . . 0.0 112.646 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.6 t -54.64 -58.9 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 117.253 0.527 . . . . 0.0 111.341 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 43.45 19.89 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -150.84 106.32 3.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.132 1.773 . . . . 0.0 109.335 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.0 138.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -141.35 118.36 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -110.79 142.93 21.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 t -90.67 146.34 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.81 -49.35 30.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.14 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -81.62 -57.94 3.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.799 0.439 . . . . 0.0 112.103 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.85 152.32 41.57 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.12 53.28 1.87 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -123.57 133.84 53.91 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.647 1.224 . . . . 0.0 110.863 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.97 115.04 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.256 2.622 . . . . 0.0 108.764 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.35 135.17 34.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.38 133.99 57.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.54 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 16.0 tp10 -123.33 103.64 8.63 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.07 -170.22 41.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.661 1.124 . . . . 0.0 111.995 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -111.85 14.86 21.01 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.728 2.811 . . . . 0.0 115.585 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 142.06 57.63 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.302 -1.499 . . . . 0.0 109.496 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.01 151.1 81.5 Favored Pre-proline 0 C--O 1.237 0.429 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.301 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -55.32 -47.3 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.607 2.205 . . . . 0.0 111.519 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -55.1 -38.76 68.55 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.55 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.67 80.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.829 0.74 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.5 mt -68.21 -47.7 67.18 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.941 -0.474 . . . . 0.0 110.352 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.5 t -55.66 -56.37 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 124.413 1.085 . . . . 0.0 108.722 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -57.34 -50.22 73.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.589 -1.196 . . . . 0.0 110.036 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.11 64.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.303 0.956 . . . . 0.0 111.697 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -76.38 -43.18 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.7 -23.28 64.74 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.079 1.752 . . . . 0.0 110.914 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -62.46 -23.51 66.93 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.089 1.356 . . . . 0.0 110.532 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.29 39.5 mt-10 -104.36 16.43 26.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.836 0.854 . . . . 0.0 111.436 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.96 1.77 49.4 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 127.216 2.341 . . . . 0.0 116.129 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -74.92 151.24 38.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.137 1.469 . . . . 0.0 109.388 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -75.05 105.07 5.89 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.11 39.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.514 1.125 . . . . 0.0 109.125 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -141.58 114.05 8.27 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.82 167.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 pp -119.38 -173.09 2.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 108.597 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.685 1.594 . . . . 0.0 107.402 179.361 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtm . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.14 166.06 22.64 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.336 1.454 . . . . 0.0 107.202 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -124.72 107.73 11.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.503 0.721 . . . . 0.0 111.063 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.01 137.65 36.06 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.383 -1.448 . . . . 0.0 108.028 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -109.17 137.72 46.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.7 143.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.554 1.07 . . . . 0.0 109.792 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -147.52 156.98 43.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.605 0.717 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.01 -28.17 2.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.3 -1.278 . . . . 0.0 111.298 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 35.4 tpp -147.99 152.98 38.39 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.023 1.411 . . . . 0.0 110.339 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -141.46 78.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.9 m -150.42 150.39 31.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.967 2.107 . . . . 0.0 108.122 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -53.37 -31.84 46.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.661 1.985 . . . . 0.0 114.481 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -63.85 -22.31 66.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.328 -0.857 . . . . 0.0 112.356 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.2 t -52.83 -52.55 56.62 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.405 1.082 . . . . 0.0 108.242 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.1 t -52.56 -51.18 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.571 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -57.12 -49.96 74.28 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.79 0.836 . . . . 0.0 110.937 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.49 -38.54 90.05 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.199 0.999 . . . . 0.0 111.963 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.68 -54.75 30.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 108.987 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -65.61 -32.41 73.97 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.811 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -62.43 -42.59 99.56 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.565 -1.334 . . . . 0.0 111.106 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.52 -48.55 26.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.305 0.957 . . . . 0.0 111.97 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.43 -41.56 89.88 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.107 0.963 . . . . 0.0 113.33 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -49.8 -28.47 6.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -57.57 -27.1 62.38 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.48 1.036 . . . . 0.0 111.031 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.03 104.45 14.96 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 125.579 1.552 . . . . 0.0 108.527 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 168.84 23.77 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.452 1.435 . . . . 0.0 109.305 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.8 16.27 61.82 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 122.31 -0.244 . . . . 0.0 113.417 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.45 -58.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 39.45 2.84 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 131.37 3.868 . . . . 0.0 119.21 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -143.69 102.94 4.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.175 1.39 . . . . 0.0 107.59 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.32 142.41 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.98 116.96 11.64 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 t -90.72 143.16 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -89.52 132.99 34.79 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.84 -48.78 34.83 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.05 -0.5 . . . . 0.0 112.197 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -83.03 -12.68 56.99 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.024 1.33 . . . . 0.0 114.052 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HE3' ' OE1' ' A' ' 39' ' ' GLU . 21.2 mtpp -126.64 151.69 47.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.598 -0.689 . . . . 0.0 111.601 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.61 78.15 2.0 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.43 ' OE1' ' HE3' ' A' ' 37' ' ' LYS . 8.6 pt-20 -165.9 158.39 14.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.353 0.661 . . . . 0.0 110.588 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.78 125.87 12.9 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.027 0.931 . . . . 0.0 109.554 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.7 mt -74.55 142.67 44.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.68 131.23 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 110.83 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -123.02 151.22 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.17 -157.47 15.01 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.83 29.62 7.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.905 1.282 . . . . 0.0 114.315 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.79 123.9 26.4 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.46 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.15 152.89 83.25 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.783 1.633 . . . . 0.0 112.127 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.56 -57.37 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.518 2.812 . . . . 0.0 113.565 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -56.65 -40.88 76.23 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 117.934 0.334 . . . . 0.0 110.549 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.5 88.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -54.69 35.25 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.233 0.613 . . . . 0.0 111.271 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.4 m -59.98 -35.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.037 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -71.42 -37.83 71.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.37 -0.831 . . . . 0.0 110.409 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.12 97.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.198 0.908 . . . . 0.0 109.281 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.32 -32.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.788 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.95 -23.39 45.14 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.56 1.144 . . . . 0.0 112.388 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.61 -29.06 69.8 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.953 0.797 . . . . 0.0 110.158 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -86.81 -13.71 44.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.471 1.508 . . . . 0.0 111.323 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.16 66.45 1.61 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.176 1.369 . . . . 0.0 115.365 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -139.83 170.14 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 108.479 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -106.54 105.09 14.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.635 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.1 149.62 35.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 119.09 0.859 . . . . 0.0 110.161 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -149.31 165.98 30.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.551 1.94 . . . . 0.0 108.502 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.1 154.56 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 121.348 -0.845 . . . . 0.0 111.212 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.7 tp -76.0 106.82 7.8 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.201 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.157 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.1 mt -116.69 151.15 36.95 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.633 1.173 . . . . 0.0 108.199 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -122.24 142.19 50.71 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.225 1.01 . . . . 0.0 110.797 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.99 121.68 18.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.635 1.974 . . . . 0.0 110.278 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -87.95 137.9 31.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -126.94 91.01 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.614 1.566 . . . . 0.0 107.516 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.76 146.92 35.58 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.27 -165.16 25.21 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ttt -95.92 -85.15 0.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.225 0.61 . . . . 0.0 109.446 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 m -68.78 150.08 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.785 -0.572 . . . . 0.0 110.015 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.9 t -129.32 5.41 5.24 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.455 1.502 . . . . 0.0 111.094 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -86.49 -100.69 0.07 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.581 -1.324 . . . . 0.0 109.148 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -64.01 -11.19 26.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.92 -1.113 . . . . 0.0 112.908 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -28.56 69.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.809 1.244 . . . . 0.0 110.827 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -54.59 -35.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.088 0.858 . . . . 0.0 110.692 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.76 -45.65 77.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.701 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -52.43 65.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.22 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -58.91 -47.69 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.507 1.049 . . . . 0.0 110.866 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.5 p -63.43 -40.96 98.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -75.37 -40.89 57.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.608 0.763 . . . . 0.0 111.922 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.22 84.69 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.754 0.822 . . . . 0.0 110.191 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.0 mt -56.55 -28.24 59.59 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.9 0.48 . . . . 0.0 110.248 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -59.47 -11.9 5.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.047 0.939 . . . . 0.0 112.986 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -55.12 -16.36 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.289 1.404 . . . . 0.0 112.398 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.86 92.27 20.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.69 -4.34 15.09 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.016 2.477 . . . . 0.0 114.771 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.79 2.48 54.48 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 116.841 1.497 . . . . 0.0 116.841 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.9 p -113.9 -48.02 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 119.579 1.689 . . . . 0.0 112.164 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 59.43 -2.97 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.44 103.35 8.88 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.465 1.484 . . . . 0.0 107.198 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 m -141.27 138.29 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.279 1.032 . . . . 0.0 109.666 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.79 143.12 40.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.171 1.788 . . . . 0.0 108.284 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.6 t -136.88 143.24 35.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.101 1.76 . . . . 0.0 107.46 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.1 t -76.81 138.52 39.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.31 -36.04 66.18 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -81.59 -57.94 3.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.343 1.057 . . . . 0.0 112.198 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.54 177.29 6.4 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.963 1.305 . . . . 0.0 112.49 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.58 17.27 56.86 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -90.52 143.38 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.195 1.497 . . . . 0.0 108.302 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.43 163.13 33.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.942 1.297 . . . . 0.0 110.588 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.24 144.42 30.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.897 1.279 . . . . 0.0 110.211 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.9 t -130.42 143.25 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.551 1.94 . . . . 0.0 108.12 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -130.1 105.31 7.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.216 1.006 . . . . 0.0 109.951 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.09 -161.09 34.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.574 1.559 . . . . 0.0 110.225 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 p -96.15 0.54 51.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.735 1.268 . . . . 0.0 114.362 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.71 131.86 30.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.658 1.117 . . . . 0.0 111.019 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.36 142.44 98.35 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.35 -48.55 21.41 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.224 1.949 . . . . 0.0 112.348 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -62.02 -23.17 66.28 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.761 -1.114 . . . . 0.0 112.936 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.61 85.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.802 1.183 . . . . 0.0 108.348 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.65 -48.63 59.15 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.809 0.693 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.0 t -54.19 -59.41 2.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.969 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.1 -38.59 83.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.868 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.52 -44.69 69.36 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 117.156 -1.402 . . . . 0.0 110.22 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.25 -32.32 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.857 1.208 . . . . 0.0 112.041 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.79 -44.76 82.23 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.843 1.257 . . . . 0.0 108.844 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.37 -26.42 66.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.53 1.132 . . . . 0.0 111.422 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -69.99 -36.86 75.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.478 1.035 . . . . 0.0 108.65 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.37 30.59 1.16 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.567 1.556 . . . . 0.0 112.338 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -120.14 172.21 7.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.305 1.552 . . . . 0.0 109.255 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.93 99.63 6.48 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.331 0.969 . . . . 0.0 113.186 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.24 160.84 15.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.488 1.115 . . . . 0.0 112.161 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -154.46 130.13 9.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.876 1.27 . . . . 0.0 107.991 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.52 156.55 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.34 166.81 17.13 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.87 2.068 . . . . 0.0 106.901 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 125.065 1.346 . . . . 0.0 109.394 -179.383 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttm . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.03 166.46 10.82 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -130.41 146.53 51.99 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.884 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.3 tp -136.77 110.92 8.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -81.74 119.94 24.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.99 138.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -136.78 174.02 11.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 -102.2 0.96 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 34.1 tpp -113.48 114.56 26.71 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.571 1.186 . . . . 0.0 112.364 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.47 105.01 17.0 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.9 t -138.87 157.16 46.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 110.044 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.74 -28.95 67.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 110.618 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.88 -26.33 21.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.5 0.72 . . . . 0.0 111.071 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.5 m -61.49 -43.07 99.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.811 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.0 -33.39 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.773 1.17 . . . . 0.0 111.037 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.64 -45.44 75.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.27 65.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.364 0.665 . . . . 0.0 109.985 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -57.26 -49.54 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 124.634 1.174 . . . . 0.0 109.851 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -58.03 -53.56 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.159 0.891 . . . . 0.0 110.386 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -59.44 -47.32 85.94 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.461 -0.774 . . . . 0.0 112.152 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.46 92.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.99 0.916 . . . . 0.0 111.95 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.66 -36.15 83.34 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.702 -1.249 . . . . 0.0 109.861 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.3 -19.07 64.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.953 0.901 . . . . 0.0 113.103 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -56.84 -36.18 69.7 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.113 1.524 . . . . 0.0 115.113 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.95 121.3 81.97 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 112.552 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.4 121.56 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.88 -14.96 2.4 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.273 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.38 -57.27 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 118.966 1.383 . . . . 0.0 108.809 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 63.36 -30.8 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.177 2.191 . . . . 0.0 115.25 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 122.94 35.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.8 2.091 . . . . 0.0 112.432 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.8 m -141.25 144.43 26.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.16 1.384 . . . . 0.0 107.454 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -124.0 118.67 27.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.52 115.94 49.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.134 0.974 . . . . 0.0 108.404 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -93.02 118.11 30.81 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.61 -45.11 91.8 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.214 0.461 . . . . 0.0 111.205 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -55.46 -58.09 9.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 111.496 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -70.85 -49.94 40.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.234 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 2.56 52.28 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.68 1.61 . . . . 0.0 109.64 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.47 151.67 20.68 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.303 1.441 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.81 114.23 17.65 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.173 1.389 . . . . 0.0 109.776 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.62 113.47 20.34 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.0 m -109.99 132.29 58.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 118.266 0.485 . . . . 0.0 110.65 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.26 105.56 14.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.84 158.52 11.36 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.42 -12.11 54.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.619 1.568 . . . . 0.0 112.773 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.55 155.24 2.25 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.57 136.4 85.96 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 125.432 1.493 . . . . 0.0 111.387 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.15 -25.3 37.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.441 2.094 . . . . 0.0 112.632 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -35.04 65.45 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.088 0.858 . . . . 0.0 110.725 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.47 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.96 -45.64 63.75 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.13 -47.36 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -62.2 -49.12 77.05 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.446 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.56 63.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.759 1.163 . . . . 0.0 113.164 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.4 t -81.49 -38.3 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.57 -36.0 82.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.26 -14.81 8.02 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.945 2.098 . . . . 0.0 112.36 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -115.67 -1.37 12.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.853 1.261 . . . . 0.0 111.275 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.97 42.22 9.0 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.382 0.992 . . . . 0.0 113.99 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -132.16 160.98 34.49 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.409 1.105 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -90.95 145.54 24.64 Favored 'General case' 0 CA--C 1.522 -0.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.1 143.43 47.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.866 1.266 . . . . 0.0 109.617 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -140.3 121.61 14.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 108.642 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -89.57 130.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.775 1.63 . . . . 0.0 109.993 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -133.92 126.42 30.34 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.83 1.652 . . . . 0.0 107.457 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.873 1.669 . . . . 0.0 110.092 178.867 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mmt . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.872 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.92 165.17 17.87 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.299 1.863 . . . . 0.0 110.974 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -142.55 147.66 36.29 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.49 1.916 . . . . 0.0 107.64 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.02 148.92 45.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.804 2.442 . . . . 0.0 108.547 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -97.03 138.55 34.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -122.11 128.39 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.229 2.212 . . . . 0.0 107.365 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -132.67 142.68 49.2 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.58 -179.9 24.88 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.371 1.462 . . . . 0.0 109.77 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.02 -46.33 88.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -173.14 -177.79 1.63 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.33 1.852 . . . . 0.0 107.421 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -72.97 139.19 46.54 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -152.53 170.23 20.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.898 1.279 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -57.37 -25.41 59.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.102 0.961 . . . . 0.0 109.464 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -27.57 17.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.321 2.249 . . . . 0.0 112.388 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.9 t -52.24 -46.03 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 120.353 1.433 . . . . 0.0 109.063 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -66.14 -43.4 87.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.272 -0.893 . . . . 0.0 108.648 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.43 67.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.735 0.814 . . . . 0.0 110.721 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.68 -35.4 75.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.4 m -57.53 -54.57 45.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.651 1.569 . . . . 0.0 109.439 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -64.13 -32.18 73.65 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -41.53 79.82 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.387 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.5 mt -57.11 -46.23 82.79 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -61.34 -4.33 1.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -57.99 -36.47 72.67 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 121.692 2.042 . . . . 0.0 114.413 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.07 119.78 29.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.217 1.007 . . . . 0.0 110.984 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.34 -21.99 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 113.46 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.41 4.04 66.55 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 117.696 -1.614 . . . . 0.0 115.381 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.43 -59.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.259 2.029 . . . . 0.0 109.288 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 57.77 0.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.161 2.584 . . . . 0.0 116.071 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.68 104.08 4.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.706 1.594 . . . . 0.0 110.772 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.18 140.06 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.122 0.969 . . . . 0.0 108.81 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -144.08 144.09 31.45 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.795 1.238 . . . . 0.0 108.958 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -124.58 143.81 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.569 1.947 . . . . 0.0 108.379 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -103.88 118.03 35.74 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.46 -30.09 69.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.033 1.288 . . . . 0.0 111.558 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.429 1.492 . . . . 0.0 110.313 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -83.24 -23.3 32.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 9.13 87.34 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 118.878 0.763 . . . . 0.0 112.113 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.6 160.79 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.187 1.994 . . . . 0.0 109.207 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.01 115.63 9.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.278 1.031 . . . . 0.0 109.762 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -91.07 140.13 30.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.465 1.106 . . . . 0.0 108.3 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.78 141.95 42.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 108.431 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -130.38 104.2 7.12 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.14 -176.97 40.76 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.855 1.693 . . . . 0.0 109.546 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 p -98.4 10.51 40.63 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.3 142.8 42.06 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.827 1.649 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.84 152.51 91.14 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.016 0.926 . . . . 0.0 109.972 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.84 -47.95 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.036 1.824 . . . . 0.0 110.421 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -38.78 72.83 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.485 0.314 . . . . 0.0 111.418 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.58 -53.87 44.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.962 0.905 . . . . 0.0 109.887 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.35 -52.89 62.9 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.531 0.732 . . . . 0.0 111.431 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.33 -57.84 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.833 0.853 . . . . 0.0 110.567 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -64.4 -35.88 82.35 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.005 0.82 . . . . 0.0 110.59 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.56 78.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.699 1.136 . . . . 0.0 110.337 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -77.97 -35.2 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.269 0.94 . . . . 0.0 109.535 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -61.61 -27.29 68.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.629 0.771 . . . . 0.0 110.955 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.99 -11.79 32.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.305 1.442 . . . . 0.0 111.562 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -109.49 -2.61 17.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.831 1.653 . . . . 0.0 111.125 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.55 -8.1 77.17 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.621 1.581 . . . . 0.0 113.768 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -78.98 157.91 28.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.756 1.278 . . . . 0.0 108.311 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -109.88 99.92 8.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.45 150.9 22.91 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.021 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -154.75 124.83 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 m -60.24 155.0 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.97 . . . . 0.0 109.928 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -56.9 132.15 51.73 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.884 1.273 . . . . 0.0 108.456 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.608 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.36 165.95 12.4 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.459 1.504 . . . . 0.0 107.799 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -150.4 104.05 3.2 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.413 -0.804 . . . . 0.0 108.848 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tp -79.17 147.9 32.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.817 0.847 . . . . 0.0 108.776 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -128.36 106.97 9.37 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.183 0.993 . . . . 0.0 109.497 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 t -74.95 153.07 6.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 126.13 1.772 . . . . 0.0 110.025 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -152.53 162.1 41.67 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 122.215 1.007 . . . . 0.0 111.855 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.27 -68.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 126.984 2.23 . . . . 0.0 113.416 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 mmt -84.37 162.78 19.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.899 0.85 . . . . 0.0 112.556 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -140.16 36.26 1.91 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.286 2.634 . . . . 0.0 106.772 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.97 179.46 2.72 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 119.949 -1.719 . . . . 0.0 109.504 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.94 -61.15 1.75 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.361 0.665 . . . . 0.0 110.008 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -56.72 -16.64 6.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.937 1.295 . . . . 0.0 114.05 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 p -59.58 -28.56 67.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.04 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.37 -46.49 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.529 1.513 . . . . 0.0 110.758 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.5 mtt -64.29 -49.81 70.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.334 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.42 -52.25 66.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.808 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.58 -52.02 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.305 1.442 . . . . 0.0 111.229 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 t -54.67 -43.97 72.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.184 1.357 . . . . 0.0 108.778 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -64.18 -50.69 67.13 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.626 -0.671 . . . . 0.0 111.342 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.43 79.3 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.507 1.523 . . . . 0.0 112.117 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.15 -38.06 81.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.037 0.935 . . . . 0.0 110.425 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.28 -10.55 59.7 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -46.73 -57.33 4.95 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.52 118.65 56.03 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.562 1.528 . . . . 0.0 111.734 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.55 88.79 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.706 2.271 . . . . 0.0 108.522 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.69 -33.69 0.02 OUTLIER Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.452 -0.78 . . . . 0.0 111.419 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.29 -50.2 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 117.474 0.637 . . . . 0.0 109.504 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 67.58 -46.61 0.5 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.312 2.245 . . . . 0.0 112.64 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -101.45 109.85 21.75 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.523 1.51 . . . . 0.0 112.698 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.62 130.43 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -130.73 137.55 49.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.093 1.357 . . . . 0.0 107.465 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.75 138.04 44.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 110.017 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.7 t -113.12 118.55 35.05 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.63 -24.33 66.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.406 0.682 . . . . 0.0 111.853 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.75 -13.75 61.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.746 1.618 . . . . 0.0 111.684 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -135.54 -15.74 1.85 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.79 18.46 72.35 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -100.19 145.5 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.49 114.56 9.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.9 0.48 . . . . 0.0 111.572 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.9 mp -77.55 144.42 37.61 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.965 1.706 . . . . 0.0 107.715 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.33 121.64 23.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.788 0.835 . . . . 0.0 109.298 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.05 104.99 9.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.46 177.51 21.14 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.697 1.618 . . . . 0.0 109.847 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -70.97 26.19 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.541 1.536 . . . . 0.0 113.991 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 106.11 1.19 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 142.07 98.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 123.323 0.649 . . . . 0.0 112.11 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.21 -48.14 12.75 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.457 2.105 . . . . 0.0 112.224 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -56.21 -37.26 69.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.468 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.64 63.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.309 0.644 . . . . 0.0 109.749 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -61.96 -50.07 73.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.289 1.035 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.59 -49.72 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -65.65 -42.01 91.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.836 0.744 . . . . 0.0 111.478 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.06 -31.23 70.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.656 1.182 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.8 t -88.35 -41.75 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 118.656 0.662 . . . . 0.0 109.931 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.59 -42.35 82.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.839 0.856 . . . . 0.0 110.96 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.78 -12.74 50.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.785 -0.626 . . . . 0.0 112.03 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -97.83 -10.11 25.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 120.015 1.279 . . . . 0.0 113.338 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.23 9.27 60.68 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.238 -1.312 . . . . 0.0 114.576 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.69 145.64 30.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -88.2 152.14 22.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -149.21 147.37 28.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.561 0.618 . . . . 0.0 109.647 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -134.67 153.48 51.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.242 1.017 . . . . 0.0 108.263 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.18 173.97 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.99 85.5 3.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.6 mt -119.91 160.74 22.11 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.34 139.94 53.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.629 0.772 . . . . 0.0 110.109 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -122.29 111.54 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -88.95 127.15 35.65 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.22 141.54 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -141.45 98.57 3.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.33 -162.6 28.38 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.576 2.036 . . . . 0.0 109.761 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.2 ttt -124.47 8.08 8.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.175 1.79 . . . . 0.0 108.04 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.15 174.28 9.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 128.116 2.566 . . . . 0.0 107.465 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -140.0 -77.25 0.32 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -55.13 -28.6 53.87 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -93.1 -34.87 13.49 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 109.55 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -54.79 -54.3 43.89 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.929 1.292 . . . . 0.0 110.429 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -52.01 -38.29 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.128 0.971 . . . . 0.0 112.393 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.4 mmm -62.38 -49.8 74.08 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 110.088 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.82 -38.72 83.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.216 0.606 . . . . 0.0 110.185 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.23 -44.85 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.8 m -64.71 -40.02 94.64 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.904 1.229 . . . . 0.0 109.088 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -55.66 -49.76 72.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.109 0.964 . . . . 0.0 109.614 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.48 59.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.114 1.366 . . . . 0.0 110.246 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.6 mt -58.81 -28.11 65.7 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 124.355 1.062 . . . . 0.0 112.47 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -68.86 -21.01 64.29 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.098 -1.001 . . . . 0.0 111.63 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.21 -15.46 63.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.8 m -51.94 160.93 1.02 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.319 1.848 . . . . 0.0 113.313 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.65 -71.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.872 2.381 . . . . 0.0 111.757 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -156.75 51.95 0.42 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.709 0.671 . . . . 0.0 112.157 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.31 -36.48 74.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 118.01 0.905 . . . . 0.0 111.183 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.286 4.1 pt-20 58.38 -11.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.278 2.631 . . . . 0.0 116.362 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -135.18 104.07 5.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.076 2.15 . . . . 0.0 107.762 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -141.91 120.24 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -124.4 142.78 51.03 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.777 1.631 . . . . 0.0 108.956 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 t -137.01 143.21 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.079 0.552 . . . . 0.0 109.802 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -81.56 126.2 31.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.47 -48.57 48.36 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.052 0.941 . . . . 0.0 111.508 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.11 -13.59 59.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -118.75 -164.84 1.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.613 1.565 . . . . 0.0 108.463 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.87 66.54 0.57 Allowed Glycine 0 CA--C 1.52 0.344 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -145.7 137.05 24.94 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.738 -1.448 . . . . 0.0 108.163 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.35 145.2 50.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.512 1.525 . . . . 0.0 109.406 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.16 138.98 54.28 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.65 139.75 42.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.701 0.801 . . . . 0.0 110.105 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -128.58 104.09 7.47 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.57 -169.13 27.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.0 p -59.56 6.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 130.976 3.711 . . . . 0.0 117.56 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.44 104.84 6.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.403 1.456 . . . . 0.0 110.376 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -66.1 132.91 94.62 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 123.862 0.865 . . . . 0.0 110.35 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.69 -38.55 91.29 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.464 2.109 . . . . 0.0 114.806 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.06 -38.27 85.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.867 2.122 . . . . 0.0 110.149 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.4 83.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -67.38 -50.55 59.25 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.836 1.255 . . . . 0.0 109.375 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -52.84 -54.04 18.28 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 124.976 1.31 . . . . 0.0 108.156 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.67 -50.57 69.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.451 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.34 66.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.486 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.25 -32.88 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.216 0.916 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.76 -20.27 65.62 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.613 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.52 -28.2 69.14 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.484 1.493 . . . . 0.0 110.615 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -90.41 -7.86 52.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.064 1.346 . . . . 0.0 110.211 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.51 10.41 70.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.191 1.853 . . . . 0.0 115.399 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.89 156.35 37.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.394 2.097 . . . . 0.0 109.222 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -80.57 119.49 23.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.83 143.33 31.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.569 0.748 . . . . 0.0 109.159 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -147.02 149.82 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -106.13 148.47 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 123.766 0.826 . . . . 0.0 111.532 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.3 mt -148.2 150.45 33.78 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.32 1.448 . . . . 0.0 107.5 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.275 1.03 . . . . 0.0 110.452 179.695 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtt . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.6 mt -128.39 153.43 47.08 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -131.15 109.81 10.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.746 0.818 . . . . 0.0 109.408 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -101.51 111.46 23.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -90.05 138.5 31.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.88 152.48 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.104 0.866 . . . . 0.0 110.044 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -142.73 100.11 3.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.736 2.414 . . . . 0.0 108.258 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.41 -75.58 0.1 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -142.88 150.32 39.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.151 1.78 . . . . 0.0 107.473 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -143.74 -64.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.505 1.122 . . . . 0.0 108.264 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.5 m -75.48 64.36 1.59 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.898 1.279 . . . . 0.0 109.249 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -153.12 172.57 16.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.462 2.305 . . . . 0.0 106.477 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -66.14 -4.71 8.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.094 -1.004 . . . . 0.0 112.815 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -53.05 -26.71 16.75 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.373 1.469 . . . . 0.0 111.743 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.9 t -50.23 -49.3 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.924 1.29 . . . . 0.0 109.746 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -63.12 -31.1 72.17 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.94 -42.1 34.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.167 0.987 . . . . 0.0 109.752 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.54 -50.97 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.1 p -61.1 -50.65 72.38 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.09 -0.481 . . . . 0.0 109.835 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -53.83 -54.56 36.71 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.822 0.737 . . . . 0.0 111.881 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.03 -50.76 70.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.908 0.883 . . . . 0.0 111.082 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 mp -68.38 -29.33 68.01 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.169 -0.957 . . . . 0.0 112.84 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -86.95 -9.27 56.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.771 1.628 . . . . 0.0 113.258 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -56.22 -25.5 47.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.559 1.143 . . . . 0.0 113.511 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.65 141.77 29.5 Favored Pre-proline 0 N--CA 1.447 -0.576 0 C-N-CA 125.207 1.403 . . . . 0.0 107.318 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.09 177.2 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.719 2.28 . . . . 0.0 111.245 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.39 -61.51 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -75.55 -59.28 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 52.3 -17.37 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.588 2.355 . . . . 0.0 116.498 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.94 115.99 30.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 121.546 1.976 . . . . 0.0 110.514 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -147.98 119.15 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.143 1.777 . . . . 0.0 106.432 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -125.19 120.86 32.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 t -87.76 142.74 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.6 t -125.98 117.39 23.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.44 -48.51 49.07 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.451 1.5 . . . . 0.0 113.81 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -58.64 -19.04 35.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.777 1.231 . . . . 0.0 113.102 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 7.98 9.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.963 1.305 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 43.29 56.74 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 126.75 2.119 . . . . 0.0 110.427 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.62 179.94 7.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.9 115.23 10.4 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.776 2.43 . . . . 0.0 108.625 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.7 mt -81.95 123.95 29.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.48 146.22 26.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 118.765 0.711 . . . . 0.0 109.551 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -133.29 107.92 8.42 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.92 174.07 38.52 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 127.547 2.499 . . . . 0.0 108.484 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -88.33 3.6 49.15 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.263 1.425 . . . . 0.0 113.054 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 155.76 1.03 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 117.503 2.408 . . . . 0.0 117.503 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.69 137.09 62.88 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.137 2.175 . . . . 0.0 110.317 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.39 -42.94 30.8 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.197 1.932 . . . . 0.0 109.927 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.68 -45.18 95.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.143 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.52 -43.89 93.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 110.263 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -61.58 -54.49 42.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.688 0.795 . . . . 0.0 109.254 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.17 -46.85 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.427 1.091 . . . . 0.0 109.848 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -67.68 -39.01 84.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.171 -1.395 . . . . 0.0 111.33 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.89 77.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.825 1.193 . . . . 0.0 110.268 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.81 -38.03 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.324 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.1 -40.3 86.89 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.165 -0.959 . . . . 0.0 111.944 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.11 -19.71 65.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.507 0.594 . . . . 0.0 111.28 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -88.97 -30.51 18.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.9 -1.048 . . . . 0.0 111.179 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 4.66 0.41 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 119.05 2.38 . . . . 0.0 119.05 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.17 138.98 26.92 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.593 3.196 . . . . 0.0 108.656 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -75.4 163.96 26.89 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 118.223 0.465 . . . . 0.0 109.909 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.73 161.04 43.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.719 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -151.38 128.96 11.45 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.95 161.74 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.594 -0.691 . . . . 0.0 111.528 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.6 mt -118.51 169.34 9.86 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.684 1.594 . . . . 0.0 108.856 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.492 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.5 mt -134.48 163.08 30.49 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.834 -1.166 . . . . 0.0 109.187 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -120.54 133.1 55.43 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -136.84 148.71 47.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 109.426 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -122.32 138.36 54.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.24 128.57 21.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -139.53 159.27 42.56 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.495 1.118 . . . . 0.0 111.476 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.88 -100.39 0.53 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 124.907 1.242 . . . . 0.0 111.622 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.4 mtp -128.87 -17.0 4.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.091 0.946 . . . . 0.0 113.099 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p -146.69 -178.31 6.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.902 2.081 . . . . 0.0 108.184 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.5 p -123.24 -17.54 6.58 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.008 0.923 . . . . 0.0 110.244 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -68.97 -79.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.983 0.811 . . . . 0.0 110.399 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -79.92 -14.49 58.58 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -52.46 -43.59 65.04 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.293 1.037 . . . . 0.0 110.531 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.61 -38.54 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.289 1.436 . . . . 0.0 110.741 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.62 -45.33 83.5 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.051 0.842 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.11 86.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.207 0.458 . . . . 0.0 109.888 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.22 -54.05 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.383 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -61.47 -38.65 88.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.174 1.352 . . . . 0.0 110.469 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -55.18 -50.55 69.04 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.306 0.642 . . . . 0.0 109.308 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.81 -51.63 38.72 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.52 -27.76 69.48 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -60.91 -9.6 4.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.488 1.04 . . . . 0.0 112.697 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.19 -29.64 58.31 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 114.027 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.95 156.63 91.77 Favored Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 121.446 -0.784 . . . . 0.0 112.248 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.7 -50.69 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.87 1.713 . . . . 0.0 109.77 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.32 34.04 0.02 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 121.207 -0.933 . . . . 0.0 112.231 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.11 -33.53 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 112.757 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.69 165.86 33.97 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -114.65 104.1 11.65 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.94 137.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.03 117.88 13.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.22 143.93 12.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -89.29 153.94 20.49 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.119 0.872 . . . . 0.0 108.925 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.51 -48.13 35.65 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.533 -1.354 . . . . 0.0 109.666 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -66.82 -22.56 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -145.48 145.97 31.29 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.748 1.158 . . . . 0.0 108.736 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.91 10.68 2.95 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.616 2.055 . . . . 0.0 114.414 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.62 163.94 14.37 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.2 162.5 39.34 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 126.256 1.822 . . . . 0.0 109.877 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.07 142.36 49.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.19 117.13 44.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.148 0.975 . . . . 0.0 108.8 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.93 104.95 12.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.903 2.081 . . . . 0.0 105.613 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.7 -176.27 39.03 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -95.18 7.52 45.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.569 1.148 . . . . 0.0 113.227 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.5 156.52 19.28 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.094 -1.003 . . . . 0.0 113.491 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.64 119.25 71.91 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -57.71 -41.03 74.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.901 1.734 . . . . 0.0 110.698 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -38.78 75.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.832 0.853 . . . . 0.0 110.648 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.8 82.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.76 0.709 . . . . 0.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.27 -46.53 73.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.14 -38.83 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.706 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -47.99 83.75 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.397 0.999 . . . . 0.0 109.776 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.21 87.17 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.256 1.022 . . . . 0.0 111.557 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.72 -34.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.128 0.571 . . . . 0.0 110.076 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -64.48 -51.68 61.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -67.81 -16.1 63.95 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.46 -9.13 59.56 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.29 -0.881 . . . . 0.0 108.941 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.35 52.81 3.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -141.08 175.26 9.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.981 1.712 . . . . 0.0 108.26 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -118.42 147.49 43.52 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.15 167.41 22.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -148.24 143.09 26.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -100.07 143.03 14.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -143.14 51.69 1.38 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 109.242 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.264 0 C-N-CA 128.54 2.736 . . . . 0.0 107.078 -178.487 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.85 157.39 16.41 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 120.995 -1.066 . . . . 0.0 108.395 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -115.12 124.21 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.64 148.35 38.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.03 1.332 . . . . 0.0 108.115 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -118.71 138.4 52.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.15 133.72 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -145.04 108.63 4.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.91 -97.54 1.57 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.8 mtt -143.6 -60.29 0.41 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -132.33 120.99 22.83 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -109.99 50.12 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.375 1.87 . . . . 0.0 112.147 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -111.21 -92.04 0.46 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -57.42 -31.23 65.65 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.645 1.111 . . . . 0.0 110.33 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 t -52.91 -37.24 60.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.351 2.26 . . . . 0.0 111.592 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -52.38 -41.99 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 119.181 0.901 . . . . 0.0 110.825 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 ttp -62.97 -47.58 82.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.829 0.286 . . . . 0.0 110.325 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 -52.08 62.55 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.354 1.062 . . . . 0.0 112.788 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.98 -44.65 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.463 -0.78 . . . . 0.0 109.223 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -60.73 -49.83 75.92 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.8 0.727 . . . . 0.0 109.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -51.11 -48.53 61.69 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.558 1.143 . . . . 0.0 110.323 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.06 52.72 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.444 0.465 . . . . 0.0 110.828 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.81 -29.11 62.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 112.563 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.56 -13.27 61.0 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.297 -0.877 . . . . 0.0 112.136 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.41 -56.04 27.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.567 1.076 . . . . 0.0 110.013 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.61 116.05 30.66 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.14 174.19 11.76 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.254 1.969 . . . . 0.0 110.642 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.53 12.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.226 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.409 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 71.3 t -114.76 -59.08 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 118.65 1.225 . . . . 0.0 109.434 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.304 74.4 mt-10 63.68 -44.58 0.25 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.286 2.635 . . . . 0.0 110.634 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -95.77 110.35 22.52 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.229 1.812 . . . . 0.0 110.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.16 144.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.063 1.345 . . . . 0.0 107.507 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.2 143.71 34.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.93 140.54 48.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.769 1.227 . . . . 0.0 108.669 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -115.72 115.29 26.09 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.8 -32.57 65.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -71.95 -9.21 58.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.738 0.815 . . . . 0.0 111.889 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 -14.31 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.28 60.12 Favored Glycine 0 N--CA 1.467 0.716 0 CA-C-N 120.723 1.601 . . . . 0.0 110.215 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.98 170.43 15.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.669 0.735 . . . . 0.0 112.169 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.91 157.71 43.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.372 1.869 . . . . 0.0 109.015 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.43 139.15 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.867 2.067 . . . . 0.0 106.443 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.45 121.6 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 123.287 0.635 . . . . 0.0 110.139 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -106.6 104.84 14.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . 175.24 -157.73 24.71 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.551 1.072 . . . . 0.0 111.208 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.8 p -113.48 16.94 18.7 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.431 2.292 . . . . 0.0 113.946 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.87 151.86 46.04 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.94 149.67 74.04 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.161 2.185 . . . . 0.0 109.564 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.92 -49.69 3.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 110.739 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -56.49 -49.3 75.1 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.036 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.54 -37.96 66.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.645 0.591 . . . . 0.0 111.866 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -73.87 -51.82 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.484 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.66 -36.28 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.096 0.862 . . . . 0.0 110.241 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -73.3 -40.55 64.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.943 0.897 . . . . 0.0 110.314 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.19 80.01 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.692 1.133 . . . . 0.0 108.6 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.266 17.6 m -71.58 -32.26 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.783 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.97 -28.77 62.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 120.054 1.297 . . . . 0.0 109.881 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -61.09 -18.72 59.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.414 1.007 . . . . 0.0 111.944 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.3 -6.5 58.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.516 1.053 . . . . 0.0 111.996 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.48 44.96 7.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 119.383 0.992 . . . . 0.0 113.545 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -141.19 175.72 9.41 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.863 2.465 . . . . 0.0 108.021 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -114.41 149.3 36.42 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.765 1.621 . . . . 0.0 108.738 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.97 155.72 37.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 175.29 10.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.94 -178.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.864 0.84 . . . . 0.0 110.569 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.29 111.1 2.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.74 -1.124 . . . . 0.0 108.157 -179.69 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mtp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.4 mt -140.39 163.39 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -133.86 105.33 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 tp -95.64 147.89 23.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 123.09 49.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.82 140.26 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -139.34 121.8 16.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.358 0.981 . . . . 0.0 110.904 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.4 -112.46 0.51 Allowed Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 29.6 mmm -58.61 -54.79 43.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.156 1.382 . . . . 0.0 113.76 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 p 45.35 50.22 10.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.375 1.47 . . . . 0.0 109.193 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -92.85 168.36 11.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.984 0.897 . . . . 0.0 112.61 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -62.08 -43.1 99.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.157 0.983 . . . . 0.0 113.01 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -89.36 -38.87 13.82 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -52.01 -28.12 15.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.09 -37.75 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 119.605 1.093 . . . . 0.0 110.105 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.7 mmt -59.03 -44.44 91.75 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.374 -0.829 . . . . 0.0 110.343 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.3 68.89 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 108.882 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.26 -48.54 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.992 0.917 . . . . 0.0 109.595 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.4 m -58.79 -50.11 75.17 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.436 -0.79 . . . . 0.0 109.16 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -63.08 -34.66 78.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.304 0.956 . . . . 0.0 111.495 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.19 79.22 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -64.84 -48.05 75.73 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.458 -0.776 . . . . 0.0 110.033 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -63.5 -6.76 5.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 112.523 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -65.38 -20.04 66.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.262 1.392 . . . . 0.0 110.834 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.1 t -71.31 117.11 53.85 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -53.95 -66.1 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 118.387 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.76 -10.46 45.01 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -71.9 -57.37 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.868 2.334 . . . . 0.0 109.671 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 54.1 0.39 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.546 2.338 . . . . 0.0 116.549 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -131.19 106.93 8.65 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.494 1.518 . . . . 0.0 111.163 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.9 144.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.616 1.566 . . . . 0.0 107.224 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -137.35 117.32 13.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 t -114.62 125.64 71.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -75.5 129.87 37.97 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.79 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.91 -43.4 86.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.819 0.848 . . . . 0.0 109.955 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.18 -8.56 59.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.98 161.22 38.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 121.138 1.79 . . . . 0.0 110.904 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.09 46.01 3.49 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -115.02 134.58 55.06 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.113 1.457 . . . . 0.0 107.787 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.07 113.8 12.49 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.1 mt -94.1 143.55 26.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.01 141.09 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.424 0.631 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -114.74 104.42 11.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.43 168.89 23.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -89.32 12.67 15.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.992 1.717 . . . . 0.0 113.315 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.59 135.38 57.33 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.817 0.735 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.02 155.7 77.24 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 113.596 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -60.68 -66.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.941 3.094 . . . . 0.0 112.701 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -27.27 62.34 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.02 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.73 -52.95 63.28 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.442 1.019 . . . . 0.0 108.329 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.03 -47.66 79.36 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 117.716 -1.135 . . . . 0.0 110.465 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.1 t -52.16 -60.55 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 O-C-N 124.315 1.009 . . . . 0.0 109.017 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -40.26 76.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.923 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.64 88.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.991 1.268 . . . . 0.0 113.186 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 m -78.57 -32.8 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 0.0 109.465 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -61.36 -20.28 62.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.491 0.587 . . . . 0.0 110.036 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.65 -23.83 66.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.215 0.916 . . . . 0.0 109.847 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.46 -12.86 53.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.771 1.628 . . . . 0.0 110.727 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.94 -11.7 65.94 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.41 1.957 . . . . 0.0 113.786 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -76.36 144.98 39.78 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.36 1.08 . . . . 0.0 109.217 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -75.95 162.09 28.39 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.95 161.34 38.37 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.557 1.072 . . . . 0.0 111.067 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -147.88 123.66 10.56 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.961 0.904 . . . . 0.0 112.297 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.77 146.4 8.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.438 HD12 ' H ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -68.52 153.07 44.46 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.438 ' H ' HD12 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.431 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptp . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.7 mp -140.46 159.62 41.79 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.072 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -100.9 115.79 31.23 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -104.4 143.3 33.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -125.69 128.95 48.61 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.59 152.49 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 125.892 1.677 . . . . 0.0 106.687 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -143.96 165.27 28.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.468 1.907 . . . . 0.0 108.697 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.26 -105.19 1.72 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.867 1.222 . . . . 0.0 111.755 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 85.6 mtp -84.94 -176.98 6.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.167 1.387 . . . . 0.0 110.295 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 p -153.12 105.52 2.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.441 1.096 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.6 t -163.45 148.76 11.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 121.07 1.759 . . . . 0.0 110.45 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -62.58 -41.95 99.26 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 124.304 1.041 . . . . 0.0 111.482 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -60.92 -14.88 25.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -30.67 71.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.573 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 m -58.41 -25.42 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 121.16 1.8 . . . . 0.0 111.421 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.7 mmm -69.61 -50.22 46.47 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.44 -52.44 53.15 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.791 0.836 . . . . 0.0 110.586 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.66 -55.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.645 1.578 . . . . 0.0 109.918 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 m -72.85 -25.45 61.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.811 1.187 . . . . 0.0 111.679 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -66.98 -55.99 12.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.549 1.522 . . . . 0.0 107.917 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.17 68.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.718 0.636 . . . . 0.0 110.166 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.4 -27.46 47.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 117.337 -1.316 . . . . 0.0 113.724 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -51.2 -21.8 2.25 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.975 1.716 . . . . 0.0 111.329 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 0.4 3.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.622 1.569 . . . . 0.0 113.21 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.91 143.11 23.94 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 120.796 1.635 . . . . 0.0 111.575 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.44 -81.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.349 3.366 . . . . 0.0 113.607 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.97 0.55 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.416 1.008 . . . . 0.0 110.619 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.68 -58.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.388 0.675 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 62.65 -14.95 0.06 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.907 1.683 . . . . 0.0 115.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -127.46 107.98 10.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.513 1.506 . . . . 0.0 111.657 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.12 119.3 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -119.19 143.54 47.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.861 2.064 . . . . 0.0 107.296 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.39 141.55 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.967 1.307 . . . . 0.0 108.081 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -88.03 118.65 27.74 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.78 -39.58 93.83 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.85 -9.1 59.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.549 1.068 . . . . 0.0 112.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -123.48 -168.91 1.85 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.226 1.41 . . . . 0.0 110.216 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.46 70.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 105.514 -3.034 . . . . 0.0 105.514 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -151.07 162.76 40.24 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 117.79 0.795 . . . . 0.0 109.468 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.86 154.73 40.81 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.274 1.03 . . . . 0.0 111.033 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -117.25 119.54 35.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 t -123.72 112.93 35.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 123.561 0.538 . . . . 0.0 110.194 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -104.72 105.78 16.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.743 0.817 . . . . 0.0 111.36 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.3 179.61 45.02 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.2 p -81.6 -12.08 58.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.041 0.936 . . . . 0.0 113.026 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.14 135.22 26.02 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.851 1.26 . . . . 0.0 112.692 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.82 143.17 98.43 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 125.895 1.678 . . . . 0.0 111.808 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.9 -32.24 36.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.827 1.685 . . . . 0.0 110.334 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -63.79 -48.93 74.92 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.689 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.34 67.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 123.846 0.716 . . . . 0.0 110.512 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -57.52 -52.78 64.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.768 0.827 . . . . 0.0 111.692 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.18 -46.85 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -31.71 71.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.97 -51.08 27.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.827 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.261 16.8 m -61.94 -32.9 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.442 1.019 . . . . 0.0 113.227 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.18 -20.05 50.49 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.96 -0.462 . . . . 0.0 111.58 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -73.87 -16.63 61.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.09 -52.07 5.14 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.341 1.428 . . . . 0.0 113.151 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.32 20.33 0.04 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.68 173.91 11.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.293 1.437 . . . . 0.0 108.243 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.4 163.67 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.354 -0.841 . . . . 0.0 108.794 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.79 165.82 34.83 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.629 0.728 . . . . 0.0 111.159 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -147.6 155.25 41.62 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.424 2.29 . . . . 0.0 105.762 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.02 137.8 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 O-C-N 121.224 -0.922 . . . . 0.0 111.28 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 tt -92.17 111.68 23.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.761 2.024 . . . . 0.0 105.743 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 125.579 1.552 . . . . 0.0 110.088 -179.738 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.7 mt -145.13 166.06 26.49 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 66' ' ' ALA . 33.3 mttm -127.94 124.88 38.42 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -109.06 115.68 30.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.681 1.192 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -88.48 124.35 33.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.74 131.67 69.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -138.92 156.82 46.97 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.374 1.07 . . . . 0.0 108.159 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.32 -74.17 0.26 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 108.081 -2.007 . . . . 0.0 108.081 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.2 tpp -149.29 142.66 25.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.04 116.72 22.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.2 m -144.72 117.17 8.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -59.66 -44.24 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.364 0.665 . . . . 0.0 109.837 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.85 -12.06 51.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.58 -33.21 72.38 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.946 1.248 . . . . 0.0 108.807 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.75 -31.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.519 1.127 . . . . 0.0 110.681 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.49 -51.11 60.24 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.73 97.56 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.892 0.877 . . . . 0.0 110.757 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.91 -51.99 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -63.07 -40.36 97.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.716 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -56.84 -55.38 35.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.353 0.979 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.8 85.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 122.522 0.329 . . . . 0.0 111.672 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -45.04 92.65 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -62.25 -8.46 5.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.971 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -60.89 -18.54 56.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.306 1.867 . . . . 0.0 110.749 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.24 127.13 23.19 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.51 126.93 13.34 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.679 2.919 . . . . 0.0 111.418 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.7 -17.1 8.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-O 116.758 -2.134 . . . . 0.0 113.974 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.91 2.53 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 121.176 2.488 . . . . 0.0 115.238 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -66.76 -1.64 4.09 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -95.77 104.22 16.14 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.44 139.19 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.5 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -123.08 116.54 23.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.45 131.84 53.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.91 1.684 . . . . 0.0 109.488 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 m -70.19 130.94 43.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.02 -48.62 34.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.95 0.405 . . . . 0.0 110.217 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.5 -52.25 7.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.611 1.164 . . . . 0.0 110.956 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -82.62 175.63 10.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.25 3.65 35.16 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.403 -1.221 . . . . 0.0 115.757 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -91.11 146.68 23.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.807 2.304 . . . . 0.0 109.151 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.58 138.75 44.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.766 1.627 . . . . 0.0 107.793 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.01 130.17 48.49 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -120.17 112.67 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.634 1.174 . . . . 0.0 108.8 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -90.4 114.91 27.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.93 41.67 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 118.775 0.716 . . . . 0.0 113.217 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 t -125.77 3.72 7.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.956 1.302 . . . . 0.0 112.916 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 156.7 32.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.542 0.687 . . . . 0.0 112.65 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.35 133.55 90.87 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 125.086 1.355 . . . . 0.0 109.104 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.65 -44.17 23.1 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.547 2.165 . . . . 0.0 110.151 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -56.51 -30.45 63.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.971 0.908 . . . . 0.0 112.05 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -39.69 79.21 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.635 0.652 . . . . 0.0 109.549 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.99 -45.12 74.98 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 123.717 0.807 . . . . 0.0 109.077 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -57.83 -58.5 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -60.72 -36.44 78.85 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.357 0.526 . . . . 0.0 112.063 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.28 99.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.952 0.797 . . . . 0.0 110.712 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.5 t -73.86 -33.14 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -60.62 -37.35 81.13 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.395 0.998 . . . . 0.0 110.284 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.65 -19.84 62.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.646 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -87.84 -3.41 58.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 112.225 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.53 37.12 6.25 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.058 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.54 172.96 11.82 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.401 1.101 . . . . 0.0 110.091 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -118.58 109.38 16.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.75 159.23 16.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.1 0.56 . . . . 0.0 111.552 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -158.3 159.26 35.73 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.0 2.52 . . . . 0.0 107.187 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.18 144.81 17.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.457 HD21 ' H ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -147.16 159.8 43.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.7 0.682 . . . . 0.0 110.718 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.457 ' H ' HD21 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.248 0.975 0 C-N-CA 125.861 1.665 . . . . 0.0 108.633 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.09 165.33 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -133.95 141.86 47.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.3 tp -122.65 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.521 1.529 . . . . 0.0 108.978 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -87.15 136.76 32.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.4 133.13 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 125.557 1.543 . . . . 0.0 107.236 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -145.13 163.77 33.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.48 -123.37 5.56 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.245 1.402 . . . . 0.0 113.949 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -68.0 83.03 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 129.658 3.183 . . . . 0.0 111.341 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.98 78.69 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.786 2.434 . . . . 0.0 111.06 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -137.79 161.83 35.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.981 1.712 . . . . 0.0 109.241 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.31 -57.83 4.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.995 1.718 . . . . 0.0 112.805 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -60.47 -19.1 55.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.7 m -63.26 -34.05 76.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.85 1.205 . . . . 0.0 109.667 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.23 -39.12 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.374 1.069 . . . . 0.0 109.734 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 48.6 tpp -62.16 -47.2 85.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.55 -52.32 66.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.124 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.47 -43.52 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.716 1.144 . . . . 0.0 113.092 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.9 t -60.68 -44.49 96.44 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.295 1.861 . . . . 0.0 110.002 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -69.23 -48.3 62.34 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.657 -0.652 . . . . 0.0 111.678 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.15 73.27 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.602 0.761 . . . . 0.0 111.288 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -73.13 -52.13 15.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.708 0.686 . . . . 0.0 110.076 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -69.38 -3.7 15.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -53.56 -40.67 65.78 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.589 0.756 . . . . 0.0 111.039 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.22 136.52 37.89 Favored Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.44 115.06 3.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 106.79 -2.042 . . . . 0.0 106.79 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.88 -92.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.759 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 t -64.75 -57.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 66.22 -31.6 0.16 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.278 2.231 . . . . 0.0 112.444 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -101.2 102.76 13.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.577 1.951 . . . . 0.0 106.374 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.36 127.12 37.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.548 1.139 . . . . 0.0 108.008 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.06 144.84 51.33 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.437 1.495 . . . . 0.0 111.911 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.12 143.04 42.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.729 1.612 . . . . 0.0 107.314 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -77.5 137.28 38.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 109.175 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.34 -48.09 44.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -80.76 -20.97 41.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.77 161.63 32.42 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.075 1.307 . . . . 0.0 109.485 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.21 36.16 3.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -104.26 141.62 35.97 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 120.372 -1.664 . . . . 0.0 107.583 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.22 146.06 51.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 108.562 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.93 144.31 50.73 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.015 1.726 . . . . 0.0 106.703 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.37 141.29 42.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.535 0.734 . . . . 0.0 110.909 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.13 104.19 8.39 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.446 1.117 . . . . 0.0 109.179 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.83 41.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 126.436 1.969 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -117.38 12.72 14.34 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.71 156.27 30.9 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.216 0.916 . . . . 0.0 110.436 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.31 154.93 81.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 113.24 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.7 -51.63 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.14 2.56 . . . . 0.0 109.213 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -55.48 -40.33 71.52 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.128 -1.415 . . . . 0.0 111.074 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.24 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 120.136 1.335 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -70.01 -53.13 19.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.29 0.636 . . . . 0.0 110.666 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.8 t -52.51 -54.96 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.942 0.897 . . . . 0.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.32 -47.42 86.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.121 1.369 . . . . 0.0 110.421 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.75 -45.34 74.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.638 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.86 -32.71 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 119.06 0.845 . . . . 0.0 111.274 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -56.45 -39.16 72.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 112.227 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.83 -34.15 62.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -16.89 61.47 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.398 0.545 . . . . 0.0 112.218 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.29 0.16 47.26 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.544 1.068 . . . . 0.0 110.96 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -78.83 172.27 13.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.377 1.071 . . . . 0.0 109.519 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.35 149.19 39.74 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.57 170.01 23.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.493 1.139 . . . . 0.0 111.694 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -158.04 127.6 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.62 142.12 14.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -125.64 94.8 4.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 177.475 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptt? . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.278 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -91.92 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.716 1.143 . . . . 0.0 110.106 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -127.75 141.08 51.69 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.7 tp -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -86.75 133.98 33.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 100.639 -3.837 . . . . 0.0 100.639 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.43 118.85 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -127.58 145.66 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.94 -176.39 41.47 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.45 -22.8 66.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.905 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -123.18 154.64 38.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.116 1.366 . . . . 0.0 108.152 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 p -133.36 -5.51 2.97 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.664 1.186 . . . . 0.0 113.22 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -115.8 -67.92 0.96 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.406 1.082 . . . . 0.0 111.115 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 -20.54 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.818 -1.176 . . . . 0.0 113.447 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -59.75 -27.67 66.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.771 1.229 . . . . 0.0 112.049 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 m -52.5 -29.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 119.094 0.861 . . . . 0.0 112.865 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 9.9 tpt -67.57 -50.73 57.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.19 74.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.865 0.866 . . . . 0.0 110.374 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -56.27 -55.03 20.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 110.912 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.3 m -68.33 -36.33 79.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.471 1.032 . . . . 0.0 111.222 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HZ3' ' CD ' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -60.98 -47.75 84.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.26 -49.53 75.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.516 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.38 -28.11 64.86 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.831 1.196 . . . . 0.0 112.303 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -58.27 -29.97 66.22 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.488 -0.758 . . . . 0.0 109.58 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -60.9 -16.95 47.79 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 117.258 -1.354 . . . . 0.0 112.83 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.46 92.07 1.7 Allowed Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 119.516 1.053 . . . . 0.0 108.817 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.67 117.16 4.99 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 105.878 -2.393 . . . . 0.0 105.878 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.27 -10.46 5.04 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.002 -1.443 . . . . 0.0 113.117 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.8 t -85.53 -56.93 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 120.166 1.983 . . . . 0.0 106.551 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 63.8 -19.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -130.04 114.49 15.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.829 2.104 . . . . 0.0 110.778 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.6 m -140.09 144.36 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.802 1.241 . . . . 0.0 109.737 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.01 144.75 32.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.957 1.303 . . . . 0.0 109.49 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.46 129.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -76.65 132.52 39.44 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.773 1.229 . . . . 0.0 111.243 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.2 mt -73.56 -48.61 31.57 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.2 1.0 . . . . 0.0 112.749 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.01 -31.61 69.37 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -135.68 161.62 35.03 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.632 1.106 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.59 43.22 1.33 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.236 1.398 . . . . 0.0 112.794 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -104.71 152.51 22.43 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.54 151.85 38.79 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.962 1.305 . . . . 0.0 108.387 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.41 144.6 47.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.091 1.756 . . . . 0.0 107.433 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -138.26 116.19 12.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.89 104.83 13.82 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.13 162.65 12.19 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 t -75.05 31.8 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.234 1.814 . . . . 0.0 112.321 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.71 149.77 8.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.946 1.298 . . . . 0.0 112.447 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.73 131.07 46.48 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.694 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -49.74 -61.81 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.605 2.87 . . . . 0.0 113.634 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -58.02 -23.16 53.05 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.868 -1.063 . . . . 0.0 112.633 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.76 -39.65 66.64 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.382 1.446 . . . . 0.0 109.334 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.09 -48.71 67.37 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.33 -55.86 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.068 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.51 -29.86 71.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.472 -0.775 . . . . 0.0 111.865 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.01 82.8 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.742 1.156 . . . . 0.0 108.726 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.17 -36.89 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.783 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.15 -36.43 72.99 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.234 1.014 . . . . 0.0 113.258 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.53 -15.3 49.92 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.233 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.51 ' CD ' ' HZ3' ' A' ' 20' ' ' LYS . 37.3 mt-10 -107.31 8.71 29.92 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.087 1.312 . . . . 0.0 111.833 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.63 38.39 9.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.46 152.16 43.66 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.99 152.17 19.54 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.6 159.28 42.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.637 0.586 . . . . 0.0 110.867 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -153.59 117.19 4.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.04 168.3 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 124.398 1.079 . . . . 0.0 108.471 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -69.7 -176.05 0.98 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.721 0.808 . . . . 0.0 110.947 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.877 1.671 . . . . 0.0 108.925 -179.613 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.7 165.33 12.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.893 0.854 . . . . 0.0 108.989 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -133.92 123.25 24.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 tp -97.13 111.76 23.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.663 1.185 . . . . 0.0 108.39 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 134.94 33.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.97 164.75 31.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -147.17 139.29 24.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.05 -152.11 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 mmt -63.57 157.68 23.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.027 0.442 . . . . 0.0 110.328 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -57.61 -80.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.714 2.005 . . . . 0.0 113.926 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 p -146.43 132.53 19.32 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.74 1.216 . . . . 0.0 110.148 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -172.15 -173.47 1.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.851 1.261 . . . . 0.0 109.61 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -56.67 -13.91 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.772 2.029 . . . . 0.0 113.111 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.0 m -52.94 -28.89 25.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.341 1.457 . . . . 0.0 110.958 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.34 -42.11 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.21 0.914 . . . . 0.0 109.089 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.3 mmm -63.01 -40.55 98.11 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.399 -0.813 . . . . 0.0 110.625 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.08 -52.88 44.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.495 1.118 . . . . 0.0 110.416 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.18 -40.94 86.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-O 117.696 -1.145 . . . . 0.0 110.278 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.9 m -59.36 -43.57 92.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.808 1.64 . . . . 0.0 108.839 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -64.3 -37.9 89.14 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.907 -1.121 . . . . 0.0 110.757 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -44.97 68.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.508 0.723 . . . . 0.0 110.668 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -32.27 31.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.835 2.454 . . . . 0.0 109.635 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -53.08 -23.26 7.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.081 1.353 . . . . 0.0 112.715 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.29 -12.62 1.69 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.921 1.289 . . . . 0.0 114.472 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.5 m -53.78 152.54 9.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.828 0.74 . . . . 0.0 110.851 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.26 32.27 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.101 3.201 . . . . 0.0 111.514 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.91 91.66 1.61 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 p -112.89 -36.22 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.533 0.733 . . . . 0.0 111.328 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 67.15 -36.91 0.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.67 2.788 . . . . 0.0 113.733 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -104.86 106.61 17.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.1 144.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -143.72 140.76 30.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.52 141.64 45.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -89.08 131.7 35.12 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -72.32 -48.5 41.61 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.275 0.63 . . . . 0.0 110.947 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -82.49 -9.88 59.24 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -135.15 159.6 41.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.696 1.589 . . . . 0.0 111.734 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 59.84 4.74 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.12 138.6 22.88 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 118.566 1.183 . . . . 0.0 110.594 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.55 155.6 48.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.428 1.891 . . . . 0.0 110.268 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.16 142.73 46.65 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 126.553 1.941 . . . . 0.0 107.514 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.32 131.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.87 105.39 8.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.31 -155.39 26.16 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.699 -0.626 . . . . 0.0 111.8 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 t -89.3 -6.53 56.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.997 1.319 . . . . 0.0 114.066 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.66 123.7 10.64 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.447 1.021 . . . . 0.0 112.766 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.69 153.8 95.42 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 125.694 1.598 . . . . 0.0 108.737 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 -46.47 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.297 1.998 . . . . 0.0 109.944 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -58.45 -28.09 64.99 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.118 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.55 -51.19 64.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.21 -40.64 86.45 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.457 0.703 . . . . 0.0 111.18 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.36 -51.79 59.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.04 -30.46 70.99 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.167 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.99 77.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.893 0.77 . . . . 0.0 110.309 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -88.39 -32.57 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.211 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.85 -30.56 71.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.197 0.999 . . . . 0.0 110.882 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.61 -19.55 64.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.296 0.953 . . . . 0.0 108.864 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -97.63 3.5 50.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.581 1.553 . . . . 0.0 109.605 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.85 86.53 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.778 2.132 . . . . 0.0 114.293 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -74.07 166.35 23.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.241 2.021 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -117.72 129.26 55.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 116.403 -1.76 . . . . 0.0 107.752 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.57 160.38 42.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 121.835 2.107 . . . . 0.0 114.355 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.25 163.68 39.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.64 2.376 . . . . 0.0 107.394 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.5 154.76 16.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.781 -1.199 . . . . 0.0 109.228 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -119.42 108.14 14.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 C-N-CA 124.534 1.134 . . . . 0.0 110.952 -178.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.84 165.51 12.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.387 1.475 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 118.0 22.55 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.079 1.752 . . . . 0.0 106.39 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tt -137.4 147.58 45.54 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.275 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -123.81 139.69 53.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.826 1.194 . . . . 0.0 110.42 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.95 138.0 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.576 1.151 . . . . 0.0 110.253 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.25 110.54 3.72 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.359 1.076 . . . . 0.0 111.413 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.0 -48.33 1.25 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 124.665 1.126 . . . . 0.0 113.077 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 7.3 tpt -160.78 159.56 30.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.559 1.18 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -82.51 79.0 9.07 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -149.95 138.17 20.45 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -60.42 -37.86 82.23 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -57.85 -26.98 62.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.996 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -60.01 -36.11 76.53 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.439 1.018 . . . . 0.0 110.745 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.75 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.1 mtt -65.15 -40.82 94.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.881 -0.512 . . . . 0.0 110.982 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.17 -51.28 68.45 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.415 1.086 . . . . 0.0 111.206 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.09 -37.86 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 117.972 -1.013 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 m -60.13 -50.65 72.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.924 1.238 . . . . 0.0 108.122 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -54.14 -43.13 70.27 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.133 0.973 . . . . 0.0 111.13 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.96 59.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.069 0.948 . . . . 0.0 110.088 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 mt -56.67 -34.38 67.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.223 1.409 . . . . 0.0 112.047 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -63.55 -6.08 4.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.725 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -22.61 61.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 120.314 1.416 . . . . 0.0 111.706 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.11 95.75 13.67 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.03 45.27 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.095 3.196 . . . . 0.0 112.618 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.93 17.46 5.18 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.725 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 -57.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 119.402 1.601 . . . . 0.0 107.401 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 70.02 -53.26 0.63 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.089 2.155 . . . . 0.0 113.158 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -95.87 103.32 15.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.454 1.025 . . . . 0.0 109.073 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.78 134.09 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.507 1.123 . . . . 0.0 108.965 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -142.76 142.11 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 t -134.48 143.3 38.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 125.249 1.42 . . . . 0.0 109.391 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.45 145.0 35.29 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.0 -47.33 46.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.084 -1.01 . . . . 0.0 112.289 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -77.42 -24.18 50.45 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -133.23 147.86 51.99 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.891 1.223 . . . . 0.0 108.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.64 25.11 1.44 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.426 -1.208 . . . . 0.0 113.763 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -90.28 143.55 26.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.433 2.116 . . . . 0.0 108.237 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.05 162.69 34.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.3 1.04 . . . . 0.0 112.193 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.2 140.97 52.39 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.033 2.133 . . . . 0.0 106.445 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.57 146.33 27.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.134 0.968 . . . . 0.0 108.666 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -139.01 120.21 14.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.84 170.36 21.76 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 p -75.73 6.53 4.8 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.81 133.71 47.71 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.254 -0.904 . . . . 0.0 111.438 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.0 142.48 79.55 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.188 0.995 . . . . 0.0 111.165 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.2 -43.07 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.866 2.377 . . . . 0.0 113.889 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -56.65 -40.7 75.93 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.652 0.781 . . . . 0.0 111.235 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.3 95.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.941 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.08 -50.55 70.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.839 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.48 -48.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.691 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -65.93 -31.92 73.13 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.639 1.109 . . . . 0.0 111.291 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.4 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.568 0.622 . . . . 0.0 109.933 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 m -74.57 -33.18 31.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -56.55 -26.08 53.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.044 1.738 . . . . 0.0 114.627 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.56 -29.17 67.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.377 0.99 . . . . 0.0 112.398 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.07 4.37 17.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.857 -0.527 . . . . 0.0 111.707 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.1 45.24 83.93 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -123.68 150.72 43.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.525 1.53 . . . . 0.0 108.314 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 153.91 36.67 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.266 0.555 . . . . 0.0 110.36 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.11 26.45 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -152.89 158.14 41.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.97 152.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 120.865 -1.147 . . . . 0.0 109.03 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -137.95 85.53 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 pp -146.71 165.83 28.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.454 0.701 . . . . 0.0 110.679 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -112.07 104.56 12.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.578 1.18 . . . . 0.0 111.353 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 tt -98.88 148.32 24.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.869 2.068 . . . . 0.0 108.343 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -129.35 140.31 51.42 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.791 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.55 142.34 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.68 122.86 18.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.199 1.8 . . . . 0.0 110.234 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.33 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.2 mtt -142.48 132.57 24.56 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 m -74.82 81.57 2.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.787 0.835 . . . . 0.0 110.308 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -151.54 173.7 14.3 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.162 1.785 . . . . 0.0 108.134 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -67.36 -31.26 71.39 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.826 0.851 . . . . 0.0 112.244 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -61.08 -31.66 71.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.389 0.995 . . . . 0.0 111.686 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.3 t -62.49 -50.57 70.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -52.4 -50.13 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.245 1.418 . . . . 0.0 108.587 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 65.6 mtp -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.051 0.541 . . . . 0.0 110.219 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.53 64.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 m -64.05 -48.6 85.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.092 0.86 . . . . 0.0 111.182 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -63.38 -41.64 98.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.416 1.007 . . . . 0.0 110.118 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -64.33 -30.65 71.69 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.938 -1.727 . . . . 0.0 110.261 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.68 -51.43 41.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.034 0.834 . . . . 0.0 109.456 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.54 -33.82 76.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.892 0.477 . . . . 0.0 110.715 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -61.74 -7.23 3.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.109 0.964 . . . . 0.0 111.888 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HE3' ' CB ' ' A' ' 54' ' ' ALA . 0.6 OUTLIER -57.86 -33.23 68.47 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.589 1.54 . . . . 0.0 109.687 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.0 158.35 41.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.59 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.017 2.478 . . . . 0.0 111.371 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 74.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 105.633 -2.987 . . . . 0.0 105.633 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.16 -34.89 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.27 0.628 . . . . 0.0 110.605 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -176.41 -78.64 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.973 2.509 . . . . 0.0 106.416 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -155.72 151.41 27.31 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.082 1.31 . . . . 0.0 110.984 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.8 135.91 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 125.914 1.686 . . . . 0.0 106.799 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -143.27 140.7 30.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.78 131.48 42.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.49 1.116 . . . . 0.0 109.009 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 p -106.14 117.9 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.629 0.728 . . . . 0.0 110.931 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -18.37 61.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.077 0.951 . . . . 0.0 113.457 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -78.38 -15.53 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 112.958 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -137.26 -15.82 1.44 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.09 12.83 83.77 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.4 1.0 . . . . 0.0 112.749 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -93.29 146.74 23.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.868 1.334 . . . . 0.0 108.421 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.83 114.78 16.96 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.962 2.105 . . . . 0.0 109.168 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.89 134.2 34.34 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.25 131.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.798 1.285 . . . . 0.0 112.006 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -123.92 145.48 49.1 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 127.226 2.211 . . . . 0.0 108.581 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.6 177.17 15.44 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 126.246 1.879 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.3 p -66.21 5.14 0.57 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.482 2.313 . . . . 0.0 113.595 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.54 140.45 56.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.929 -1.107 . . . . 0.0 108.315 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.94 129.53 39.45 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -58.34 -31.2 93.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.752 1.635 . . . . 0.0 112.268 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -57.06 -46.49 82.42 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.814 1.188 . . . . 0.0 110.487 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.86 76.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.619 0.768 . . . . 0.0 110.753 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 118.886 -0.578 . . . . 0.0 111.389 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.13 -52.95 52.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -60.67 -33.64 73.13 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.545 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.42 ' CB ' ' HE3' ' A' ' 24' ' ' LYS . . . -60.49 -50.89 71.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.428 1.467 . . . . 0.0 110.082 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.84 -32.45 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.34 -44.61 71.27 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.033 1.333 . . . . 0.0 109.879 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.38 -23.44 66.32 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.784 0.834 . . . . 0.0 109.802 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.67 -14.67 62.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.801 1.24 . . . . 0.0 108.921 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.57 30.0 5.73 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 128.01 2.719 . . . . 0.0 115.518 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.49 175.33 9.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.207 2.003 . . . . 0.0 112.574 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -100.06 134.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.32 160.9 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -149.41 164.64 34.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.54 158.53 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 121.582 -0.699 . . . . 0.0 111.065 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -162.39 166.91 24.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.57 2.748 . . . . 0.0 106.045 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 178.352 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.94 166.45 14.41 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.571 0.748 . . . . 0.0 110.537 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -130.07 128.45 41.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.94 122.04 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -93.21 133.95 35.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.6 t -132.22 113.0 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -134.0 166.12 23.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.303 0.573 . . . . 0.0 109.833 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.0 170.63 43.39 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -83.68 0.6 46.34 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.047 -0.678 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 t -77.58 177.61 7.93 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.089 0.956 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -83.43 -164.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.421 1.888 . . . . 0.0 112.235 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.24 -2.15 0.91 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.287 1.835 . . . . 0.0 113.294 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -62.11 -13.63 28.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.531 -1.356 . . . . 0.0 111.904 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.03 -38.91 80.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.04 -1.457 . . . . 0.0 113.224 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.59 -52.06 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 120.571 1.532 . . . . 0.0 110.6 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.7 ttp -67.88 -47.03 69.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.163 -0.335 . . . . 0.0 111.326 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.71 63.64 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.478 0.711 . . . . 0.0 111.681 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.2 -39.89 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.0 m -61.7 -43.88 98.0 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.218 1.372 . . . . 0.0 109.329 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -56.31 -51.36 68.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.361 0.982 . . . . 0.0 109.091 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.47 69.76 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.89 0.744 . . . . 0.0 111.259 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.8 -30.51 70.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.221 1.408 . . . . 0.0 112.442 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -79.53 -4.28 50.67 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.86 -1.15 . . . . 0.0 112.02 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -36.99 85.79 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.33 1.423 . . . . 0.0 111.455 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.9 148.15 84.01 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.115 0.87 . . . . 0.0 109.4 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.02 -48.57 3.54 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.099 1.866 . . . . 0.0 112.916 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.55 69.92 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.4 -10.48 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.884 0.874 . . . . 0.0 111.938 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.14 163.87 28.26 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.837 -1.165 . . . . 0.0 112.327 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -103.62 134.69 46.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.76 144.18 37.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -144.24 143.13 30.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.251 1.02 . . . . 0.0 111.283 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.5 134.23 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 109.59 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.3 t -72.2 143.17 48.96 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 110.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.4 -28.84 62.22 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -81.67 -27.59 33.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.184 2.194 . . . . 0.0 115.621 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -145.87 160.22 42.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.698 0.799 . . . . 0.0 109.248 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.94 33.88 2.38 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.858 0.742 . . . . 0.0 111.871 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -90.73 125.67 35.76 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 125.014 1.326 . . . . 0.0 107.964 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.38 120.1 37.76 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.791 1.236 . . . . 0.0 109.559 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.13 134.77 34.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.29 132.39 66.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -136.13 105.5 6.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.673 1.189 . . . . 0.0 111.275 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.2 -148.08 11.78 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -121.3 7.87 10.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.844 1.258 . . . . 0.0 111.825 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.31 138.47 57.65 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.511 -0.743 . . . . 0.0 109.075 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.28 148.29 93.62 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.596 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.67 -44.56 10.52 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.591 1.527 . . . . 0.0 110.309 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -55.95 -29.65 60.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -48.44 48.58 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.385 0.993 . . . . 0.0 108.953 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.59 -47.75 68.84 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.258 1.023 . . . . 0.0 110.502 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.28 -52.07 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -60.2 -43.31 96.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 116.533 -1.698 . . . . 0.0 110.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.88 -46.56 67.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.59 1.086 . . . . 0.0 111.465 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 m -73.05 -32.4 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.43 -0.794 . . . . 0.0 111.13 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -68.32 -20.34 64.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.596 1.558 . . . . 0.0 112.544 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -63.49 -11.64 25.43 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.6 5.21 11.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.14 64.09 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 116.387 1.315 . . . . 0.0 116.387 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -74.32 175.96 7.15 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.655 1.728 . . . . 0.0 108.225 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -103.45 124.18 48.25 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.29 120.27 36.48 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.233 1.013 . . . . 0.0 110.183 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -135.64 106.93 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.631 0.772 . . . . 0.0 111.033 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.59 156.48 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.612 -0.68 . . . . 0.0 110.185 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.21 90.9 3.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.301 -1.333 . . . . 0.0 109.659 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 13.0 ptp . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.56 166.57 26.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.32 1.848 . . . . 0.0 109.139 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -122.81 115.19 21.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.655 1.582 . . . . 0.0 107.639 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.38 148.7 43.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.316 1.046 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -124.05 138.57 54.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.63 143.49 40.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.243 1.417 . . . . 0.0 107.776 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -151.38 161.55 42.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.31 -36.86 0.1 Allowed Glycine 0 CA--C 1.521 0.409 0 O-C-N 120.959 -1.088 . . . . 0.0 113.191 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.7 mmt -147.57 3.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.832 1.316 . . . . 0.0 114.201 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.0 p 57.43 5.57 0.31 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 m -73.07 147.58 44.85 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.354 -1.466 . . . . 0.0 111.941 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.18 -23.56 67.49 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.875 0.369 . . . . 0.0 111.978 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -81.08 -4.45 55.29 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.966 -1.084 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 p -57.0 -28.27 62.29 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.08 1.309 . . . . 0.0 111.822 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -54.28 -35.72 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.222 1.409 . . . . 0.0 111.093 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.59 -50.06 70.94 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.95 67.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.08 -49.17 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.967 0.803 . . . . 0.0 110.464 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -54.76 -53.94 48.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.413 1.006 . . . . 0.0 110.002 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -65.19 -33.15 75.33 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.796 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.19 -44.92 74.77 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.256 1.389 . . . . 0.0 108.936 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.68 -30.25 71.26 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.92 0.888 . . . . 0.0 109.137 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -70.44 -14.28 62.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -53.7 -46.52 70.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.646 1.566 . . . . 0.0 110.108 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.13 122.82 84.77 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.07 158.1 42.11 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.662 1.575 . . . . 0.0 109.42 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.31 -70.13 0.21 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-O 117.922 -1.488 . . . . 0.0 116.216 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.07 -57.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.181 1.491 . . . . 0.0 112.555 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 54.86 -26.6 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -96.28 104.63 16.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.026 1.731 . . . . 0.0 110.593 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.26 119.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -110.7 116.88 32.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.8 125.47 54.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.521 1.128 . . . . 0.0 110.405 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.7 t -71.9 132.9 45.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.775 0.798 . . . . 0.0 108.903 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.68 -38.61 64.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.381 1.072 . . . . 0.0 110.604 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -78.52 -46.33 19.8 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -107.81 171.37 7.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.09 0.556 . . . . 0.0 110.432 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.19 15.99 56.87 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.925 -0.931 . . . . 0.0 111.753 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.67 135.45 33.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 118.874 1.337 . . . . 0.0 110.189 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.73 114.7 17.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.997 2.119 . . . . 0.0 107.728 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -77.62 145.46 36.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.9 p -129.48 138.19 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -117.55 104.56 11.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.64 -166.51 37.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.698 2.094 . . . . 0.0 108.524 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -117.47 -2.18 11.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.11 1.764 . . . . 0.0 113.727 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.27 131.65 28.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.453 1.024 . . . . 0.0 112.014 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.56 126.74 31.11 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 126.527 1.931 . . . . 0.0 110.589 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.0 -33.49 98.8 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.491 1.46 . . . . 0.0 112.782 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -61.34 -30.34 70.46 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.134 1.334 . . . . 0.0 111.33 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.93 -44.8 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.48 0.712 . . . . 0.0 110.245 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.74 -53.96 38.96 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.37 -43.49 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.05 -42.32 89.68 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.073 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.69 -41.37 66.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -80.82 -33.66 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.971 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -69.39 -20.92 63.81 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.361 1.464 . . . . 0.0 111.898 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.86 -32.25 71.78 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.945 1.298 . . . . 0.0 108.911 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -75.94 -19.12 59.02 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.21 56.61 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.239 1.876 . . . . 0.0 112.313 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.5 155.66 33.6 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -88.27 150.23 23.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.963 -1.086 . . . . 0.0 109.146 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.75 158.12 43.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -145.7 150.38 36.18 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.675 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.4 147.58 22.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.86 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -146.88 170.73 16.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.182 1.793 . . . . 0.0 109.211 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.12 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.54 ' H1 ' ' CD ' ' A' ' 43' ' ' GLU . 18.0 ptt? . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.2 165.53 13.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.36 148.79 49.53 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.08 145.7 44.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -99.41 132.93 44.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.855 1.262 . . . . 0.0 107.678 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.8 t -126.76 102.11 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -119.74 168.39 11.12 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.112 0.869 . . . . 0.0 112.112 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.16 12.65 0.04 OUTLIER Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.134 2.302 . . . . 0.0 112.326 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.4 ttt 65.35 90.74 0.09 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.925 2.09 . . . . 0.0 109.608 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 m 57.11 80.49 0.16 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.145 1.778 . . . . 0.0 112.075 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 69.0 m -55.27 127.63 30.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.718 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -71.25 -175.82 1.31 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.676 1.19 . . . . 0.0 108.694 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -48.7 -23.14 0.93 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.594 1.558 . . . . 0.0 113.357 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 t -53.96 -28.26 36.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.071 1.348 . . . . 0.0 110.217 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.15 -36.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 119.041 0.837 . . . . 0.0 109.966 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.3 ttm -66.86 -43.31 83.94 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.808 -1.182 . . . . 0.0 109.703 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.95 -52.64 64.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.668 0.787 . . . . 0.0 110.037 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.33 -41.79 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -60.89 -48.7 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.915 -1.116 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -64.22 -37.52 87.75 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 121.731 -0.606 . . . . 0.0 111.68 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.11 -47.53 67.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.346 1.058 . . . . 0.0 109.597 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.5 mt -57.48 -37.65 73.25 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.568 0.747 . . . . 0.0 109.181 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -68.91 -13.07 62.2 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.16 -0.963 . . . . 0.0 112.913 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -73.48 -21.08 60.52 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.538 1.517 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.8 m -52.31 142.06 30.27 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.65 94.04 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.173 3.249 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.16 -74.02 0.37 Allowed Glycine 0 C--N 1.332 0.353 0 O-C-N 121.411 -0.805 . . . . 0.0 112.646 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.6 t -54.64 -58.9 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 117.253 0.527 . . . . 0.0 111.341 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 43.45 19.89 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -150.84 106.32 3.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.132 1.773 . . . . 0.0 109.335 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.0 138.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -141.35 118.36 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -110.79 142.93 21.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 t -90.67 146.34 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.81 -49.35 30.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.14 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -81.62 -57.94 3.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.799 0.439 . . . . 0.0 112.103 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.85 152.32 41.57 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.12 53.28 1.87 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -123.57 133.84 53.91 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.647 1.224 . . . . 0.0 110.863 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.97 115.04 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.256 2.622 . . . . 0.0 108.764 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.35 135.17 34.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.38 133.99 57.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.54 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 16.0 tp10 -123.33 103.64 8.63 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.07 -170.22 41.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.661 1.124 . . . . 0.0 111.995 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -111.85 14.86 21.01 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.728 2.811 . . . . 0.0 115.585 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 142.06 57.63 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.302 -1.499 . . . . 0.0 109.496 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.01 151.1 81.5 Favored Pre-proline 0 C--O 1.237 0.429 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.301 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -55.32 -47.3 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.607 2.205 . . . . 0.0 111.519 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -55.1 -38.76 68.55 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.55 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.67 80.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.829 0.74 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.5 mt -68.21 -47.7 67.18 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.941 -0.474 . . . . 0.0 110.352 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.5 t -55.66 -56.37 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 124.413 1.085 . . . . 0.0 108.722 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -57.34 -50.22 73.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.589 -1.196 . . . . 0.0 110.036 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.11 64.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.303 0.956 . . . . 0.0 111.697 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -76.38 -43.18 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.7 -23.28 64.74 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.079 1.752 . . . . 0.0 110.914 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -62.46 -23.51 66.93 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.089 1.356 . . . . 0.0 110.532 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.29 39.5 mt-10 -104.36 16.43 26.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.836 0.854 . . . . 0.0 111.436 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.96 1.77 49.4 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 127.216 2.341 . . . . 0.0 116.129 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -74.92 151.24 38.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.137 1.469 . . . . 0.0 109.388 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -75.05 105.07 5.89 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.11 39.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.514 1.125 . . . . 0.0 109.125 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -141.58 114.05 8.27 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.82 167.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 pp -119.38 -173.09 2.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 108.597 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.685 1.594 . . . . 0.0 107.402 179.361 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtm . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.14 166.06 22.64 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.336 1.454 . . . . 0.0 107.202 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -124.72 107.73 11.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.503 0.721 . . . . 0.0 111.063 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.01 137.65 36.06 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.383 -1.448 . . . . 0.0 108.028 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -109.17 137.72 46.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.7 143.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.554 1.07 . . . . 0.0 109.792 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -147.52 156.98 43.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.605 0.717 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.01 -28.17 2.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.3 -1.278 . . . . 0.0 111.298 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 35.4 tpp -147.99 152.98 38.39 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.023 1.411 . . . . 0.0 110.339 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -141.46 78.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.9 m -150.42 150.39 31.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.967 2.107 . . . . 0.0 108.122 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -53.37 -31.84 46.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.661 1.985 . . . . 0.0 114.481 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -63.85 -22.31 66.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.328 -0.857 . . . . 0.0 112.356 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.2 t -52.83 -52.55 56.62 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.405 1.082 . . . . 0.0 108.242 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.1 t -52.56 -51.18 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.571 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -57.12 -49.96 74.28 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.79 0.836 . . . . 0.0 110.937 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.49 -38.54 90.05 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.199 0.999 . . . . 0.0 111.963 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.68 -54.75 30.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 108.987 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -65.61 -32.41 73.97 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.811 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -62.43 -42.59 99.56 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.565 -1.334 . . . . 0.0 111.106 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.52 -48.55 26.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.305 0.957 . . . . 0.0 111.97 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.43 -41.56 89.88 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.107 0.963 . . . . 0.0 113.33 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -49.8 -28.47 6.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -57.57 -27.1 62.38 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.48 1.036 . . . . 0.0 111.031 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.03 104.45 14.96 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 125.579 1.552 . . . . 0.0 108.527 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 168.84 23.77 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.452 1.435 . . . . 0.0 109.305 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.8 16.27 61.82 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 122.31 -0.244 . . . . 0.0 113.417 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.45 -58.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 39.45 2.84 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 131.37 3.868 . . . . 0.0 119.21 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -143.69 102.94 4.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.175 1.39 . . . . 0.0 107.59 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.32 142.41 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.98 116.96 11.64 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 t -90.72 143.16 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -89.52 132.99 34.79 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.84 -48.78 34.83 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.05 -0.5 . . . . 0.0 112.197 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -83.03 -12.68 56.99 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.024 1.33 . . . . 0.0 114.052 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HE3' ' OE1' ' A' ' 39' ' ' GLU . 21.2 mtpp -126.64 151.69 47.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.598 -0.689 . . . . 0.0 111.601 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.61 78.15 2.0 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.43 ' OE1' ' HE3' ' A' ' 37' ' ' LYS . 8.6 pt-20 -165.9 158.39 14.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.353 0.661 . . . . 0.0 110.588 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.78 125.87 12.9 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.027 0.931 . . . . 0.0 109.554 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.7 mt -74.55 142.67 44.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.68 131.23 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 110.83 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -123.02 151.22 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.17 -157.47 15.01 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.83 29.62 7.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.905 1.282 . . . . 0.0 114.315 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.79 123.9 26.4 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.46 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.15 152.89 83.25 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.783 1.633 . . . . 0.0 112.127 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.56 -57.37 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.518 2.812 . . . . 0.0 113.565 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -56.65 -40.88 76.23 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 117.934 0.334 . . . . 0.0 110.549 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.5 88.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -54.69 35.25 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.233 0.613 . . . . 0.0 111.271 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.4 m -59.98 -35.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.037 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -71.42 -37.83 71.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.37 -0.831 . . . . 0.0 110.409 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.12 97.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.198 0.908 . . . . 0.0 109.281 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.32 -32.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.788 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.95 -23.39 45.14 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.56 1.144 . . . . 0.0 112.388 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.61 -29.06 69.8 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.953 0.797 . . . . 0.0 110.158 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -86.81 -13.71 44.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.471 1.508 . . . . 0.0 111.323 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.16 66.45 1.61 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.176 1.369 . . . . 0.0 115.365 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -139.83 170.14 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 108.479 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -106.54 105.09 14.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.635 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.1 149.62 35.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 119.09 0.859 . . . . 0.0 110.161 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -149.31 165.98 30.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.551 1.94 . . . . 0.0 108.502 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.1 154.56 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 121.348 -0.845 . . . . 0.0 111.212 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.7 tp -76.0 106.82 7.8 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.201 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.157 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.1 mt -116.69 151.15 36.95 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.633 1.173 . . . . 0.0 108.199 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -122.24 142.19 50.71 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.225 1.01 . . . . 0.0 110.797 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.99 121.68 18.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.635 1.974 . . . . 0.0 110.278 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -87.95 137.9 31.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -126.94 91.01 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.614 1.566 . . . . 0.0 107.516 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.76 146.92 35.58 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.27 -165.16 25.21 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ttt -95.92 -85.15 0.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.225 0.61 . . . . 0.0 109.446 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 m -68.78 150.08 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.785 -0.572 . . . . 0.0 110.015 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.9 t -129.32 5.41 5.24 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.455 1.502 . . . . 0.0 111.094 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -86.49 -100.69 0.07 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.581 -1.324 . . . . 0.0 109.148 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -64.01 -11.19 26.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.92 -1.113 . . . . 0.0 112.908 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -28.56 69.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.809 1.244 . . . . 0.0 110.827 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -54.59 -35.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.088 0.858 . . . . 0.0 110.692 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.76 -45.65 77.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.701 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -52.43 65.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.22 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -58.91 -47.69 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.507 1.049 . . . . 0.0 110.866 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.5 p -63.43 -40.96 98.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -75.37 -40.89 57.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.608 0.763 . . . . 0.0 111.922 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.22 84.69 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.754 0.822 . . . . 0.0 110.191 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.0 mt -56.55 -28.24 59.59 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.9 0.48 . . . . 0.0 110.248 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -59.47 -11.9 5.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.047 0.939 . . . . 0.0 112.986 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -55.12 -16.36 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.289 1.404 . . . . 0.0 112.398 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.86 92.27 20.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.69 -4.34 15.09 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.016 2.477 . . . . 0.0 114.771 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.79 2.48 54.48 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 116.841 1.497 . . . . 0.0 116.841 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.9 p -113.9 -48.02 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 119.579 1.689 . . . . 0.0 112.164 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 59.43 -2.97 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.44 103.35 8.88 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.465 1.484 . . . . 0.0 107.198 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 m -141.27 138.29 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.279 1.032 . . . . 0.0 109.666 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.79 143.12 40.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.171 1.788 . . . . 0.0 108.284 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.6 t -136.88 143.24 35.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.101 1.76 . . . . 0.0 107.46 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.1 t -76.81 138.52 39.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.31 -36.04 66.18 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -81.59 -57.94 3.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.343 1.057 . . . . 0.0 112.198 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.54 177.29 6.4 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.963 1.305 . . . . 0.0 112.49 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.58 17.27 56.86 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -90.52 143.38 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.195 1.497 . . . . 0.0 108.302 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.43 163.13 33.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.942 1.297 . . . . 0.0 110.588 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.24 144.42 30.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.897 1.279 . . . . 0.0 110.211 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.9 t -130.42 143.25 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.551 1.94 . . . . 0.0 108.12 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -130.1 105.31 7.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.216 1.006 . . . . 0.0 109.951 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.09 -161.09 34.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.574 1.559 . . . . 0.0 110.225 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 p -96.15 0.54 51.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.735 1.268 . . . . 0.0 114.362 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.71 131.86 30.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.658 1.117 . . . . 0.0 111.019 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.36 142.44 98.35 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.35 -48.55 21.41 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.224 1.949 . . . . 0.0 112.348 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -62.02 -23.17 66.28 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.761 -1.114 . . . . 0.0 112.936 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.61 85.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.802 1.183 . . . . 0.0 108.348 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.65 -48.63 59.15 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.809 0.693 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.0 t -54.19 -59.41 2.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.969 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.1 -38.59 83.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.868 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.52 -44.69 69.36 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 117.156 -1.402 . . . . 0.0 110.22 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.25 -32.32 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.857 1.208 . . . . 0.0 112.041 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.79 -44.76 82.23 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.843 1.257 . . . . 0.0 108.844 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.37 -26.42 66.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.53 1.132 . . . . 0.0 111.422 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -69.99 -36.86 75.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.478 1.035 . . . . 0.0 108.65 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.37 30.59 1.16 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.567 1.556 . . . . 0.0 112.338 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -120.14 172.21 7.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.305 1.552 . . . . 0.0 109.255 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.93 99.63 6.48 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.331 0.969 . . . . 0.0 113.186 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.24 160.84 15.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.488 1.115 . . . . 0.0 112.161 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -154.46 130.13 9.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.876 1.27 . . . . 0.0 107.991 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.52 156.55 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.34 166.81 17.13 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.87 2.068 . . . . 0.0 106.901 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 125.065 1.346 . . . . 0.0 109.394 -179.383 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttm . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.03 166.46 10.82 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -130.41 146.53 51.99 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.884 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.3 tp -136.77 110.92 8.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -81.74 119.94 24.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.99 138.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -136.78 174.02 11.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 -102.2 0.96 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 34.1 tpp -113.48 114.56 26.71 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.571 1.186 . . . . 0.0 112.364 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.47 105.01 17.0 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.9 t -138.87 157.16 46.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 110.044 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.74 -28.95 67.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 110.618 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.88 -26.33 21.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.5 0.72 . . . . 0.0 111.071 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.5 m -61.49 -43.07 99.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.811 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.0 -33.39 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.773 1.17 . . . . 0.0 111.037 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.64 -45.44 75.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.27 65.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.364 0.665 . . . . 0.0 109.985 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -57.26 -49.54 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 124.634 1.174 . . . . 0.0 109.851 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -58.03 -53.56 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.159 0.891 . . . . 0.0 110.386 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -59.44 -47.32 85.94 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.461 -0.774 . . . . 0.0 112.152 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.46 92.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.99 0.916 . . . . 0.0 111.95 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.66 -36.15 83.34 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.702 -1.249 . . . . 0.0 109.861 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.3 -19.07 64.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.953 0.901 . . . . 0.0 113.103 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -56.84 -36.18 69.7 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.113 1.524 . . . . 0.0 115.113 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.95 121.3 81.97 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 112.552 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.4 121.56 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.88 -14.96 2.4 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.273 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.38 -57.27 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 118.966 1.383 . . . . 0.0 108.809 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 63.36 -30.8 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.177 2.191 . . . . 0.0 115.25 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 122.94 35.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.8 2.091 . . . . 0.0 112.432 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.8 m -141.25 144.43 26.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.16 1.384 . . . . 0.0 107.454 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -124.0 118.67 27.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.52 115.94 49.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.134 0.974 . . . . 0.0 108.404 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -93.02 118.11 30.81 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.61 -45.11 91.8 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.214 0.461 . . . . 0.0 111.205 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -55.46 -58.09 9.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 111.496 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -70.85 -49.94 40.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.234 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 2.56 52.28 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.68 1.61 . . . . 0.0 109.64 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.47 151.67 20.68 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.303 1.441 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.81 114.23 17.65 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.173 1.389 . . . . 0.0 109.776 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.62 113.47 20.34 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.0 m -109.99 132.29 58.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 118.266 0.485 . . . . 0.0 110.65 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.26 105.56 14.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.84 158.52 11.36 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.42 -12.11 54.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.619 1.568 . . . . 0.0 112.773 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.55 155.24 2.25 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.57 136.4 85.96 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 125.432 1.493 . . . . 0.0 111.387 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.15 -25.3 37.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.441 2.094 . . . . 0.0 112.632 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -35.04 65.45 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.088 0.858 . . . . 0.0 110.725 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.47 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.96 -45.64 63.75 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.13 -47.36 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -62.2 -49.12 77.05 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.446 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.56 63.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.759 1.163 . . . . 0.0 113.164 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.4 t -81.49 -38.3 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.57 -36.0 82.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.26 -14.81 8.02 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.945 2.098 . . . . 0.0 112.36 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -115.67 -1.37 12.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.853 1.261 . . . . 0.0 111.275 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.97 42.22 9.0 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.382 0.992 . . . . 0.0 113.99 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -132.16 160.98 34.49 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.409 1.105 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -90.95 145.54 24.64 Favored 'General case' 0 CA--C 1.522 -0.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.1 143.43 47.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.866 1.266 . . . . 0.0 109.617 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -140.3 121.61 14.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 108.642 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -89.57 130.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.775 1.63 . . . . 0.0 109.993 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -133.92 126.42 30.34 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.83 1.652 . . . . 0.0 107.457 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.873 1.669 . . . . 0.0 110.092 178.867 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mmt . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.872 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.92 165.17 17.87 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.299 1.863 . . . . 0.0 110.974 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -142.55 147.66 36.29 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.49 1.916 . . . . 0.0 107.64 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.02 148.92 45.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.804 2.442 . . . . 0.0 108.547 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -97.03 138.55 34.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -122.11 128.39 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.229 2.212 . . . . 0.0 107.365 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -132.67 142.68 49.2 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.58 -179.9 24.88 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.371 1.462 . . . . 0.0 109.77 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.02 -46.33 88.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -173.14 -177.79 1.63 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.33 1.852 . . . . 0.0 107.421 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -72.97 139.19 46.54 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -152.53 170.23 20.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.898 1.279 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -57.37 -25.41 59.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.102 0.961 . . . . 0.0 109.464 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -27.57 17.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.321 2.249 . . . . 0.0 112.388 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.9 t -52.24 -46.03 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 120.353 1.433 . . . . 0.0 109.063 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -66.14 -43.4 87.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.272 -0.893 . . . . 0.0 108.648 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.43 67.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.735 0.814 . . . . 0.0 110.721 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.68 -35.4 75.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.4 m -57.53 -54.57 45.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.651 1.569 . . . . 0.0 109.439 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -64.13 -32.18 73.65 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -41.53 79.82 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.387 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.5 mt -57.11 -46.23 82.79 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -61.34 -4.33 1.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -57.99 -36.47 72.67 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 121.692 2.042 . . . . 0.0 114.413 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.07 119.78 29.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.217 1.007 . . . . 0.0 110.984 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.34 -21.99 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 113.46 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.41 4.04 66.55 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 117.696 -1.614 . . . . 0.0 115.381 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.43 -59.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.259 2.029 . . . . 0.0 109.288 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 57.77 0.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.161 2.584 . . . . 0.0 116.071 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.68 104.08 4.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.706 1.594 . . . . 0.0 110.772 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.18 140.06 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.122 0.969 . . . . 0.0 108.81 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -144.08 144.09 31.45 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.795 1.238 . . . . 0.0 108.958 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -124.58 143.81 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.569 1.947 . . . . 0.0 108.379 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -103.88 118.03 35.74 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.46 -30.09 69.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.033 1.288 . . . . 0.0 111.558 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.429 1.492 . . . . 0.0 110.313 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -83.24 -23.3 32.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 9.13 87.34 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 118.878 0.763 . . . . 0.0 112.113 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.6 160.79 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.187 1.994 . . . . 0.0 109.207 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.01 115.63 9.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.278 1.031 . . . . 0.0 109.762 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -91.07 140.13 30.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.465 1.106 . . . . 0.0 108.3 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.78 141.95 42.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 108.431 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -130.38 104.2 7.12 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.14 -176.97 40.76 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.855 1.693 . . . . 0.0 109.546 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 p -98.4 10.51 40.63 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.3 142.8 42.06 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.827 1.649 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.84 152.51 91.14 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.016 0.926 . . . . 0.0 109.972 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.84 -47.95 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.036 1.824 . . . . 0.0 110.421 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -38.78 72.83 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.485 0.314 . . . . 0.0 111.418 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.58 -53.87 44.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.962 0.905 . . . . 0.0 109.887 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.35 -52.89 62.9 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.531 0.732 . . . . 0.0 111.431 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.33 -57.84 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.833 0.853 . . . . 0.0 110.567 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -64.4 -35.88 82.35 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.005 0.82 . . . . 0.0 110.59 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.56 78.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.699 1.136 . . . . 0.0 110.337 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -77.97 -35.2 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.269 0.94 . . . . 0.0 109.535 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -61.61 -27.29 68.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.629 0.771 . . . . 0.0 110.955 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.99 -11.79 32.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.305 1.442 . . . . 0.0 111.562 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -109.49 -2.61 17.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.831 1.653 . . . . 0.0 111.125 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.55 -8.1 77.17 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.621 1.581 . . . . 0.0 113.768 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -78.98 157.91 28.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.756 1.278 . . . . 0.0 108.311 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -109.88 99.92 8.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.45 150.9 22.91 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.021 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -154.75 124.83 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 m -60.24 155.0 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.97 . . . . 0.0 109.928 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -56.9 132.15 51.73 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.884 1.273 . . . . 0.0 108.456 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.608 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.36 165.95 12.4 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.459 1.504 . . . . 0.0 107.799 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -150.4 104.05 3.2 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.413 -0.804 . . . . 0.0 108.848 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tp -79.17 147.9 32.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.817 0.847 . . . . 0.0 108.776 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -128.36 106.97 9.37 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.183 0.993 . . . . 0.0 109.497 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 t -74.95 153.07 6.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 126.13 1.772 . . . . 0.0 110.025 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -152.53 162.1 41.67 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 122.215 1.007 . . . . 0.0 111.855 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.27 -68.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 126.984 2.23 . . . . 0.0 113.416 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 mmt -84.37 162.78 19.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.899 0.85 . . . . 0.0 112.556 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -140.16 36.26 1.91 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.286 2.634 . . . . 0.0 106.772 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.97 179.46 2.72 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 119.949 -1.719 . . . . 0.0 109.504 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.94 -61.15 1.75 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.361 0.665 . . . . 0.0 110.008 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -56.72 -16.64 6.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.937 1.295 . . . . 0.0 114.05 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 p -59.58 -28.56 67.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.04 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.37 -46.49 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.529 1.513 . . . . 0.0 110.758 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.5 mtt -64.29 -49.81 70.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.334 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.42 -52.25 66.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.808 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.58 -52.02 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.305 1.442 . . . . 0.0 111.229 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 t -54.67 -43.97 72.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.184 1.357 . . . . 0.0 108.778 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -64.18 -50.69 67.13 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.626 -0.671 . . . . 0.0 111.342 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.43 79.3 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.507 1.523 . . . . 0.0 112.117 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.15 -38.06 81.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.037 0.935 . . . . 0.0 110.425 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.28 -10.55 59.7 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -46.73 -57.33 4.95 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.52 118.65 56.03 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.562 1.528 . . . . 0.0 111.734 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.55 88.79 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.706 2.271 . . . . 0.0 108.522 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.69 -33.69 0.02 OUTLIER Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.452 -0.78 . . . . 0.0 111.419 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.29 -50.2 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 117.474 0.637 . . . . 0.0 109.504 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 67.58 -46.61 0.5 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.312 2.245 . . . . 0.0 112.64 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -101.45 109.85 21.75 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.523 1.51 . . . . 0.0 112.698 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.62 130.43 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -130.73 137.55 49.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.093 1.357 . . . . 0.0 107.465 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.75 138.04 44.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 110.017 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.7 t -113.12 118.55 35.05 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.63 -24.33 66.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.406 0.682 . . . . 0.0 111.853 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.75 -13.75 61.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.746 1.618 . . . . 0.0 111.684 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -135.54 -15.74 1.85 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.79 18.46 72.35 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -100.19 145.5 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.49 114.56 9.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.9 0.48 . . . . 0.0 111.572 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.9 mp -77.55 144.42 37.61 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.965 1.706 . . . . 0.0 107.715 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.33 121.64 23.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.788 0.835 . . . . 0.0 109.298 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.05 104.99 9.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.46 177.51 21.14 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.697 1.618 . . . . 0.0 109.847 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -70.97 26.19 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.541 1.536 . . . . 0.0 113.991 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 106.11 1.19 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 142.07 98.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 123.323 0.649 . . . . 0.0 112.11 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.21 -48.14 12.75 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.457 2.105 . . . . 0.0 112.224 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -56.21 -37.26 69.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.468 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.64 63.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.309 0.644 . . . . 0.0 109.749 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -61.96 -50.07 73.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.289 1.035 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.59 -49.72 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -65.65 -42.01 91.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.836 0.744 . . . . 0.0 111.478 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.06 -31.23 70.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.656 1.182 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.8 t -88.35 -41.75 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 118.656 0.662 . . . . 0.0 109.931 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.59 -42.35 82.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.839 0.856 . . . . 0.0 110.96 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.78 -12.74 50.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.785 -0.626 . . . . 0.0 112.03 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -97.83 -10.11 25.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 120.015 1.279 . . . . 0.0 113.338 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.23 9.27 60.68 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.238 -1.312 . . . . 0.0 114.576 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.69 145.64 30.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -88.2 152.14 22.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -149.21 147.37 28.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.561 0.618 . . . . 0.0 109.647 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -134.67 153.48 51.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.242 1.017 . . . . 0.0 108.263 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.18 173.97 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.99 85.5 3.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.6 mt -119.91 160.74 22.11 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.34 139.94 53.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.629 0.772 . . . . 0.0 110.109 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -122.29 111.54 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -88.95 127.15 35.65 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.22 141.54 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -141.45 98.57 3.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.33 -162.6 28.38 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.576 2.036 . . . . 0.0 109.761 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.2 ttt -124.47 8.08 8.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.175 1.79 . . . . 0.0 108.04 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.15 174.28 9.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 128.116 2.566 . . . . 0.0 107.465 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -140.0 -77.25 0.32 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -55.13 -28.6 53.87 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -93.1 -34.87 13.49 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 109.55 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -54.79 -54.3 43.89 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.929 1.292 . . . . 0.0 110.429 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -52.01 -38.29 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.128 0.971 . . . . 0.0 112.393 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.4 mmm -62.38 -49.8 74.08 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 110.088 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.82 -38.72 83.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.216 0.606 . . . . 0.0 110.185 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.23 -44.85 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.8 m -64.71 -40.02 94.64 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.904 1.229 . . . . 0.0 109.088 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -55.66 -49.76 72.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.109 0.964 . . . . 0.0 109.614 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.48 59.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.114 1.366 . . . . 0.0 110.246 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.6 mt -58.81 -28.11 65.7 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 124.355 1.062 . . . . 0.0 112.47 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -68.86 -21.01 64.29 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.098 -1.001 . . . . 0.0 111.63 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.21 -15.46 63.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.8 m -51.94 160.93 1.02 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.319 1.848 . . . . 0.0 113.313 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.65 -71.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.872 2.381 . . . . 0.0 111.757 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -156.75 51.95 0.42 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.709 0.671 . . . . 0.0 112.157 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.31 -36.48 74.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 118.01 0.905 . . . . 0.0 111.183 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.286 4.1 pt-20 58.38 -11.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.278 2.631 . . . . 0.0 116.362 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -135.18 104.07 5.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.076 2.15 . . . . 0.0 107.762 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -141.91 120.24 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -124.4 142.78 51.03 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.777 1.631 . . . . 0.0 108.956 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 t -137.01 143.21 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.079 0.552 . . . . 0.0 109.802 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -81.56 126.2 31.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.47 -48.57 48.36 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.052 0.941 . . . . 0.0 111.508 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.11 -13.59 59.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -118.75 -164.84 1.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.613 1.565 . . . . 0.0 108.463 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.87 66.54 0.57 Allowed Glycine 0 CA--C 1.52 0.344 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -145.7 137.05 24.94 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.738 -1.448 . . . . 0.0 108.163 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.35 145.2 50.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.512 1.525 . . . . 0.0 109.406 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.16 138.98 54.28 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.65 139.75 42.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.701 0.801 . . . . 0.0 110.105 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -128.58 104.09 7.47 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.57 -169.13 27.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.0 p -59.56 6.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 130.976 3.711 . . . . 0.0 117.56 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.44 104.84 6.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.403 1.456 . . . . 0.0 110.376 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -66.1 132.91 94.62 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 123.862 0.865 . . . . 0.0 110.35 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.69 -38.55 91.29 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.464 2.109 . . . . 0.0 114.806 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.06 -38.27 85.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.867 2.122 . . . . 0.0 110.149 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.4 83.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -67.38 -50.55 59.25 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.836 1.255 . . . . 0.0 109.375 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -52.84 -54.04 18.28 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 124.976 1.31 . . . . 0.0 108.156 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.67 -50.57 69.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.451 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.34 66.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.486 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.25 -32.88 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.216 0.916 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.76 -20.27 65.62 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.613 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.52 -28.2 69.14 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.484 1.493 . . . . 0.0 110.615 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -90.41 -7.86 52.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.064 1.346 . . . . 0.0 110.211 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.51 10.41 70.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.191 1.853 . . . . 0.0 115.399 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.89 156.35 37.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.394 2.097 . . . . 0.0 109.222 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -80.57 119.49 23.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.83 143.33 31.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.569 0.748 . . . . 0.0 109.159 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -147.02 149.82 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -106.13 148.47 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 123.766 0.826 . . . . 0.0 111.532 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.3 mt -148.2 150.45 33.78 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.32 1.448 . . . . 0.0 107.5 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.275 1.03 . . . . 0.0 110.452 179.695 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtt . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.6 mt -128.39 153.43 47.08 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -131.15 109.81 10.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.746 0.818 . . . . 0.0 109.408 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -101.51 111.46 23.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -90.05 138.5 31.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.88 152.48 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.104 0.866 . . . . 0.0 110.044 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -142.73 100.11 3.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.736 2.414 . . . . 0.0 108.258 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.41 -75.58 0.1 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -142.88 150.32 39.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.151 1.78 . . . . 0.0 107.473 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -143.74 -64.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.505 1.122 . . . . 0.0 108.264 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.5 m -75.48 64.36 1.59 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.898 1.279 . . . . 0.0 109.249 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -153.12 172.57 16.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.462 2.305 . . . . 0.0 106.477 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -66.14 -4.71 8.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.094 -1.004 . . . . 0.0 112.815 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -53.05 -26.71 16.75 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.373 1.469 . . . . 0.0 111.743 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.9 t -50.23 -49.3 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.924 1.29 . . . . 0.0 109.746 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -63.12 -31.1 72.17 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.94 -42.1 34.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.167 0.987 . . . . 0.0 109.752 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.54 -50.97 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.1 p -61.1 -50.65 72.38 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.09 -0.481 . . . . 0.0 109.835 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -53.83 -54.56 36.71 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.822 0.737 . . . . 0.0 111.881 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.03 -50.76 70.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.908 0.883 . . . . 0.0 111.082 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 mp -68.38 -29.33 68.01 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.169 -0.957 . . . . 0.0 112.84 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -86.95 -9.27 56.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.771 1.628 . . . . 0.0 113.258 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -56.22 -25.5 47.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.559 1.143 . . . . 0.0 113.511 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.65 141.77 29.5 Favored Pre-proline 0 N--CA 1.447 -0.576 0 C-N-CA 125.207 1.403 . . . . 0.0 107.318 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.09 177.2 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.719 2.28 . . . . 0.0 111.245 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.39 -61.51 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -75.55 -59.28 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 52.3 -17.37 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.588 2.355 . . . . 0.0 116.498 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.94 115.99 30.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 121.546 1.976 . . . . 0.0 110.514 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -147.98 119.15 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.143 1.777 . . . . 0.0 106.432 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -125.19 120.86 32.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 t -87.76 142.74 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.6 t -125.98 117.39 23.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.44 -48.51 49.07 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.451 1.5 . . . . 0.0 113.81 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -58.64 -19.04 35.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.777 1.231 . . . . 0.0 113.102 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 7.98 9.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.963 1.305 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 43.29 56.74 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 126.75 2.119 . . . . 0.0 110.427 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.62 179.94 7.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.9 115.23 10.4 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.776 2.43 . . . . 0.0 108.625 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.7 mt -81.95 123.95 29.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.48 146.22 26.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 118.765 0.711 . . . . 0.0 109.551 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -133.29 107.92 8.42 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.92 174.07 38.52 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 127.547 2.499 . . . . 0.0 108.484 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -88.33 3.6 49.15 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.263 1.425 . . . . 0.0 113.054 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 155.76 1.03 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 117.503 2.408 . . . . 0.0 117.503 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.69 137.09 62.88 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.137 2.175 . . . . 0.0 110.317 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.39 -42.94 30.8 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.197 1.932 . . . . 0.0 109.927 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.68 -45.18 95.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.143 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.52 -43.89 93.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 110.263 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -61.58 -54.49 42.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.688 0.795 . . . . 0.0 109.254 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.17 -46.85 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.427 1.091 . . . . 0.0 109.848 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -67.68 -39.01 84.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.171 -1.395 . . . . 0.0 111.33 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.89 77.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.825 1.193 . . . . 0.0 110.268 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.81 -38.03 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.324 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.1 -40.3 86.89 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.165 -0.959 . . . . 0.0 111.944 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.11 -19.71 65.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.507 0.594 . . . . 0.0 111.28 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -88.97 -30.51 18.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.9 -1.048 . . . . 0.0 111.179 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 4.66 0.41 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 119.05 2.38 . . . . 0.0 119.05 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.17 138.98 26.92 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.593 3.196 . . . . 0.0 108.656 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -75.4 163.96 26.89 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 118.223 0.465 . . . . 0.0 109.909 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.73 161.04 43.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.719 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -151.38 128.96 11.45 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.95 161.74 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.594 -0.691 . . . . 0.0 111.528 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.6 mt -118.51 169.34 9.86 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.684 1.594 . . . . 0.0 108.856 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.492 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.5 mt -134.48 163.08 30.49 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.834 -1.166 . . . . 0.0 109.187 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -120.54 133.1 55.43 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -136.84 148.71 47.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 109.426 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -122.32 138.36 54.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.24 128.57 21.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -139.53 159.27 42.56 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.495 1.118 . . . . 0.0 111.476 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.88 -100.39 0.53 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 124.907 1.242 . . . . 0.0 111.622 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.4 mtp -128.87 -17.0 4.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.091 0.946 . . . . 0.0 113.099 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p -146.69 -178.31 6.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.902 2.081 . . . . 0.0 108.184 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.5 p -123.24 -17.54 6.58 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.008 0.923 . . . . 0.0 110.244 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -68.97 -79.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.983 0.811 . . . . 0.0 110.399 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -79.92 -14.49 58.58 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -52.46 -43.59 65.04 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.293 1.037 . . . . 0.0 110.531 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.61 -38.54 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.289 1.436 . . . . 0.0 110.741 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.62 -45.33 83.5 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.051 0.842 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.11 86.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.207 0.458 . . . . 0.0 109.888 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.22 -54.05 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.383 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -61.47 -38.65 88.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.174 1.352 . . . . 0.0 110.469 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -55.18 -50.55 69.04 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.306 0.642 . . . . 0.0 109.308 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.81 -51.63 38.72 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.52 -27.76 69.48 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -60.91 -9.6 4.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.488 1.04 . . . . 0.0 112.697 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.19 -29.64 58.31 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 114.027 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.95 156.63 91.77 Favored Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 121.446 -0.784 . . . . 0.0 112.248 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.7 -50.69 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.87 1.713 . . . . 0.0 109.77 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.32 34.04 0.02 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 121.207 -0.933 . . . . 0.0 112.231 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.11 -33.53 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 112.757 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.69 165.86 33.97 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -114.65 104.1 11.65 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.94 137.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.03 117.88 13.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.22 143.93 12.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -89.29 153.94 20.49 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.119 0.872 . . . . 0.0 108.925 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.51 -48.13 35.65 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.533 -1.354 . . . . 0.0 109.666 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -66.82 -22.56 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -145.48 145.97 31.29 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.748 1.158 . . . . 0.0 108.736 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.91 10.68 2.95 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.616 2.055 . . . . 0.0 114.414 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.62 163.94 14.37 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.2 162.5 39.34 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 126.256 1.822 . . . . 0.0 109.877 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.07 142.36 49.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.19 117.13 44.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.148 0.975 . . . . 0.0 108.8 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.93 104.95 12.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.903 2.081 . . . . 0.0 105.613 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.7 -176.27 39.03 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -95.18 7.52 45.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.569 1.148 . . . . 0.0 113.227 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.5 156.52 19.28 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.094 -1.003 . . . . 0.0 113.491 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.64 119.25 71.91 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -57.71 -41.03 74.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.901 1.734 . . . . 0.0 110.698 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -38.78 75.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.832 0.853 . . . . 0.0 110.648 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.8 82.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.76 0.709 . . . . 0.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.27 -46.53 73.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.14 -38.83 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.706 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -47.99 83.75 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.397 0.999 . . . . 0.0 109.776 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.21 87.17 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.256 1.022 . . . . 0.0 111.557 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.72 -34.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.128 0.571 . . . . 0.0 110.076 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -64.48 -51.68 61.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -67.81 -16.1 63.95 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.46 -9.13 59.56 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.29 -0.881 . . . . 0.0 108.941 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.35 52.81 3.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -141.08 175.26 9.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.981 1.712 . . . . 0.0 108.26 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -118.42 147.49 43.52 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.15 167.41 22.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -148.24 143.09 26.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -100.07 143.03 14.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -143.14 51.69 1.38 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 109.242 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.264 0 C-N-CA 128.54 2.736 . . . . 0.0 107.078 -178.487 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.85 157.39 16.41 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 120.995 -1.066 . . . . 0.0 108.395 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -115.12 124.21 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.64 148.35 38.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.03 1.332 . . . . 0.0 108.115 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -118.71 138.4 52.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.15 133.72 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -145.04 108.63 4.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.91 -97.54 1.57 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.8 mtt -143.6 -60.29 0.41 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -132.33 120.99 22.83 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -109.99 50.12 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.375 1.87 . . . . 0.0 112.147 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -111.21 -92.04 0.46 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -57.42 -31.23 65.65 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.645 1.111 . . . . 0.0 110.33 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 t -52.91 -37.24 60.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.351 2.26 . . . . 0.0 111.592 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -52.38 -41.99 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 119.181 0.901 . . . . 0.0 110.825 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 ttp -62.97 -47.58 82.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.829 0.286 . . . . 0.0 110.325 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 -52.08 62.55 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.354 1.062 . . . . 0.0 112.788 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.98 -44.65 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.463 -0.78 . . . . 0.0 109.223 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -60.73 -49.83 75.92 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.8 0.727 . . . . 0.0 109.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -51.11 -48.53 61.69 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.558 1.143 . . . . 0.0 110.323 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.06 52.72 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.444 0.465 . . . . 0.0 110.828 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.81 -29.11 62.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 112.563 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.56 -13.27 61.0 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.297 -0.877 . . . . 0.0 112.136 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.41 -56.04 27.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.567 1.076 . . . . 0.0 110.013 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.61 116.05 30.66 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.14 174.19 11.76 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.254 1.969 . . . . 0.0 110.642 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.53 12.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.226 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.409 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 71.3 t -114.76 -59.08 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 118.65 1.225 . . . . 0.0 109.434 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.304 74.4 mt-10 63.68 -44.58 0.25 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.286 2.635 . . . . 0.0 110.634 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -95.77 110.35 22.52 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.229 1.812 . . . . 0.0 110.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.16 144.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.063 1.345 . . . . 0.0 107.507 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.2 143.71 34.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.93 140.54 48.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.769 1.227 . . . . 0.0 108.669 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -115.72 115.29 26.09 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.8 -32.57 65.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -71.95 -9.21 58.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.738 0.815 . . . . 0.0 111.889 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 -14.31 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.28 60.12 Favored Glycine 0 N--CA 1.467 0.716 0 CA-C-N 120.723 1.601 . . . . 0.0 110.215 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.98 170.43 15.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.669 0.735 . . . . 0.0 112.169 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.91 157.71 43.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.372 1.869 . . . . 0.0 109.015 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.43 139.15 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.867 2.067 . . . . 0.0 106.443 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.45 121.6 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 123.287 0.635 . . . . 0.0 110.139 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -106.6 104.84 14.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . 175.24 -157.73 24.71 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.551 1.072 . . . . 0.0 111.208 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.8 p -113.48 16.94 18.7 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.431 2.292 . . . . 0.0 113.946 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.87 151.86 46.04 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.94 149.67 74.04 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.161 2.185 . . . . 0.0 109.564 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.92 -49.69 3.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 110.739 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -56.49 -49.3 75.1 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.036 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.54 -37.96 66.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.645 0.591 . . . . 0.0 111.866 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -73.87 -51.82 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.484 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.66 -36.28 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.096 0.862 . . . . 0.0 110.241 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -73.3 -40.55 64.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.943 0.897 . . . . 0.0 110.314 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.19 80.01 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.692 1.133 . . . . 0.0 108.6 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.266 17.6 m -71.58 -32.26 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.783 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.97 -28.77 62.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 120.054 1.297 . . . . 0.0 109.881 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -61.09 -18.72 59.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.414 1.007 . . . . 0.0 111.944 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.3 -6.5 58.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.516 1.053 . . . . 0.0 111.996 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.48 44.96 7.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 119.383 0.992 . . . . 0.0 113.545 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -141.19 175.72 9.41 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.863 2.465 . . . . 0.0 108.021 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -114.41 149.3 36.42 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.765 1.621 . . . . 0.0 108.738 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.97 155.72 37.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 175.29 10.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.94 -178.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.864 0.84 . . . . 0.0 110.569 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.29 111.1 2.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.74 -1.124 . . . . 0.0 108.157 -179.69 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mtp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.4 mt -140.39 163.39 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -133.86 105.33 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 tp -95.64 147.89 23.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 123.09 49.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.82 140.26 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -139.34 121.8 16.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.358 0.981 . . . . 0.0 110.904 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.4 -112.46 0.51 Allowed Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 29.6 mmm -58.61 -54.79 43.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.156 1.382 . . . . 0.0 113.76 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 p 45.35 50.22 10.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.375 1.47 . . . . 0.0 109.193 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -92.85 168.36 11.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.984 0.897 . . . . 0.0 112.61 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -62.08 -43.1 99.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.157 0.983 . . . . 0.0 113.01 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -89.36 -38.87 13.82 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -52.01 -28.12 15.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.09 -37.75 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 119.605 1.093 . . . . 0.0 110.105 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.7 mmt -59.03 -44.44 91.75 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.374 -0.829 . . . . 0.0 110.343 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.3 68.89 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 108.882 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.26 -48.54 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.992 0.917 . . . . 0.0 109.595 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.4 m -58.79 -50.11 75.17 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.436 -0.79 . . . . 0.0 109.16 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -63.08 -34.66 78.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.304 0.956 . . . . 0.0 111.495 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.19 79.22 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -64.84 -48.05 75.73 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.458 -0.776 . . . . 0.0 110.033 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -63.5 -6.76 5.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 112.523 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -65.38 -20.04 66.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.262 1.392 . . . . 0.0 110.834 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.1 t -71.31 117.11 53.85 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -53.95 -66.1 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 118.387 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.76 -10.46 45.01 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -71.9 -57.37 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.868 2.334 . . . . 0.0 109.671 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 54.1 0.39 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.546 2.338 . . . . 0.0 116.549 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -131.19 106.93 8.65 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.494 1.518 . . . . 0.0 111.163 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.9 144.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.616 1.566 . . . . 0.0 107.224 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -137.35 117.32 13.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 t -114.62 125.64 71.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -75.5 129.87 37.97 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.79 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.91 -43.4 86.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.819 0.848 . . . . 0.0 109.955 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.18 -8.56 59.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.98 161.22 38.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 121.138 1.79 . . . . 0.0 110.904 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.09 46.01 3.49 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -115.02 134.58 55.06 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.113 1.457 . . . . 0.0 107.787 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.07 113.8 12.49 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.1 mt -94.1 143.55 26.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.01 141.09 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.424 0.631 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -114.74 104.42 11.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.43 168.89 23.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -89.32 12.67 15.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.992 1.717 . . . . 0.0 113.315 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.59 135.38 57.33 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.817 0.735 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.02 155.7 77.24 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 113.596 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -60.68 -66.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.941 3.094 . . . . 0.0 112.701 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -27.27 62.34 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.02 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.73 -52.95 63.28 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.442 1.019 . . . . 0.0 108.329 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.03 -47.66 79.36 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 117.716 -1.135 . . . . 0.0 110.465 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.1 t -52.16 -60.55 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 O-C-N 124.315 1.009 . . . . 0.0 109.017 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -40.26 76.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.923 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.64 88.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.991 1.268 . . . . 0.0 113.186 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 m -78.57 -32.8 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 0.0 109.465 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -61.36 -20.28 62.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.491 0.587 . . . . 0.0 110.036 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.65 -23.83 66.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.215 0.916 . . . . 0.0 109.847 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.46 -12.86 53.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.771 1.628 . . . . 0.0 110.727 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.94 -11.7 65.94 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.41 1.957 . . . . 0.0 113.786 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -76.36 144.98 39.78 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.36 1.08 . . . . 0.0 109.217 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -75.95 162.09 28.39 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.95 161.34 38.37 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.557 1.072 . . . . 0.0 111.067 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -147.88 123.66 10.56 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.961 0.904 . . . . 0.0 112.297 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.77 146.4 8.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.438 HD12 ' H ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -68.52 153.07 44.46 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' H ' HD12 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.431 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptp . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.7 mp -140.46 159.62 41.79 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.072 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -100.9 115.79 31.23 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -104.4 143.3 33.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -125.69 128.95 48.61 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.59 152.49 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 125.892 1.677 . . . . 0.0 106.687 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -143.96 165.27 28.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.468 1.907 . . . . 0.0 108.697 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.26 -105.19 1.72 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.867 1.222 . . . . 0.0 111.755 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 85.6 mtp -84.94 -176.98 6.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.167 1.387 . . . . 0.0 110.295 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 p -153.12 105.52 2.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.441 1.096 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.6 t -163.45 148.76 11.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 121.07 1.759 . . . . 0.0 110.45 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -62.58 -41.95 99.26 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 124.304 1.041 . . . . 0.0 111.482 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -60.92 -14.88 25.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -30.67 71.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.573 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 m -58.41 -25.42 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 121.16 1.8 . . . . 0.0 111.421 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.7 mmm -69.61 -50.22 46.47 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.44 -52.44 53.15 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.791 0.836 . . . . 0.0 110.586 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.66 -55.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.645 1.578 . . . . 0.0 109.918 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 m -72.85 -25.45 61.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.811 1.187 . . . . 0.0 111.679 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -66.98 -55.99 12.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.549 1.522 . . . . 0.0 107.917 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.17 68.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.718 0.636 . . . . 0.0 110.166 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.4 -27.46 47.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 117.337 -1.316 . . . . 0.0 113.724 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -51.2 -21.8 2.25 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.975 1.716 . . . . 0.0 111.329 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 0.4 3.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.622 1.569 . . . . 0.0 113.21 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.91 143.11 23.94 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 120.796 1.635 . . . . 0.0 111.575 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.44 -81.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.349 3.366 . . . . 0.0 113.607 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.97 0.55 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.416 1.008 . . . . 0.0 110.619 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.68 -58.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.388 0.675 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 62.65 -14.95 0.06 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.907 1.683 . . . . 0.0 115.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -127.46 107.98 10.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.513 1.506 . . . . 0.0 111.657 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.12 119.3 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -119.19 143.54 47.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.861 2.064 . . . . 0.0 107.296 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.39 141.55 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.967 1.307 . . . . 0.0 108.081 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -88.03 118.65 27.74 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.78 -39.58 93.83 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.85 -9.1 59.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.549 1.068 . . . . 0.0 112.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -123.48 -168.91 1.85 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.226 1.41 . . . . 0.0 110.216 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.46 70.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 105.514 -3.034 . . . . 0.0 105.514 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -151.07 162.76 40.24 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 117.79 0.795 . . . . 0.0 109.468 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.86 154.73 40.81 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.274 1.03 . . . . 0.0 111.033 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -117.25 119.54 35.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 t -123.72 112.93 35.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 123.561 0.538 . . . . 0.0 110.194 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -104.72 105.78 16.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.743 0.817 . . . . 0.0 111.36 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.3 179.61 45.02 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.2 p -81.6 -12.08 58.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.041 0.936 . . . . 0.0 113.026 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.14 135.22 26.02 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.851 1.26 . . . . 0.0 112.692 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.82 143.17 98.43 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 125.895 1.678 . . . . 0.0 111.808 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.9 -32.24 36.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.827 1.685 . . . . 0.0 110.334 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -63.79 -48.93 74.92 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.689 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.34 67.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 123.846 0.716 . . . . 0.0 110.512 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -57.52 -52.78 64.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.768 0.827 . . . . 0.0 111.692 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.18 -46.85 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -31.71 71.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.97 -51.08 27.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.827 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.261 16.8 m -61.94 -32.9 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.442 1.019 . . . . 0.0 113.227 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.18 -20.05 50.49 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.96 -0.462 . . . . 0.0 111.58 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -73.87 -16.63 61.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.09 -52.07 5.14 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.341 1.428 . . . . 0.0 113.151 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.32 20.33 0.04 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.68 173.91 11.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.293 1.437 . . . . 0.0 108.243 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.4 163.67 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.354 -0.841 . . . . 0.0 108.794 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.79 165.82 34.83 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.629 0.728 . . . . 0.0 111.159 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -147.6 155.25 41.62 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.424 2.29 . . . . 0.0 105.762 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.02 137.8 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 O-C-N 121.224 -0.922 . . . . 0.0 111.28 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 tt -92.17 111.68 23.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.761 2.024 . . . . 0.0 105.743 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 125.579 1.552 . . . . 0.0 110.088 -179.738 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.7 mt -145.13 166.06 26.49 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 66' ' ' ALA . 33.3 mttm -127.94 124.88 38.42 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -109.06 115.68 30.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.681 1.192 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -88.48 124.35 33.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.74 131.67 69.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -138.92 156.82 46.97 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.374 1.07 . . . . 0.0 108.159 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.32 -74.17 0.26 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 108.081 -2.007 . . . . 0.0 108.081 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.2 tpp -149.29 142.66 25.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.04 116.72 22.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.2 m -144.72 117.17 8.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -59.66 -44.24 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.364 0.665 . . . . 0.0 109.837 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.85 -12.06 51.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.58 -33.21 72.38 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.946 1.248 . . . . 0.0 108.807 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.75 -31.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.519 1.127 . . . . 0.0 110.681 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.49 -51.11 60.24 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.73 97.56 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.892 0.877 . . . . 0.0 110.757 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.91 -51.99 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -63.07 -40.36 97.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.716 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -56.84 -55.38 35.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.353 0.979 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.8 85.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 122.522 0.329 . . . . 0.0 111.672 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -45.04 92.65 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -62.25 -8.46 5.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.971 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -60.89 -18.54 56.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.306 1.867 . . . . 0.0 110.749 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.24 127.13 23.19 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.51 126.93 13.34 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.679 2.919 . . . . 0.0 111.418 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.7 -17.1 8.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-O 116.758 -2.134 . . . . 0.0 113.974 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.91 2.53 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 121.176 2.488 . . . . 0.0 115.238 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -66.76 -1.64 4.09 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -95.77 104.22 16.14 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.44 139.19 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.5 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -123.08 116.54 23.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.45 131.84 53.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.91 1.684 . . . . 0.0 109.488 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 m -70.19 130.94 43.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.02 -48.62 34.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.95 0.405 . . . . 0.0 110.217 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.5 -52.25 7.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.611 1.164 . . . . 0.0 110.956 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -82.62 175.63 10.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.25 3.65 35.16 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.403 -1.221 . . . . 0.0 115.757 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -91.11 146.68 23.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.807 2.304 . . . . 0.0 109.151 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.58 138.75 44.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.766 1.627 . . . . 0.0 107.793 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.01 130.17 48.49 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -120.17 112.67 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.634 1.174 . . . . 0.0 108.8 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -90.4 114.91 27.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.93 41.67 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 118.775 0.716 . . . . 0.0 113.217 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 t -125.77 3.72 7.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.956 1.302 . . . . 0.0 112.916 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 156.7 32.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.542 0.687 . . . . 0.0 112.65 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.35 133.55 90.87 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 125.086 1.355 . . . . 0.0 109.104 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.65 -44.17 23.1 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.547 2.165 . . . . 0.0 110.151 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -56.51 -30.45 63.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.971 0.908 . . . . 0.0 112.05 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -39.69 79.21 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.635 0.652 . . . . 0.0 109.549 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.99 -45.12 74.98 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 123.717 0.807 . . . . 0.0 109.077 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -57.83 -58.5 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -60.72 -36.44 78.85 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.357 0.526 . . . . 0.0 112.063 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.28 99.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.952 0.797 . . . . 0.0 110.712 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.5 t -73.86 -33.14 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -60.62 -37.35 81.13 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.395 0.998 . . . . 0.0 110.284 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.65 -19.84 62.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.646 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -87.84 -3.41 58.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 112.225 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.53 37.12 6.25 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.058 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.54 172.96 11.82 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.401 1.101 . . . . 0.0 110.091 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -118.58 109.38 16.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.75 159.23 16.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.1 0.56 . . . . 0.0 111.552 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -158.3 159.26 35.73 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.0 2.52 . . . . 0.0 107.187 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.18 144.81 17.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.457 HD21 ' H ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -147.16 159.8 43.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.7 0.682 . . . . 0.0 110.718 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.457 ' H ' HD21 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.248 0.975 0 C-N-CA 125.861 1.665 . . . . 0.0 108.633 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.09 165.33 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -133.95 141.86 47.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.3 tp -122.65 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.521 1.529 . . . . 0.0 108.978 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -87.15 136.76 32.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.4 133.13 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 125.557 1.543 . . . . 0.0 107.236 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -145.13 163.77 33.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.48 -123.37 5.56 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.245 1.402 . . . . 0.0 113.949 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -68.0 83.03 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 129.658 3.183 . . . . 0.0 111.341 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.98 78.69 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.786 2.434 . . . . 0.0 111.06 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -137.79 161.83 35.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.981 1.712 . . . . 0.0 109.241 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.31 -57.83 4.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.995 1.718 . . . . 0.0 112.805 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -60.47 -19.1 55.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.7 m -63.26 -34.05 76.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.85 1.205 . . . . 0.0 109.667 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.23 -39.12 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.374 1.069 . . . . 0.0 109.734 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 48.6 tpp -62.16 -47.2 85.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.55 -52.32 66.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.124 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.47 -43.52 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.716 1.144 . . . . 0.0 113.092 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.9 t -60.68 -44.49 96.44 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.295 1.861 . . . . 0.0 110.002 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -69.23 -48.3 62.34 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.657 -0.652 . . . . 0.0 111.678 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.15 73.27 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.602 0.761 . . . . 0.0 111.288 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.567 HD22 ' HG ' ' A' ' 51' ' ' LEU . 19.6 mt -73.13 -52.13 15.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.708 0.686 . . . . 0.0 110.076 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -69.38 -3.7 15.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -53.56 -40.67 65.78 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.589 0.756 . . . . 0.0 111.039 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.22 136.52 37.89 Favored Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.44 115.06 3.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 106.79 -2.042 . . . . 0.0 106.79 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.88 -92.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.759 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 t -64.75 -57.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 66.22 -31.6 0.16 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.278 2.231 . . . . 0.0 112.444 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -101.2 102.76 13.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.577 1.951 . . . . 0.0 106.374 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.36 127.12 37.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.548 1.139 . . . . 0.0 108.008 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.06 144.84 51.33 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.437 1.495 . . . . 0.0 111.911 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.12 143.04 42.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.729 1.612 . . . . 0.0 107.314 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -77.5 137.28 38.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 109.175 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.34 -48.09 44.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -80.76 -20.97 41.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.77 161.63 32.42 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.075 1.307 . . . . 0.0 109.485 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.21 36.16 3.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -104.26 141.62 35.97 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 120.372 -1.664 . . . . 0.0 107.583 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.22 146.06 51.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 108.562 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.93 144.31 50.73 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.015 1.726 . . . . 0.0 106.703 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.37 141.29 42.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.535 0.734 . . . . 0.0 110.909 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.13 104.19 8.39 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.446 1.117 . . . . 0.0 109.179 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.83 41.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 126.436 1.969 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -117.38 12.72 14.34 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.71 156.27 30.9 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.216 0.916 . . . . 0.0 110.436 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.31 154.93 81.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 113.24 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.7 -51.63 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.14 2.56 . . . . 0.0 109.213 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -55.48 -40.33 71.52 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.128 -1.415 . . . . 0.0 111.074 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.24 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 120.136 1.335 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HG ' HD22 ' A' ' 22' ' ' LEU . 10.5 mp -70.01 -53.13 19.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.29 0.636 . . . . 0.0 110.666 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.8 t -52.51 -54.96 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.942 0.897 . . . . 0.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.32 -47.42 86.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.121 1.369 . . . . 0.0 110.421 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.75 -45.34 74.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.638 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.438 HG13 HD21 ' A' ' 22' ' ' LEU . 33.3 m -73.86 -32.71 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 119.06 0.845 . . . . 0.0 111.274 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -56.45 -39.16 72.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 112.227 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.83 -34.15 62.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -16.89 61.47 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.398 0.545 . . . . 0.0 112.218 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.29 0.16 47.26 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.544 1.068 . . . . 0.0 110.96 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -78.83 172.27 13.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.377 1.071 . . . . 0.0 109.519 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.35 149.19 39.74 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.57 170.01 23.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.493 1.139 . . . . 0.0 111.694 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -158.04 127.6 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.62 142.12 14.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -125.64 94.8 4.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 177.475 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptt? . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.278 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -91.92 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.716 1.143 . . . . 0.0 110.106 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -127.75 141.08 51.69 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.7 tp -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -86.75 133.98 33.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 100.639 -3.837 . . . . 0.0 100.639 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.43 118.85 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -127.58 145.66 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.94 -176.39 41.47 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.45 -22.8 66.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.905 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -123.18 154.64 38.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.116 1.366 . . . . 0.0 108.152 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 p -133.36 -5.51 2.97 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.664 1.186 . . . . 0.0 113.22 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -115.8 -67.92 0.96 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.406 1.082 . . . . 0.0 111.115 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 -20.54 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.818 -1.176 . . . . 0.0 113.447 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -59.75 -27.67 66.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.771 1.229 . . . . 0.0 112.049 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 m -52.5 -29.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 119.094 0.861 . . . . 0.0 112.865 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 9.9 tpt -67.57 -50.73 57.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.19 74.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.865 0.866 . . . . 0.0 110.374 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -56.27 -55.03 20.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 110.912 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.3 m -68.33 -36.33 79.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.471 1.032 . . . . 0.0 111.222 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -47.75 84.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.26 -49.53 75.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.516 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.38 -28.11 64.86 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.831 1.196 . . . . 0.0 112.303 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -58.27 -29.97 66.22 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.488 -0.758 . . . . 0.0 109.58 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -60.9 -16.95 47.79 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 117.258 -1.354 . . . . 0.0 112.83 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.46 92.07 1.7 Allowed Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 119.516 1.053 . . . . 0.0 108.817 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.67 117.16 4.99 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 105.878 -2.393 . . . . 0.0 105.878 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.27 -10.46 5.04 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.002 -1.443 . . . . 0.0 113.117 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.8 t -85.53 -56.93 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 120.166 1.983 . . . . 0.0 106.551 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 63.8 -19.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -130.04 114.49 15.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.829 2.104 . . . . 0.0 110.778 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.6 m -140.09 144.36 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.802 1.241 . . . . 0.0 109.737 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.01 144.75 32.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.957 1.303 . . . . 0.0 109.49 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.46 129.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -76.65 132.52 39.44 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.773 1.229 . . . . 0.0 111.243 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.2 mt -73.56 -48.61 31.57 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.2 1.0 . . . . 0.0 112.749 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.01 -31.61 69.37 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -135.68 161.62 35.03 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.632 1.106 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.59 43.22 1.33 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.236 1.398 . . . . 0.0 112.794 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -104.71 152.51 22.43 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.54 151.85 38.79 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.962 1.305 . . . . 0.0 108.387 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.41 144.6 47.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.091 1.756 . . . . 0.0 107.433 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -138.26 116.19 12.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.89 104.83 13.82 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.13 162.65 12.19 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 t -75.05 31.8 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.234 1.814 . . . . 0.0 112.321 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.71 149.77 8.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.946 1.298 . . . . 0.0 112.447 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.73 131.07 46.48 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.694 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -49.74 -61.81 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.605 2.87 . . . . 0.0 113.634 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -58.02 -23.16 53.05 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.868 -1.063 . . . . 0.0 112.633 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.76 -39.65 66.64 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.382 1.446 . . . . 0.0 109.334 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.09 -48.71 67.37 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.33 -55.86 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.068 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.51 -29.86 71.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.472 -0.775 . . . . 0.0 111.865 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.01 82.8 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.742 1.156 . . . . 0.0 108.726 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.17 -36.89 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.783 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.15 -36.43 72.99 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.234 1.014 . . . . 0.0 113.258 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.53 -15.3 49.92 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.233 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.31 8.71 29.92 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.087 1.312 . . . . 0.0 111.833 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.63 38.39 9.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.46 152.16 43.66 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.99 152.17 19.54 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.6 159.28 42.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.637 0.586 . . . . 0.0 110.867 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -153.59 117.19 4.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.04 168.3 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 124.398 1.079 . . . . 0.0 108.471 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -69.7 -176.05 0.98 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.721 0.808 . . . . 0.0 110.947 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.877 1.671 . . . . 0.0 108.925 -179.613 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 2' ' ' LEU . 3.5 mm? -114.7 165.33 12.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.893 0.854 . . . . 0.0 108.989 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -133.92 123.25 24.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 tp -97.13 111.76 23.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.663 1.185 . . . . 0.0 108.39 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 134.94 33.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.97 164.75 31.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -147.17 139.29 24.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.05 -152.11 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 mmt -63.57 157.68 23.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.027 0.442 . . . . 0.0 110.328 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -57.61 -80.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.714 2.005 . . . . 0.0 113.926 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 p -146.43 132.53 19.32 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.74 1.216 . . . . 0.0 110.148 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -172.15 -173.47 1.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.851 1.261 . . . . 0.0 109.61 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -56.67 -13.91 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.772 2.029 . . . . 0.0 113.111 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.0 m -52.94 -28.89 25.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.341 1.457 . . . . 0.0 110.958 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.34 -42.11 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.21 0.914 . . . . 0.0 109.089 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.3 mmm -63.01 -40.55 98.11 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.399 -0.813 . . . . 0.0 110.625 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB1' ' CD ' ' A' ' 58' ' ' GLU . . . -66.08 -52.88 44.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.495 1.118 . . . . 0.0 110.416 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.18 -40.94 86.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-O 117.696 -1.145 . . . . 0.0 110.278 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.9 m -59.36 -43.57 92.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.808 1.64 . . . . 0.0 108.839 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -64.3 -37.9 89.14 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.907 -1.121 . . . . 0.0 110.757 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -44.97 68.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.508 0.723 . . . . 0.0 110.668 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -32.27 31.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.835 2.454 . . . . 0.0 109.635 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -53.08 -23.26 7.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.081 1.353 . . . . 0.0 112.715 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.29 -12.62 1.69 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.921 1.289 . . . . 0.0 114.472 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.5 m -53.78 152.54 9.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.828 0.74 . . . . 0.0 110.851 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.26 32.27 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.101 3.201 . . . . 0.0 111.514 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.91 91.66 1.61 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 p -112.89 -36.22 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.533 0.733 . . . . 0.0 111.328 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 67.15 -36.91 0.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.67 2.788 . . . . 0.0 113.733 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -104.86 106.61 17.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.1 144.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -143.72 140.76 30.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.52 141.64 45.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -89.08 131.7 35.12 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -72.32 -48.5 41.61 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.275 0.63 . . . . 0.0 110.947 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -82.49 -9.88 59.24 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -135.15 159.6 41.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.696 1.589 . . . . 0.0 111.734 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 59.84 4.74 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.12 138.6 22.88 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 118.566 1.183 . . . . 0.0 110.594 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.55 155.6 48.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.428 1.891 . . . . 0.0 110.268 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.16 142.73 46.65 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 126.553 1.941 . . . . 0.0 107.514 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.32 131.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.87 105.39 8.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.31 -155.39 26.16 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.699 -0.626 . . . . 0.0 111.8 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 t -89.3 -6.53 56.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.997 1.319 . . . . 0.0 114.066 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.66 123.7 10.64 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.447 1.021 . . . . 0.0 112.766 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.69 153.8 95.42 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 125.694 1.598 . . . . 0.0 108.737 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 -46.47 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.297 1.998 . . . . 0.0 109.944 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -58.45 -28.09 64.99 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.118 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.55 -51.19 64.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.21 -40.64 86.45 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.457 0.703 . . . . 0.0 111.18 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.36 -51.79 59.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.04 -30.46 70.99 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.167 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.99 77.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.893 0.77 . . . . 0.0 110.309 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -88.39 -32.57 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.211 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.85 -30.56 71.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.197 0.999 . . . . 0.0 110.882 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.61 -19.55 64.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.296 0.953 . . . . 0.0 108.864 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.52 ' CD ' ' HB1' ' A' ' 17' ' ' ALA . 75.6 mm-40 -97.63 3.5 50.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.581 1.553 . . . . 0.0 109.605 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.85 86.53 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.778 2.132 . . . . 0.0 114.293 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -74.07 166.35 23.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.241 2.021 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -117.72 129.26 55.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 116.403 -1.76 . . . . 0.0 107.752 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.57 160.38 42.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 121.835 2.107 . . . . 0.0 114.355 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.25 163.68 39.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.64 2.376 . . . . 0.0 107.394 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.5 154.76 16.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.781 -1.199 . . . . 0.0 109.228 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 65' ' ' LEU . 1.6 tm? -119.42 108.14 14.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 C-N-CA 124.534 1.134 . . . . 0.0 110.952 -178.928 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.84 165.51 12.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.387 1.475 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 118.0 22.55 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.079 1.752 . . . . 0.0 106.39 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tt -137.4 147.58 45.54 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.275 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -123.81 139.69 53.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.826 1.194 . . . . 0.0 110.42 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.95 138.0 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.576 1.151 . . . . 0.0 110.253 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.25 110.54 3.72 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.359 1.076 . . . . 0.0 111.413 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.0 -48.33 1.25 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 124.665 1.126 . . . . 0.0 113.077 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 7.3 tpt -160.78 159.56 30.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.559 1.18 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -82.51 79.0 9.07 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -149.95 138.17 20.45 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -60.42 -37.86 82.23 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -57.85 -26.98 62.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.996 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -60.01 -36.11 76.53 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.439 1.018 . . . . 0.0 110.745 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.75 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.1 mtt -65.15 -40.82 94.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.881 -0.512 . . . . 0.0 110.982 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.17 -51.28 68.45 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.415 1.086 . . . . 0.0 111.206 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.09 -37.86 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 117.972 -1.013 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 m -60.13 -50.65 72.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.924 1.238 . . . . 0.0 108.122 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -54.14 -43.13 70.27 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.133 0.973 . . . . 0.0 111.13 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.96 59.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.069 0.948 . . . . 0.0 110.088 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 mt -56.67 -34.38 67.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.223 1.409 . . . . 0.0 112.047 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -63.55 -6.08 4.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.725 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -22.61 61.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 120.314 1.416 . . . . 0.0 111.706 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.11 95.75 13.67 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.03 45.27 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.095 3.196 . . . . 0.0 112.618 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.93 17.46 5.18 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.725 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 -57.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 119.402 1.601 . . . . 0.0 107.401 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 70.02 -53.26 0.63 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.089 2.155 . . . . 0.0 113.158 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -95.87 103.32 15.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.454 1.025 . . . . 0.0 109.073 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.78 134.09 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.507 1.123 . . . . 0.0 108.965 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -142.76 142.11 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 t -134.48 143.3 38.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 125.249 1.42 . . . . 0.0 109.391 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.45 145.0 35.29 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.0 -47.33 46.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.084 -1.01 . . . . 0.0 112.289 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -77.42 -24.18 50.45 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -133.23 147.86 51.99 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.891 1.223 . . . . 0.0 108.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.64 25.11 1.44 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.426 -1.208 . . . . 0.0 113.763 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -90.28 143.55 26.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.433 2.116 . . . . 0.0 108.237 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.05 162.69 34.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.3 1.04 . . . . 0.0 112.193 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.2 140.97 52.39 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.033 2.133 . . . . 0.0 106.445 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.57 146.33 27.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.134 0.968 . . . . 0.0 108.666 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -139.01 120.21 14.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.84 170.36 21.76 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 p -75.73 6.53 4.8 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.81 133.71 47.71 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.254 -0.904 . . . . 0.0 111.438 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.0 142.48 79.55 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.188 0.995 . . . . 0.0 111.165 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.2 -43.07 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.866 2.377 . . . . 0.0 113.889 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -56.65 -40.7 75.93 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.652 0.781 . . . . 0.0 111.235 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.3 95.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.941 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.08 -50.55 70.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.839 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.48 -48.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.691 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -65.93 -31.92 73.13 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.639 1.109 . . . . 0.0 111.291 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.4 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.568 0.622 . . . . 0.0 109.933 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 m -74.57 -33.18 31.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -56.55 -26.08 53.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.044 1.738 . . . . 0.0 114.627 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.56 -29.17 67.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.377 0.99 . . . . 0.0 112.398 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.07 4.37 17.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.857 -0.527 . . . . 0.0 111.707 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.1 45.24 83.93 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -123.68 150.72 43.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.525 1.53 . . . . 0.0 108.314 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 153.91 36.67 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.266 0.555 . . . . 0.0 110.36 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.11 26.45 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -152.89 158.14 41.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.97 152.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 120.865 -1.147 . . . . 0.0 109.03 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -137.95 85.53 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.987 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 pp -146.71 165.83 28.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.454 0.701 . . . . 0.0 110.679 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -112.07 104.56 12.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.578 1.18 . . . . 0.0 111.353 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 tt -98.88 148.32 24.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.869 2.068 . . . . 0.0 108.343 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -129.35 140.31 51.42 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.791 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.55 142.34 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.68 122.86 18.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.199 1.8 . . . . 0.0 110.234 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.33 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.2 mtt -142.48 132.57 24.56 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 m -74.82 81.57 2.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.787 0.835 . . . . 0.0 110.308 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -151.54 173.7 14.3 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.162 1.785 . . . . 0.0 108.134 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -67.36 -31.26 71.39 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.826 0.851 . . . . 0.0 112.244 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -61.08 -31.66 71.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.389 0.995 . . . . 0.0 111.686 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.3 t -62.49 -50.57 70.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -52.4 -50.13 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.245 1.418 . . . . 0.0 108.587 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 65.6 mtp -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.051 0.541 . . . . 0.0 110.219 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.53 64.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 m -64.05 -48.6 85.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.092 0.86 . . . . 0.0 111.182 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -63.38 -41.64 98.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.416 1.007 . . . . 0.0 110.118 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -64.33 -30.65 71.69 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.938 -1.727 . . . . 0.0 110.261 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.68 -51.43 41.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.034 0.834 . . . . 0.0 109.456 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.54 -33.82 76.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.892 0.477 . . . . 0.0 110.715 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -61.74 -7.23 3.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.109 0.964 . . . . 0.0 111.888 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HE3' ' CB ' ' A' ' 54' ' ' ALA . 0.6 OUTLIER -57.86 -33.23 68.47 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.589 1.54 . . . . 0.0 109.687 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.0 158.35 41.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.59 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.017 2.478 . . . . 0.0 111.371 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 74.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 105.633 -2.987 . . . . 0.0 105.633 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.16 -34.89 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.27 0.628 . . . . 0.0 110.605 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -176.41 -78.64 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.973 2.509 . . . . 0.0 106.416 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -155.72 151.41 27.31 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.082 1.31 . . . . 0.0 110.984 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.8 135.91 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 125.914 1.686 . . . . 0.0 106.799 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -143.27 140.7 30.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.78 131.48 42.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.49 1.116 . . . . 0.0 109.009 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 p -106.14 117.9 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.629 0.728 . . . . 0.0 110.931 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -18.37 61.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.077 0.951 . . . . 0.0 113.457 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -78.38 -15.53 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 112.958 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -137.26 -15.82 1.44 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.09 12.83 83.77 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.4 1.0 . . . . 0.0 112.749 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -93.29 146.74 23.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.868 1.334 . . . . 0.0 108.421 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.83 114.78 16.96 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.962 2.105 . . . . 0.0 109.168 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.89 134.2 34.34 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.25 131.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.798 1.285 . . . . 0.0 112.006 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -123.92 145.48 49.1 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 127.226 2.211 . . . . 0.0 108.581 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.6 177.17 15.44 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 126.246 1.879 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.3 p -66.21 5.14 0.57 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.482 2.313 . . . . 0.0 113.595 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.54 140.45 56.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.929 -1.107 . . . . 0.0 108.315 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.94 129.53 39.45 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -58.34 -31.2 93.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.752 1.635 . . . . 0.0 112.268 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -57.06 -46.49 82.42 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.814 1.188 . . . . 0.0 110.487 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.86 76.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.619 0.768 . . . . 0.0 110.753 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 118.886 -0.578 . . . . 0.0 111.389 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.13 -52.95 52.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -60.67 -33.64 73.13 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.545 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.471 ' CB ' ' HE3' ' A' ' 24' ' ' LYS . . . -60.49 -50.89 71.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.428 1.467 . . . . 0.0 110.082 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.84 -32.45 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.34 -44.61 71.27 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.033 1.333 . . . . 0.0 109.879 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.38 -23.44 66.32 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.784 0.834 . . . . 0.0 109.802 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.67 -14.67 62.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.801 1.24 . . . . 0.0 108.921 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.57 30.0 5.73 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 128.01 2.719 . . . . 0.0 115.518 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.49 175.33 9.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.207 2.003 . . . . 0.0 112.574 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -100.06 134.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.32 160.9 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -149.41 164.64 34.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.54 158.53 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 121.582 -0.699 . . . . 0.0 111.065 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -162.39 166.91 24.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.57 2.748 . . . . 0.0 106.045 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 178.352 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.94 166.45 14.41 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.571 0.748 . . . . 0.0 110.537 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -130.07 128.45 41.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.94 122.04 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -93.21 133.95 35.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.409 HG11 ' CG2' ' A' ' 18' ' ' VAL . 79.6 t -132.22 113.0 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -134.0 166.12 23.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.303 0.573 . . . . 0.0 109.833 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.0 170.63 43.39 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -83.68 0.6 46.34 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.047 -0.678 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 t -77.58 177.61 7.93 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.089 0.956 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -83.43 -164.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.421 1.888 . . . . 0.0 112.235 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.24 -2.15 0.91 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.287 1.835 . . . . 0.0 113.294 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -62.11 -13.63 28.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.531 -1.356 . . . . 0.0 111.904 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.03 -38.91 80.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.04 -1.457 . . . . 0.0 113.224 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.59 -52.06 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 120.571 1.532 . . . . 0.0 110.6 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.7 ttp -67.88 -47.03 69.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.163 -0.335 . . . . 0.0 111.326 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.71 63.64 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.478 0.711 . . . . 0.0 111.681 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.409 ' CG2' HG11 ' A' ' 6' ' ' VAL . 79.1 t -62.2 -39.89 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.0 m -61.7 -43.88 98.0 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.218 1.372 . . . . 0.0 109.329 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -56.31 -51.36 68.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.361 0.982 . . . . 0.0 109.091 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.47 69.76 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.89 0.744 . . . . 0.0 111.259 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.8 -30.51 70.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.221 1.408 . . . . 0.0 112.442 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -79.53 -4.28 50.67 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.86 -1.15 . . . . 0.0 112.02 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -36.99 85.79 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.33 1.423 . . . . 0.0 111.455 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.9 148.15 84.01 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.115 0.87 . . . . 0.0 109.4 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.02 -48.57 3.54 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.099 1.866 . . . . 0.0 112.916 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.55 69.92 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.4 -10.48 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.884 0.874 . . . . 0.0 111.938 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.14 163.87 28.26 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.837 -1.165 . . . . 0.0 112.327 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -103.62 134.69 46.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.76 144.18 37.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -144.24 143.13 30.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.251 1.02 . . . . 0.0 111.283 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.5 134.23 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 109.59 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.3 t -72.2 143.17 48.96 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 110.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.4 -28.84 62.22 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -81.67 -27.59 33.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.184 2.194 . . . . 0.0 115.621 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -145.87 160.22 42.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.698 0.799 . . . . 0.0 109.248 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.94 33.88 2.38 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.858 0.742 . . . . 0.0 111.871 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -90.73 125.67 35.76 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 125.014 1.326 . . . . 0.0 107.964 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.38 120.1 37.76 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.791 1.236 . . . . 0.0 109.559 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.13 134.77 34.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.29 132.39 66.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -136.13 105.5 6.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.673 1.189 . . . . 0.0 111.275 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.2 -148.08 11.78 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -121.3 7.87 10.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.844 1.258 . . . . 0.0 111.825 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.31 138.47 57.65 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.511 -0.743 . . . . 0.0 109.075 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.28 148.29 93.62 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.596 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.67 -44.56 10.52 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.591 1.527 . . . . 0.0 110.309 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -55.95 -29.65 60.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -48.44 48.58 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.385 0.993 . . . . 0.0 108.953 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.59 -47.75 68.84 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.258 1.023 . . . . 0.0 110.502 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.28 -52.07 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -60.2 -43.31 96.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 116.533 -1.698 . . . . 0.0 110.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.88 -46.56 67.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.59 1.086 . . . . 0.0 111.465 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 m -73.05 -32.4 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.43 -0.794 . . . . 0.0 111.13 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -68.32 -20.34 64.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.596 1.558 . . . . 0.0 112.544 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -63.49 -11.64 25.43 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.6 5.21 11.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.14 64.09 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 116.387 1.315 . . . . 0.0 116.387 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -74.32 175.96 7.15 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.655 1.728 . . . . 0.0 108.225 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -103.45 124.18 48.25 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.29 120.27 36.48 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.233 1.013 . . . . 0.0 110.183 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -135.64 106.93 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.631 0.772 . . . . 0.0 111.033 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.59 156.48 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.612 -0.68 . . . . 0.0 110.185 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.21 90.9 3.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.301 -1.333 . . . . 0.0 109.659 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 13.0 ptp . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.442 HD13 ' H ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -147.56 166.57 26.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.32 1.848 . . . . 0.0 109.139 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' H ' HD13 ' A' ' 2' ' ' LEU . 5.0 ptpt -122.81 115.19 21.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.655 1.582 . . . . 0.0 107.639 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.38 148.7 43.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.316 1.046 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -124.05 138.57 54.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.63 143.49 40.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.243 1.417 . . . . 0.0 107.776 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -151.38 161.55 42.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.31 -36.86 0.1 Allowed Glycine 0 CA--C 1.521 0.409 0 O-C-N 120.959 -1.088 . . . . 0.0 113.191 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.7 mmt -147.57 3.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.832 1.316 . . . . 0.0 114.201 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.0 p 57.43 5.57 0.31 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 m -73.07 147.58 44.85 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.354 -1.466 . . . . 0.0 111.941 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.18 -23.56 67.49 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.875 0.369 . . . . 0.0 111.978 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -81.08 -4.45 55.29 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.966 -1.084 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 p -57.0 -28.27 62.29 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.08 1.309 . . . . 0.0 111.822 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -54.28 -35.72 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.222 1.409 . . . . 0.0 111.093 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.59 -50.06 70.94 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.95 67.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.08 -49.17 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.967 0.803 . . . . 0.0 110.464 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -54.76 -53.94 48.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.413 1.006 . . . . 0.0 110.002 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -65.19 -33.15 75.33 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.796 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.19 -44.92 74.77 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.256 1.389 . . . . 0.0 108.936 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.68 -30.25 71.26 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.92 0.888 . . . . 0.0 109.137 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -70.44 -14.28 62.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -53.7 -46.52 70.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.646 1.566 . . . . 0.0 110.108 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.13 122.82 84.77 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.07 158.1 42.11 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.662 1.575 . . . . 0.0 109.42 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.31 -70.13 0.21 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-O 117.922 -1.488 . . . . 0.0 116.216 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.07 -57.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.181 1.491 . . . . 0.0 112.555 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 54.86 -26.6 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -96.28 104.63 16.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.026 1.731 . . . . 0.0 110.593 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.26 119.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -110.7 116.88 32.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.8 125.47 54.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.521 1.128 . . . . 0.0 110.405 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.7 t -71.9 132.9 45.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.775 0.798 . . . . 0.0 108.903 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.68 -38.61 64.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.381 1.072 . . . . 0.0 110.604 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -78.52 -46.33 19.8 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -107.81 171.37 7.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.09 0.556 . . . . 0.0 110.432 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.19 15.99 56.87 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.925 -0.931 . . . . 0.0 111.753 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.67 135.45 33.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 118.874 1.337 . . . . 0.0 110.189 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.73 114.7 17.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.997 2.119 . . . . 0.0 107.728 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -77.62 145.46 36.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.9 p -129.48 138.19 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -117.55 104.56 11.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.64 -166.51 37.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.698 2.094 . . . . 0.0 108.524 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -117.47 -2.18 11.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.11 1.764 . . . . 0.0 113.727 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.27 131.65 28.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.453 1.024 . . . . 0.0 112.014 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.56 126.74 31.11 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 126.527 1.931 . . . . 0.0 110.589 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.0 -33.49 98.8 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.491 1.46 . . . . 0.0 112.782 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -61.34 -30.34 70.46 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.134 1.334 . . . . 0.0 111.33 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.93 -44.8 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.48 0.712 . . . . 0.0 110.245 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.74 -53.96 38.96 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.37 -43.49 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.05 -42.32 89.68 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.073 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.69 -41.37 66.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -80.82 -33.66 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.971 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -69.39 -20.92 63.81 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.361 1.464 . . . . 0.0 111.898 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.86 -32.25 71.78 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.945 1.298 . . . . 0.0 108.911 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -75.94 -19.12 59.02 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.21 56.61 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.239 1.876 . . . . 0.0 112.313 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.5 155.66 33.6 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -88.27 150.23 23.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.963 -1.086 . . . . 0.0 109.146 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.75 158.12 43.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -145.7 150.38 36.18 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.675 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.4 147.58 22.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.86 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -146.88 170.73 16.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.182 1.793 . . . . 0.0 109.211 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.12 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.564 ' H1 ' ' CD ' ' A' ' 43' ' ' GLU . 18.0 ptt? . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.2 165.53 13.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.36 148.79 49.53 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.08 145.7 44.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -99.41 132.93 44.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.855 1.262 . . . . 0.0 107.678 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.8 t -126.76 102.11 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -119.74 168.39 11.12 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.112 0.869 . . . . 0.0 112.112 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.16 12.65 0.04 OUTLIER Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.134 2.302 . . . . 0.0 112.326 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.4 ttt 65.35 90.74 0.09 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.925 2.09 . . . . 0.0 109.608 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 m 57.11 80.49 0.16 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.145 1.778 . . . . 0.0 112.075 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 69.0 m -55.27 127.63 30.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.718 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -71.25 -175.82 1.31 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.676 1.19 . . . . 0.0 108.694 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -48.7 -23.14 0.93 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.594 1.558 . . . . 0.0 113.357 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 t -53.96 -28.26 36.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.071 1.348 . . . . 0.0 110.217 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.15 -36.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 119.041 0.837 . . . . 0.0 109.966 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.3 ttm -66.86 -43.31 83.94 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.808 -1.182 . . . . 0.0 109.703 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.95 -52.64 64.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.668 0.787 . . . . 0.0 110.037 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.33 -41.79 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -60.89 -48.7 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.915 -1.116 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -64.22 -37.52 87.75 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 121.731 -0.606 . . . . 0.0 111.68 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.11 -47.53 67.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.346 1.058 . . . . 0.0 109.597 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.5 mt -57.48 -37.65 73.25 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.568 0.747 . . . . 0.0 109.181 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -68.91 -13.07 62.2 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.16 -0.963 . . . . 0.0 112.913 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -73.48 -21.08 60.52 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.538 1.517 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.8 m -52.31 142.06 30.27 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.65 94.04 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.173 3.249 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.16 -74.02 0.37 Allowed Glycine 0 C--N 1.332 0.353 0 O-C-N 121.411 -0.805 . . . . 0.0 112.646 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.6 t -54.64 -58.9 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 117.253 0.527 . . . . 0.0 111.341 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 43.45 19.89 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -150.84 106.32 3.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.132 1.773 . . . . 0.0 109.335 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.0 138.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -141.35 118.36 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -110.79 142.93 21.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 t -90.67 146.34 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.81 -49.35 30.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.14 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -81.62 -57.94 3.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.799 0.439 . . . . 0.0 112.103 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.85 152.32 41.57 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.12 53.28 1.87 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -123.57 133.84 53.91 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.647 1.224 . . . . 0.0 110.863 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.97 115.04 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.256 2.622 . . . . 0.0 108.764 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.35 135.17 34.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.38 133.99 57.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.564 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 16.0 tp10 -123.33 103.64 8.63 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.07 -170.22 41.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.661 1.124 . . . . 0.0 111.995 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -111.85 14.86 21.01 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.728 2.811 . . . . 0.0 115.585 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 142.06 57.63 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.302 -1.499 . . . . 0.0 109.496 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.01 151.1 81.5 Favored Pre-proline 0 C--O 1.237 0.429 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.301 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -55.32 -47.3 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.607 2.205 . . . . 0.0 111.519 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -55.1 -38.76 68.55 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.55 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.67 80.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.829 0.74 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.5 mt -68.21 -47.7 67.18 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.941 -0.474 . . . . 0.0 110.352 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.5 t -55.66 -56.37 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 124.413 1.085 . . . . 0.0 108.722 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -57.34 -50.22 73.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.589 -1.196 . . . . 0.0 110.036 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.11 64.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.303 0.956 . . . . 0.0 111.697 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -76.38 -43.18 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.7 -23.28 64.74 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.079 1.752 . . . . 0.0 110.914 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -62.46 -23.51 66.93 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.089 1.356 . . . . 0.0 110.532 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.29 39.5 mt-10 -104.36 16.43 26.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.836 0.854 . . . . 0.0 111.436 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.96 1.77 49.4 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 127.216 2.341 . . . . 0.0 116.129 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -74.92 151.24 38.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.137 1.469 . . . . 0.0 109.388 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -75.05 105.07 5.89 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.11 39.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.514 1.125 . . . . 0.0 109.125 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -141.58 114.05 8.27 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.82 167.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 pp -119.38 -173.09 2.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 108.597 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.685 1.594 . . . . 0.0 107.402 179.361 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtm . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.14 166.06 22.64 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.336 1.454 . . . . 0.0 107.202 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -124.72 107.73 11.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.503 0.721 . . . . 0.0 111.063 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.01 137.65 36.06 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.383 -1.448 . . . . 0.0 108.028 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -109.17 137.72 46.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.7 143.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.554 1.07 . . . . 0.0 109.792 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -147.52 156.98 43.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.605 0.717 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.01 -28.17 2.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.3 -1.278 . . . . 0.0 111.298 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 35.4 tpp -147.99 152.98 38.39 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.023 1.411 . . . . 0.0 110.339 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -141.46 78.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.9 m -150.42 150.39 31.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.967 2.107 . . . . 0.0 108.122 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -53.37 -31.84 46.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.661 1.985 . . . . 0.0 114.481 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -63.85 -22.31 66.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.328 -0.857 . . . . 0.0 112.356 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.2 t -52.83 -52.55 56.62 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.405 1.082 . . . . 0.0 108.242 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.1 t -52.56 -51.18 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.571 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -57.12 -49.96 74.28 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.79 0.836 . . . . 0.0 110.937 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.49 -38.54 90.05 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.199 0.999 . . . . 0.0 111.963 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.68 -54.75 30.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 108.987 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -65.61 -32.41 73.97 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.811 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -62.43 -42.59 99.56 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.565 -1.334 . . . . 0.0 111.106 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.52 -48.55 26.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.305 0.957 . . . . 0.0 111.97 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.43 -41.56 89.88 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.107 0.963 . . . . 0.0 113.33 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -49.8 -28.47 6.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -57.57 -27.1 62.38 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.48 1.036 . . . . 0.0 111.031 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.03 104.45 14.96 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 125.579 1.552 . . . . 0.0 108.527 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 168.84 23.77 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.452 1.435 . . . . 0.0 109.305 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.8 16.27 61.82 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 122.31 -0.244 . . . . 0.0 113.417 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.45 -58.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 39.45 2.84 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 131.37 3.868 . . . . 0.0 119.21 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -143.69 102.94 4.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.175 1.39 . . . . 0.0 107.59 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.32 142.41 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.98 116.96 11.64 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 t -90.72 143.16 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -89.52 132.99 34.79 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.84 -48.78 34.83 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.05 -0.5 . . . . 0.0 112.197 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -83.03 -12.68 56.99 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.024 1.33 . . . . 0.0 114.052 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HE3' ' OE1' ' A' ' 39' ' ' GLU . 21.2 mtpp -126.64 151.69 47.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.598 -0.689 . . . . 0.0 111.601 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.61 78.15 2.0 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.441 ' OE1' ' HE3' ' A' ' 37' ' ' LYS . 8.6 pt-20 -165.9 158.39 14.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.353 0.661 . . . . 0.0 110.588 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.78 125.87 12.9 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.027 0.931 . . . . 0.0 109.554 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.7 mt -74.55 142.67 44.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.68 131.23 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 110.83 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -123.02 151.22 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.17 -157.47 15.01 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.83 29.62 7.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.905 1.282 . . . . 0.0 114.315 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.79 123.9 26.4 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.46 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.15 152.89 83.25 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.783 1.633 . . . . 0.0 112.127 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.56 -57.37 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.518 2.812 . . . . 0.0 113.565 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -56.65 -40.88 76.23 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 117.934 0.334 . . . . 0.0 110.549 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.5 88.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -54.69 35.25 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.233 0.613 . . . . 0.0 111.271 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.4 m -59.98 -35.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.037 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -71.42 -37.83 71.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.37 -0.831 . . . . 0.0 110.409 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.12 97.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.198 0.908 . . . . 0.0 109.281 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.32 -32.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.788 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.95 -23.39 45.14 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.56 1.144 . . . . 0.0 112.388 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.61 -29.06 69.8 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.953 0.797 . . . . 0.0 110.158 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -86.81 -13.71 44.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.471 1.508 . . . . 0.0 111.323 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.16 66.45 1.61 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.176 1.369 . . . . 0.0 115.365 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -139.83 170.14 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 108.479 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -106.54 105.09 14.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.635 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.1 149.62 35.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 119.09 0.859 . . . . 0.0 110.161 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -149.31 165.98 30.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.551 1.94 . . . . 0.0 108.502 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.1 154.56 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 121.348 -0.845 . . . . 0.0 111.212 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.7 tp -76.0 106.82 7.8 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.201 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.157 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.1 mt -116.69 151.15 36.95 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.633 1.173 . . . . 0.0 108.199 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -122.24 142.19 50.71 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.225 1.01 . . . . 0.0 110.797 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.99 121.68 18.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.635 1.974 . . . . 0.0 110.278 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -87.95 137.9 31.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -126.94 91.01 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.614 1.566 . . . . 0.0 107.516 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.76 146.92 35.58 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.27 -165.16 25.21 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ttt -95.92 -85.15 0.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.225 0.61 . . . . 0.0 109.446 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 12' ' ' ASN . 4.2 m -68.78 150.08 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.785 -0.572 . . . . 0.0 110.015 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.9 t -129.32 5.41 5.24 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.455 1.502 . . . . 0.0 111.094 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.494 ' H ' HG22 ' A' ' 10' ' ' THR . 29.1 m120 -86.49 -100.69 0.07 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.581 -1.324 . . . . 0.0 109.148 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -64.01 -11.19 26.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.92 -1.113 . . . . 0.0 112.908 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -28.56 69.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.809 1.244 . . . . 0.0 110.827 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -54.59 -35.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.088 0.858 . . . . 0.0 110.692 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.76 -45.65 77.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.701 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -52.43 65.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.22 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -58.91 -47.69 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.507 1.049 . . . . 0.0 110.866 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.5 p -63.43 -40.96 98.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -75.37 -40.89 57.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.608 0.763 . . . . 0.0 111.922 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.22 84.69 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.754 0.822 . . . . 0.0 110.191 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.0 mt -56.55 -28.24 59.59 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.9 0.48 . . . . 0.0 110.248 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -59.47 -11.9 5.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.047 0.939 . . . . 0.0 112.986 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -55.12 -16.36 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.289 1.404 . . . . 0.0 112.398 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.86 92.27 20.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.69 -4.34 15.09 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.016 2.477 . . . . 0.0 114.771 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.79 2.48 54.48 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 116.841 1.497 . . . . 0.0 116.841 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.549 HG21 ' CG1' ' A' ' 42' ' ' VAL . 5.9 p -113.9 -48.02 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 119.579 1.689 . . . . 0.0 112.164 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 59.43 -2.97 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.44 103.35 8.88 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.465 1.484 . . . . 0.0 107.198 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 m -141.27 138.29 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.279 1.032 . . . . 0.0 109.666 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.79 143.12 40.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.171 1.788 . . . . 0.0 108.284 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.6 t -136.88 143.24 35.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.101 1.76 . . . . 0.0 107.46 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.1 t -76.81 138.52 39.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.31 -36.04 66.18 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -81.59 -57.94 3.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.343 1.057 . . . . 0.0 112.198 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.54 177.29 6.4 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.963 1.305 . . . . 0.0 112.49 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.58 17.27 56.86 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -90.52 143.38 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.195 1.497 . . . . 0.0 108.302 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.43 163.13 33.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.942 1.297 . . . . 0.0 110.588 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.24 144.42 30.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.897 1.279 . . . . 0.0 110.211 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.549 ' CG1' HG21 ' A' ' 28' ' ' VAL . 79.9 t -130.42 143.25 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.551 1.94 . . . . 0.0 108.12 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -130.1 105.31 7.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.216 1.006 . . . . 0.0 109.951 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA3' HG23 ' A' ' 28' ' ' VAL . . . 167.09 -161.09 34.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.574 1.559 . . . . 0.0 110.225 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 p -96.15 0.54 51.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.735 1.268 . . . . 0.0 114.362 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.71 131.86 30.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.658 1.117 . . . . 0.0 111.019 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.36 142.44 98.35 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.35 -48.55 21.41 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.224 1.949 . . . . 0.0 112.348 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -62.02 -23.17 66.28 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.761 -1.114 . . . . 0.0 112.936 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.61 85.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.802 1.183 . . . . 0.0 108.348 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.65 -48.63 59.15 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.809 0.693 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.0 t -54.19 -59.41 2.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.969 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.1 -38.59 83.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.868 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.52 -44.69 69.36 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 117.156 -1.402 . . . . 0.0 110.22 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.25 -32.32 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.857 1.208 . . . . 0.0 112.041 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.79 -44.76 82.23 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.843 1.257 . . . . 0.0 108.844 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.37 -26.42 66.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.53 1.132 . . . . 0.0 111.422 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -69.99 -36.86 75.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.478 1.035 . . . . 0.0 108.65 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.37 30.59 1.16 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.567 1.556 . . . . 0.0 112.338 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -120.14 172.21 7.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.305 1.552 . . . . 0.0 109.255 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.93 99.63 6.48 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.331 0.969 . . . . 0.0 113.186 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.24 160.84 15.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.488 1.115 . . . . 0.0 112.161 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -154.46 130.13 9.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.876 1.27 . . . . 0.0 107.991 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.52 156.55 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.34 166.81 17.13 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.87 2.068 . . . . 0.0 106.901 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 125.065 1.346 . . . . 0.0 109.394 -179.383 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttm . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.03 166.46 10.82 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -130.41 146.53 51.99 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.884 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.3 tp -136.77 110.92 8.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -81.74 119.94 24.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.99 138.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -136.78 174.02 11.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 -102.2 0.96 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 34.1 tpp -113.48 114.56 26.71 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.571 1.186 . . . . 0.0 112.364 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.47 105.01 17.0 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.407 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 48.9 t -138.87 157.16 46.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 110.044 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.74 -28.95 67.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 110.618 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.88 -26.33 21.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.5 0.72 . . . . 0.0 111.071 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 79.5 m -61.49 -43.07 99.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.811 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.0 -33.39 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.773 1.17 . . . . 0.0 111.037 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.64 -45.44 75.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.27 65.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.364 0.665 . . . . 0.0 109.985 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -57.26 -49.54 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 124.634 1.174 . . . . 0.0 109.851 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -58.03 -53.56 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.159 0.891 . . . . 0.0 110.386 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -59.44 -47.32 85.94 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.461 -0.774 . . . . 0.0 112.152 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.46 92.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.99 0.916 . . . . 0.0 111.95 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.66 -36.15 83.34 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.702 -1.249 . . . . 0.0 109.861 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.3 -19.07 64.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.953 0.901 . . . . 0.0 113.103 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -56.84 -36.18 69.7 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.113 1.524 . . . . 0.0 115.113 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.95 121.3 81.97 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 112.552 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.4 121.56 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.88 -14.96 2.4 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.273 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.38 -57.27 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 118.966 1.383 . . . . 0.0 108.809 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 63.36 -30.8 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.177 2.191 . . . . 0.0 115.25 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 122.94 35.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.8 2.091 . . . . 0.0 112.432 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 42' ' ' VAL . 22.8 m -141.25 144.43 26.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.16 1.384 . . . . 0.0 107.454 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -124.0 118.67 27.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.52 115.94 49.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.134 0.974 . . . . 0.0 108.404 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -93.02 118.11 30.81 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.61 -45.11 91.8 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.214 0.461 . . . . 0.0 111.205 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -55.46 -58.09 9.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 111.496 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -70.85 -49.94 40.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.234 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 2.56 52.28 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.68 1.61 . . . . 0.0 109.64 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.47 151.67 20.68 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.303 1.441 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.81 114.23 17.65 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.173 1.389 . . . . 0.0 109.776 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.62 113.47 20.34 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 31' ' ' VAL . 25.0 m -109.99 132.29 58.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 118.266 0.485 . . . . 0.0 110.65 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.26 105.56 14.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.84 158.52 11.36 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.42 -12.11 54.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.619 1.568 . . . . 0.0 112.773 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.55 155.24 2.25 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.57 136.4 85.96 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 125.432 1.493 . . . . 0.0 111.387 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.15 -25.3 37.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.441 2.094 . . . . 0.0 112.632 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -35.04 65.45 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.088 0.858 . . . . 0.0 110.725 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.47 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.96 -45.64 63.75 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.13 -47.36 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -62.2 -49.12 77.05 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.446 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.56 63.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.759 1.163 . . . . 0.0 113.164 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.4 t -81.49 -38.3 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.57 -36.0 82.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.26 -14.81 8.02 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.945 2.098 . . . . 0.0 112.36 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -115.67 -1.37 12.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.853 1.261 . . . . 0.0 111.275 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.97 42.22 9.0 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.382 0.992 . . . . 0.0 113.99 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -132.16 160.98 34.49 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.409 1.105 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -90.95 145.54 24.64 Favored 'General case' 0 CA--C 1.522 -0.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.1 143.43 47.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.866 1.266 . . . . 0.0 109.617 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -140.3 121.61 14.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 108.642 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -89.57 130.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.775 1.63 . . . . 0.0 109.993 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -133.92 126.42 30.34 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.83 1.652 . . . . 0.0 107.457 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.873 1.669 . . . . 0.0 110.092 178.867 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mmt . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.872 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.92 165.17 17.87 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.299 1.863 . . . . 0.0 110.974 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -142.55 147.66 36.29 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.49 1.916 . . . . 0.0 107.64 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.02 148.92 45.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.804 2.442 . . . . 0.0 108.547 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -97.03 138.55 34.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -122.11 128.39 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.229 2.212 . . . . 0.0 107.365 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -132.67 142.68 49.2 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.58 -179.9 24.88 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.371 1.462 . . . . 0.0 109.77 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.02 -46.33 88.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -173.14 -177.79 1.63 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.33 1.852 . . . . 0.0 107.421 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -72.97 139.19 46.54 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -152.53 170.23 20.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.898 1.279 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -57.37 -25.41 59.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.102 0.961 . . . . 0.0 109.464 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -27.57 17.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.321 2.249 . . . . 0.0 112.388 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.9 t -52.24 -46.03 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 120.353 1.433 . . . . 0.0 109.063 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -66.14 -43.4 87.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.272 -0.893 . . . . 0.0 108.648 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.43 67.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.735 0.814 . . . . 0.0 110.721 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.68 -35.4 75.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.4 m -57.53 -54.57 45.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.651 1.569 . . . . 0.0 109.439 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -64.13 -32.18 73.65 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -41.53 79.82 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.387 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.5 mt -57.11 -46.23 82.79 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -61.34 -4.33 1.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -57.99 -36.47 72.67 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 121.692 2.042 . . . . 0.0 114.413 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.07 119.78 29.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.217 1.007 . . . . 0.0 110.984 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.34 -21.99 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 113.46 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.41 4.04 66.55 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 117.696 -1.614 . . . . 0.0 115.381 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.43 -59.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.259 2.029 . . . . 0.0 109.288 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 57.77 0.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.161 2.584 . . . . 0.0 116.071 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.68 104.08 4.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.706 1.594 . . . . 0.0 110.772 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.18 140.06 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.122 0.969 . . . . 0.0 108.81 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -144.08 144.09 31.45 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.795 1.238 . . . . 0.0 108.958 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -124.58 143.81 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.569 1.947 . . . . 0.0 108.379 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -103.88 118.03 35.74 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.46 -30.09 69.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.033 1.288 . . . . 0.0 111.558 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.429 1.492 . . . . 0.0 110.313 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -83.24 -23.3 32.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 9.13 87.34 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 118.878 0.763 . . . . 0.0 112.113 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.6 160.79 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.187 1.994 . . . . 0.0 109.207 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.01 115.63 9.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.278 1.031 . . . . 0.0 109.762 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -91.07 140.13 30.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.465 1.106 . . . . 0.0 108.3 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.78 141.95 42.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 108.431 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -130.38 104.2 7.12 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.14 -176.97 40.76 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.855 1.693 . . . . 0.0 109.546 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 p -98.4 10.51 40.63 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.3 142.8 42.06 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.827 1.649 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.84 152.51 91.14 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.016 0.926 . . . . 0.0 109.972 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.84 -47.95 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.036 1.824 . . . . 0.0 110.421 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -38.78 72.83 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.485 0.314 . . . . 0.0 111.418 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.58 -53.87 44.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.962 0.905 . . . . 0.0 109.887 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.35 -52.89 62.9 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.531 0.732 . . . . 0.0 111.431 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.33 -57.84 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.833 0.853 . . . . 0.0 110.567 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -64.4 -35.88 82.35 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.005 0.82 . . . . 0.0 110.59 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.56 78.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.699 1.136 . . . . 0.0 110.337 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -77.97 -35.2 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.269 0.94 . . . . 0.0 109.535 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -61.61 -27.29 68.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.629 0.771 . . . . 0.0 110.955 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.99 -11.79 32.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.305 1.442 . . . . 0.0 111.562 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -109.49 -2.61 17.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.831 1.653 . . . . 0.0 111.125 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.55 -8.1 77.17 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.621 1.581 . . . . 0.0 113.768 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -78.98 157.91 28.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.756 1.278 . . . . 0.0 108.311 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -109.88 99.92 8.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.45 150.9 22.91 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.021 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -154.75 124.83 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 m -60.24 155.0 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.97 . . . . 0.0 109.928 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -56.9 132.15 51.73 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.884 1.273 . . . . 0.0 108.456 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.608 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.36 165.95 12.4 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.459 1.504 . . . . 0.0 107.799 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -150.4 104.05 3.2 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.413 -0.804 . . . . 0.0 108.848 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tp -79.17 147.9 32.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.817 0.847 . . . . 0.0 108.776 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -128.36 106.97 9.37 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.183 0.993 . . . . 0.0 109.497 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 t -74.95 153.07 6.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 126.13 1.772 . . . . 0.0 110.025 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -152.53 162.1 41.67 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 122.215 1.007 . . . . 0.0 111.855 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.27 -68.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 126.984 2.23 . . . . 0.0 113.416 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 mmt -84.37 162.78 19.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.899 0.85 . . . . 0.0 112.556 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -140.16 36.26 1.91 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.286 2.634 . . . . 0.0 106.772 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.97 179.46 2.72 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 119.949 -1.719 . . . . 0.0 109.504 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.94 -61.15 1.75 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.361 0.665 . . . . 0.0 110.008 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -56.72 -16.64 6.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.937 1.295 . . . . 0.0 114.05 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 p -59.58 -28.56 67.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.04 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.37 -46.49 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.529 1.513 . . . . 0.0 110.758 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.5 mtt -64.29 -49.81 70.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.334 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.42 -52.25 66.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.808 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.58 -52.02 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.305 1.442 . . . . 0.0 111.229 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 t -54.67 -43.97 72.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.184 1.357 . . . . 0.0 108.778 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -64.18 -50.69 67.13 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.626 -0.671 . . . . 0.0 111.342 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.43 79.3 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.507 1.523 . . . . 0.0 112.117 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.15 -38.06 81.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.037 0.935 . . . . 0.0 110.425 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.28 -10.55 59.7 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -46.73 -57.33 4.95 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.52 118.65 56.03 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.562 1.528 . . . . 0.0 111.734 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.55 88.79 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.706 2.271 . . . . 0.0 108.522 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.69 -33.69 0.02 OUTLIER Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.452 -0.78 . . . . 0.0 111.419 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.29 -50.2 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 117.474 0.637 . . . . 0.0 109.504 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 67.58 -46.61 0.5 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.312 2.245 . . . . 0.0 112.64 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -101.45 109.85 21.75 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.523 1.51 . . . . 0.0 112.698 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.62 130.43 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -130.73 137.55 49.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.093 1.357 . . . . 0.0 107.465 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.75 138.04 44.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 110.017 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.7 t -113.12 118.55 35.05 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.63 -24.33 66.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.406 0.682 . . . . 0.0 111.853 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.75 -13.75 61.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.746 1.618 . . . . 0.0 111.684 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -135.54 -15.74 1.85 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.79 18.46 72.35 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -100.19 145.5 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.49 114.56 9.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.9 0.48 . . . . 0.0 111.572 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.9 mp -77.55 144.42 37.61 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.965 1.706 . . . . 0.0 107.715 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.33 121.64 23.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.788 0.835 . . . . 0.0 109.298 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.05 104.99 9.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.46 177.51 21.14 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.697 1.618 . . . . 0.0 109.847 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -70.97 26.19 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.541 1.536 . . . . 0.0 113.991 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 106.11 1.19 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 142.07 98.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 123.323 0.649 . . . . 0.0 112.11 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.21 -48.14 12.75 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.457 2.105 . . . . 0.0 112.224 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -56.21 -37.26 69.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.468 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.64 63.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.309 0.644 . . . . 0.0 109.749 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -61.96 -50.07 73.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.289 1.035 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.59 -49.72 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -65.65 -42.01 91.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.836 0.744 . . . . 0.0 111.478 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.06 -31.23 70.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.656 1.182 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 62' ' ' ALA . 95.8 t -88.35 -41.75 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 118.656 0.662 . . . . 0.0 109.931 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.59 -42.35 82.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.839 0.856 . . . . 0.0 110.96 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.78 -12.74 50.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.785 -0.626 . . . . 0.0 112.03 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -97.83 -10.11 25.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 120.015 1.279 . . . . 0.0 113.338 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.23 9.27 60.68 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.238 -1.312 . . . . 0.0 114.576 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.69 145.64 30.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -88.2 152.14 22.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -149.21 147.37 28.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.561 0.618 . . . . 0.0 109.647 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -134.67 153.48 51.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.242 1.017 . . . . 0.0 108.263 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.18 173.97 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.99 85.5 3.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.6 mt -119.91 160.74 22.11 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.34 139.94 53.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.629 0.772 . . . . 0.0 110.109 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -122.29 111.54 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -88.95 127.15 35.65 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.22 141.54 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -141.45 98.57 3.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.33 -162.6 28.38 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.576 2.036 . . . . 0.0 109.761 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.2 ttt -124.47 8.08 8.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.175 1.79 . . . . 0.0 108.04 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.15 174.28 9.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 128.116 2.566 . . . . 0.0 107.465 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -140.0 -77.25 0.32 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -55.13 -28.6 53.87 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -93.1 -34.87 13.49 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 109.55 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -54.79 -54.3 43.89 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.929 1.292 . . . . 0.0 110.429 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -52.01 -38.29 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.128 0.971 . . . . 0.0 112.393 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.4 mmm -62.38 -49.8 74.08 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 110.088 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.82 -38.72 83.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.216 0.606 . . . . 0.0 110.185 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.23 -44.85 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.8 m -64.71 -40.02 94.64 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.904 1.229 . . . . 0.0 109.088 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -55.66 -49.76 72.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.109 0.964 . . . . 0.0 109.614 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.48 59.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.114 1.366 . . . . 0.0 110.246 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.6 mt -58.81 -28.11 65.7 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 124.355 1.062 . . . . 0.0 112.47 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -68.86 -21.01 64.29 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.098 -1.001 . . . . 0.0 111.63 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.21 -15.46 63.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.8 m -51.94 160.93 1.02 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.319 1.848 . . . . 0.0 113.313 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.65 -71.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.872 2.381 . . . . 0.0 111.757 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -156.75 51.95 0.42 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.709 0.671 . . . . 0.0 112.157 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.31 -36.48 74.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 118.01 0.905 . . . . 0.0 111.183 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.286 4.1 pt-20 58.38 -11.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.278 2.631 . . . . 0.0 116.362 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -135.18 104.07 5.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.076 2.15 . . . . 0.0 107.762 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -141.91 120.24 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -124.4 142.78 51.03 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.777 1.631 . . . . 0.0 108.956 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 t -137.01 143.21 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.079 0.552 . . . . 0.0 109.802 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -81.56 126.2 31.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.47 -48.57 48.36 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.052 0.941 . . . . 0.0 111.508 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.11 -13.59 59.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -118.75 -164.84 1.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.613 1.565 . . . . 0.0 108.463 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.87 66.54 0.57 Allowed Glycine 0 CA--C 1.52 0.344 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -145.7 137.05 24.94 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.738 -1.448 . . . . 0.0 108.163 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.35 145.2 50.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.512 1.525 . . . . 0.0 109.406 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.16 138.98 54.28 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.65 139.75 42.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.701 0.801 . . . . 0.0 110.105 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -128.58 104.09 7.47 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.57 -169.13 27.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.0 p -59.56 6.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 130.976 3.711 . . . . 0.0 117.56 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.44 104.84 6.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.403 1.456 . . . . 0.0 110.376 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -66.1 132.91 94.62 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 123.862 0.865 . . . . 0.0 110.35 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.69 -38.55 91.29 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.464 2.109 . . . . 0.0 114.806 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.06 -38.27 85.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.867 2.122 . . . . 0.0 110.149 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.4 83.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -67.38 -50.55 59.25 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.836 1.255 . . . . 0.0 109.375 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -52.84 -54.04 18.28 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 124.976 1.31 . . . . 0.0 108.156 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.67 -50.57 69.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.451 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.34 66.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.486 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.25 -32.88 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.216 0.916 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.76 -20.27 65.62 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.613 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.52 -28.2 69.14 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.484 1.493 . . . . 0.0 110.615 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -90.41 -7.86 52.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.064 1.346 . . . . 0.0 110.211 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.51 10.41 70.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.191 1.853 . . . . 0.0 115.399 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.89 156.35 37.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.394 2.097 . . . . 0.0 109.222 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -80.57 119.49 23.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.83 143.33 31.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.569 0.748 . . . . 0.0 109.159 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -147.02 149.82 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -106.13 148.47 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 123.766 0.826 . . . . 0.0 111.532 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.3 mt -148.2 150.45 33.78 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.32 1.448 . . . . 0.0 107.5 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.275 1.03 . . . . 0.0 110.452 179.695 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtt . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.6 mt -128.39 153.43 47.08 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -131.15 109.81 10.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.746 0.818 . . . . 0.0 109.408 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -101.51 111.46 23.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -90.05 138.5 31.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.88 152.48 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.104 0.866 . . . . 0.0 110.044 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -142.73 100.11 3.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.736 2.414 . . . . 0.0 108.258 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.41 -75.58 0.1 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -142.88 150.32 39.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.151 1.78 . . . . 0.0 107.473 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -143.74 -64.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.505 1.122 . . . . 0.0 108.264 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.5 m -75.48 64.36 1.59 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.898 1.279 . . . . 0.0 109.249 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -153.12 172.57 16.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.462 2.305 . . . . 0.0 106.477 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -66.14 -4.71 8.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.094 -1.004 . . . . 0.0 112.815 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -53.05 -26.71 16.75 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.373 1.469 . . . . 0.0 111.743 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.9 t -50.23 -49.3 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.924 1.29 . . . . 0.0 109.746 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -63.12 -31.1 72.17 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.94 -42.1 34.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.167 0.987 . . . . 0.0 109.752 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.54 -50.97 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.1 p -61.1 -50.65 72.38 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.09 -0.481 . . . . 0.0 109.835 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -53.83 -54.56 36.71 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.822 0.737 . . . . 0.0 111.881 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.03 -50.76 70.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.908 0.883 . . . . 0.0 111.082 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 mp -68.38 -29.33 68.01 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.169 -0.957 . . . . 0.0 112.84 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -86.95 -9.27 56.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.771 1.628 . . . . 0.0 113.258 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -56.22 -25.5 47.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.559 1.143 . . . . 0.0 113.511 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.65 141.77 29.5 Favored Pre-proline 0 N--CA 1.447 -0.576 0 C-N-CA 125.207 1.403 . . . . 0.0 107.318 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.09 177.2 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.719 2.28 . . . . 0.0 111.245 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.39 -61.51 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -75.55 -59.28 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 52.3 -17.37 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.588 2.355 . . . . 0.0 116.498 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.94 115.99 30.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 121.546 1.976 . . . . 0.0 110.514 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -147.98 119.15 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.143 1.777 . . . . 0.0 106.432 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -125.19 120.86 32.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 t -87.76 142.74 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.6 t -125.98 117.39 23.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.44 -48.51 49.07 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.451 1.5 . . . . 0.0 113.81 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -58.64 -19.04 35.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.777 1.231 . . . . 0.0 113.102 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 7.98 9.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.963 1.305 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 43.29 56.74 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 126.75 2.119 . . . . 0.0 110.427 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.62 179.94 7.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.9 115.23 10.4 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.776 2.43 . . . . 0.0 108.625 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.7 mt -81.95 123.95 29.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.48 146.22 26.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 118.765 0.711 . . . . 0.0 109.551 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -133.29 107.92 8.42 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.92 174.07 38.52 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 127.547 2.499 . . . . 0.0 108.484 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -88.33 3.6 49.15 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.263 1.425 . . . . 0.0 113.054 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 155.76 1.03 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 117.503 2.408 . . . . 0.0 117.503 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.69 137.09 62.88 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.137 2.175 . . . . 0.0 110.317 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.39 -42.94 30.8 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.197 1.932 . . . . 0.0 109.927 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.68 -45.18 95.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.143 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.52 -43.89 93.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 110.263 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -61.58 -54.49 42.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.688 0.795 . . . . 0.0 109.254 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.17 -46.85 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.427 1.091 . . . . 0.0 109.848 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -67.68 -39.01 84.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.171 -1.395 . . . . 0.0 111.33 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.89 77.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.825 1.193 . . . . 0.0 110.268 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.81 -38.03 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.324 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.1 -40.3 86.89 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.165 -0.959 . . . . 0.0 111.944 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.11 -19.71 65.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.507 0.594 . . . . 0.0 111.28 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -88.97 -30.51 18.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.9 -1.048 . . . . 0.0 111.179 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 4.66 0.41 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 119.05 2.38 . . . . 0.0 119.05 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.17 138.98 26.92 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.593 3.196 . . . . 0.0 108.656 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -75.4 163.96 26.89 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 118.223 0.465 . . . . 0.0 109.909 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.73 161.04 43.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.719 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -151.38 128.96 11.45 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.95 161.74 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.594 -0.691 . . . . 0.0 111.528 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.6 mt -118.51 169.34 9.86 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.684 1.594 . . . . 0.0 108.856 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.492 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.5 mt -134.48 163.08 30.49 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.834 -1.166 . . . . 0.0 109.187 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -120.54 133.1 55.43 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -136.84 148.71 47.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 109.426 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -122.32 138.36 54.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.24 128.57 21.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -139.53 159.27 42.56 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.495 1.118 . . . . 0.0 111.476 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.88 -100.39 0.53 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 124.907 1.242 . . . . 0.0 111.622 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.4 mtp -128.87 -17.0 4.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.091 0.946 . . . . 0.0 113.099 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p -146.69 -178.31 6.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.902 2.081 . . . . 0.0 108.184 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.5 p -123.24 -17.54 6.58 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.008 0.923 . . . . 0.0 110.244 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -68.97 -79.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.983 0.811 . . . . 0.0 110.399 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -79.92 -14.49 58.58 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -52.46 -43.59 65.04 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.293 1.037 . . . . 0.0 110.531 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.61 -38.54 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.289 1.436 . . . . 0.0 110.741 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.62 -45.33 83.5 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.051 0.842 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.11 86.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.207 0.458 . . . . 0.0 109.888 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.22 -54.05 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.383 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -61.47 -38.65 88.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.174 1.352 . . . . 0.0 110.469 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -55.18 -50.55 69.04 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.306 0.642 . . . . 0.0 109.308 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.81 -51.63 38.72 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.52 -27.76 69.48 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -60.91 -9.6 4.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.488 1.04 . . . . 0.0 112.697 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.19 -29.64 58.31 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 114.027 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.95 156.63 91.77 Favored Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 121.446 -0.784 . . . . 0.0 112.248 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.7 -50.69 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.87 1.713 . . . . 0.0 109.77 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.32 34.04 0.02 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 121.207 -0.933 . . . . 0.0 112.231 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.11 -33.53 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 112.757 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.69 165.86 33.97 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -114.65 104.1 11.65 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.94 137.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.03 117.88 13.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.22 143.93 12.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -89.29 153.94 20.49 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.119 0.872 . . . . 0.0 108.925 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.51 -48.13 35.65 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.533 -1.354 . . . . 0.0 109.666 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -66.82 -22.56 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -145.48 145.97 31.29 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.748 1.158 . . . . 0.0 108.736 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.91 10.68 2.95 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.616 2.055 . . . . 0.0 114.414 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.62 163.94 14.37 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.2 162.5 39.34 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 126.256 1.822 . . . . 0.0 109.877 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.07 142.36 49.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.19 117.13 44.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.148 0.975 . . . . 0.0 108.8 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.93 104.95 12.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.903 2.081 . . . . 0.0 105.613 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.7 -176.27 39.03 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -95.18 7.52 45.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.569 1.148 . . . . 0.0 113.227 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.5 156.52 19.28 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.094 -1.003 . . . . 0.0 113.491 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.64 119.25 71.91 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -57.71 -41.03 74.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.901 1.734 . . . . 0.0 110.698 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -38.78 75.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.832 0.853 . . . . 0.0 110.648 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.8 82.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.76 0.709 . . . . 0.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.27 -46.53 73.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.14 -38.83 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.706 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -47.99 83.75 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.397 0.999 . . . . 0.0 109.776 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.21 87.17 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.256 1.022 . . . . 0.0 111.557 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.72 -34.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.128 0.571 . . . . 0.0 110.076 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -64.48 -51.68 61.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -67.81 -16.1 63.95 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.46 -9.13 59.56 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.29 -0.881 . . . . 0.0 108.941 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.35 52.81 3.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -141.08 175.26 9.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.981 1.712 . . . . 0.0 108.26 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -118.42 147.49 43.52 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.15 167.41 22.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -148.24 143.09 26.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -100.07 143.03 14.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -143.14 51.69 1.38 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 109.242 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.264 0 C-N-CA 128.54 2.736 . . . . 0.0 107.078 -178.487 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.85 157.39 16.41 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 120.995 -1.066 . . . . 0.0 108.395 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -115.12 124.21 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.64 148.35 38.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.03 1.332 . . . . 0.0 108.115 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -118.71 138.4 52.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.15 133.72 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -145.04 108.63 4.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.91 -97.54 1.57 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.8 mtt -143.6 -60.29 0.41 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -132.33 120.99 22.83 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -109.99 50.12 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.375 1.87 . . . . 0.0 112.147 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -111.21 -92.04 0.46 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -57.42 -31.23 65.65 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.645 1.111 . . . . 0.0 110.33 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 t -52.91 -37.24 60.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.351 2.26 . . . . 0.0 111.592 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -52.38 -41.99 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 119.181 0.901 . . . . 0.0 110.825 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 ttp -62.97 -47.58 82.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.829 0.286 . . . . 0.0 110.325 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 -52.08 62.55 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.354 1.062 . . . . 0.0 112.788 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.98 -44.65 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.463 -0.78 . . . . 0.0 109.223 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -60.73 -49.83 75.92 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.8 0.727 . . . . 0.0 109.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -51.11 -48.53 61.69 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.558 1.143 . . . . 0.0 110.323 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.06 52.72 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.444 0.465 . . . . 0.0 110.828 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.81 -29.11 62.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 112.563 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.56 -13.27 61.0 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.297 -0.877 . . . . 0.0 112.136 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.41 -56.04 27.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.567 1.076 . . . . 0.0 110.013 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.61 116.05 30.66 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.14 174.19 11.76 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.254 1.969 . . . . 0.0 110.642 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.53 12.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.226 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 71.3 t -114.76 -59.08 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 118.65 1.225 . . . . 0.0 109.434 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.304 74.4 mt-10 63.68 -44.58 0.25 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.286 2.635 . . . . 0.0 110.634 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -95.77 110.35 22.52 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.229 1.812 . . . . 0.0 110.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.16 144.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.063 1.345 . . . . 0.0 107.507 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.2 143.71 34.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.93 140.54 48.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.769 1.227 . . . . 0.0 108.669 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -115.72 115.29 26.09 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.8 -32.57 65.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -71.95 -9.21 58.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.738 0.815 . . . . 0.0 111.889 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 -14.31 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.28 60.12 Favored Glycine 0 N--CA 1.467 0.716 0 CA-C-N 120.723 1.601 . . . . 0.0 110.215 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.98 170.43 15.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.669 0.735 . . . . 0.0 112.169 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.91 157.71 43.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.372 1.869 . . . . 0.0 109.015 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.43 139.15 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.867 2.067 . . . . 0.0 106.443 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.45 121.6 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 123.287 0.635 . . . . 0.0 110.139 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -106.6 104.84 14.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . 175.24 -157.73 24.71 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.551 1.072 . . . . 0.0 111.208 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.8 p -113.48 16.94 18.7 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.431 2.292 . . . . 0.0 113.946 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.87 151.86 46.04 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.94 149.67 74.04 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.161 2.185 . . . . 0.0 109.564 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.92 -49.69 3.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 110.739 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -56.49 -49.3 75.1 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.036 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.54 -37.96 66.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.645 0.591 . . . . 0.0 111.866 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -73.87 -51.82 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.484 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.66 -36.28 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.096 0.862 . . . . 0.0 110.241 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -73.3 -40.55 64.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.943 0.897 . . . . 0.0 110.314 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.19 80.01 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.692 1.133 . . . . 0.0 108.6 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.266 17.6 m -71.58 -32.26 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.783 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.97 -28.77 62.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 120.054 1.297 . . . . 0.0 109.881 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -61.09 -18.72 59.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.414 1.007 . . . . 0.0 111.944 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.3 -6.5 58.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.516 1.053 . . . . 0.0 111.996 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.48 44.96 7.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 119.383 0.992 . . . . 0.0 113.545 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -141.19 175.72 9.41 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.863 2.465 . . . . 0.0 108.021 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -114.41 149.3 36.42 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.765 1.621 . . . . 0.0 108.738 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.97 155.72 37.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 175.29 10.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.94 -178.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.864 0.84 . . . . 0.0 110.569 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.29 111.1 2.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.74 -1.124 . . . . 0.0 108.157 -179.69 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mtp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.4 mt -140.39 163.39 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -133.86 105.33 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 tp -95.64 147.89 23.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 123.09 49.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.82 140.26 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -139.34 121.8 16.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.358 0.981 . . . . 0.0 110.904 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.4 -112.46 0.51 Allowed Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 29.6 mmm -58.61 -54.79 43.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.156 1.382 . . . . 0.0 113.76 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 p 45.35 50.22 10.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.375 1.47 . . . . 0.0 109.193 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -92.85 168.36 11.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.984 0.897 . . . . 0.0 112.61 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -62.08 -43.1 99.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.157 0.983 . . . . 0.0 113.01 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -89.36 -38.87 13.82 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -52.01 -28.12 15.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.09 -37.75 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 119.605 1.093 . . . . 0.0 110.105 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.7 mmt -59.03 -44.44 91.75 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.374 -0.829 . . . . 0.0 110.343 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.3 68.89 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 108.882 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.26 -48.54 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.992 0.917 . . . . 0.0 109.595 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.4 m -58.79 -50.11 75.17 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.436 -0.79 . . . . 0.0 109.16 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -63.08 -34.66 78.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.304 0.956 . . . . 0.0 111.495 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.19 79.22 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -64.84 -48.05 75.73 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.458 -0.776 . . . . 0.0 110.033 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -63.5 -6.76 5.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 112.523 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -65.38 -20.04 66.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.262 1.392 . . . . 0.0 110.834 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.1 t -71.31 117.11 53.85 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -53.95 -66.1 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 118.387 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.76 -10.46 45.01 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -71.9 -57.37 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.868 2.334 . . . . 0.0 109.671 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 54.1 0.39 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.546 2.338 . . . . 0.0 116.549 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -131.19 106.93 8.65 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.494 1.518 . . . . 0.0 111.163 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.9 144.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.616 1.566 . . . . 0.0 107.224 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -137.35 117.32 13.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 t -114.62 125.64 71.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -75.5 129.87 37.97 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.79 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.91 -43.4 86.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.819 0.848 . . . . 0.0 109.955 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.18 -8.56 59.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.98 161.22 38.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 121.138 1.79 . . . . 0.0 110.904 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.09 46.01 3.49 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -115.02 134.58 55.06 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.113 1.457 . . . . 0.0 107.787 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.07 113.8 12.49 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.1 mt -94.1 143.55 26.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.01 141.09 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.424 0.631 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -114.74 104.42 11.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.43 168.89 23.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -89.32 12.67 15.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.992 1.717 . . . . 0.0 113.315 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.59 135.38 57.33 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.817 0.735 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.02 155.7 77.24 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 113.596 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -60.68 -66.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.941 3.094 . . . . 0.0 112.701 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -27.27 62.34 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.02 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.73 -52.95 63.28 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.442 1.019 . . . . 0.0 108.329 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.03 -47.66 79.36 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 117.716 -1.135 . . . . 0.0 110.465 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.1 t -52.16 -60.55 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 O-C-N 124.315 1.009 . . . . 0.0 109.017 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -40.26 76.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.923 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.64 88.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.991 1.268 . . . . 0.0 113.186 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 m -78.57 -32.8 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 0.0 109.465 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -61.36 -20.28 62.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.491 0.587 . . . . 0.0 110.036 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.65 -23.83 66.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.215 0.916 . . . . 0.0 109.847 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.46 -12.86 53.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.771 1.628 . . . . 0.0 110.727 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.94 -11.7 65.94 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.41 1.957 . . . . 0.0 113.786 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -76.36 144.98 39.78 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.36 1.08 . . . . 0.0 109.217 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -75.95 162.09 28.39 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.95 161.34 38.37 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.557 1.072 . . . . 0.0 111.067 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -147.88 123.66 10.56 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.961 0.904 . . . . 0.0 112.297 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.77 146.4 8.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.616 HD13 ' H ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -68.52 153.07 44.46 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.616 ' H ' HD13 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.431 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.555 ' C ' HD12 ' A' ' 2' ' ' LEU . 21.6 ptp . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.555 HD12 ' C ' ' A' ' 1' ' ' MET . 6.7 mp -140.46 159.62 41.79 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.072 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -100.9 115.79 31.23 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -104.4 143.3 33.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -125.69 128.95 48.61 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.59 152.49 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 125.892 1.677 . . . . 0.0 106.687 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -143.96 165.27 28.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.468 1.907 . . . . 0.0 108.697 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.26 -105.19 1.72 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.867 1.222 . . . . 0.0 111.755 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 85.6 mtp -84.94 -176.98 6.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.167 1.387 . . . . 0.0 110.295 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 p -153.12 105.52 2.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.441 1.096 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.6 t -163.45 148.76 11.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 121.07 1.759 . . . . 0.0 110.45 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -62.58 -41.95 99.26 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 124.304 1.041 . . . . 0.0 111.482 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -60.92 -14.88 25.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -30.67 71.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.573 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 m -58.41 -25.42 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 121.16 1.8 . . . . 0.0 111.421 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.7 mmm -69.61 -50.22 46.47 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.44 -52.44 53.15 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.791 0.836 . . . . 0.0 110.586 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.66 -55.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.645 1.578 . . . . 0.0 109.918 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 m -72.85 -25.45 61.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.811 1.187 . . . . 0.0 111.679 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -66.98 -55.99 12.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.549 1.522 . . . . 0.0 107.917 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.17 68.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.718 0.636 . . . . 0.0 110.166 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.4 -27.46 47.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 117.337 -1.316 . . . . 0.0 113.724 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -51.2 -21.8 2.25 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.975 1.716 . . . . 0.0 111.329 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 0.4 3.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.622 1.569 . . . . 0.0 113.21 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.91 143.11 23.94 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 120.796 1.635 . . . . 0.0 111.575 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.44 -81.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.349 3.366 . . . . 0.0 113.607 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.97 0.55 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.416 1.008 . . . . 0.0 110.619 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.68 -58.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.388 0.675 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 62.65 -14.95 0.06 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.907 1.683 . . . . 0.0 115.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -127.46 107.98 10.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.513 1.506 . . . . 0.0 111.657 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.12 119.3 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -119.19 143.54 47.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.861 2.064 . . . . 0.0 107.296 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.39 141.55 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.967 1.307 . . . . 0.0 108.081 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -88.03 118.65 27.74 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.78 -39.58 93.83 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.85 -9.1 59.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.549 1.068 . . . . 0.0 112.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -123.48 -168.91 1.85 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.226 1.41 . . . . 0.0 110.216 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.46 70.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 105.514 -3.034 . . . . 0.0 105.514 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -151.07 162.76 40.24 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 117.79 0.795 . . . . 0.0 109.468 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.86 154.73 40.81 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.274 1.03 . . . . 0.0 111.033 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -117.25 119.54 35.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 t -123.72 112.93 35.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 123.561 0.538 . . . . 0.0 110.194 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -104.72 105.78 16.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.743 0.817 . . . . 0.0 111.36 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.3 179.61 45.02 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.2 p -81.6 -12.08 58.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.041 0.936 . . . . 0.0 113.026 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.14 135.22 26.02 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.851 1.26 . . . . 0.0 112.692 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.82 143.17 98.43 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 125.895 1.678 . . . . 0.0 111.808 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.9 -32.24 36.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.827 1.685 . . . . 0.0 110.334 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -63.79 -48.93 74.92 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.689 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.34 67.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 123.846 0.716 . . . . 0.0 110.512 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -57.52 -52.78 64.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.768 0.827 . . . . 0.0 111.692 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.18 -46.85 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -31.71 71.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.97 -51.08 27.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.827 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.261 16.8 m -61.94 -32.9 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.442 1.019 . . . . 0.0 113.227 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.18 -20.05 50.49 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.96 -0.462 . . . . 0.0 111.58 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -73.87 -16.63 61.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.09 -52.07 5.14 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.341 1.428 . . . . 0.0 113.151 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.32 20.33 0.04 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.68 173.91 11.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.293 1.437 . . . . 0.0 108.243 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.4 163.67 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.354 -0.841 . . . . 0.0 108.794 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.79 165.82 34.83 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.629 0.728 . . . . 0.0 111.159 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -147.6 155.25 41.62 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.424 2.29 . . . . 0.0 105.762 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -128.02 137.8 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 O-C-N 121.224 -0.922 . . . . 0.0 111.28 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 tt -92.17 111.68 23.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.761 2.024 . . . . 0.0 105.743 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 125.579 1.552 . . . . 0.0 110.088 -179.738 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.7 mt -145.13 166.06 26.49 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 66' ' ' ALA . 33.3 mttm -127.94 124.88 38.42 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -109.06 115.68 30.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.681 1.192 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -88.48 124.35 33.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.74 131.67 69.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -138.92 156.82 46.97 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.374 1.07 . . . . 0.0 108.159 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.32 -74.17 0.26 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 108.081 -2.007 . . . . 0.0 108.081 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.2 tpp -149.29 142.66 25.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.04 116.72 22.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.2 m -144.72 117.17 8.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -59.66 -44.24 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.364 0.665 . . . . 0.0 109.837 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.85 -12.06 51.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.58 -33.21 72.38 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.946 1.248 . . . . 0.0 108.807 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.75 -31.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.519 1.127 . . . . 0.0 110.681 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.49 -51.11 60.24 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.73 97.56 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.892 0.877 . . . . 0.0 110.757 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.91 -51.99 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -63.07 -40.36 97.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.716 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -56.84 -55.38 35.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.353 0.979 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.8 85.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 122.522 0.329 . . . . 0.0 111.672 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -45.04 92.65 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -62.25 -8.46 5.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.971 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -60.89 -18.54 56.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.306 1.867 . . . . 0.0 110.749 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.24 127.13 23.19 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.51 126.93 13.34 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.679 2.919 . . . . 0.0 111.418 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.7 -17.1 8.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-O 116.758 -2.134 . . . . 0.0 113.974 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.91 2.53 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 121.176 2.488 . . . . 0.0 115.238 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -66.76 -1.64 4.09 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -95.77 104.22 16.14 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.44 139.19 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.5 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -123.08 116.54 23.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.45 131.84 53.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.91 1.684 . . . . 0.0 109.488 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 m -70.19 130.94 43.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.02 -48.62 34.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.95 0.405 . . . . 0.0 110.217 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.5 -52.25 7.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.611 1.164 . . . . 0.0 110.956 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -82.62 175.63 10.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.25 3.65 35.16 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.403 -1.221 . . . . 0.0 115.757 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -91.11 146.68 23.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.807 2.304 . . . . 0.0 109.151 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.58 138.75 44.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.766 1.627 . . . . 0.0 107.793 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.01 130.17 48.49 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -120.17 112.67 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.634 1.174 . . . . 0.0 108.8 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -90.4 114.91 27.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.93 41.67 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 118.775 0.716 . . . . 0.0 113.217 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 t -125.77 3.72 7.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.956 1.302 . . . . 0.0 112.916 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 156.7 32.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.542 0.687 . . . . 0.0 112.65 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.35 133.55 90.87 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 125.086 1.355 . . . . 0.0 109.104 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.65 -44.17 23.1 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.547 2.165 . . . . 0.0 110.151 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -56.51 -30.45 63.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.971 0.908 . . . . 0.0 112.05 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -39.69 79.21 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.635 0.652 . . . . 0.0 109.549 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.99 -45.12 74.98 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 123.717 0.807 . . . . 0.0 109.077 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -57.83 -58.5 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -60.72 -36.44 78.85 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.357 0.526 . . . . 0.0 112.063 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.28 99.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.952 0.797 . . . . 0.0 110.712 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.5 t -73.86 -33.14 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -60.62 -37.35 81.13 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.395 0.998 . . . . 0.0 110.284 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.65 -19.84 62.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.646 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -87.84 -3.41 58.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 112.225 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.53 37.12 6.25 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.058 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.54 172.96 11.82 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.401 1.101 . . . . 0.0 110.091 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -118.58 109.38 16.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.75 159.23 16.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.1 0.56 . . . . 0.0 111.552 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -158.3 159.26 35.73 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.0 2.52 . . . . 0.0 107.187 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.18 144.81 17.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.628 HD23 ' H ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -147.16 159.8 43.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.7 0.682 . . . . 0.0 110.718 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.628 ' H ' HD23 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.248 0.975 0 C-N-CA 125.861 1.665 . . . . 0.0 108.633 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.09 165.33 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -133.95 141.86 47.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.3 tp -122.65 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.521 1.529 . . . . 0.0 108.978 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -87.15 136.76 32.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.4 133.13 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 125.557 1.543 . . . . 0.0 107.236 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -145.13 163.77 33.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.48 -123.37 5.56 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.245 1.402 . . . . 0.0 113.949 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -68.0 83.03 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 129.658 3.183 . . . . 0.0 111.341 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.98 78.69 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.786 2.434 . . . . 0.0 111.06 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -137.79 161.83 35.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.981 1.712 . . . . 0.0 109.241 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.31 -57.83 4.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.995 1.718 . . . . 0.0 112.805 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -60.47 -19.1 55.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.7 m -63.26 -34.05 76.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.85 1.205 . . . . 0.0 109.667 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.23 -39.12 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.374 1.069 . . . . 0.0 109.734 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 48.6 tpp -62.16 -47.2 85.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.55 -52.32 66.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.124 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.47 -43.52 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.716 1.144 . . . . 0.0 113.092 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.9 t -60.68 -44.49 96.44 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.295 1.861 . . . . 0.0 110.002 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -69.23 -48.3 62.34 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.657 -0.652 . . . . 0.0 111.678 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.15 73.27 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.602 0.761 . . . . 0.0 111.288 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.567 HD22 ' HG ' ' A' ' 51' ' ' LEU . 19.6 mt -73.13 -52.13 15.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.708 0.686 . . . . 0.0 110.076 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -69.38 -3.7 15.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -53.56 -40.67 65.78 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.589 0.756 . . . . 0.0 111.039 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.22 136.52 37.89 Favored Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.44 115.06 3.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 106.79 -2.042 . . . . 0.0 106.79 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.88 -92.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.759 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 t -64.75 -57.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 66.22 -31.6 0.16 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.278 2.231 . . . . 0.0 112.444 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -101.2 102.76 13.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.577 1.951 . . . . 0.0 106.374 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.36 127.12 37.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.548 1.139 . . . . 0.0 108.008 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.06 144.84 51.33 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.437 1.495 . . . . 0.0 111.911 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.12 143.04 42.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.729 1.612 . . . . 0.0 107.314 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -77.5 137.28 38.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 109.175 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.34 -48.09 44.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -80.76 -20.97 41.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.77 161.63 32.42 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.075 1.307 . . . . 0.0 109.485 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.21 36.16 3.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -104.26 141.62 35.97 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 120.372 -1.664 . . . . 0.0 107.583 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.22 146.06 51.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 108.562 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.93 144.31 50.73 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.015 1.726 . . . . 0.0 106.703 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.37 141.29 42.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.535 0.734 . . . . 0.0 110.909 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.13 104.19 8.39 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.446 1.117 . . . . 0.0 109.179 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.83 41.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 126.436 1.969 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -117.38 12.72 14.34 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.71 156.27 30.9 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.216 0.916 . . . . 0.0 110.436 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.31 154.93 81.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 113.24 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.7 -51.63 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.14 2.56 . . . . 0.0 109.213 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -55.48 -40.33 71.52 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.128 -1.415 . . . . 0.0 111.074 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.24 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 120.136 1.335 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HG ' HD22 ' A' ' 22' ' ' LEU . 10.5 mp -70.01 -53.13 19.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.29 0.636 . . . . 0.0 110.666 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.8 t -52.51 -54.96 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.942 0.897 . . . . 0.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.32 -47.42 86.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.121 1.369 . . . . 0.0 110.421 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.75 -45.34 74.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.638 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.438 HG13 HD21 ' A' ' 22' ' ' LEU . 33.3 m -73.86 -32.71 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 119.06 0.845 . . . . 0.0 111.274 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -56.45 -39.16 72.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 112.227 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.83 -34.15 62.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -16.89 61.47 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.398 0.545 . . . . 0.0 112.218 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.29 0.16 47.26 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.544 1.068 . . . . 0.0 110.96 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -78.83 172.27 13.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.377 1.071 . . . . 0.0 109.519 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.35 149.19 39.74 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.57 170.01 23.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.493 1.139 . . . . 0.0 111.694 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -158.04 127.6 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.62 142.12 14.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -125.64 94.8 4.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 177.475 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptt? . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.278 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -91.92 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.716 1.143 . . . . 0.0 110.106 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -127.75 141.08 51.69 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.7 tp -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -86.75 133.98 33.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 100.639 -3.837 . . . . 0.0 100.639 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.43 118.85 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -127.58 145.66 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.94 -176.39 41.47 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.45 -22.8 66.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.905 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -123.18 154.64 38.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.116 1.366 . . . . 0.0 108.152 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 p -133.36 -5.51 2.97 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.664 1.186 . . . . 0.0 113.22 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -115.8 -67.92 0.96 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.406 1.082 . . . . 0.0 111.115 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 -20.54 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.818 -1.176 . . . . 0.0 113.447 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -59.75 -27.67 66.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.771 1.229 . . . . 0.0 112.049 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 m -52.5 -29.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 119.094 0.861 . . . . 0.0 112.865 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 9.9 tpt -67.57 -50.73 57.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.19 74.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.865 0.866 . . . . 0.0 110.374 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -56.27 -55.03 20.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 110.912 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.3 m -68.33 -36.33 79.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.471 1.032 . . . . 0.0 111.222 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -47.75 84.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.26 -49.53 75.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.516 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.38 -28.11 64.86 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.831 1.196 . . . . 0.0 112.303 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -58.27 -29.97 66.22 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.488 -0.758 . . . . 0.0 109.58 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -60.9 -16.95 47.79 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 117.258 -1.354 . . . . 0.0 112.83 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.46 92.07 1.7 Allowed Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 119.516 1.053 . . . . 0.0 108.817 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.67 117.16 4.99 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 105.878 -2.393 . . . . 0.0 105.878 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.27 -10.46 5.04 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.002 -1.443 . . . . 0.0 113.117 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.8 t -85.53 -56.93 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 120.166 1.983 . . . . 0.0 106.551 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 63.8 -19.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -130.04 114.49 15.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.829 2.104 . . . . 0.0 110.778 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.6 m -140.09 144.36 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.802 1.241 . . . . 0.0 109.737 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.01 144.75 32.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.957 1.303 . . . . 0.0 109.49 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.46 129.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -76.65 132.52 39.44 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.773 1.229 . . . . 0.0 111.243 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.2 mt -73.56 -48.61 31.57 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.2 1.0 . . . . 0.0 112.749 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.01 -31.61 69.37 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -135.68 161.62 35.03 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.632 1.106 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.59 43.22 1.33 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.236 1.398 . . . . 0.0 112.794 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -104.71 152.51 22.43 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.54 151.85 38.79 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.962 1.305 . . . . 0.0 108.387 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.41 144.6 47.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.091 1.756 . . . . 0.0 107.433 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -138.26 116.19 12.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.89 104.83 13.82 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.13 162.65 12.19 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 t -75.05 31.8 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.234 1.814 . . . . 0.0 112.321 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.71 149.77 8.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.946 1.298 . . . . 0.0 112.447 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.73 131.07 46.48 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.694 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -49.74 -61.81 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.605 2.87 . . . . 0.0 113.634 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -58.02 -23.16 53.05 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.868 -1.063 . . . . 0.0 112.633 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.76 -39.65 66.64 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.382 1.446 . . . . 0.0 109.334 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.09 -48.71 67.37 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.33 -55.86 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.068 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.51 -29.86 71.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.472 -0.775 . . . . 0.0 111.865 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.01 82.8 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.742 1.156 . . . . 0.0 108.726 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.17 -36.89 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.783 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.15 -36.43 72.99 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.234 1.014 . . . . 0.0 113.258 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.53 -15.3 49.92 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.233 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.31 8.71 29.92 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.087 1.312 . . . . 0.0 111.833 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.63 38.39 9.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.46 152.16 43.66 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.99 152.17 19.54 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.6 159.28 42.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.637 0.586 . . . . 0.0 110.867 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -153.59 117.19 4.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.04 168.3 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 124.398 1.079 . . . . 0.0 108.471 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -69.7 -176.05 0.98 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.721 0.808 . . . . 0.0 110.947 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.877 1.671 . . . . 0.0 108.925 -179.613 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 2' ' ' LEU . 3.5 mm? -114.7 165.33 12.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.893 0.854 . . . . 0.0 108.989 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -133.92 123.25 24.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 tp -97.13 111.76 23.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.663 1.185 . . . . 0.0 108.39 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 134.94 33.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.97 164.75 31.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -147.17 139.29 24.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.05 -152.11 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 mmt -63.57 157.68 23.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.027 0.442 . . . . 0.0 110.328 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -57.61 -80.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.714 2.005 . . . . 0.0 113.926 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 p -146.43 132.53 19.32 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.74 1.216 . . . . 0.0 110.148 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -172.15 -173.47 1.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.851 1.261 . . . . 0.0 109.61 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -56.67 -13.91 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.772 2.029 . . . . 0.0 113.111 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.0 m -52.94 -28.89 25.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.341 1.457 . . . . 0.0 110.958 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.34 -42.11 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.21 0.914 . . . . 0.0 109.089 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.3 mmm -63.01 -40.55 98.11 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.399 -0.813 . . . . 0.0 110.625 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB1' ' CD ' ' A' ' 58' ' ' GLU . . . -66.08 -52.88 44.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.495 1.118 . . . . 0.0 110.416 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.18 -40.94 86.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-O 117.696 -1.145 . . . . 0.0 110.278 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.9 m -59.36 -43.57 92.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.808 1.64 . . . . 0.0 108.839 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -64.3 -37.9 89.14 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.907 -1.121 . . . . 0.0 110.757 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -44.97 68.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.508 0.723 . . . . 0.0 110.668 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -32.27 31.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.835 2.454 . . . . 0.0 109.635 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -53.08 -23.26 7.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.081 1.353 . . . . 0.0 112.715 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.29 -12.62 1.69 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.921 1.289 . . . . 0.0 114.472 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.5 m -53.78 152.54 9.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.828 0.74 . . . . 0.0 110.851 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.26 32.27 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.101 3.201 . . . . 0.0 111.514 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.91 91.66 1.61 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 p -112.89 -36.22 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.533 0.733 . . . . 0.0 111.328 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 67.15 -36.91 0.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.67 2.788 . . . . 0.0 113.733 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -104.86 106.61 17.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.1 144.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -143.72 140.76 30.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.52 141.64 45.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -89.08 131.7 35.12 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -72.32 -48.5 41.61 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.275 0.63 . . . . 0.0 110.947 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -82.49 -9.88 59.24 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -135.15 159.6 41.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.696 1.589 . . . . 0.0 111.734 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 59.84 4.74 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.12 138.6 22.88 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 118.566 1.183 . . . . 0.0 110.594 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.55 155.6 48.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.428 1.891 . . . . 0.0 110.268 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.16 142.73 46.65 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 126.553 1.941 . . . . 0.0 107.514 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.32 131.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.87 105.39 8.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.31 -155.39 26.16 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.699 -0.626 . . . . 0.0 111.8 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 t -89.3 -6.53 56.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.997 1.319 . . . . 0.0 114.066 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.66 123.7 10.64 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.447 1.021 . . . . 0.0 112.766 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.69 153.8 95.42 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 125.694 1.598 . . . . 0.0 108.737 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 -46.47 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.297 1.998 . . . . 0.0 109.944 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -58.45 -28.09 64.99 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.118 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.55 -51.19 64.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.21 -40.64 86.45 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.457 0.703 . . . . 0.0 111.18 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.36 -51.79 59.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.04 -30.46 70.99 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.167 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.99 77.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.893 0.77 . . . . 0.0 110.309 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -88.39 -32.57 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.211 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.85 -30.56 71.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.197 0.999 . . . . 0.0 110.882 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.61 -19.55 64.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.296 0.953 . . . . 0.0 108.864 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.52 ' CD ' ' HB1' ' A' ' 17' ' ' ALA . 75.6 mm-40 -97.63 3.5 50.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.581 1.553 . . . . 0.0 109.605 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.85 86.53 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.778 2.132 . . . . 0.0 114.293 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -74.07 166.35 23.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.241 2.021 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -117.72 129.26 55.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 116.403 -1.76 . . . . 0.0 107.752 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.57 160.38 42.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 121.835 2.107 . . . . 0.0 114.355 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.25 163.68 39.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.64 2.376 . . . . 0.0 107.394 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.5 154.76 16.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.781 -1.199 . . . . 0.0 109.228 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 65' ' ' LEU . 1.6 tm? -119.42 108.14 14.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 C-N-CA 124.534 1.134 . . . . 0.0 110.952 -178.928 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.84 165.51 12.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.387 1.475 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 118.0 22.55 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.079 1.752 . . . . 0.0 106.39 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tt -137.4 147.58 45.54 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.275 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -123.81 139.69 53.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.826 1.194 . . . . 0.0 110.42 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.95 138.0 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.576 1.151 . . . . 0.0 110.253 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.25 110.54 3.72 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.359 1.076 . . . . 0.0 111.413 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.0 -48.33 1.25 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 124.665 1.126 . . . . 0.0 113.077 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 7.3 tpt -160.78 159.56 30.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.559 1.18 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -82.51 79.0 9.07 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -149.95 138.17 20.45 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -60.42 -37.86 82.23 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -57.85 -26.98 62.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.996 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -60.01 -36.11 76.53 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.439 1.018 . . . . 0.0 110.745 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.75 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.1 mtt -65.15 -40.82 94.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.881 -0.512 . . . . 0.0 110.982 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.17 -51.28 68.45 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.415 1.086 . . . . 0.0 111.206 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.09 -37.86 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 117.972 -1.013 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 m -60.13 -50.65 72.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.924 1.238 . . . . 0.0 108.122 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -54.14 -43.13 70.27 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.133 0.973 . . . . 0.0 111.13 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.96 59.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.069 0.948 . . . . 0.0 110.088 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 mt -56.67 -34.38 67.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.223 1.409 . . . . 0.0 112.047 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -63.55 -6.08 4.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.725 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -22.61 61.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 120.314 1.416 . . . . 0.0 111.706 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.11 95.75 13.67 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.03 45.27 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.095 3.196 . . . . 0.0 112.618 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.93 17.46 5.18 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.725 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 -57.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 119.402 1.601 . . . . 0.0 107.401 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 70.02 -53.26 0.63 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.089 2.155 . . . . 0.0 113.158 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -95.87 103.32 15.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.454 1.025 . . . . 0.0 109.073 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.78 134.09 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.507 1.123 . . . . 0.0 108.965 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -142.76 142.11 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 t -134.48 143.3 38.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 125.249 1.42 . . . . 0.0 109.391 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.45 145.0 35.29 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.0 -47.33 46.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.084 -1.01 . . . . 0.0 112.289 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -77.42 -24.18 50.45 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -133.23 147.86 51.99 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.891 1.223 . . . . 0.0 108.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.64 25.11 1.44 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.426 -1.208 . . . . 0.0 113.763 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -90.28 143.55 26.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.433 2.116 . . . . 0.0 108.237 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.05 162.69 34.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.3 1.04 . . . . 0.0 112.193 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.2 140.97 52.39 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.033 2.133 . . . . 0.0 106.445 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.57 146.33 27.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.134 0.968 . . . . 0.0 108.666 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -139.01 120.21 14.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.84 170.36 21.76 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 p -75.73 6.53 4.8 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.81 133.71 47.71 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.254 -0.904 . . . . 0.0 111.438 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.0 142.48 79.55 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.188 0.995 . . . . 0.0 111.165 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.2 -43.07 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.866 2.377 . . . . 0.0 113.889 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -56.65 -40.7 75.93 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.652 0.781 . . . . 0.0 111.235 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.3 95.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.941 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.08 -50.55 70.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.839 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.48 -48.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.691 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -65.93 -31.92 73.13 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.639 1.109 . . . . 0.0 111.291 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.4 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.568 0.622 . . . . 0.0 109.933 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 m -74.57 -33.18 31.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -56.55 -26.08 53.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.044 1.738 . . . . 0.0 114.627 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.56 -29.17 67.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.377 0.99 . . . . 0.0 112.398 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.07 4.37 17.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.857 -0.527 . . . . 0.0 111.707 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.1 45.24 83.93 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -123.68 150.72 43.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.525 1.53 . . . . 0.0 108.314 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 153.91 36.67 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.266 0.555 . . . . 0.0 110.36 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.11 26.45 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -152.89 158.14 41.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.97 152.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 120.865 -1.147 . . . . 0.0 109.03 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -137.95 85.53 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 pp -146.71 165.83 28.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.454 0.701 . . . . 0.0 110.679 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -112.07 104.56 12.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.578 1.18 . . . . 0.0 111.353 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 tt -98.88 148.32 24.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.869 2.068 . . . . 0.0 108.343 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -129.35 140.31 51.42 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.791 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.55 142.34 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.68 122.86 18.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.199 1.8 . . . . 0.0 110.234 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.33 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.2 mtt -142.48 132.57 24.56 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 m -74.82 81.57 2.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.787 0.835 . . . . 0.0 110.308 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -151.54 173.7 14.3 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.162 1.785 . . . . 0.0 108.134 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -67.36 -31.26 71.39 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.826 0.851 . . . . 0.0 112.244 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -61.08 -31.66 71.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.389 0.995 . . . . 0.0 111.686 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.3 t -62.49 -50.57 70.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -52.4 -50.13 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.245 1.418 . . . . 0.0 108.587 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 65.6 mtp -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.051 0.541 . . . . 0.0 110.219 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.53 64.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 m -64.05 -48.6 85.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.092 0.86 . . . . 0.0 111.182 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -63.38 -41.64 98.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.416 1.007 . . . . 0.0 110.118 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -64.33 -30.65 71.69 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.938 -1.727 . . . . 0.0 110.261 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.68 -51.43 41.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.034 0.834 . . . . 0.0 109.456 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.54 -33.82 76.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.892 0.477 . . . . 0.0 110.715 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -61.74 -7.23 3.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.109 0.964 . . . . 0.0 111.888 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HE3' ' CB ' ' A' ' 54' ' ' ALA . 0.6 OUTLIER -57.86 -33.23 68.47 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.589 1.54 . . . . 0.0 109.687 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.0 158.35 41.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.59 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.017 2.478 . . . . 0.0 111.371 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 74.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 105.633 -2.987 . . . . 0.0 105.633 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.16 -34.89 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.27 0.628 . . . . 0.0 110.605 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -176.41 -78.64 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.973 2.509 . . . . 0.0 106.416 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -155.72 151.41 27.31 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.082 1.31 . . . . 0.0 110.984 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.8 135.91 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 125.914 1.686 . . . . 0.0 106.799 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -143.27 140.7 30.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.78 131.48 42.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.49 1.116 . . . . 0.0 109.009 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 p -106.14 117.9 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.629 0.728 . . . . 0.0 110.931 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -18.37 61.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.077 0.951 . . . . 0.0 113.457 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -78.38 -15.53 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 112.958 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -137.26 -15.82 1.44 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.09 12.83 83.77 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.4 1.0 . . . . 0.0 112.749 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -93.29 146.74 23.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.868 1.334 . . . . 0.0 108.421 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.83 114.78 16.96 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.962 2.105 . . . . 0.0 109.168 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.89 134.2 34.34 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.25 131.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.798 1.285 . . . . 0.0 112.006 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -123.92 145.48 49.1 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 127.226 2.211 . . . . 0.0 108.581 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.6 177.17 15.44 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 126.246 1.879 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.3 p -66.21 5.14 0.57 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.482 2.313 . . . . 0.0 113.595 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.54 140.45 56.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.929 -1.107 . . . . 0.0 108.315 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.94 129.53 39.45 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -58.34 -31.2 93.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.752 1.635 . . . . 0.0 112.268 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -57.06 -46.49 82.42 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.814 1.188 . . . . 0.0 110.487 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.86 76.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.619 0.768 . . . . 0.0 110.753 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 118.886 -0.578 . . . . 0.0 111.389 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.13 -52.95 52.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -60.67 -33.64 73.13 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.545 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.471 ' CB ' ' HE3' ' A' ' 24' ' ' LYS . . . -60.49 -50.89 71.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.428 1.467 . . . . 0.0 110.082 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.84 -32.45 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.34 -44.61 71.27 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.033 1.333 . . . . 0.0 109.879 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.38 -23.44 66.32 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.784 0.834 . . . . 0.0 109.802 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.67 -14.67 62.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.801 1.24 . . . . 0.0 108.921 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.57 30.0 5.73 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 128.01 2.719 . . . . 0.0 115.518 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.49 175.33 9.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.207 2.003 . . . . 0.0 112.574 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -100.06 134.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.32 160.9 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -149.41 164.64 34.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.54 158.53 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 121.582 -0.699 . . . . 0.0 111.065 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -162.39 166.91 24.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.57 2.748 . . . . 0.0 106.045 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 178.352 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.94 166.45 14.41 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.571 0.748 . . . . 0.0 110.537 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -130.07 128.45 41.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.94 122.04 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -93.21 133.95 35.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.409 HG11 ' CG2' ' A' ' 18' ' ' VAL . 79.6 t -132.22 113.0 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -134.0 166.12 23.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.303 0.573 . . . . 0.0 109.833 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.0 170.63 43.39 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -83.68 0.6 46.34 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.047 -0.678 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 t -77.58 177.61 7.93 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.089 0.956 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -83.43 -164.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.421 1.888 . . . . 0.0 112.235 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.24 -2.15 0.91 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.287 1.835 . . . . 0.0 113.294 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -62.11 -13.63 28.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.531 -1.356 . . . . 0.0 111.904 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.03 -38.91 80.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.04 -1.457 . . . . 0.0 113.224 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.59 -52.06 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 120.571 1.532 . . . . 0.0 110.6 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.7 ttp -67.88 -47.03 69.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.163 -0.335 . . . . 0.0 111.326 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.71 63.64 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.478 0.711 . . . . 0.0 111.681 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.409 ' CG2' HG11 ' A' ' 6' ' ' VAL . 79.1 t -62.2 -39.89 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.0 m -61.7 -43.88 98.0 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.218 1.372 . . . . 0.0 109.329 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -56.31 -51.36 68.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.361 0.982 . . . . 0.0 109.091 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.47 69.76 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.89 0.744 . . . . 0.0 111.259 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.8 -30.51 70.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.221 1.408 . . . . 0.0 112.442 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -79.53 -4.28 50.67 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.86 -1.15 . . . . 0.0 112.02 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -36.99 85.79 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.33 1.423 . . . . 0.0 111.455 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.9 148.15 84.01 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.115 0.87 . . . . 0.0 109.4 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.02 -48.57 3.54 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.099 1.866 . . . . 0.0 112.916 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.55 69.92 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.4 -10.48 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.884 0.874 . . . . 0.0 111.938 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.14 163.87 28.26 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.837 -1.165 . . . . 0.0 112.327 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -103.62 134.69 46.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.76 144.18 37.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -144.24 143.13 30.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.251 1.02 . . . . 0.0 111.283 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.5 134.23 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 109.59 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.3 t -72.2 143.17 48.96 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 110.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.4 -28.84 62.22 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -81.67 -27.59 33.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.184 2.194 . . . . 0.0 115.621 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -145.87 160.22 42.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.698 0.799 . . . . 0.0 109.248 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.94 33.88 2.38 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.858 0.742 . . . . 0.0 111.871 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -90.73 125.67 35.76 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 125.014 1.326 . . . . 0.0 107.964 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.38 120.1 37.76 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.791 1.236 . . . . 0.0 109.559 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.13 134.77 34.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.29 132.39 66.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -136.13 105.5 6.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.673 1.189 . . . . 0.0 111.275 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.2 -148.08 11.78 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -121.3 7.87 10.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.844 1.258 . . . . 0.0 111.825 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.31 138.47 57.65 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.511 -0.743 . . . . 0.0 109.075 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.28 148.29 93.62 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.596 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.67 -44.56 10.52 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.591 1.527 . . . . 0.0 110.309 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -55.95 -29.65 60.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -48.44 48.58 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.385 0.993 . . . . 0.0 108.953 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.59 -47.75 68.84 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.258 1.023 . . . . 0.0 110.502 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.28 -52.07 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -60.2 -43.31 96.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 116.533 -1.698 . . . . 0.0 110.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.88 -46.56 67.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.59 1.086 . . . . 0.0 111.465 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 m -73.05 -32.4 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.43 -0.794 . . . . 0.0 111.13 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -68.32 -20.34 64.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.596 1.558 . . . . 0.0 112.544 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -63.49 -11.64 25.43 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.6 5.21 11.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.14 64.09 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 116.387 1.315 . . . . 0.0 116.387 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -74.32 175.96 7.15 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.655 1.728 . . . . 0.0 108.225 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -103.45 124.18 48.25 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.29 120.27 36.48 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.233 1.013 . . . . 0.0 110.183 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -135.64 106.93 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.631 0.772 . . . . 0.0 111.033 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.59 156.48 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.612 -0.68 . . . . 0.0 110.185 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.21 90.9 3.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.301 -1.333 . . . . 0.0 109.659 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 13.0 ptp . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.442 HD13 ' H ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -147.56 166.57 26.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.32 1.848 . . . . 0.0 109.139 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' H ' HD13 ' A' ' 2' ' ' LEU . 5.0 ptpt -122.81 115.19 21.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.655 1.582 . . . . 0.0 107.639 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.38 148.7 43.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.316 1.046 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -124.05 138.57 54.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.63 143.49 40.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.243 1.417 . . . . 0.0 107.776 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -151.38 161.55 42.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.31 -36.86 0.1 Allowed Glycine 0 CA--C 1.521 0.409 0 O-C-N 120.959 -1.088 . . . . 0.0 113.191 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.7 mmt -147.57 3.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.832 1.316 . . . . 0.0 114.201 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.0 p 57.43 5.57 0.31 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 m -73.07 147.58 44.85 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.354 -1.466 . . . . 0.0 111.941 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.18 -23.56 67.49 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.875 0.369 . . . . 0.0 111.978 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -81.08 -4.45 55.29 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.966 -1.084 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 p -57.0 -28.27 62.29 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.08 1.309 . . . . 0.0 111.822 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -54.28 -35.72 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.222 1.409 . . . . 0.0 111.093 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.59 -50.06 70.94 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.95 67.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.08 -49.17 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.967 0.803 . . . . 0.0 110.464 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -54.76 -53.94 48.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.413 1.006 . . . . 0.0 110.002 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -65.19 -33.15 75.33 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.796 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.19 -44.92 74.77 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.256 1.389 . . . . 0.0 108.936 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.68 -30.25 71.26 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.92 0.888 . . . . 0.0 109.137 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -70.44 -14.28 62.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -53.7 -46.52 70.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.646 1.566 . . . . 0.0 110.108 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.13 122.82 84.77 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.07 158.1 42.11 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.662 1.575 . . . . 0.0 109.42 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.31 -70.13 0.21 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-O 117.922 -1.488 . . . . 0.0 116.216 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.07 -57.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.181 1.491 . . . . 0.0 112.555 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 54.86 -26.6 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -96.28 104.63 16.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.026 1.731 . . . . 0.0 110.593 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.26 119.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -110.7 116.88 32.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.8 125.47 54.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.521 1.128 . . . . 0.0 110.405 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.7 t -71.9 132.9 45.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.775 0.798 . . . . 0.0 108.903 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.68 -38.61 64.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.381 1.072 . . . . 0.0 110.604 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -78.52 -46.33 19.8 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -107.81 171.37 7.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.09 0.556 . . . . 0.0 110.432 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.19 15.99 56.87 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.925 -0.931 . . . . 0.0 111.753 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.67 135.45 33.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 118.874 1.337 . . . . 0.0 110.189 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.73 114.7 17.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.997 2.119 . . . . 0.0 107.728 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -77.62 145.46 36.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.9 p -129.48 138.19 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -117.55 104.56 11.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.64 -166.51 37.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.698 2.094 . . . . 0.0 108.524 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -117.47 -2.18 11.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.11 1.764 . . . . 0.0 113.727 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.27 131.65 28.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.453 1.024 . . . . 0.0 112.014 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.56 126.74 31.11 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 126.527 1.931 . . . . 0.0 110.589 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.0 -33.49 98.8 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.491 1.46 . . . . 0.0 112.782 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -61.34 -30.34 70.46 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.134 1.334 . . . . 0.0 111.33 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.93 -44.8 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.48 0.712 . . . . 0.0 110.245 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.74 -53.96 38.96 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.37 -43.49 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.05 -42.32 89.68 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.073 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.69 -41.37 66.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -80.82 -33.66 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.971 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -69.39 -20.92 63.81 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.361 1.464 . . . . 0.0 111.898 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.86 -32.25 71.78 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.945 1.298 . . . . 0.0 108.911 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -75.94 -19.12 59.02 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.21 56.61 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.239 1.876 . . . . 0.0 112.313 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.5 155.66 33.6 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -88.27 150.23 23.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.963 -1.086 . . . . 0.0 109.146 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.75 158.12 43.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -145.7 150.38 36.18 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.675 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.4 147.58 22.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.86 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -146.88 170.73 16.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.182 1.793 . . . . 0.0 109.211 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.12 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.564 ' H1 ' ' CD ' ' A' ' 43' ' ' GLU . 18.0 ptt? . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.2 165.53 13.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.36 148.79 49.53 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.08 145.7 44.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -99.41 132.93 44.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.855 1.262 . . . . 0.0 107.678 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.8 t -126.76 102.11 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -119.74 168.39 11.12 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.112 0.869 . . . . 0.0 112.112 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.16 12.65 0.04 OUTLIER Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.134 2.302 . . . . 0.0 112.326 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.4 ttt 65.35 90.74 0.09 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.925 2.09 . . . . 0.0 109.608 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 m 57.11 80.49 0.16 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.145 1.778 . . . . 0.0 112.075 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 69.0 m -55.27 127.63 30.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.718 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -71.25 -175.82 1.31 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.676 1.19 . . . . 0.0 108.694 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -48.7 -23.14 0.93 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.594 1.558 . . . . 0.0 113.357 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 t -53.96 -28.26 36.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.071 1.348 . . . . 0.0 110.217 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.15 -36.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 119.041 0.837 . . . . 0.0 109.966 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.3 ttm -66.86 -43.31 83.94 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.808 -1.182 . . . . 0.0 109.703 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.95 -52.64 64.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.668 0.787 . . . . 0.0 110.037 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.33 -41.79 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -60.89 -48.7 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.915 -1.116 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -64.22 -37.52 87.75 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 121.731 -0.606 . . . . 0.0 111.68 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.11 -47.53 67.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.346 1.058 . . . . 0.0 109.597 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.5 mt -57.48 -37.65 73.25 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.568 0.747 . . . . 0.0 109.181 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -68.91 -13.07 62.2 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.16 -0.963 . . . . 0.0 112.913 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -73.48 -21.08 60.52 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.538 1.517 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.8 m -52.31 142.06 30.27 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.65 94.04 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.173 3.249 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.16 -74.02 0.37 Allowed Glycine 0 C--N 1.332 0.353 0 O-C-N 121.411 -0.805 . . . . 0.0 112.646 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.6 t -54.64 -58.9 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 117.253 0.527 . . . . 0.0 111.341 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 43.45 19.89 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -150.84 106.32 3.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.132 1.773 . . . . 0.0 109.335 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.0 138.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -141.35 118.36 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -110.79 142.93 21.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 t -90.67 146.34 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.81 -49.35 30.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.14 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -81.62 -57.94 3.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.799 0.439 . . . . 0.0 112.103 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.85 152.32 41.57 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.12 53.28 1.87 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -123.57 133.84 53.91 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.647 1.224 . . . . 0.0 110.863 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.97 115.04 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.256 2.622 . . . . 0.0 108.764 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.35 135.17 34.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.38 133.99 57.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.564 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 16.0 tp10 -123.33 103.64 8.63 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.07 -170.22 41.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.661 1.124 . . . . 0.0 111.995 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -111.85 14.86 21.01 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.728 2.811 . . . . 0.0 115.585 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 142.06 57.63 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.302 -1.499 . . . . 0.0 109.496 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.01 151.1 81.5 Favored Pre-proline 0 C--O 1.237 0.429 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.301 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -55.32 -47.3 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.607 2.205 . . . . 0.0 111.519 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -55.1 -38.76 68.55 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.55 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.67 80.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.829 0.74 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.5 mt -68.21 -47.7 67.18 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.941 -0.474 . . . . 0.0 110.352 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.5 t -55.66 -56.37 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 124.413 1.085 . . . . 0.0 108.722 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -57.34 -50.22 73.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.589 -1.196 . . . . 0.0 110.036 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.11 64.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.303 0.956 . . . . 0.0 111.697 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -76.38 -43.18 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.7 -23.28 64.74 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.079 1.752 . . . . 0.0 110.914 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -62.46 -23.51 66.93 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.089 1.356 . . . . 0.0 110.532 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.29 39.5 mt-10 -104.36 16.43 26.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.836 0.854 . . . . 0.0 111.436 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.96 1.77 49.4 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 127.216 2.341 . . . . 0.0 116.129 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -74.92 151.24 38.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.137 1.469 . . . . 0.0 109.388 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -75.05 105.07 5.89 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.11 39.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.514 1.125 . . . . 0.0 109.125 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -141.58 114.05 8.27 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.82 167.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 pp -119.38 -173.09 2.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 108.597 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.685 1.594 . . . . 0.0 107.402 179.361 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtm . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.14 166.06 22.64 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.336 1.454 . . . . 0.0 107.202 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -124.72 107.73 11.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.503 0.721 . . . . 0.0 111.063 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.01 137.65 36.06 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.383 -1.448 . . . . 0.0 108.028 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -109.17 137.72 46.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.7 143.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.554 1.07 . . . . 0.0 109.792 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -147.52 156.98 43.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.605 0.717 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.01 -28.17 2.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.3 -1.278 . . . . 0.0 111.298 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 35.4 tpp -147.99 152.98 38.39 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.023 1.411 . . . . 0.0 110.339 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -141.46 78.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.9 m -150.42 150.39 31.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.967 2.107 . . . . 0.0 108.122 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -53.37 -31.84 46.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.661 1.985 . . . . 0.0 114.481 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -63.85 -22.31 66.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.328 -0.857 . . . . 0.0 112.356 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.2 t -52.83 -52.55 56.62 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.405 1.082 . . . . 0.0 108.242 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.1 t -52.56 -51.18 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.571 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -57.12 -49.96 74.28 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.79 0.836 . . . . 0.0 110.937 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.49 -38.54 90.05 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.199 0.999 . . . . 0.0 111.963 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.68 -54.75 30.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 108.987 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -65.61 -32.41 73.97 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.811 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -62.43 -42.59 99.56 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.565 -1.334 . . . . 0.0 111.106 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.52 -48.55 26.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.305 0.957 . . . . 0.0 111.97 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.43 -41.56 89.88 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.107 0.963 . . . . 0.0 113.33 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -49.8 -28.47 6.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -57.57 -27.1 62.38 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.48 1.036 . . . . 0.0 111.031 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.03 104.45 14.96 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 125.579 1.552 . . . . 0.0 108.527 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 168.84 23.77 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.452 1.435 . . . . 0.0 109.305 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.8 16.27 61.82 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 122.31 -0.244 . . . . 0.0 113.417 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.45 -58.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 39.45 2.84 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 131.37 3.868 . . . . 0.0 119.21 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -143.69 102.94 4.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.175 1.39 . . . . 0.0 107.59 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.32 142.41 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.98 116.96 11.64 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 t -90.72 143.16 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -89.52 132.99 34.79 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.84 -48.78 34.83 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.05 -0.5 . . . . 0.0 112.197 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -83.03 -12.68 56.99 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.024 1.33 . . . . 0.0 114.052 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HE3' ' OE1' ' A' ' 39' ' ' GLU . 21.2 mtpp -126.64 151.69 47.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.598 -0.689 . . . . 0.0 111.601 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.61 78.15 2.0 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.441 ' OE1' ' HE3' ' A' ' 37' ' ' LYS . 8.6 pt-20 -165.9 158.39 14.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.353 0.661 . . . . 0.0 110.588 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.78 125.87 12.9 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.027 0.931 . . . . 0.0 109.554 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.7 mt -74.55 142.67 44.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.68 131.23 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 110.83 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -123.02 151.22 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.17 -157.47 15.01 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.83 29.62 7.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.905 1.282 . . . . 0.0 114.315 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.79 123.9 26.4 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.46 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.15 152.89 83.25 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.783 1.633 . . . . 0.0 112.127 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.56 -57.37 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.518 2.812 . . . . 0.0 113.565 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -56.65 -40.88 76.23 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 117.934 0.334 . . . . 0.0 110.549 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.5 88.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -54.69 35.25 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.233 0.613 . . . . 0.0 111.271 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.4 m -59.98 -35.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.037 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -71.42 -37.83 71.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.37 -0.831 . . . . 0.0 110.409 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.12 97.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.198 0.908 . . . . 0.0 109.281 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.32 -32.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.788 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.95 -23.39 45.14 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.56 1.144 . . . . 0.0 112.388 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.61 -29.06 69.8 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.953 0.797 . . . . 0.0 110.158 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -86.81 -13.71 44.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.471 1.508 . . . . 0.0 111.323 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.16 66.45 1.61 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.176 1.369 . . . . 0.0 115.365 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -139.83 170.14 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 108.479 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -106.54 105.09 14.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.635 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.1 149.62 35.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 119.09 0.859 . . . . 0.0 110.161 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -149.31 165.98 30.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.551 1.94 . . . . 0.0 108.502 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.1 154.56 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 121.348 -0.845 . . . . 0.0 111.212 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.7 tp -76.0 106.82 7.8 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.201 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.157 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.1 mt -116.69 151.15 36.95 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.633 1.173 . . . . 0.0 108.199 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -122.24 142.19 50.71 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.225 1.01 . . . . 0.0 110.797 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.99 121.68 18.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.635 1.974 . . . . 0.0 110.278 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -87.95 137.9 31.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -126.94 91.01 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.614 1.566 . . . . 0.0 107.516 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.76 146.92 35.58 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.27 -165.16 25.21 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ttt -95.92 -85.15 0.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.225 0.61 . . . . 0.0 109.446 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 12' ' ' ASN . 4.2 m -68.78 150.08 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.785 -0.572 . . . . 0.0 110.015 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.9 t -129.32 5.41 5.24 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.455 1.502 . . . . 0.0 111.094 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.494 ' H ' HG22 ' A' ' 10' ' ' THR . 29.1 m120 -86.49 -100.69 0.07 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.581 -1.324 . . . . 0.0 109.148 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -64.01 -11.19 26.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.92 -1.113 . . . . 0.0 112.908 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -28.56 69.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.809 1.244 . . . . 0.0 110.827 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -54.59 -35.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.088 0.858 . . . . 0.0 110.692 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.76 -45.65 77.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.701 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -52.43 65.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.22 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -58.91 -47.69 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.507 1.049 . . . . 0.0 110.866 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.5 p -63.43 -40.96 98.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -75.37 -40.89 57.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.608 0.763 . . . . 0.0 111.922 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.22 84.69 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.754 0.822 . . . . 0.0 110.191 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.0 mt -56.55 -28.24 59.59 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.9 0.48 . . . . 0.0 110.248 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -59.47 -11.9 5.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.047 0.939 . . . . 0.0 112.986 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -55.12 -16.36 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.289 1.404 . . . . 0.0 112.398 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.86 92.27 20.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.69 -4.34 15.09 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.016 2.477 . . . . 0.0 114.771 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.79 2.48 54.48 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 116.841 1.497 . . . . 0.0 116.841 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.549 HG21 ' CG1' ' A' ' 42' ' ' VAL . 5.9 p -113.9 -48.02 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 119.579 1.689 . . . . 0.0 112.164 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 59.43 -2.97 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.44 103.35 8.88 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.465 1.484 . . . . 0.0 107.198 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 m -141.27 138.29 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.279 1.032 . . . . 0.0 109.666 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.79 143.12 40.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.171 1.788 . . . . 0.0 108.284 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.6 t -136.88 143.24 35.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.101 1.76 . . . . 0.0 107.46 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.1 t -76.81 138.52 39.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.31 -36.04 66.18 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -81.59 -57.94 3.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.343 1.057 . . . . 0.0 112.198 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.54 177.29 6.4 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.963 1.305 . . . . 0.0 112.49 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.58 17.27 56.86 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -90.52 143.38 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.195 1.497 . . . . 0.0 108.302 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.43 163.13 33.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.942 1.297 . . . . 0.0 110.588 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.24 144.42 30.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.897 1.279 . . . . 0.0 110.211 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.549 ' CG1' HG21 ' A' ' 28' ' ' VAL . 79.9 t -130.42 143.25 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.551 1.94 . . . . 0.0 108.12 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -130.1 105.31 7.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.216 1.006 . . . . 0.0 109.951 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA3' HG23 ' A' ' 28' ' ' VAL . . . 167.09 -161.09 34.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.574 1.559 . . . . 0.0 110.225 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 p -96.15 0.54 51.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.735 1.268 . . . . 0.0 114.362 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.71 131.86 30.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.658 1.117 . . . . 0.0 111.019 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.36 142.44 98.35 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.35 -48.55 21.41 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.224 1.949 . . . . 0.0 112.348 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -62.02 -23.17 66.28 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.761 -1.114 . . . . 0.0 112.936 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.61 85.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.802 1.183 . . . . 0.0 108.348 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.65 -48.63 59.15 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.809 0.693 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.0 t -54.19 -59.41 2.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.969 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.1 -38.59 83.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.868 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.52 -44.69 69.36 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 117.156 -1.402 . . . . 0.0 110.22 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.25 -32.32 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.857 1.208 . . . . 0.0 112.041 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.79 -44.76 82.23 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.843 1.257 . . . . 0.0 108.844 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.37 -26.42 66.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.53 1.132 . . . . 0.0 111.422 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -69.99 -36.86 75.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.478 1.035 . . . . 0.0 108.65 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.37 30.59 1.16 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.567 1.556 . . . . 0.0 112.338 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -120.14 172.21 7.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.305 1.552 . . . . 0.0 109.255 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.93 99.63 6.48 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.331 0.969 . . . . 0.0 113.186 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.24 160.84 15.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.488 1.115 . . . . 0.0 112.161 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -154.46 130.13 9.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.876 1.27 . . . . 0.0 107.991 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.52 156.55 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.34 166.81 17.13 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.87 2.068 . . . . 0.0 106.901 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 125.065 1.346 . . . . 0.0 109.394 -179.383 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttm . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.03 166.46 10.82 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -130.41 146.53 51.99 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.884 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.3 tp -136.77 110.92 8.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -81.74 119.94 24.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.99 138.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -136.78 174.02 11.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 -102.2 0.96 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 34.1 tpp -113.48 114.56 26.71 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.571 1.186 . . . . 0.0 112.364 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.47 105.01 17.0 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.407 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 48.9 t -138.87 157.16 46.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 110.044 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.74 -28.95 67.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 110.618 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.88 -26.33 21.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.5 0.72 . . . . 0.0 111.071 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 79.5 m -61.49 -43.07 99.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.811 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.0 -33.39 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.773 1.17 . . . . 0.0 111.037 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.64 -45.44 75.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.27 65.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.364 0.665 . . . . 0.0 109.985 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -57.26 -49.54 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 124.634 1.174 . . . . 0.0 109.851 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -58.03 -53.56 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.159 0.891 . . . . 0.0 110.386 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -59.44 -47.32 85.94 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.461 -0.774 . . . . 0.0 112.152 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.46 92.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.99 0.916 . . . . 0.0 111.95 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.66 -36.15 83.34 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.702 -1.249 . . . . 0.0 109.861 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.3 -19.07 64.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.953 0.901 . . . . 0.0 113.103 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -56.84 -36.18 69.7 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.113 1.524 . . . . 0.0 115.113 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.95 121.3 81.97 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 112.552 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.4 121.56 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.88 -14.96 2.4 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.273 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.38 -57.27 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 118.966 1.383 . . . . 0.0 108.809 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 63.36 -30.8 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.177 2.191 . . . . 0.0 115.25 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 122.94 35.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.8 2.091 . . . . 0.0 112.432 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 42' ' ' VAL . 22.8 m -141.25 144.43 26.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.16 1.384 . . . . 0.0 107.454 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -124.0 118.67 27.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.52 115.94 49.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.134 0.974 . . . . 0.0 108.404 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -93.02 118.11 30.81 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.61 -45.11 91.8 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.214 0.461 . . . . 0.0 111.205 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -55.46 -58.09 9.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 111.496 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -70.85 -49.94 40.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.234 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 2.56 52.28 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.68 1.61 . . . . 0.0 109.64 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.47 151.67 20.68 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.303 1.441 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.81 114.23 17.65 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.173 1.389 . . . . 0.0 109.776 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.62 113.47 20.34 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 31' ' ' VAL . 25.0 m -109.99 132.29 58.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 118.266 0.485 . . . . 0.0 110.65 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.26 105.56 14.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.84 158.52 11.36 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.42 -12.11 54.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.619 1.568 . . . . 0.0 112.773 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.55 155.24 2.25 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.57 136.4 85.96 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 125.432 1.493 . . . . 0.0 111.387 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.15 -25.3 37.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.441 2.094 . . . . 0.0 112.632 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -35.04 65.45 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.088 0.858 . . . . 0.0 110.725 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.47 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.96 -45.64 63.75 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.13 -47.36 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -62.2 -49.12 77.05 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.446 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.56 63.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.759 1.163 . . . . 0.0 113.164 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.4 t -81.49 -38.3 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.57 -36.0 82.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.26 -14.81 8.02 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.945 2.098 . . . . 0.0 112.36 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -115.67 -1.37 12.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.853 1.261 . . . . 0.0 111.275 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.97 42.22 9.0 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.382 0.992 . . . . 0.0 113.99 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -132.16 160.98 34.49 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.409 1.105 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -90.95 145.54 24.64 Favored 'General case' 0 CA--C 1.522 -0.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.1 143.43 47.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.866 1.266 . . . . 0.0 109.617 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -140.3 121.61 14.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 108.642 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -89.57 130.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.775 1.63 . . . . 0.0 109.993 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -133.92 126.42 30.34 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.83 1.652 . . . . 0.0 107.457 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.873 1.669 . . . . 0.0 110.092 178.867 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mmt . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.872 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.92 165.17 17.87 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.299 1.863 . . . . 0.0 110.974 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -142.55 147.66 36.29 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.49 1.916 . . . . 0.0 107.64 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.02 148.92 45.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.804 2.442 . . . . 0.0 108.547 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -97.03 138.55 34.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -122.11 128.39 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.229 2.212 . . . . 0.0 107.365 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -132.67 142.68 49.2 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.58 -179.9 24.88 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.371 1.462 . . . . 0.0 109.77 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.02 -46.33 88.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -173.14 -177.79 1.63 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.33 1.852 . . . . 0.0 107.421 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -72.97 139.19 46.54 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -152.53 170.23 20.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.898 1.279 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -57.37 -25.41 59.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.102 0.961 . . . . 0.0 109.464 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -27.57 17.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.321 2.249 . . . . 0.0 112.388 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.9 t -52.24 -46.03 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 120.353 1.433 . . . . 0.0 109.063 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -66.14 -43.4 87.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.272 -0.893 . . . . 0.0 108.648 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.43 67.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.735 0.814 . . . . 0.0 110.721 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.68 -35.4 75.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.4 m -57.53 -54.57 45.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.651 1.569 . . . . 0.0 109.439 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -64.13 -32.18 73.65 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -41.53 79.82 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.387 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.5 mt -57.11 -46.23 82.79 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -61.34 -4.33 1.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -57.99 -36.47 72.67 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 121.692 2.042 . . . . 0.0 114.413 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.07 119.78 29.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.217 1.007 . . . . 0.0 110.984 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.34 -21.99 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 113.46 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.41 4.04 66.55 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 117.696 -1.614 . . . . 0.0 115.381 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.43 -59.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.259 2.029 . . . . 0.0 109.288 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 57.77 0.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.161 2.584 . . . . 0.0 116.071 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.68 104.08 4.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.706 1.594 . . . . 0.0 110.772 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.18 140.06 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.122 0.969 . . . . 0.0 108.81 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -144.08 144.09 31.45 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.795 1.238 . . . . 0.0 108.958 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -124.58 143.81 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.569 1.947 . . . . 0.0 108.379 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -103.88 118.03 35.74 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.46 -30.09 69.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.033 1.288 . . . . 0.0 111.558 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.429 1.492 . . . . 0.0 110.313 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -83.24 -23.3 32.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 9.13 87.34 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 118.878 0.763 . . . . 0.0 112.113 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.6 160.79 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.187 1.994 . . . . 0.0 109.207 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.01 115.63 9.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.278 1.031 . . . . 0.0 109.762 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -91.07 140.13 30.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.465 1.106 . . . . 0.0 108.3 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.78 141.95 42.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 108.431 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -130.38 104.2 7.12 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.14 -176.97 40.76 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.855 1.693 . . . . 0.0 109.546 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 p -98.4 10.51 40.63 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.3 142.8 42.06 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.827 1.649 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.84 152.51 91.14 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.016 0.926 . . . . 0.0 109.972 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.84 -47.95 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.036 1.824 . . . . 0.0 110.421 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -38.78 72.83 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.485 0.314 . . . . 0.0 111.418 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.58 -53.87 44.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.962 0.905 . . . . 0.0 109.887 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.35 -52.89 62.9 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.531 0.732 . . . . 0.0 111.431 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.33 -57.84 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.833 0.853 . . . . 0.0 110.567 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -64.4 -35.88 82.35 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.005 0.82 . . . . 0.0 110.59 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.56 78.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.699 1.136 . . . . 0.0 110.337 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -77.97 -35.2 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.269 0.94 . . . . 0.0 109.535 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -61.61 -27.29 68.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.629 0.771 . . . . 0.0 110.955 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.99 -11.79 32.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.305 1.442 . . . . 0.0 111.562 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -109.49 -2.61 17.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.831 1.653 . . . . 0.0 111.125 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.55 -8.1 77.17 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.621 1.581 . . . . 0.0 113.768 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -78.98 157.91 28.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.756 1.278 . . . . 0.0 108.311 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -109.88 99.92 8.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.45 150.9 22.91 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.021 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -154.75 124.83 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 m -60.24 155.0 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.97 . . . . 0.0 109.928 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -56.9 132.15 51.73 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.884 1.273 . . . . 0.0 108.456 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.608 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.36 165.95 12.4 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.459 1.504 . . . . 0.0 107.799 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -150.4 104.05 3.2 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.413 -0.804 . . . . 0.0 108.848 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tp -79.17 147.9 32.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.817 0.847 . . . . 0.0 108.776 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -128.36 106.97 9.37 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.183 0.993 . . . . 0.0 109.497 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 t -74.95 153.07 6.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 126.13 1.772 . . . . 0.0 110.025 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -152.53 162.1 41.67 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 122.215 1.007 . . . . 0.0 111.855 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.27 -68.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 126.984 2.23 . . . . 0.0 113.416 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 mmt -84.37 162.78 19.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.899 0.85 . . . . 0.0 112.556 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -140.16 36.26 1.91 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.286 2.634 . . . . 0.0 106.772 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.97 179.46 2.72 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 119.949 -1.719 . . . . 0.0 109.504 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.94 -61.15 1.75 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.361 0.665 . . . . 0.0 110.008 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -56.72 -16.64 6.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.937 1.295 . . . . 0.0 114.05 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 p -59.58 -28.56 67.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.04 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.37 -46.49 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.529 1.513 . . . . 0.0 110.758 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.5 mtt -64.29 -49.81 70.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.334 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.42 -52.25 66.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.808 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.58 -52.02 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.305 1.442 . . . . 0.0 111.229 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 t -54.67 -43.97 72.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.184 1.357 . . . . 0.0 108.778 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -64.18 -50.69 67.13 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.626 -0.671 . . . . 0.0 111.342 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.43 79.3 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.507 1.523 . . . . 0.0 112.117 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.15 -38.06 81.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.037 0.935 . . . . 0.0 110.425 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.28 -10.55 59.7 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -46.73 -57.33 4.95 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.52 118.65 56.03 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.562 1.528 . . . . 0.0 111.734 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.55 88.79 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.706 2.271 . . . . 0.0 108.522 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.69 -33.69 0.02 OUTLIER Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.452 -0.78 . . . . 0.0 111.419 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.29 -50.2 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 117.474 0.637 . . . . 0.0 109.504 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 67.58 -46.61 0.5 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.312 2.245 . . . . 0.0 112.64 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -101.45 109.85 21.75 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.523 1.51 . . . . 0.0 112.698 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.62 130.43 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -130.73 137.55 49.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.093 1.357 . . . . 0.0 107.465 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.75 138.04 44.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 110.017 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.7 t -113.12 118.55 35.05 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.63 -24.33 66.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.406 0.682 . . . . 0.0 111.853 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.75 -13.75 61.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.746 1.618 . . . . 0.0 111.684 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -135.54 -15.74 1.85 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.79 18.46 72.35 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -100.19 145.5 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.49 114.56 9.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.9 0.48 . . . . 0.0 111.572 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.9 mp -77.55 144.42 37.61 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.965 1.706 . . . . 0.0 107.715 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.33 121.64 23.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.788 0.835 . . . . 0.0 109.298 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.05 104.99 9.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.46 177.51 21.14 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.697 1.618 . . . . 0.0 109.847 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -70.97 26.19 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.541 1.536 . . . . 0.0 113.991 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 106.11 1.19 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 142.07 98.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 123.323 0.649 . . . . 0.0 112.11 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.21 -48.14 12.75 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.457 2.105 . . . . 0.0 112.224 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -56.21 -37.26 69.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.468 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.64 63.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.309 0.644 . . . . 0.0 109.749 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -61.96 -50.07 73.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.289 1.035 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.59 -49.72 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -65.65 -42.01 91.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.836 0.744 . . . . 0.0 111.478 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.06 -31.23 70.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.656 1.182 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 62' ' ' ALA . 95.8 t -88.35 -41.75 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 118.656 0.662 . . . . 0.0 109.931 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.59 -42.35 82.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.839 0.856 . . . . 0.0 110.96 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.78 -12.74 50.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.785 -0.626 . . . . 0.0 112.03 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -97.83 -10.11 25.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 120.015 1.279 . . . . 0.0 113.338 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.23 9.27 60.68 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.238 -1.312 . . . . 0.0 114.576 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.69 145.64 30.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -88.2 152.14 22.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -149.21 147.37 28.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.561 0.618 . . . . 0.0 109.647 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -134.67 153.48 51.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.242 1.017 . . . . 0.0 108.263 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.18 173.97 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.99 85.5 3.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.6 mt -119.91 160.74 22.11 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.34 139.94 53.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.629 0.772 . . . . 0.0 110.109 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -122.29 111.54 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -88.95 127.15 35.65 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.22 141.54 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -141.45 98.57 3.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.33 -162.6 28.38 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.576 2.036 . . . . 0.0 109.761 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.2 ttt -124.47 8.08 8.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.175 1.79 . . . . 0.0 108.04 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.15 174.28 9.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 128.116 2.566 . . . . 0.0 107.465 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -140.0 -77.25 0.32 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -55.13 -28.6 53.87 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -93.1 -34.87 13.49 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 109.55 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -54.79 -54.3 43.89 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.929 1.292 . . . . 0.0 110.429 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -52.01 -38.29 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.128 0.971 . . . . 0.0 112.393 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.4 mmm -62.38 -49.8 74.08 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 110.088 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.82 -38.72 83.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.216 0.606 . . . . 0.0 110.185 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.23 -44.85 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.8 m -64.71 -40.02 94.64 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.904 1.229 . . . . 0.0 109.088 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -55.66 -49.76 72.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.109 0.964 . . . . 0.0 109.614 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.48 59.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.114 1.366 . . . . 0.0 110.246 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.6 mt -58.81 -28.11 65.7 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 124.355 1.062 . . . . 0.0 112.47 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -68.86 -21.01 64.29 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.098 -1.001 . . . . 0.0 111.63 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.21 -15.46 63.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.8 m -51.94 160.93 1.02 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.319 1.848 . . . . 0.0 113.313 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.65 -71.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.872 2.381 . . . . 0.0 111.757 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -156.75 51.95 0.42 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.709 0.671 . . . . 0.0 112.157 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.31 -36.48 74.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 118.01 0.905 . . . . 0.0 111.183 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.286 4.1 pt-20 58.38 -11.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.278 2.631 . . . . 0.0 116.362 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -135.18 104.07 5.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.076 2.15 . . . . 0.0 107.762 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -141.91 120.24 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -124.4 142.78 51.03 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.777 1.631 . . . . 0.0 108.956 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 t -137.01 143.21 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.079 0.552 . . . . 0.0 109.802 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -81.56 126.2 31.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.47 -48.57 48.36 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.052 0.941 . . . . 0.0 111.508 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.11 -13.59 59.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -118.75 -164.84 1.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.613 1.565 . . . . 0.0 108.463 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.87 66.54 0.57 Allowed Glycine 0 CA--C 1.52 0.344 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -145.7 137.05 24.94 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.738 -1.448 . . . . 0.0 108.163 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.35 145.2 50.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.512 1.525 . . . . 0.0 109.406 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.16 138.98 54.28 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.65 139.75 42.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.701 0.801 . . . . 0.0 110.105 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -128.58 104.09 7.47 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.57 -169.13 27.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.0 p -59.56 6.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 130.976 3.711 . . . . 0.0 117.56 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.44 104.84 6.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.403 1.456 . . . . 0.0 110.376 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -66.1 132.91 94.62 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 123.862 0.865 . . . . 0.0 110.35 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.69 -38.55 91.29 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.464 2.109 . . . . 0.0 114.806 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.06 -38.27 85.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.867 2.122 . . . . 0.0 110.149 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.4 83.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -67.38 -50.55 59.25 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.836 1.255 . . . . 0.0 109.375 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -52.84 -54.04 18.28 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 124.976 1.31 . . . . 0.0 108.156 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.67 -50.57 69.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.451 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.34 66.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.486 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.25 -32.88 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.216 0.916 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.76 -20.27 65.62 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.613 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.52 -28.2 69.14 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.484 1.493 . . . . 0.0 110.615 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -90.41 -7.86 52.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.064 1.346 . . . . 0.0 110.211 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.51 10.41 70.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.191 1.853 . . . . 0.0 115.399 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.89 156.35 37.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.394 2.097 . . . . 0.0 109.222 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -80.57 119.49 23.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.83 143.33 31.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.569 0.748 . . . . 0.0 109.159 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -147.02 149.82 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -106.13 148.47 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 123.766 0.826 . . . . 0.0 111.532 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.3 mt -148.2 150.45 33.78 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.32 1.448 . . . . 0.0 107.5 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.275 1.03 . . . . 0.0 110.452 179.695 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtt . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.6 mt -128.39 153.43 47.08 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -131.15 109.81 10.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.746 0.818 . . . . 0.0 109.408 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -101.51 111.46 23.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -90.05 138.5 31.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.88 152.48 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.104 0.866 . . . . 0.0 110.044 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -142.73 100.11 3.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.736 2.414 . . . . 0.0 108.258 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.41 -75.58 0.1 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -142.88 150.32 39.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.151 1.78 . . . . 0.0 107.473 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -143.74 -64.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.505 1.122 . . . . 0.0 108.264 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.5 m -75.48 64.36 1.59 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.898 1.279 . . . . 0.0 109.249 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -153.12 172.57 16.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.462 2.305 . . . . 0.0 106.477 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -66.14 -4.71 8.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.094 -1.004 . . . . 0.0 112.815 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -53.05 -26.71 16.75 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.373 1.469 . . . . 0.0 111.743 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.9 t -50.23 -49.3 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.924 1.29 . . . . 0.0 109.746 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -63.12 -31.1 72.17 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.94 -42.1 34.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.167 0.987 . . . . 0.0 109.752 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.54 -50.97 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.1 p -61.1 -50.65 72.38 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.09 -0.481 . . . . 0.0 109.835 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -53.83 -54.56 36.71 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.822 0.737 . . . . 0.0 111.881 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.03 -50.76 70.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.908 0.883 . . . . 0.0 111.082 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 mp -68.38 -29.33 68.01 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.169 -0.957 . . . . 0.0 112.84 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -86.95 -9.27 56.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.771 1.628 . . . . 0.0 113.258 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -56.22 -25.5 47.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.559 1.143 . . . . 0.0 113.511 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.65 141.77 29.5 Favored Pre-proline 0 N--CA 1.447 -0.576 0 C-N-CA 125.207 1.403 . . . . 0.0 107.318 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.09 177.2 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.719 2.28 . . . . 0.0 111.245 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.39 -61.51 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -75.55 -59.28 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 52.3 -17.37 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.588 2.355 . . . . 0.0 116.498 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.94 115.99 30.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 121.546 1.976 . . . . 0.0 110.514 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -147.98 119.15 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.143 1.777 . . . . 0.0 106.432 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -125.19 120.86 32.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 t -87.76 142.74 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.6 t -125.98 117.39 23.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.44 -48.51 49.07 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.451 1.5 . . . . 0.0 113.81 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -58.64 -19.04 35.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.777 1.231 . . . . 0.0 113.102 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 7.98 9.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.963 1.305 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 43.29 56.74 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 126.75 2.119 . . . . 0.0 110.427 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.62 179.94 7.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.9 115.23 10.4 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.776 2.43 . . . . 0.0 108.625 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.7 mt -81.95 123.95 29.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.48 146.22 26.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 118.765 0.711 . . . . 0.0 109.551 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -133.29 107.92 8.42 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.92 174.07 38.52 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 127.547 2.499 . . . . 0.0 108.484 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -88.33 3.6 49.15 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.263 1.425 . . . . 0.0 113.054 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 155.76 1.03 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 117.503 2.408 . . . . 0.0 117.503 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.69 137.09 62.88 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.137 2.175 . . . . 0.0 110.317 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.39 -42.94 30.8 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.197 1.932 . . . . 0.0 109.927 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.68 -45.18 95.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.143 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.52 -43.89 93.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 110.263 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -61.58 -54.49 42.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.688 0.795 . . . . 0.0 109.254 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.17 -46.85 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.427 1.091 . . . . 0.0 109.848 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -67.68 -39.01 84.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.171 -1.395 . . . . 0.0 111.33 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.89 77.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.825 1.193 . . . . 0.0 110.268 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.81 -38.03 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.324 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.1 -40.3 86.89 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.165 -0.959 . . . . 0.0 111.944 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.11 -19.71 65.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.507 0.594 . . . . 0.0 111.28 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -88.97 -30.51 18.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.9 -1.048 . . . . 0.0 111.179 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 4.66 0.41 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 119.05 2.38 . . . . 0.0 119.05 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.17 138.98 26.92 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.593 3.196 . . . . 0.0 108.656 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -75.4 163.96 26.89 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 118.223 0.465 . . . . 0.0 109.909 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.73 161.04 43.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.719 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -151.38 128.96 11.45 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.95 161.74 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.594 -0.691 . . . . 0.0 111.528 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.6 mt -118.51 169.34 9.86 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.684 1.594 . . . . 0.0 108.856 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.492 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.5 mt -134.48 163.08 30.49 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.834 -1.166 . . . . 0.0 109.187 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -120.54 133.1 55.43 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -136.84 148.71 47.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 109.426 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -122.32 138.36 54.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.24 128.57 21.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -139.53 159.27 42.56 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.495 1.118 . . . . 0.0 111.476 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.88 -100.39 0.53 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 124.907 1.242 . . . . 0.0 111.622 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.4 mtp -128.87 -17.0 4.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.091 0.946 . . . . 0.0 113.099 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p -146.69 -178.31 6.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.902 2.081 . . . . 0.0 108.184 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.5 p -123.24 -17.54 6.58 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.008 0.923 . . . . 0.0 110.244 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -68.97 -79.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.983 0.811 . . . . 0.0 110.399 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -79.92 -14.49 58.58 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -52.46 -43.59 65.04 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.293 1.037 . . . . 0.0 110.531 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.61 -38.54 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.289 1.436 . . . . 0.0 110.741 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.62 -45.33 83.5 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.051 0.842 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.11 86.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.207 0.458 . . . . 0.0 109.888 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.22 -54.05 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.383 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -61.47 -38.65 88.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.174 1.352 . . . . 0.0 110.469 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -55.18 -50.55 69.04 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.306 0.642 . . . . 0.0 109.308 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.81 -51.63 38.72 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.52 -27.76 69.48 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -60.91 -9.6 4.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.488 1.04 . . . . 0.0 112.697 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.19 -29.64 58.31 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 114.027 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.95 156.63 91.77 Favored Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 121.446 -0.784 . . . . 0.0 112.248 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.7 -50.69 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.87 1.713 . . . . 0.0 109.77 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.32 34.04 0.02 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 121.207 -0.933 . . . . 0.0 112.231 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.11 -33.53 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 112.757 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.69 165.86 33.97 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -114.65 104.1 11.65 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.94 137.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.03 117.88 13.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.22 143.93 12.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -89.29 153.94 20.49 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.119 0.872 . . . . 0.0 108.925 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.51 -48.13 35.65 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.533 -1.354 . . . . 0.0 109.666 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -66.82 -22.56 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -145.48 145.97 31.29 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.748 1.158 . . . . 0.0 108.736 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.91 10.68 2.95 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.616 2.055 . . . . 0.0 114.414 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.62 163.94 14.37 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.2 162.5 39.34 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 126.256 1.822 . . . . 0.0 109.877 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.07 142.36 49.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.19 117.13 44.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.148 0.975 . . . . 0.0 108.8 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.93 104.95 12.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.903 2.081 . . . . 0.0 105.613 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.7 -176.27 39.03 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -95.18 7.52 45.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.569 1.148 . . . . 0.0 113.227 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.5 156.52 19.28 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.094 -1.003 . . . . 0.0 113.491 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.64 119.25 71.91 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -57.71 -41.03 74.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.901 1.734 . . . . 0.0 110.698 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -38.78 75.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.832 0.853 . . . . 0.0 110.648 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.8 82.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.76 0.709 . . . . 0.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.27 -46.53 73.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.14 -38.83 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.706 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -47.99 83.75 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.397 0.999 . . . . 0.0 109.776 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.21 87.17 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.256 1.022 . . . . 0.0 111.557 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.72 -34.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.128 0.571 . . . . 0.0 110.076 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -64.48 -51.68 61.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -67.81 -16.1 63.95 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.46 -9.13 59.56 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.29 -0.881 . . . . 0.0 108.941 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.35 52.81 3.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -141.08 175.26 9.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.981 1.712 . . . . 0.0 108.26 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -118.42 147.49 43.52 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.15 167.41 22.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -148.24 143.09 26.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -100.07 143.03 14.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -143.14 51.69 1.38 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 109.242 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.264 0 C-N-CA 128.54 2.736 . . . . 0.0 107.078 -178.487 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.85 157.39 16.41 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 120.995 -1.066 . . . . 0.0 108.395 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -115.12 124.21 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.64 148.35 38.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.03 1.332 . . . . 0.0 108.115 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -118.71 138.4 52.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.15 133.72 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -145.04 108.63 4.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.91 -97.54 1.57 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.8 mtt -143.6 -60.29 0.41 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -132.33 120.99 22.83 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -109.99 50.12 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.375 1.87 . . . . 0.0 112.147 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -111.21 -92.04 0.46 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -57.42 -31.23 65.65 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.645 1.111 . . . . 0.0 110.33 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 t -52.91 -37.24 60.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.351 2.26 . . . . 0.0 111.592 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -52.38 -41.99 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 119.181 0.901 . . . . 0.0 110.825 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 ttp -62.97 -47.58 82.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.829 0.286 . . . . 0.0 110.325 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 -52.08 62.55 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.354 1.062 . . . . 0.0 112.788 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.98 -44.65 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.463 -0.78 . . . . 0.0 109.223 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -60.73 -49.83 75.92 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.8 0.727 . . . . 0.0 109.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -51.11 -48.53 61.69 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.558 1.143 . . . . 0.0 110.323 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.06 52.72 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.444 0.465 . . . . 0.0 110.828 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.81 -29.11 62.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 112.563 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.56 -13.27 61.0 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.297 -0.877 . . . . 0.0 112.136 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.41 -56.04 27.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.567 1.076 . . . . 0.0 110.013 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.61 116.05 30.66 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.14 174.19 11.76 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.254 1.969 . . . . 0.0 110.642 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.53 12.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.226 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 71.3 t -114.76 -59.08 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 118.65 1.225 . . . . 0.0 109.434 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.304 74.4 mt-10 63.68 -44.58 0.25 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.286 2.635 . . . . 0.0 110.634 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -95.77 110.35 22.52 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.229 1.812 . . . . 0.0 110.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.16 144.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.063 1.345 . . . . 0.0 107.507 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.2 143.71 34.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.93 140.54 48.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.769 1.227 . . . . 0.0 108.669 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -115.72 115.29 26.09 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.8 -32.57 65.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -71.95 -9.21 58.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.738 0.815 . . . . 0.0 111.889 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 -14.31 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.28 60.12 Favored Glycine 0 N--CA 1.467 0.716 0 CA-C-N 120.723 1.601 . . . . 0.0 110.215 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.98 170.43 15.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.669 0.735 . . . . 0.0 112.169 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.91 157.71 43.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.372 1.869 . . . . 0.0 109.015 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.43 139.15 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.867 2.067 . . . . 0.0 106.443 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.45 121.6 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 123.287 0.635 . . . . 0.0 110.139 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -106.6 104.84 14.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . 175.24 -157.73 24.71 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.551 1.072 . . . . 0.0 111.208 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.8 p -113.48 16.94 18.7 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.431 2.292 . . . . 0.0 113.946 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.87 151.86 46.04 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.94 149.67 74.04 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.161 2.185 . . . . 0.0 109.564 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.92 -49.69 3.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 110.739 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -56.49 -49.3 75.1 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.036 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.54 -37.96 66.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.645 0.591 . . . . 0.0 111.866 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -73.87 -51.82 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.484 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.66 -36.28 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.096 0.862 . . . . 0.0 110.241 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -73.3 -40.55 64.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.943 0.897 . . . . 0.0 110.314 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.19 80.01 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.692 1.133 . . . . 0.0 108.6 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.266 17.6 m -71.58 -32.26 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.783 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.97 -28.77 62.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 120.054 1.297 . . . . 0.0 109.881 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -61.09 -18.72 59.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.414 1.007 . . . . 0.0 111.944 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.3 -6.5 58.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.516 1.053 . . . . 0.0 111.996 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.48 44.96 7.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 119.383 0.992 . . . . 0.0 113.545 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -141.19 175.72 9.41 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.863 2.465 . . . . 0.0 108.021 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -114.41 149.3 36.42 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.765 1.621 . . . . 0.0 108.738 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.97 155.72 37.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 175.29 10.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.94 -178.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.864 0.84 . . . . 0.0 110.569 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.29 111.1 2.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.74 -1.124 . . . . 0.0 108.157 -179.69 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mtp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.4 mt -140.39 163.39 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -133.86 105.33 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 tp -95.64 147.89 23.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 123.09 49.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.82 140.26 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -139.34 121.8 16.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.358 0.981 . . . . 0.0 110.904 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.4 -112.46 0.51 Allowed Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 29.6 mmm -58.61 -54.79 43.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.156 1.382 . . . . 0.0 113.76 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 p 45.35 50.22 10.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.375 1.47 . . . . 0.0 109.193 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -92.85 168.36 11.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.984 0.897 . . . . 0.0 112.61 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -62.08 -43.1 99.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.157 0.983 . . . . 0.0 113.01 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -89.36 -38.87 13.82 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -52.01 -28.12 15.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.09 -37.75 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 119.605 1.093 . . . . 0.0 110.105 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.7 mmt -59.03 -44.44 91.75 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.374 -0.829 . . . . 0.0 110.343 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.3 68.89 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 108.882 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.26 -48.54 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.992 0.917 . . . . 0.0 109.595 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.4 m -58.79 -50.11 75.17 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.436 -0.79 . . . . 0.0 109.16 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -63.08 -34.66 78.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.304 0.956 . . . . 0.0 111.495 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.19 79.22 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -64.84 -48.05 75.73 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.458 -0.776 . . . . 0.0 110.033 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -63.5 -6.76 5.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 112.523 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -65.38 -20.04 66.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.262 1.392 . . . . 0.0 110.834 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.1 t -71.31 117.11 53.85 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -53.95 -66.1 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 118.387 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.76 -10.46 45.01 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -71.9 -57.37 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.868 2.334 . . . . 0.0 109.671 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 54.1 0.39 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.546 2.338 . . . . 0.0 116.549 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -131.19 106.93 8.65 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.494 1.518 . . . . 0.0 111.163 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.9 144.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.616 1.566 . . . . 0.0 107.224 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -137.35 117.32 13.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 t -114.62 125.64 71.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -75.5 129.87 37.97 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.79 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.91 -43.4 86.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.819 0.848 . . . . 0.0 109.955 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.18 -8.56 59.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.98 161.22 38.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 121.138 1.79 . . . . 0.0 110.904 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.09 46.01 3.49 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -115.02 134.58 55.06 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.113 1.457 . . . . 0.0 107.787 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.07 113.8 12.49 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.1 mt -94.1 143.55 26.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.01 141.09 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.424 0.631 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -114.74 104.42 11.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.43 168.89 23.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -89.32 12.67 15.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.992 1.717 . . . . 0.0 113.315 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.59 135.38 57.33 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.817 0.735 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.02 155.7 77.24 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 113.596 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -60.68 -66.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.941 3.094 . . . . 0.0 112.701 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -27.27 62.34 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.02 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.73 -52.95 63.28 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.442 1.019 . . . . 0.0 108.329 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.03 -47.66 79.36 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 117.716 -1.135 . . . . 0.0 110.465 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.1 t -52.16 -60.55 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 O-C-N 124.315 1.009 . . . . 0.0 109.017 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -40.26 76.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.923 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.64 88.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.991 1.268 . . . . 0.0 113.186 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 m -78.57 -32.8 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 0.0 109.465 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -61.36 -20.28 62.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.491 0.587 . . . . 0.0 110.036 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.65 -23.83 66.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.215 0.916 . . . . 0.0 109.847 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.46 -12.86 53.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.771 1.628 . . . . 0.0 110.727 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.94 -11.7 65.94 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.41 1.957 . . . . 0.0 113.786 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -76.36 144.98 39.78 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.36 1.08 . . . . 0.0 109.217 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -75.95 162.09 28.39 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.95 161.34 38.37 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.557 1.072 . . . . 0.0 111.067 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -147.88 123.66 10.56 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.961 0.904 . . . . 0.0 112.297 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.77 146.4 8.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.616 HD13 ' H ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -68.52 153.07 44.46 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.616 ' H ' HD13 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.431 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.555 ' C ' HD12 ' A' ' 2' ' ' LEU . 21.6 ptp . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.555 HD12 ' C ' ' A' ' 1' ' ' MET . 6.7 mp -140.46 159.62 41.79 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.072 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -100.9 115.79 31.23 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -104.4 143.3 33.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -125.69 128.95 48.61 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.59 152.49 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 125.892 1.677 . . . . 0.0 106.687 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -143.96 165.27 28.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.468 1.907 . . . . 0.0 108.697 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.26 -105.19 1.72 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.867 1.222 . . . . 0.0 111.755 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 85.6 mtp -84.94 -176.98 6.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.167 1.387 . . . . 0.0 110.295 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 p -153.12 105.52 2.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.441 1.096 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.6 t -163.45 148.76 11.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 121.07 1.759 . . . . 0.0 110.45 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -62.58 -41.95 99.26 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 124.304 1.041 . . . . 0.0 111.482 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -60.92 -14.88 25.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -30.67 71.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.573 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 m -58.41 -25.42 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 121.16 1.8 . . . . 0.0 111.421 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.7 mmm -69.61 -50.22 46.47 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.44 -52.44 53.15 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.791 0.836 . . . . 0.0 110.586 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.66 -55.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.645 1.578 . . . . 0.0 109.918 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 m -72.85 -25.45 61.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.811 1.187 . . . . 0.0 111.679 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -66.98 -55.99 12.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.549 1.522 . . . . 0.0 107.917 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.17 68.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.718 0.636 . . . . 0.0 110.166 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.4 -27.46 47.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 117.337 -1.316 . . . . 0.0 113.724 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -51.2 -21.8 2.25 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.975 1.716 . . . . 0.0 111.329 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 0.4 3.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.622 1.569 . . . . 0.0 113.21 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.91 143.11 23.94 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 120.796 1.635 . . . . 0.0 111.575 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.44 -81.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.349 3.366 . . . . 0.0 113.607 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.97 0.55 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.416 1.008 . . . . 0.0 110.619 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.68 -58.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.388 0.675 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 62.65 -14.95 0.06 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.907 1.683 . . . . 0.0 115.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -127.46 107.98 10.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.513 1.506 . . . . 0.0 111.657 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.12 119.3 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -119.19 143.54 47.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.861 2.064 . . . . 0.0 107.296 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.39 141.55 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.967 1.307 . . . . 0.0 108.081 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -88.03 118.65 27.74 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.78 -39.58 93.83 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.85 -9.1 59.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.549 1.068 . . . . 0.0 112.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -123.48 -168.91 1.85 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.226 1.41 . . . . 0.0 110.216 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.46 70.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 105.514 -3.034 . . . . 0.0 105.514 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -151.07 162.76 40.24 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 117.79 0.795 . . . . 0.0 109.468 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.86 154.73 40.81 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.274 1.03 . . . . 0.0 111.033 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -117.25 119.54 35.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 t -123.72 112.93 35.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 123.561 0.538 . . . . 0.0 110.194 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -104.72 105.78 16.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.743 0.817 . . . . 0.0 111.36 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.3 179.61 45.02 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.2 p -81.6 -12.08 58.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.041 0.936 . . . . 0.0 113.026 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.14 135.22 26.02 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.851 1.26 . . . . 0.0 112.692 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.82 143.17 98.43 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 125.895 1.678 . . . . 0.0 111.808 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.9 -32.24 36.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.827 1.685 . . . . 0.0 110.334 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -63.79 -48.93 74.92 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.689 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.34 67.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 123.846 0.716 . . . . 0.0 110.512 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -57.52 -52.78 64.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.768 0.827 . . . . 0.0 111.692 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.18 -46.85 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -31.71 71.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.97 -51.08 27.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.827 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.261 16.8 m -61.94 -32.9 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.442 1.019 . . . . 0.0 113.227 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.18 -20.05 50.49 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.96 -0.462 . . . . 0.0 111.58 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -73.87 -16.63 61.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.09 -52.07 5.14 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.341 1.428 . . . . 0.0 113.151 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.32 20.33 0.04 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.68 173.91 11.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.293 1.437 . . . . 0.0 108.243 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.4 163.67 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.354 -0.841 . . . . 0.0 108.794 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.79 165.82 34.83 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.629 0.728 . . . . 0.0 111.159 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -147.6 155.25 41.62 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.424 2.29 . . . . 0.0 105.762 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -128.02 137.8 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 O-C-N 121.224 -0.922 . . . . 0.0 111.28 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 tt -92.17 111.68 23.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.761 2.024 . . . . 0.0 105.743 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 125.579 1.552 . . . . 0.0 110.088 -179.738 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.7 mt -145.13 166.06 26.49 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 66' ' ' ALA . 33.3 mttm -127.94 124.88 38.42 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -109.06 115.68 30.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.681 1.192 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -88.48 124.35 33.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.74 131.67 69.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -138.92 156.82 46.97 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.374 1.07 . . . . 0.0 108.159 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.32 -74.17 0.26 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 108.081 -2.007 . . . . 0.0 108.081 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.2 tpp -149.29 142.66 25.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.04 116.72 22.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.2 m -144.72 117.17 8.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -59.66 -44.24 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.364 0.665 . . . . 0.0 109.837 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.85 -12.06 51.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.58 -33.21 72.38 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.946 1.248 . . . . 0.0 108.807 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.75 -31.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.519 1.127 . . . . 0.0 110.681 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.49 -51.11 60.24 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.73 97.56 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.892 0.877 . . . . 0.0 110.757 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.91 -51.99 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -63.07 -40.36 97.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.716 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -56.84 -55.38 35.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.353 0.979 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.8 85.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 122.522 0.329 . . . . 0.0 111.672 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -45.04 92.65 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -62.25 -8.46 5.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.971 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -60.89 -18.54 56.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.306 1.867 . . . . 0.0 110.749 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.24 127.13 23.19 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.51 126.93 13.34 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.679 2.919 . . . . 0.0 111.418 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.7 -17.1 8.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-O 116.758 -2.134 . . . . 0.0 113.974 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.91 2.53 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 121.176 2.488 . . . . 0.0 115.238 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -66.76 -1.64 4.09 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -95.77 104.22 16.14 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.44 139.19 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.5 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -123.08 116.54 23.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.45 131.84 53.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.91 1.684 . . . . 0.0 109.488 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 m -70.19 130.94 43.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.02 -48.62 34.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.95 0.405 . . . . 0.0 110.217 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.5 -52.25 7.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.611 1.164 . . . . 0.0 110.956 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -82.62 175.63 10.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.25 3.65 35.16 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.403 -1.221 . . . . 0.0 115.757 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -91.11 146.68 23.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.807 2.304 . . . . 0.0 109.151 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.58 138.75 44.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.766 1.627 . . . . 0.0 107.793 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.01 130.17 48.49 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -120.17 112.67 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.634 1.174 . . . . 0.0 108.8 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -90.4 114.91 27.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.93 41.67 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 118.775 0.716 . . . . 0.0 113.217 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 t -125.77 3.72 7.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.956 1.302 . . . . 0.0 112.916 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 156.7 32.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.542 0.687 . . . . 0.0 112.65 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.35 133.55 90.87 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 125.086 1.355 . . . . 0.0 109.104 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.65 -44.17 23.1 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.547 2.165 . . . . 0.0 110.151 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -56.51 -30.45 63.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.971 0.908 . . . . 0.0 112.05 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -39.69 79.21 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.635 0.652 . . . . 0.0 109.549 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.99 -45.12 74.98 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 123.717 0.807 . . . . 0.0 109.077 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -57.83 -58.5 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -60.72 -36.44 78.85 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.357 0.526 . . . . 0.0 112.063 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.28 99.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.952 0.797 . . . . 0.0 110.712 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.5 t -73.86 -33.14 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -60.62 -37.35 81.13 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.395 0.998 . . . . 0.0 110.284 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.65 -19.84 62.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.646 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -87.84 -3.41 58.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 112.225 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.53 37.12 6.25 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.058 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.54 172.96 11.82 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.401 1.101 . . . . 0.0 110.091 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -118.58 109.38 16.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.75 159.23 16.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.1 0.56 . . . . 0.0 111.552 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -158.3 159.26 35.73 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.0 2.52 . . . . 0.0 107.187 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.18 144.81 17.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.628 HD23 ' H ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -147.16 159.8 43.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.7 0.682 . . . . 0.0 110.718 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.628 ' H ' HD23 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.248 0.975 0 C-N-CA 125.861 1.665 . . . . 0.0 108.633 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.09 165.33 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -133.95 141.86 47.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.3 tp -122.65 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.521 1.529 . . . . 0.0 108.978 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -87.15 136.76 32.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.4 133.13 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 125.557 1.543 . . . . 0.0 107.236 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -145.13 163.77 33.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.48 -123.37 5.56 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.245 1.402 . . . . 0.0 113.949 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -68.0 83.03 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 129.658 3.183 . . . . 0.0 111.341 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.98 78.69 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.786 2.434 . . . . 0.0 111.06 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -137.79 161.83 35.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.981 1.712 . . . . 0.0 109.241 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.31 -57.83 4.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.995 1.718 . . . . 0.0 112.805 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -60.47 -19.1 55.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.7 m -63.26 -34.05 76.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.85 1.205 . . . . 0.0 109.667 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.23 -39.12 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.374 1.069 . . . . 0.0 109.734 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 48.6 tpp -62.16 -47.2 85.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.55 -52.32 66.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.124 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.47 -43.52 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.716 1.144 . . . . 0.0 113.092 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.9 t -60.68 -44.49 96.44 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.295 1.861 . . . . 0.0 110.002 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -69.23 -48.3 62.34 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.657 -0.652 . . . . 0.0 111.678 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.15 73.27 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.602 0.761 . . . . 0.0 111.288 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.567 HD22 ' HG ' ' A' ' 51' ' ' LEU . 19.6 mt -73.13 -52.13 15.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.708 0.686 . . . . 0.0 110.076 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -69.38 -3.7 15.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -53.56 -40.67 65.78 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.589 0.756 . . . . 0.0 111.039 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.22 136.52 37.89 Favored Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.44 115.06 3.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 106.79 -2.042 . . . . 0.0 106.79 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.88 -92.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.759 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 t -64.75 -57.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 66.22 -31.6 0.16 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.278 2.231 . . . . 0.0 112.444 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -101.2 102.76 13.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.577 1.951 . . . . 0.0 106.374 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.36 127.12 37.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.548 1.139 . . . . 0.0 108.008 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.06 144.84 51.33 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.437 1.495 . . . . 0.0 111.911 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.12 143.04 42.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.729 1.612 . . . . 0.0 107.314 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -77.5 137.28 38.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 109.175 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.34 -48.09 44.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -80.76 -20.97 41.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.77 161.63 32.42 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.075 1.307 . . . . 0.0 109.485 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.21 36.16 3.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -104.26 141.62 35.97 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 120.372 -1.664 . . . . 0.0 107.583 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.22 146.06 51.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 108.562 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.93 144.31 50.73 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.015 1.726 . . . . 0.0 106.703 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.37 141.29 42.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.535 0.734 . . . . 0.0 110.909 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.13 104.19 8.39 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.446 1.117 . . . . 0.0 109.179 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.83 41.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 126.436 1.969 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -117.38 12.72 14.34 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.71 156.27 30.9 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.216 0.916 . . . . 0.0 110.436 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.31 154.93 81.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 113.24 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.7 -51.63 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.14 2.56 . . . . 0.0 109.213 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -55.48 -40.33 71.52 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.128 -1.415 . . . . 0.0 111.074 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.24 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 120.136 1.335 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HG ' HD22 ' A' ' 22' ' ' LEU . 10.5 mp -70.01 -53.13 19.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.29 0.636 . . . . 0.0 110.666 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.8 t -52.51 -54.96 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.942 0.897 . . . . 0.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.32 -47.42 86.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.121 1.369 . . . . 0.0 110.421 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.75 -45.34 74.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.638 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.438 HG13 HD21 ' A' ' 22' ' ' LEU . 33.3 m -73.86 -32.71 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 119.06 0.845 . . . . 0.0 111.274 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -56.45 -39.16 72.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 112.227 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.83 -34.15 62.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -16.89 61.47 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.398 0.545 . . . . 0.0 112.218 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.29 0.16 47.26 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.544 1.068 . . . . 0.0 110.96 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -78.83 172.27 13.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.377 1.071 . . . . 0.0 109.519 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.35 149.19 39.74 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.57 170.01 23.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.493 1.139 . . . . 0.0 111.694 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -158.04 127.6 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.62 142.12 14.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -125.64 94.8 4.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 177.475 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptt? . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.278 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -91.92 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.716 1.143 . . . . 0.0 110.106 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -127.75 141.08 51.69 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.7 tp -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -86.75 133.98 33.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 100.639 -3.837 . . . . 0.0 100.639 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.43 118.85 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -127.58 145.66 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.94 -176.39 41.47 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.45 -22.8 66.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.905 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -123.18 154.64 38.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.116 1.366 . . . . 0.0 108.152 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 p -133.36 -5.51 2.97 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.664 1.186 . . . . 0.0 113.22 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -115.8 -67.92 0.96 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.406 1.082 . . . . 0.0 111.115 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 -20.54 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.818 -1.176 . . . . 0.0 113.447 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -59.75 -27.67 66.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.771 1.229 . . . . 0.0 112.049 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 m -52.5 -29.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 119.094 0.861 . . . . 0.0 112.865 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 9.9 tpt -67.57 -50.73 57.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.19 74.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.865 0.866 . . . . 0.0 110.374 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -56.27 -55.03 20.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 110.912 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.3 m -68.33 -36.33 79.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.471 1.032 . . . . 0.0 111.222 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -47.75 84.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.26 -49.53 75.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.516 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.38 -28.11 64.86 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.831 1.196 . . . . 0.0 112.303 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -58.27 -29.97 66.22 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.488 -0.758 . . . . 0.0 109.58 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -60.9 -16.95 47.79 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 117.258 -1.354 . . . . 0.0 112.83 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.46 92.07 1.7 Allowed Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 119.516 1.053 . . . . 0.0 108.817 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.67 117.16 4.99 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 105.878 -2.393 . . . . 0.0 105.878 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.27 -10.46 5.04 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.002 -1.443 . . . . 0.0 113.117 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.8 t -85.53 -56.93 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 120.166 1.983 . . . . 0.0 106.551 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 63.8 -19.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -130.04 114.49 15.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.829 2.104 . . . . 0.0 110.778 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.6 m -140.09 144.36 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.802 1.241 . . . . 0.0 109.737 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.01 144.75 32.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.957 1.303 . . . . 0.0 109.49 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.46 129.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -76.65 132.52 39.44 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.773 1.229 . . . . 0.0 111.243 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.2 mt -73.56 -48.61 31.57 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.2 1.0 . . . . 0.0 112.749 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.01 -31.61 69.37 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -135.68 161.62 35.03 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.632 1.106 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.59 43.22 1.33 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.236 1.398 . . . . 0.0 112.794 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -104.71 152.51 22.43 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.54 151.85 38.79 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.962 1.305 . . . . 0.0 108.387 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.41 144.6 47.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.091 1.756 . . . . 0.0 107.433 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -138.26 116.19 12.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.89 104.83 13.82 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.13 162.65 12.19 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 t -75.05 31.8 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.234 1.814 . . . . 0.0 112.321 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.71 149.77 8.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.946 1.298 . . . . 0.0 112.447 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.73 131.07 46.48 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.694 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -49.74 -61.81 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.605 2.87 . . . . 0.0 113.634 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -58.02 -23.16 53.05 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.868 -1.063 . . . . 0.0 112.633 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.76 -39.65 66.64 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.382 1.446 . . . . 0.0 109.334 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.09 -48.71 67.37 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.33 -55.86 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.068 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.51 -29.86 71.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.472 -0.775 . . . . 0.0 111.865 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.01 82.8 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.742 1.156 . . . . 0.0 108.726 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.17 -36.89 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.783 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.15 -36.43 72.99 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.234 1.014 . . . . 0.0 113.258 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.53 -15.3 49.92 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.233 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.31 8.71 29.92 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.087 1.312 . . . . 0.0 111.833 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.63 38.39 9.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.46 152.16 43.66 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.99 152.17 19.54 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.6 159.28 42.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.637 0.586 . . . . 0.0 110.867 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -153.59 117.19 4.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.04 168.3 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 124.398 1.079 . . . . 0.0 108.471 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -69.7 -176.05 0.98 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.721 0.808 . . . . 0.0 110.947 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.877 1.671 . . . . 0.0 108.925 -179.613 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 2' ' ' LEU . 3.5 mm? -114.7 165.33 12.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.893 0.854 . . . . 0.0 108.989 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -133.92 123.25 24.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 tp -97.13 111.76 23.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.663 1.185 . . . . 0.0 108.39 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 134.94 33.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.97 164.75 31.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -147.17 139.29 24.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.05 -152.11 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 mmt -63.57 157.68 23.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.027 0.442 . . . . 0.0 110.328 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -57.61 -80.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.714 2.005 . . . . 0.0 113.926 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 p -146.43 132.53 19.32 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.74 1.216 . . . . 0.0 110.148 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -172.15 -173.47 1.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.851 1.261 . . . . 0.0 109.61 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -56.67 -13.91 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.772 2.029 . . . . 0.0 113.111 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.0 m -52.94 -28.89 25.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.341 1.457 . . . . 0.0 110.958 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.34 -42.11 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.21 0.914 . . . . 0.0 109.089 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.3 mmm -63.01 -40.55 98.11 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.399 -0.813 . . . . 0.0 110.625 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB1' ' CD ' ' A' ' 58' ' ' GLU . . . -66.08 -52.88 44.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.495 1.118 . . . . 0.0 110.416 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.18 -40.94 86.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-O 117.696 -1.145 . . . . 0.0 110.278 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.9 m -59.36 -43.57 92.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.808 1.64 . . . . 0.0 108.839 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -64.3 -37.9 89.14 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.907 -1.121 . . . . 0.0 110.757 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -44.97 68.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.508 0.723 . . . . 0.0 110.668 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -32.27 31.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.835 2.454 . . . . 0.0 109.635 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -53.08 -23.26 7.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.081 1.353 . . . . 0.0 112.715 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.29 -12.62 1.69 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.921 1.289 . . . . 0.0 114.472 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.5 m -53.78 152.54 9.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.828 0.74 . . . . 0.0 110.851 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.26 32.27 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.101 3.201 . . . . 0.0 111.514 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.91 91.66 1.61 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 p -112.89 -36.22 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.533 0.733 . . . . 0.0 111.328 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 67.15 -36.91 0.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.67 2.788 . . . . 0.0 113.733 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -104.86 106.61 17.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.1 144.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -143.72 140.76 30.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.52 141.64 45.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -89.08 131.7 35.12 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -72.32 -48.5 41.61 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.275 0.63 . . . . 0.0 110.947 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -82.49 -9.88 59.24 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -135.15 159.6 41.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.696 1.589 . . . . 0.0 111.734 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 59.84 4.74 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.12 138.6 22.88 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 118.566 1.183 . . . . 0.0 110.594 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.55 155.6 48.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.428 1.891 . . . . 0.0 110.268 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.16 142.73 46.65 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 126.553 1.941 . . . . 0.0 107.514 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.32 131.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.87 105.39 8.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.31 -155.39 26.16 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.699 -0.626 . . . . 0.0 111.8 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 t -89.3 -6.53 56.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.997 1.319 . . . . 0.0 114.066 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.66 123.7 10.64 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.447 1.021 . . . . 0.0 112.766 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.69 153.8 95.42 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 125.694 1.598 . . . . 0.0 108.737 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 -46.47 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.297 1.998 . . . . 0.0 109.944 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -58.45 -28.09 64.99 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.118 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.55 -51.19 64.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.21 -40.64 86.45 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.457 0.703 . . . . 0.0 111.18 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.36 -51.79 59.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.04 -30.46 70.99 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.167 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.99 77.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.893 0.77 . . . . 0.0 110.309 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -88.39 -32.57 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.211 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.85 -30.56 71.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.197 0.999 . . . . 0.0 110.882 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.61 -19.55 64.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.296 0.953 . . . . 0.0 108.864 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.52 ' CD ' ' HB1' ' A' ' 17' ' ' ALA . 75.6 mm-40 -97.63 3.5 50.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.581 1.553 . . . . 0.0 109.605 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.85 86.53 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.778 2.132 . . . . 0.0 114.293 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -74.07 166.35 23.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.241 2.021 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -117.72 129.26 55.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 116.403 -1.76 . . . . 0.0 107.752 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.57 160.38 42.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 121.835 2.107 . . . . 0.0 114.355 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.25 163.68 39.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.64 2.376 . . . . 0.0 107.394 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.5 154.76 16.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.781 -1.199 . . . . 0.0 109.228 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 65' ' ' LEU . 1.6 tm? -119.42 108.14 14.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 C-N-CA 124.534 1.134 . . . . 0.0 110.952 -178.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.84 165.51 12.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.387 1.475 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 118.0 22.55 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.079 1.752 . . . . 0.0 106.39 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tt -137.4 147.58 45.54 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.275 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -123.81 139.69 53.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.826 1.194 . . . . 0.0 110.42 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.95 138.0 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.576 1.151 . . . . 0.0 110.253 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.25 110.54 3.72 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.359 1.076 . . . . 0.0 111.413 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.0 -48.33 1.25 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 124.665 1.126 . . . . 0.0 113.077 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 7.3 tpt -160.78 159.56 30.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.559 1.18 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -82.51 79.0 9.07 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -149.95 138.17 20.45 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -60.42 -37.86 82.23 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -57.85 -26.98 62.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.996 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -60.01 -36.11 76.53 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.439 1.018 . . . . 0.0 110.745 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.75 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.1 mtt -65.15 -40.82 94.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.881 -0.512 . . . . 0.0 110.982 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.17 -51.28 68.45 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.415 1.086 . . . . 0.0 111.206 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.09 -37.86 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 117.972 -1.013 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 m -60.13 -50.65 72.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.924 1.238 . . . . 0.0 108.122 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -54.14 -43.13 70.27 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.133 0.973 . . . . 0.0 111.13 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.96 59.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.069 0.948 . . . . 0.0 110.088 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 mt -56.67 -34.38 67.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.223 1.409 . . . . 0.0 112.047 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -63.55 -6.08 4.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.725 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -22.61 61.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 120.314 1.416 . . . . 0.0 111.706 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.11 95.75 13.67 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.03 45.27 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.095 3.196 . . . . 0.0 112.618 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.93 17.46 5.18 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.725 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 -57.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 119.402 1.601 . . . . 0.0 107.401 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 70.02 -53.26 0.63 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.089 2.155 . . . . 0.0 113.158 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -95.87 103.32 15.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.454 1.025 . . . . 0.0 109.073 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.78 134.09 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.507 1.123 . . . . 0.0 108.965 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -142.76 142.11 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 t -134.48 143.3 38.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 125.249 1.42 . . . . 0.0 109.391 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.45 145.0 35.29 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.0 -47.33 46.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.084 -1.01 . . . . 0.0 112.289 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -77.42 -24.18 50.45 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -133.23 147.86 51.99 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.891 1.223 . . . . 0.0 108.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.64 25.11 1.44 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.426 -1.208 . . . . 0.0 113.763 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -90.28 143.55 26.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.433 2.116 . . . . 0.0 108.237 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.05 162.69 34.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.3 1.04 . . . . 0.0 112.193 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.2 140.97 52.39 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.033 2.133 . . . . 0.0 106.445 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.57 146.33 27.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.134 0.968 . . . . 0.0 108.666 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -139.01 120.21 14.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.84 170.36 21.76 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 p -75.73 6.53 4.8 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.81 133.71 47.71 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.254 -0.904 . . . . 0.0 111.438 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.0 142.48 79.55 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.188 0.995 . . . . 0.0 111.165 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.2 -43.07 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.866 2.377 . . . . 0.0 113.889 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -56.65 -40.7 75.93 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.652 0.781 . . . . 0.0 111.235 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.3 95.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.941 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.08 -50.55 70.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.839 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.48 -48.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.691 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -65.93 -31.92 73.13 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.639 1.109 . . . . 0.0 111.291 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.4 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.568 0.622 . . . . 0.0 109.933 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 m -74.57 -33.18 31.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -56.55 -26.08 53.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.044 1.738 . . . . 0.0 114.627 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.56 -29.17 67.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.377 0.99 . . . . 0.0 112.398 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.07 4.37 17.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.857 -0.527 . . . . 0.0 111.707 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.1 45.24 83.93 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -123.68 150.72 43.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.525 1.53 . . . . 0.0 108.314 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 153.91 36.67 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.266 0.555 . . . . 0.0 110.36 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.11 26.45 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -152.89 158.14 41.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.97 152.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 120.865 -1.147 . . . . 0.0 109.03 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -137.95 85.53 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 pp -146.71 165.83 28.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.454 0.701 . . . . 0.0 110.679 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -112.07 104.56 12.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.578 1.18 . . . . 0.0 111.353 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 tt -98.88 148.32 24.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.869 2.068 . . . . 0.0 108.343 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -129.35 140.31 51.42 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.791 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.55 142.34 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.68 122.86 18.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.199 1.8 . . . . 0.0 110.234 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.33 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.2 mtt -142.48 132.57 24.56 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 m -74.82 81.57 2.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.787 0.835 . . . . 0.0 110.308 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -151.54 173.7 14.3 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.162 1.785 . . . . 0.0 108.134 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -67.36 -31.26 71.39 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.826 0.851 . . . . 0.0 112.244 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -61.08 -31.66 71.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.389 0.995 . . . . 0.0 111.686 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.3 t -62.49 -50.57 70.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -52.4 -50.13 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.245 1.418 . . . . 0.0 108.587 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 65.6 mtp -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.051 0.541 . . . . 0.0 110.219 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.53 64.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 m -64.05 -48.6 85.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.092 0.86 . . . . 0.0 111.182 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -63.38 -41.64 98.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.416 1.007 . . . . 0.0 110.118 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -64.33 -30.65 71.69 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.938 -1.727 . . . . 0.0 110.261 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.68 -51.43 41.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.034 0.834 . . . . 0.0 109.456 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.54 -33.82 76.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.892 0.477 . . . . 0.0 110.715 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -61.74 -7.23 3.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.109 0.964 . . . . 0.0 111.888 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HE3' ' CB ' ' A' ' 54' ' ' ALA . 0.6 OUTLIER -57.86 -33.23 68.47 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.589 1.54 . . . . 0.0 109.687 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.0 158.35 41.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.59 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.017 2.478 . . . . 0.0 111.371 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 74.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 105.633 -2.987 . . . . 0.0 105.633 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.16 -34.89 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.27 0.628 . . . . 0.0 110.605 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -176.41 -78.64 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.973 2.509 . . . . 0.0 106.416 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -155.72 151.41 27.31 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.082 1.31 . . . . 0.0 110.984 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.8 135.91 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 125.914 1.686 . . . . 0.0 106.799 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -143.27 140.7 30.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.78 131.48 42.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.49 1.116 . . . . 0.0 109.009 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 p -106.14 117.9 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.629 0.728 . . . . 0.0 110.931 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -18.37 61.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.077 0.951 . . . . 0.0 113.457 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -78.38 -15.53 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 112.958 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -137.26 -15.82 1.44 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.09 12.83 83.77 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.4 1.0 . . . . 0.0 112.749 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -93.29 146.74 23.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.868 1.334 . . . . 0.0 108.421 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.83 114.78 16.96 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.962 2.105 . . . . 0.0 109.168 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.89 134.2 34.34 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.25 131.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.798 1.285 . . . . 0.0 112.006 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -123.92 145.48 49.1 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 127.226 2.211 . . . . 0.0 108.581 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.6 177.17 15.44 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 126.246 1.879 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.3 p -66.21 5.14 0.57 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.482 2.313 . . . . 0.0 113.595 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.54 140.45 56.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.929 -1.107 . . . . 0.0 108.315 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.94 129.53 39.45 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -58.34 -31.2 93.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.752 1.635 . . . . 0.0 112.268 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -57.06 -46.49 82.42 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.814 1.188 . . . . 0.0 110.487 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.86 76.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.619 0.768 . . . . 0.0 110.753 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 118.886 -0.578 . . . . 0.0 111.389 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.13 -52.95 52.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -60.67 -33.64 73.13 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.545 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.471 ' CB ' ' HE3' ' A' ' 24' ' ' LYS . . . -60.49 -50.89 71.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.428 1.467 . . . . 0.0 110.082 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.84 -32.45 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.34 -44.61 71.27 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.033 1.333 . . . . 0.0 109.879 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.38 -23.44 66.32 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.784 0.834 . . . . 0.0 109.802 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.67 -14.67 62.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.801 1.24 . . . . 0.0 108.921 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.57 30.0 5.73 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 128.01 2.719 . . . . 0.0 115.518 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.49 175.33 9.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.207 2.003 . . . . 0.0 112.574 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -100.06 134.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.32 160.9 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -149.41 164.64 34.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.54 158.53 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 121.582 -0.699 . . . . 0.0 111.065 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -162.39 166.91 24.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.57 2.748 . . . . 0.0 106.045 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 178.352 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.94 166.45 14.41 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.571 0.748 . . . . 0.0 110.537 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -130.07 128.45 41.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.94 122.04 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -93.21 133.95 35.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.409 HG11 ' CG2' ' A' ' 18' ' ' VAL . 79.6 t -132.22 113.0 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -134.0 166.12 23.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.303 0.573 . . . . 0.0 109.833 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.0 170.63 43.39 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -83.68 0.6 46.34 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.047 -0.678 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 t -77.58 177.61 7.93 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.089 0.956 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -83.43 -164.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.421 1.888 . . . . 0.0 112.235 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.24 -2.15 0.91 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.287 1.835 . . . . 0.0 113.294 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -62.11 -13.63 28.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.531 -1.356 . . . . 0.0 111.904 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.03 -38.91 80.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.04 -1.457 . . . . 0.0 113.224 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.59 -52.06 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 120.571 1.532 . . . . 0.0 110.6 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.7 ttp -67.88 -47.03 69.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.163 -0.335 . . . . 0.0 111.326 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.71 63.64 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.478 0.711 . . . . 0.0 111.681 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.409 ' CG2' HG11 ' A' ' 6' ' ' VAL . 79.1 t -62.2 -39.89 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.0 m -61.7 -43.88 98.0 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.218 1.372 . . . . 0.0 109.329 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -56.31 -51.36 68.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.361 0.982 . . . . 0.0 109.091 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.47 69.76 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.89 0.744 . . . . 0.0 111.259 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.8 -30.51 70.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.221 1.408 . . . . 0.0 112.442 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -79.53 -4.28 50.67 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.86 -1.15 . . . . 0.0 112.02 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -36.99 85.79 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.33 1.423 . . . . 0.0 111.455 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.9 148.15 84.01 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.115 0.87 . . . . 0.0 109.4 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.02 -48.57 3.54 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.099 1.866 . . . . 0.0 112.916 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.55 69.92 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.4 -10.48 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.884 0.874 . . . . 0.0 111.938 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.14 163.87 28.26 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.837 -1.165 . . . . 0.0 112.327 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -103.62 134.69 46.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.76 144.18 37.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -144.24 143.13 30.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.251 1.02 . . . . 0.0 111.283 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.5 134.23 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 109.59 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.3 t -72.2 143.17 48.96 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 110.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.4 -28.84 62.22 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -81.67 -27.59 33.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.184 2.194 . . . . 0.0 115.621 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -145.87 160.22 42.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.698 0.799 . . . . 0.0 109.248 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.94 33.88 2.38 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.858 0.742 . . . . 0.0 111.871 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -90.73 125.67 35.76 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 125.014 1.326 . . . . 0.0 107.964 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.38 120.1 37.76 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.791 1.236 . . . . 0.0 109.559 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.13 134.77 34.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.29 132.39 66.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -136.13 105.5 6.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.673 1.189 . . . . 0.0 111.275 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.2 -148.08 11.78 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -121.3 7.87 10.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.844 1.258 . . . . 0.0 111.825 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.31 138.47 57.65 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.511 -0.743 . . . . 0.0 109.075 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.28 148.29 93.62 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.596 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.67 -44.56 10.52 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.591 1.527 . . . . 0.0 110.309 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -55.95 -29.65 60.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -48.44 48.58 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.385 0.993 . . . . 0.0 108.953 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.59 -47.75 68.84 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.258 1.023 . . . . 0.0 110.502 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.28 -52.07 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -60.2 -43.31 96.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 116.533 -1.698 . . . . 0.0 110.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.88 -46.56 67.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.59 1.086 . . . . 0.0 111.465 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 m -73.05 -32.4 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.43 -0.794 . . . . 0.0 111.13 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -68.32 -20.34 64.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.596 1.558 . . . . 0.0 112.544 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -63.49 -11.64 25.43 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.6 5.21 11.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.14 64.09 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 116.387 1.315 . . . . 0.0 116.387 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -74.32 175.96 7.15 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.655 1.728 . . . . 0.0 108.225 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -103.45 124.18 48.25 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.29 120.27 36.48 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.233 1.013 . . . . 0.0 110.183 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -135.64 106.93 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.631 0.772 . . . . 0.0 111.033 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.59 156.48 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.612 -0.68 . . . . 0.0 110.185 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.21 90.9 3.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.301 -1.333 . . . . 0.0 109.659 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 13.0 ptp . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.442 HD13 ' H ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -147.56 166.57 26.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.32 1.848 . . . . 0.0 109.139 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' H ' HD13 ' A' ' 2' ' ' LEU . 5.0 ptpt -122.81 115.19 21.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.655 1.582 . . . . 0.0 107.639 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.38 148.7 43.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.316 1.046 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -124.05 138.57 54.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.63 143.49 40.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.243 1.417 . . . . 0.0 107.776 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -151.38 161.55 42.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.31 -36.86 0.1 Allowed Glycine 0 CA--C 1.521 0.409 0 O-C-N 120.959 -1.088 . . . . 0.0 113.191 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.7 mmt -147.57 3.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.832 1.316 . . . . 0.0 114.201 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.0 p 57.43 5.57 0.31 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 m -73.07 147.58 44.85 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.354 -1.466 . . . . 0.0 111.941 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.18 -23.56 67.49 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.875 0.369 . . . . 0.0 111.978 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -81.08 -4.45 55.29 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.966 -1.084 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 p -57.0 -28.27 62.29 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.08 1.309 . . . . 0.0 111.822 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -54.28 -35.72 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.222 1.409 . . . . 0.0 111.093 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.59 -50.06 70.94 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.95 67.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.08 -49.17 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.967 0.803 . . . . 0.0 110.464 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -54.76 -53.94 48.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.413 1.006 . . . . 0.0 110.002 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -65.19 -33.15 75.33 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.796 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.19 -44.92 74.77 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.256 1.389 . . . . 0.0 108.936 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.68 -30.25 71.26 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.92 0.888 . . . . 0.0 109.137 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -70.44 -14.28 62.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -53.7 -46.52 70.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.646 1.566 . . . . 0.0 110.108 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.13 122.82 84.77 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.07 158.1 42.11 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.662 1.575 . . . . 0.0 109.42 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.31 -70.13 0.21 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-O 117.922 -1.488 . . . . 0.0 116.216 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.07 -57.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.181 1.491 . . . . 0.0 112.555 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 54.86 -26.6 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -96.28 104.63 16.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.026 1.731 . . . . 0.0 110.593 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.26 119.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -110.7 116.88 32.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.8 125.47 54.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.521 1.128 . . . . 0.0 110.405 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.7 t -71.9 132.9 45.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.775 0.798 . . . . 0.0 108.903 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.68 -38.61 64.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.381 1.072 . . . . 0.0 110.604 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -78.52 -46.33 19.8 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -107.81 171.37 7.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.09 0.556 . . . . 0.0 110.432 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.19 15.99 56.87 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.925 -0.931 . . . . 0.0 111.753 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.67 135.45 33.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 118.874 1.337 . . . . 0.0 110.189 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.73 114.7 17.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.997 2.119 . . . . 0.0 107.728 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -77.62 145.46 36.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.9 p -129.48 138.19 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -117.55 104.56 11.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.64 -166.51 37.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.698 2.094 . . . . 0.0 108.524 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -117.47 -2.18 11.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.11 1.764 . . . . 0.0 113.727 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.27 131.65 28.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.453 1.024 . . . . 0.0 112.014 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.56 126.74 31.11 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 126.527 1.931 . . . . 0.0 110.589 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.0 -33.49 98.8 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.491 1.46 . . . . 0.0 112.782 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -61.34 -30.34 70.46 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.134 1.334 . . . . 0.0 111.33 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.93 -44.8 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.48 0.712 . . . . 0.0 110.245 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.74 -53.96 38.96 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.37 -43.49 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.05 -42.32 89.68 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.073 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.69 -41.37 66.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -80.82 -33.66 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.971 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -69.39 -20.92 63.81 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.361 1.464 . . . . 0.0 111.898 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.86 -32.25 71.78 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.945 1.298 . . . . 0.0 108.911 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -75.94 -19.12 59.02 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.21 56.61 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.239 1.876 . . . . 0.0 112.313 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.5 155.66 33.6 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -88.27 150.23 23.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.963 -1.086 . . . . 0.0 109.146 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.75 158.12 43.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -145.7 150.38 36.18 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.675 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.4 147.58 22.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.86 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -146.88 170.73 16.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.182 1.793 . . . . 0.0 109.211 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.12 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.564 ' H1 ' ' CD ' ' A' ' 43' ' ' GLU . 18.0 ptt? . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.2 165.53 13.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.36 148.79 49.53 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.08 145.7 44.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -99.41 132.93 44.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.855 1.262 . . . . 0.0 107.678 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.8 t -126.76 102.11 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -119.74 168.39 11.12 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.112 0.869 . . . . 0.0 112.112 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.16 12.65 0.04 OUTLIER Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.134 2.302 . . . . 0.0 112.326 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.4 ttt 65.35 90.74 0.09 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.925 2.09 . . . . 0.0 109.608 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 m 57.11 80.49 0.16 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.145 1.778 . . . . 0.0 112.075 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 69.0 m -55.27 127.63 30.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.718 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -71.25 -175.82 1.31 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.676 1.19 . . . . 0.0 108.694 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -48.7 -23.14 0.93 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.594 1.558 . . . . 0.0 113.357 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 t -53.96 -28.26 36.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.071 1.348 . . . . 0.0 110.217 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.15 -36.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 119.041 0.837 . . . . 0.0 109.966 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.3 ttm -66.86 -43.31 83.94 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.808 -1.182 . . . . 0.0 109.703 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.95 -52.64 64.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.668 0.787 . . . . 0.0 110.037 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.33 -41.79 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -60.89 -48.7 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.915 -1.116 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -64.22 -37.52 87.75 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 121.731 -0.606 . . . . 0.0 111.68 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.11 -47.53 67.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.346 1.058 . . . . 0.0 109.597 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.5 mt -57.48 -37.65 73.25 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.568 0.747 . . . . 0.0 109.181 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -68.91 -13.07 62.2 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.16 -0.963 . . . . 0.0 112.913 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -73.48 -21.08 60.52 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.538 1.517 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.8 m -52.31 142.06 30.27 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.65 94.04 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.173 3.249 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.16 -74.02 0.37 Allowed Glycine 0 C--N 1.332 0.353 0 O-C-N 121.411 -0.805 . . . . 0.0 112.646 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.6 t -54.64 -58.9 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 117.253 0.527 . . . . 0.0 111.341 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 43.45 19.89 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -150.84 106.32 3.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.132 1.773 . . . . 0.0 109.335 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.0 138.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -141.35 118.36 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -110.79 142.93 21.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 t -90.67 146.34 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.81 -49.35 30.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.14 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -81.62 -57.94 3.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.799 0.439 . . . . 0.0 112.103 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.85 152.32 41.57 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.12 53.28 1.87 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -123.57 133.84 53.91 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.647 1.224 . . . . 0.0 110.863 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.97 115.04 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.256 2.622 . . . . 0.0 108.764 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.35 135.17 34.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.38 133.99 57.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.564 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 16.0 tp10 -123.33 103.64 8.63 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.07 -170.22 41.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.661 1.124 . . . . 0.0 111.995 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -111.85 14.86 21.01 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.728 2.811 . . . . 0.0 115.585 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 142.06 57.63 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.302 -1.499 . . . . 0.0 109.496 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.01 151.1 81.5 Favored Pre-proline 0 C--O 1.237 0.429 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.301 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -55.32 -47.3 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.607 2.205 . . . . 0.0 111.519 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -55.1 -38.76 68.55 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.55 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.67 80.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.829 0.74 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.5 mt -68.21 -47.7 67.18 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.941 -0.474 . . . . 0.0 110.352 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.5 t -55.66 -56.37 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 124.413 1.085 . . . . 0.0 108.722 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -57.34 -50.22 73.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.589 -1.196 . . . . 0.0 110.036 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.11 64.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.303 0.956 . . . . 0.0 111.697 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -76.38 -43.18 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.7 -23.28 64.74 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.079 1.752 . . . . 0.0 110.914 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -62.46 -23.51 66.93 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.089 1.356 . . . . 0.0 110.532 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.29 39.5 mt-10 -104.36 16.43 26.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.836 0.854 . . . . 0.0 111.436 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.96 1.77 49.4 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 127.216 2.341 . . . . 0.0 116.129 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -74.92 151.24 38.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.137 1.469 . . . . 0.0 109.388 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -75.05 105.07 5.89 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.11 39.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.514 1.125 . . . . 0.0 109.125 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -141.58 114.05 8.27 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.82 167.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 pp -119.38 -173.09 2.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 108.597 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.685 1.594 . . . . 0.0 107.402 179.361 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtm . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.14 166.06 22.64 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.336 1.454 . . . . 0.0 107.202 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -124.72 107.73 11.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.503 0.721 . . . . 0.0 111.063 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.01 137.65 36.06 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.383 -1.448 . . . . 0.0 108.028 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -109.17 137.72 46.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.7 143.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.554 1.07 . . . . 0.0 109.792 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -147.52 156.98 43.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.605 0.717 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.01 -28.17 2.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.3 -1.278 . . . . 0.0 111.298 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 35.4 tpp -147.99 152.98 38.39 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.023 1.411 . . . . 0.0 110.339 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -141.46 78.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.9 m -150.42 150.39 31.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.967 2.107 . . . . 0.0 108.122 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -53.37 -31.84 46.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.661 1.985 . . . . 0.0 114.481 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -63.85 -22.31 66.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.328 -0.857 . . . . 0.0 112.356 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.2 t -52.83 -52.55 56.62 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.405 1.082 . . . . 0.0 108.242 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.1 t -52.56 -51.18 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.571 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -57.12 -49.96 74.28 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.79 0.836 . . . . 0.0 110.937 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.49 -38.54 90.05 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.199 0.999 . . . . 0.0 111.963 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.68 -54.75 30.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 108.987 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -65.61 -32.41 73.97 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.811 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -62.43 -42.59 99.56 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.565 -1.334 . . . . 0.0 111.106 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.52 -48.55 26.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.305 0.957 . . . . 0.0 111.97 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.43 -41.56 89.88 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.107 0.963 . . . . 0.0 113.33 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -49.8 -28.47 6.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -57.57 -27.1 62.38 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.48 1.036 . . . . 0.0 111.031 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.03 104.45 14.96 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 125.579 1.552 . . . . 0.0 108.527 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 168.84 23.77 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.452 1.435 . . . . 0.0 109.305 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.8 16.27 61.82 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 122.31 -0.244 . . . . 0.0 113.417 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.45 -58.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 39.45 2.84 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 131.37 3.868 . . . . 0.0 119.21 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -143.69 102.94 4.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.175 1.39 . . . . 0.0 107.59 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.32 142.41 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.98 116.96 11.64 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 t -90.72 143.16 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -89.52 132.99 34.79 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.84 -48.78 34.83 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.05 -0.5 . . . . 0.0 112.197 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -83.03 -12.68 56.99 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.024 1.33 . . . . 0.0 114.052 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HE3' ' OE1' ' A' ' 39' ' ' GLU . 21.2 mtpp -126.64 151.69 47.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.598 -0.689 . . . . 0.0 111.601 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.61 78.15 2.0 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.441 ' OE1' ' HE3' ' A' ' 37' ' ' LYS . 8.6 pt-20 -165.9 158.39 14.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.353 0.661 . . . . 0.0 110.588 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.78 125.87 12.9 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.027 0.931 . . . . 0.0 109.554 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.7 mt -74.55 142.67 44.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.68 131.23 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 110.83 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -123.02 151.22 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.17 -157.47 15.01 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.83 29.62 7.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.905 1.282 . . . . 0.0 114.315 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.79 123.9 26.4 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.46 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.15 152.89 83.25 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.783 1.633 . . . . 0.0 112.127 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.56 -57.37 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.518 2.812 . . . . 0.0 113.565 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -56.65 -40.88 76.23 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 117.934 0.334 . . . . 0.0 110.549 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.5 88.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -54.69 35.25 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.233 0.613 . . . . 0.0 111.271 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.4 m -59.98 -35.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.037 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -71.42 -37.83 71.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.37 -0.831 . . . . 0.0 110.409 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.12 97.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.198 0.908 . . . . 0.0 109.281 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.32 -32.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.788 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.95 -23.39 45.14 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.56 1.144 . . . . 0.0 112.388 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.61 -29.06 69.8 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.953 0.797 . . . . 0.0 110.158 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -86.81 -13.71 44.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.471 1.508 . . . . 0.0 111.323 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.16 66.45 1.61 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.176 1.369 . . . . 0.0 115.365 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -139.83 170.14 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 108.479 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -106.54 105.09 14.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.635 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.1 149.62 35.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 119.09 0.859 . . . . 0.0 110.161 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -149.31 165.98 30.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.551 1.94 . . . . 0.0 108.502 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.1 154.56 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 121.348 -0.845 . . . . 0.0 111.212 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.7 tp -76.0 106.82 7.8 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.201 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.157 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.1 mt -116.69 151.15 36.95 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.633 1.173 . . . . 0.0 108.199 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -122.24 142.19 50.71 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.225 1.01 . . . . 0.0 110.797 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.99 121.68 18.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.635 1.974 . . . . 0.0 110.278 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -87.95 137.9 31.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -126.94 91.01 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.614 1.566 . . . . 0.0 107.516 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.76 146.92 35.58 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.27 -165.16 25.21 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ttt -95.92 -85.15 0.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.225 0.61 . . . . 0.0 109.446 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 12' ' ' ASN . 4.2 m -68.78 150.08 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.785 -0.572 . . . . 0.0 110.015 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.9 t -129.32 5.41 5.24 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.455 1.502 . . . . 0.0 111.094 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.494 ' H ' HG22 ' A' ' 10' ' ' THR . 29.1 m120 -86.49 -100.69 0.07 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.581 -1.324 . . . . 0.0 109.148 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -64.01 -11.19 26.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.92 -1.113 . . . . 0.0 112.908 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -28.56 69.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.809 1.244 . . . . 0.0 110.827 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -54.59 -35.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.088 0.858 . . . . 0.0 110.692 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.76 -45.65 77.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.701 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -52.43 65.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.22 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -58.91 -47.69 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.507 1.049 . . . . 0.0 110.866 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.5 p -63.43 -40.96 98.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -75.37 -40.89 57.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.608 0.763 . . . . 0.0 111.922 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.22 84.69 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.754 0.822 . . . . 0.0 110.191 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.0 mt -56.55 -28.24 59.59 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.9 0.48 . . . . 0.0 110.248 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -59.47 -11.9 5.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.047 0.939 . . . . 0.0 112.986 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -55.12 -16.36 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.289 1.404 . . . . 0.0 112.398 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.86 92.27 20.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.69 -4.34 15.09 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.016 2.477 . . . . 0.0 114.771 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.79 2.48 54.48 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 116.841 1.497 . . . . 0.0 116.841 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.549 HG21 ' CG1' ' A' ' 42' ' ' VAL . 5.9 p -113.9 -48.02 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 119.579 1.689 . . . . 0.0 112.164 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 59.43 -2.97 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.44 103.35 8.88 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.465 1.484 . . . . 0.0 107.198 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 m -141.27 138.29 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.279 1.032 . . . . 0.0 109.666 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.79 143.12 40.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.171 1.788 . . . . 0.0 108.284 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.6 t -136.88 143.24 35.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.101 1.76 . . . . 0.0 107.46 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.1 t -76.81 138.52 39.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.31 -36.04 66.18 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -81.59 -57.94 3.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.343 1.057 . . . . 0.0 112.198 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.54 177.29 6.4 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.963 1.305 . . . . 0.0 112.49 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.58 17.27 56.86 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -90.52 143.38 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.195 1.497 . . . . 0.0 108.302 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.43 163.13 33.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.942 1.297 . . . . 0.0 110.588 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.24 144.42 30.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.897 1.279 . . . . 0.0 110.211 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.549 ' CG1' HG21 ' A' ' 28' ' ' VAL . 79.9 t -130.42 143.25 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.551 1.94 . . . . 0.0 108.12 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -130.1 105.31 7.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.216 1.006 . . . . 0.0 109.951 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA3' HG23 ' A' ' 28' ' ' VAL . . . 167.09 -161.09 34.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.574 1.559 . . . . 0.0 110.225 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 p -96.15 0.54 51.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.735 1.268 . . . . 0.0 114.362 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.71 131.86 30.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.658 1.117 . . . . 0.0 111.019 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.36 142.44 98.35 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.35 -48.55 21.41 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.224 1.949 . . . . 0.0 112.348 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -62.02 -23.17 66.28 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.761 -1.114 . . . . 0.0 112.936 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.61 85.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.802 1.183 . . . . 0.0 108.348 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.65 -48.63 59.15 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.809 0.693 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.0 t -54.19 -59.41 2.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.969 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.1 -38.59 83.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.868 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.52 -44.69 69.36 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 117.156 -1.402 . . . . 0.0 110.22 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.25 -32.32 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.857 1.208 . . . . 0.0 112.041 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.79 -44.76 82.23 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.843 1.257 . . . . 0.0 108.844 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.37 -26.42 66.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.53 1.132 . . . . 0.0 111.422 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -69.99 -36.86 75.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.478 1.035 . . . . 0.0 108.65 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.37 30.59 1.16 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.567 1.556 . . . . 0.0 112.338 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -120.14 172.21 7.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.305 1.552 . . . . 0.0 109.255 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.93 99.63 6.48 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.331 0.969 . . . . 0.0 113.186 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.24 160.84 15.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.488 1.115 . . . . 0.0 112.161 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -154.46 130.13 9.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.876 1.27 . . . . 0.0 107.991 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.52 156.55 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.34 166.81 17.13 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.87 2.068 . . . . 0.0 106.901 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 125.065 1.346 . . . . 0.0 109.394 -179.383 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttm . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.03 166.46 10.82 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -130.41 146.53 51.99 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.884 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.3 tp -136.77 110.92 8.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -81.74 119.94 24.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.99 138.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -136.78 174.02 11.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 -102.2 0.96 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 34.1 tpp -113.48 114.56 26.71 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.571 1.186 . . . . 0.0 112.364 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.47 105.01 17.0 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.407 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 48.9 t -138.87 157.16 46.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 110.044 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.74 -28.95 67.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 110.618 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.88 -26.33 21.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.5 0.72 . . . . 0.0 111.071 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 79.5 m -61.49 -43.07 99.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.811 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.0 -33.39 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.773 1.17 . . . . 0.0 111.037 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.64 -45.44 75.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.27 65.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.364 0.665 . . . . 0.0 109.985 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -57.26 -49.54 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 124.634 1.174 . . . . 0.0 109.851 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -58.03 -53.56 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.159 0.891 . . . . 0.0 110.386 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -59.44 -47.32 85.94 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.461 -0.774 . . . . 0.0 112.152 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.46 92.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.99 0.916 . . . . 0.0 111.95 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.66 -36.15 83.34 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.702 -1.249 . . . . 0.0 109.861 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.3 -19.07 64.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.953 0.901 . . . . 0.0 113.103 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -56.84 -36.18 69.7 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.113 1.524 . . . . 0.0 115.113 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.95 121.3 81.97 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 112.552 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.4 121.56 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.88 -14.96 2.4 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.273 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.38 -57.27 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 118.966 1.383 . . . . 0.0 108.809 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 63.36 -30.8 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.177 2.191 . . . . 0.0 115.25 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 122.94 35.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.8 2.091 . . . . 0.0 112.432 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 42' ' ' VAL . 22.8 m -141.25 144.43 26.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.16 1.384 . . . . 0.0 107.454 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -124.0 118.67 27.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.52 115.94 49.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.134 0.974 . . . . 0.0 108.404 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -93.02 118.11 30.81 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.61 -45.11 91.8 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.214 0.461 . . . . 0.0 111.205 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -55.46 -58.09 9.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 111.496 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -70.85 -49.94 40.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.234 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 2.56 52.28 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.68 1.61 . . . . 0.0 109.64 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.47 151.67 20.68 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.303 1.441 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.81 114.23 17.65 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.173 1.389 . . . . 0.0 109.776 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.62 113.47 20.34 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 31' ' ' VAL . 25.0 m -109.99 132.29 58.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 118.266 0.485 . . . . 0.0 110.65 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.26 105.56 14.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.84 158.52 11.36 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.42 -12.11 54.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.619 1.568 . . . . 0.0 112.773 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.55 155.24 2.25 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.57 136.4 85.96 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 125.432 1.493 . . . . 0.0 111.387 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.15 -25.3 37.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.441 2.094 . . . . 0.0 112.632 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -35.04 65.45 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.088 0.858 . . . . 0.0 110.725 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.47 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.96 -45.64 63.75 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.13 -47.36 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -62.2 -49.12 77.05 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.446 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.56 63.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.759 1.163 . . . . 0.0 113.164 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.4 t -81.49 -38.3 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.57 -36.0 82.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.26 -14.81 8.02 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.945 2.098 . . . . 0.0 112.36 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -115.67 -1.37 12.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.853 1.261 . . . . 0.0 111.275 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.97 42.22 9.0 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.382 0.992 . . . . 0.0 113.99 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -132.16 160.98 34.49 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.409 1.105 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -90.95 145.54 24.64 Favored 'General case' 0 CA--C 1.522 -0.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.1 143.43 47.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.866 1.266 . . . . 0.0 109.617 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -140.3 121.61 14.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 108.642 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -89.57 130.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.775 1.63 . . . . 0.0 109.993 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -133.92 126.42 30.34 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.83 1.652 . . . . 0.0 107.457 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.873 1.669 . . . . 0.0 110.092 178.867 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mmt . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.872 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.92 165.17 17.87 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.299 1.863 . . . . 0.0 110.974 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -142.55 147.66 36.29 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.49 1.916 . . . . 0.0 107.64 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.02 148.92 45.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.804 2.442 . . . . 0.0 108.547 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -97.03 138.55 34.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -122.11 128.39 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.229 2.212 . . . . 0.0 107.365 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -132.67 142.68 49.2 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.58 -179.9 24.88 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.371 1.462 . . . . 0.0 109.77 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.02 -46.33 88.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -173.14 -177.79 1.63 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.33 1.852 . . . . 0.0 107.421 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -72.97 139.19 46.54 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -152.53 170.23 20.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.898 1.279 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -57.37 -25.41 59.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.102 0.961 . . . . 0.0 109.464 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -27.57 17.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.321 2.249 . . . . 0.0 112.388 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.9 t -52.24 -46.03 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 120.353 1.433 . . . . 0.0 109.063 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -66.14 -43.4 87.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.272 -0.893 . . . . 0.0 108.648 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.43 67.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.735 0.814 . . . . 0.0 110.721 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.68 -35.4 75.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.4 m -57.53 -54.57 45.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.651 1.569 . . . . 0.0 109.439 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -64.13 -32.18 73.65 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -41.53 79.82 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.387 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.5 mt -57.11 -46.23 82.79 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -61.34 -4.33 1.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -57.99 -36.47 72.67 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 121.692 2.042 . . . . 0.0 114.413 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.07 119.78 29.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.217 1.007 . . . . 0.0 110.984 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.34 -21.99 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 113.46 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.41 4.04 66.55 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 117.696 -1.614 . . . . 0.0 115.381 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.43 -59.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.259 2.029 . . . . 0.0 109.288 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 57.77 0.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.161 2.584 . . . . 0.0 116.071 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.68 104.08 4.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.706 1.594 . . . . 0.0 110.772 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.18 140.06 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.122 0.969 . . . . 0.0 108.81 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -144.08 144.09 31.45 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.795 1.238 . . . . 0.0 108.958 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -124.58 143.81 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.569 1.947 . . . . 0.0 108.379 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -103.88 118.03 35.74 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.46 -30.09 69.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.033 1.288 . . . . 0.0 111.558 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.429 1.492 . . . . 0.0 110.313 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -83.24 -23.3 32.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 9.13 87.34 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 118.878 0.763 . . . . 0.0 112.113 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.6 160.79 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.187 1.994 . . . . 0.0 109.207 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.01 115.63 9.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.278 1.031 . . . . 0.0 109.762 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -91.07 140.13 30.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.465 1.106 . . . . 0.0 108.3 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.78 141.95 42.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 108.431 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -130.38 104.2 7.12 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.14 -176.97 40.76 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.855 1.693 . . . . 0.0 109.546 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 p -98.4 10.51 40.63 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.3 142.8 42.06 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.827 1.649 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.84 152.51 91.14 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.016 0.926 . . . . 0.0 109.972 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.84 -47.95 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.036 1.824 . . . . 0.0 110.421 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -38.78 72.83 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.485 0.314 . . . . 0.0 111.418 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.58 -53.87 44.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.962 0.905 . . . . 0.0 109.887 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.35 -52.89 62.9 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.531 0.732 . . . . 0.0 111.431 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.33 -57.84 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.833 0.853 . . . . 0.0 110.567 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -64.4 -35.88 82.35 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.005 0.82 . . . . 0.0 110.59 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.56 78.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.699 1.136 . . . . 0.0 110.337 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -77.97 -35.2 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.269 0.94 . . . . 0.0 109.535 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -61.61 -27.29 68.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.629 0.771 . . . . 0.0 110.955 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.99 -11.79 32.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.305 1.442 . . . . 0.0 111.562 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -109.49 -2.61 17.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.831 1.653 . . . . 0.0 111.125 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.55 -8.1 77.17 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.621 1.581 . . . . 0.0 113.768 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -78.98 157.91 28.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.756 1.278 . . . . 0.0 108.311 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -109.88 99.92 8.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.45 150.9 22.91 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.021 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -154.75 124.83 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 m -60.24 155.0 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.97 . . . . 0.0 109.928 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -56.9 132.15 51.73 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.884 1.273 . . . . 0.0 108.456 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.608 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.36 165.95 12.4 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.459 1.504 . . . . 0.0 107.799 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -150.4 104.05 3.2 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.413 -0.804 . . . . 0.0 108.848 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tp -79.17 147.9 32.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.817 0.847 . . . . 0.0 108.776 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -128.36 106.97 9.37 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.183 0.993 . . . . 0.0 109.497 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 t -74.95 153.07 6.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 126.13 1.772 . . . . 0.0 110.025 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -152.53 162.1 41.67 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 122.215 1.007 . . . . 0.0 111.855 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.27 -68.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 126.984 2.23 . . . . 0.0 113.416 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 mmt -84.37 162.78 19.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.899 0.85 . . . . 0.0 112.556 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -140.16 36.26 1.91 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.286 2.634 . . . . 0.0 106.772 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.97 179.46 2.72 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 119.949 -1.719 . . . . 0.0 109.504 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.94 -61.15 1.75 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.361 0.665 . . . . 0.0 110.008 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -56.72 -16.64 6.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.937 1.295 . . . . 0.0 114.05 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 p -59.58 -28.56 67.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.04 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.37 -46.49 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.529 1.513 . . . . 0.0 110.758 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.5 mtt -64.29 -49.81 70.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.334 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.42 -52.25 66.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.808 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.58 -52.02 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.305 1.442 . . . . 0.0 111.229 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 t -54.67 -43.97 72.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.184 1.357 . . . . 0.0 108.778 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -64.18 -50.69 67.13 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.626 -0.671 . . . . 0.0 111.342 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.43 79.3 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.507 1.523 . . . . 0.0 112.117 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.15 -38.06 81.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.037 0.935 . . . . 0.0 110.425 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.28 -10.55 59.7 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -46.73 -57.33 4.95 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.52 118.65 56.03 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.562 1.528 . . . . 0.0 111.734 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.55 88.79 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.706 2.271 . . . . 0.0 108.522 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.69 -33.69 0.02 OUTLIER Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.452 -0.78 . . . . 0.0 111.419 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.29 -50.2 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 117.474 0.637 . . . . 0.0 109.504 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 67.58 -46.61 0.5 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.312 2.245 . . . . 0.0 112.64 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -101.45 109.85 21.75 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.523 1.51 . . . . 0.0 112.698 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.62 130.43 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -130.73 137.55 49.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.093 1.357 . . . . 0.0 107.465 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.75 138.04 44.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 110.017 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.7 t -113.12 118.55 35.05 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.63 -24.33 66.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.406 0.682 . . . . 0.0 111.853 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.75 -13.75 61.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.746 1.618 . . . . 0.0 111.684 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -135.54 -15.74 1.85 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.79 18.46 72.35 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -100.19 145.5 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.49 114.56 9.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.9 0.48 . . . . 0.0 111.572 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.9 mp -77.55 144.42 37.61 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.965 1.706 . . . . 0.0 107.715 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.33 121.64 23.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.788 0.835 . . . . 0.0 109.298 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.05 104.99 9.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.46 177.51 21.14 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.697 1.618 . . . . 0.0 109.847 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -70.97 26.19 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.541 1.536 . . . . 0.0 113.991 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 106.11 1.19 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 142.07 98.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 123.323 0.649 . . . . 0.0 112.11 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.21 -48.14 12.75 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.457 2.105 . . . . 0.0 112.224 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -56.21 -37.26 69.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.468 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.64 63.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.309 0.644 . . . . 0.0 109.749 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -61.96 -50.07 73.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.289 1.035 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.59 -49.72 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -65.65 -42.01 91.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.836 0.744 . . . . 0.0 111.478 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.06 -31.23 70.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.656 1.182 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 62' ' ' ALA . 95.8 t -88.35 -41.75 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 118.656 0.662 . . . . 0.0 109.931 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.59 -42.35 82.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.839 0.856 . . . . 0.0 110.96 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.78 -12.74 50.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.785 -0.626 . . . . 0.0 112.03 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -97.83 -10.11 25.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 120.015 1.279 . . . . 0.0 113.338 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.23 9.27 60.68 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.238 -1.312 . . . . 0.0 114.576 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.69 145.64 30.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -88.2 152.14 22.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -149.21 147.37 28.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.561 0.618 . . . . 0.0 109.647 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -134.67 153.48 51.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.242 1.017 . . . . 0.0 108.263 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.18 173.97 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.99 85.5 3.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.6 mt -119.91 160.74 22.11 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.34 139.94 53.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.629 0.772 . . . . 0.0 110.109 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -122.29 111.54 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -88.95 127.15 35.65 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.22 141.54 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -141.45 98.57 3.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.33 -162.6 28.38 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.576 2.036 . . . . 0.0 109.761 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.2 ttt -124.47 8.08 8.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.175 1.79 . . . . 0.0 108.04 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.15 174.28 9.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 128.116 2.566 . . . . 0.0 107.465 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -140.0 -77.25 0.32 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -55.13 -28.6 53.87 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -93.1 -34.87 13.49 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 109.55 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -54.79 -54.3 43.89 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.929 1.292 . . . . 0.0 110.429 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -52.01 -38.29 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.128 0.971 . . . . 0.0 112.393 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.4 mmm -62.38 -49.8 74.08 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 110.088 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.82 -38.72 83.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.216 0.606 . . . . 0.0 110.185 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.23 -44.85 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.8 m -64.71 -40.02 94.64 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.904 1.229 . . . . 0.0 109.088 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -55.66 -49.76 72.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.109 0.964 . . . . 0.0 109.614 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.48 59.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.114 1.366 . . . . 0.0 110.246 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.6 mt -58.81 -28.11 65.7 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 124.355 1.062 . . . . 0.0 112.47 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -68.86 -21.01 64.29 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.098 -1.001 . . . . 0.0 111.63 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.21 -15.46 63.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.8 m -51.94 160.93 1.02 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.319 1.848 . . . . 0.0 113.313 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.65 -71.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.872 2.381 . . . . 0.0 111.757 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -156.75 51.95 0.42 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.709 0.671 . . . . 0.0 112.157 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.31 -36.48 74.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 118.01 0.905 . . . . 0.0 111.183 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.286 4.1 pt-20 58.38 -11.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.278 2.631 . . . . 0.0 116.362 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -135.18 104.07 5.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.076 2.15 . . . . 0.0 107.762 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -141.91 120.24 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -124.4 142.78 51.03 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.777 1.631 . . . . 0.0 108.956 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 t -137.01 143.21 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.079 0.552 . . . . 0.0 109.802 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -81.56 126.2 31.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.47 -48.57 48.36 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.052 0.941 . . . . 0.0 111.508 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.11 -13.59 59.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -118.75 -164.84 1.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.613 1.565 . . . . 0.0 108.463 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.87 66.54 0.57 Allowed Glycine 0 CA--C 1.52 0.344 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -145.7 137.05 24.94 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.738 -1.448 . . . . 0.0 108.163 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.35 145.2 50.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.512 1.525 . . . . 0.0 109.406 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.16 138.98 54.28 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.65 139.75 42.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.701 0.801 . . . . 0.0 110.105 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -128.58 104.09 7.47 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.57 -169.13 27.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.0 p -59.56 6.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 130.976 3.711 . . . . 0.0 117.56 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.44 104.84 6.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.403 1.456 . . . . 0.0 110.376 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -66.1 132.91 94.62 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 123.862 0.865 . . . . 0.0 110.35 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.69 -38.55 91.29 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.464 2.109 . . . . 0.0 114.806 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.06 -38.27 85.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.867 2.122 . . . . 0.0 110.149 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.4 83.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -67.38 -50.55 59.25 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.836 1.255 . . . . 0.0 109.375 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -52.84 -54.04 18.28 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 124.976 1.31 . . . . 0.0 108.156 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.67 -50.57 69.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.451 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.34 66.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.486 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.25 -32.88 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.216 0.916 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.76 -20.27 65.62 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.613 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.52 -28.2 69.14 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.484 1.493 . . . . 0.0 110.615 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -90.41 -7.86 52.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.064 1.346 . . . . 0.0 110.211 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.51 10.41 70.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.191 1.853 . . . . 0.0 115.399 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.89 156.35 37.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.394 2.097 . . . . 0.0 109.222 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -80.57 119.49 23.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.83 143.33 31.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.569 0.748 . . . . 0.0 109.159 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -147.02 149.82 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -106.13 148.47 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 123.766 0.826 . . . . 0.0 111.532 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.3 mt -148.2 150.45 33.78 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.32 1.448 . . . . 0.0 107.5 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.275 1.03 . . . . 0.0 110.452 179.695 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtt . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.6 mt -128.39 153.43 47.08 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -131.15 109.81 10.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.746 0.818 . . . . 0.0 109.408 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -101.51 111.46 23.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -90.05 138.5 31.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.88 152.48 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.104 0.866 . . . . 0.0 110.044 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -142.73 100.11 3.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.736 2.414 . . . . 0.0 108.258 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.41 -75.58 0.1 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -142.88 150.32 39.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.151 1.78 . . . . 0.0 107.473 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -143.74 -64.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.505 1.122 . . . . 0.0 108.264 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.5 m -75.48 64.36 1.59 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.898 1.279 . . . . 0.0 109.249 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -153.12 172.57 16.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.462 2.305 . . . . 0.0 106.477 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -66.14 -4.71 8.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.094 -1.004 . . . . 0.0 112.815 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -53.05 -26.71 16.75 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.373 1.469 . . . . 0.0 111.743 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.9 t -50.23 -49.3 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.924 1.29 . . . . 0.0 109.746 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -63.12 -31.1 72.17 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.94 -42.1 34.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.167 0.987 . . . . 0.0 109.752 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.54 -50.97 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.1 p -61.1 -50.65 72.38 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.09 -0.481 . . . . 0.0 109.835 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -53.83 -54.56 36.71 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.822 0.737 . . . . 0.0 111.881 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.03 -50.76 70.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.908 0.883 . . . . 0.0 111.082 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 mp -68.38 -29.33 68.01 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.169 -0.957 . . . . 0.0 112.84 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -86.95 -9.27 56.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.771 1.628 . . . . 0.0 113.258 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -56.22 -25.5 47.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.559 1.143 . . . . 0.0 113.511 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.65 141.77 29.5 Favored Pre-proline 0 N--CA 1.447 -0.576 0 C-N-CA 125.207 1.403 . . . . 0.0 107.318 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.09 177.2 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.719 2.28 . . . . 0.0 111.245 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.39 -61.51 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -75.55 -59.28 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 52.3 -17.37 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.588 2.355 . . . . 0.0 116.498 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.94 115.99 30.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 121.546 1.976 . . . . 0.0 110.514 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -147.98 119.15 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.143 1.777 . . . . 0.0 106.432 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -125.19 120.86 32.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 t -87.76 142.74 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.6 t -125.98 117.39 23.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.44 -48.51 49.07 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.451 1.5 . . . . 0.0 113.81 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -58.64 -19.04 35.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.777 1.231 . . . . 0.0 113.102 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 7.98 9.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.963 1.305 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 43.29 56.74 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 126.75 2.119 . . . . 0.0 110.427 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.62 179.94 7.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.9 115.23 10.4 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.776 2.43 . . . . 0.0 108.625 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.7 mt -81.95 123.95 29.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.48 146.22 26.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 118.765 0.711 . . . . 0.0 109.551 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -133.29 107.92 8.42 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.92 174.07 38.52 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 127.547 2.499 . . . . 0.0 108.484 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -88.33 3.6 49.15 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.263 1.425 . . . . 0.0 113.054 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 155.76 1.03 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 117.503 2.408 . . . . 0.0 117.503 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.69 137.09 62.88 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.137 2.175 . . . . 0.0 110.317 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.39 -42.94 30.8 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.197 1.932 . . . . 0.0 109.927 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.68 -45.18 95.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.143 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.52 -43.89 93.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 110.263 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -61.58 -54.49 42.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.688 0.795 . . . . 0.0 109.254 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.17 -46.85 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.427 1.091 . . . . 0.0 109.848 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -67.68 -39.01 84.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.171 -1.395 . . . . 0.0 111.33 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.89 77.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.825 1.193 . . . . 0.0 110.268 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.81 -38.03 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.324 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.1 -40.3 86.89 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.165 -0.959 . . . . 0.0 111.944 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.11 -19.71 65.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.507 0.594 . . . . 0.0 111.28 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -88.97 -30.51 18.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.9 -1.048 . . . . 0.0 111.179 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 4.66 0.41 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 119.05 2.38 . . . . 0.0 119.05 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.17 138.98 26.92 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.593 3.196 . . . . 0.0 108.656 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -75.4 163.96 26.89 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 118.223 0.465 . . . . 0.0 109.909 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.73 161.04 43.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.719 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -151.38 128.96 11.45 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.95 161.74 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.594 -0.691 . . . . 0.0 111.528 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.6 mt -118.51 169.34 9.86 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.684 1.594 . . . . 0.0 108.856 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.492 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.5 mt -134.48 163.08 30.49 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.834 -1.166 . . . . 0.0 109.187 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -120.54 133.1 55.43 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -136.84 148.71 47.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 109.426 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -122.32 138.36 54.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.24 128.57 21.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -139.53 159.27 42.56 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.495 1.118 . . . . 0.0 111.476 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.88 -100.39 0.53 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 124.907 1.242 . . . . 0.0 111.622 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.4 mtp -128.87 -17.0 4.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.091 0.946 . . . . 0.0 113.099 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p -146.69 -178.31 6.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.902 2.081 . . . . 0.0 108.184 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.5 p -123.24 -17.54 6.58 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.008 0.923 . . . . 0.0 110.244 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -68.97 -79.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.983 0.811 . . . . 0.0 110.399 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -79.92 -14.49 58.58 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -52.46 -43.59 65.04 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.293 1.037 . . . . 0.0 110.531 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.61 -38.54 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.289 1.436 . . . . 0.0 110.741 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.62 -45.33 83.5 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.051 0.842 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.11 86.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.207 0.458 . . . . 0.0 109.888 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.22 -54.05 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.383 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -61.47 -38.65 88.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.174 1.352 . . . . 0.0 110.469 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -55.18 -50.55 69.04 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.306 0.642 . . . . 0.0 109.308 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.81 -51.63 38.72 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.52 -27.76 69.48 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -60.91 -9.6 4.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.488 1.04 . . . . 0.0 112.697 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.19 -29.64 58.31 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 114.027 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.95 156.63 91.77 Favored Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 121.446 -0.784 . . . . 0.0 112.248 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.7 -50.69 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.87 1.713 . . . . 0.0 109.77 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.32 34.04 0.02 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 121.207 -0.933 . . . . 0.0 112.231 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.11 -33.53 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 112.757 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.69 165.86 33.97 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -114.65 104.1 11.65 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.94 137.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.03 117.88 13.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.22 143.93 12.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -89.29 153.94 20.49 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.119 0.872 . . . . 0.0 108.925 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.51 -48.13 35.65 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.533 -1.354 . . . . 0.0 109.666 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -66.82 -22.56 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -145.48 145.97 31.29 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.748 1.158 . . . . 0.0 108.736 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.91 10.68 2.95 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.616 2.055 . . . . 0.0 114.414 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.62 163.94 14.37 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.2 162.5 39.34 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 126.256 1.822 . . . . 0.0 109.877 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.07 142.36 49.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.19 117.13 44.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.148 0.975 . . . . 0.0 108.8 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.93 104.95 12.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.903 2.081 . . . . 0.0 105.613 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.7 -176.27 39.03 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -95.18 7.52 45.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.569 1.148 . . . . 0.0 113.227 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.5 156.52 19.28 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.094 -1.003 . . . . 0.0 113.491 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.64 119.25 71.91 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -57.71 -41.03 74.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.901 1.734 . . . . 0.0 110.698 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -38.78 75.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.832 0.853 . . . . 0.0 110.648 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.8 82.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.76 0.709 . . . . 0.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.27 -46.53 73.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.14 -38.83 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.706 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -47.99 83.75 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.397 0.999 . . . . 0.0 109.776 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.21 87.17 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.256 1.022 . . . . 0.0 111.557 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.72 -34.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.128 0.571 . . . . 0.0 110.076 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -64.48 -51.68 61.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -67.81 -16.1 63.95 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.46 -9.13 59.56 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.29 -0.881 . . . . 0.0 108.941 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.35 52.81 3.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -141.08 175.26 9.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.981 1.712 . . . . 0.0 108.26 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -118.42 147.49 43.52 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.15 167.41 22.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -148.24 143.09 26.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -100.07 143.03 14.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -143.14 51.69 1.38 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 109.242 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.264 0 C-N-CA 128.54 2.736 . . . . 0.0 107.078 -178.487 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.85 157.39 16.41 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 120.995 -1.066 . . . . 0.0 108.395 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -115.12 124.21 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.64 148.35 38.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.03 1.332 . . . . 0.0 108.115 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -118.71 138.4 52.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.15 133.72 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -145.04 108.63 4.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.91 -97.54 1.57 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.8 mtt -143.6 -60.29 0.41 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -132.33 120.99 22.83 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -109.99 50.12 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.375 1.87 . . . . 0.0 112.147 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -111.21 -92.04 0.46 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -57.42 -31.23 65.65 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.645 1.111 . . . . 0.0 110.33 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 t -52.91 -37.24 60.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.351 2.26 . . . . 0.0 111.592 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -52.38 -41.99 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 119.181 0.901 . . . . 0.0 110.825 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 ttp -62.97 -47.58 82.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.829 0.286 . . . . 0.0 110.325 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 -52.08 62.55 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.354 1.062 . . . . 0.0 112.788 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.98 -44.65 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.463 -0.78 . . . . 0.0 109.223 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -60.73 -49.83 75.92 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.8 0.727 . . . . 0.0 109.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -51.11 -48.53 61.69 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.558 1.143 . . . . 0.0 110.323 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.06 52.72 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.444 0.465 . . . . 0.0 110.828 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.81 -29.11 62.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 112.563 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.56 -13.27 61.0 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.297 -0.877 . . . . 0.0 112.136 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.41 -56.04 27.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.567 1.076 . . . . 0.0 110.013 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.61 116.05 30.66 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.14 174.19 11.76 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.254 1.969 . . . . 0.0 110.642 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.53 12.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.226 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 71.3 t -114.76 -59.08 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 118.65 1.225 . . . . 0.0 109.434 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.304 74.4 mt-10 63.68 -44.58 0.25 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.286 2.635 . . . . 0.0 110.634 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -95.77 110.35 22.52 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.229 1.812 . . . . 0.0 110.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.16 144.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.063 1.345 . . . . 0.0 107.507 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.2 143.71 34.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.93 140.54 48.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.769 1.227 . . . . 0.0 108.669 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -115.72 115.29 26.09 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.8 -32.57 65.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -71.95 -9.21 58.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.738 0.815 . . . . 0.0 111.889 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 -14.31 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.28 60.12 Favored Glycine 0 N--CA 1.467 0.716 0 CA-C-N 120.723 1.601 . . . . 0.0 110.215 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.98 170.43 15.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.669 0.735 . . . . 0.0 112.169 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.91 157.71 43.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.372 1.869 . . . . 0.0 109.015 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.43 139.15 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.867 2.067 . . . . 0.0 106.443 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.45 121.6 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 123.287 0.635 . . . . 0.0 110.139 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -106.6 104.84 14.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . 175.24 -157.73 24.71 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.551 1.072 . . . . 0.0 111.208 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.8 p -113.48 16.94 18.7 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.431 2.292 . . . . 0.0 113.946 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.87 151.86 46.04 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.94 149.67 74.04 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.161 2.185 . . . . 0.0 109.564 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.92 -49.69 3.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 110.739 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -56.49 -49.3 75.1 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.036 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.54 -37.96 66.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.645 0.591 . . . . 0.0 111.866 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -73.87 -51.82 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.484 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.66 -36.28 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.096 0.862 . . . . 0.0 110.241 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -73.3 -40.55 64.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.943 0.897 . . . . 0.0 110.314 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.19 80.01 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.692 1.133 . . . . 0.0 108.6 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.266 17.6 m -71.58 -32.26 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.783 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.97 -28.77 62.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 120.054 1.297 . . . . 0.0 109.881 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -61.09 -18.72 59.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.414 1.007 . . . . 0.0 111.944 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.3 -6.5 58.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.516 1.053 . . . . 0.0 111.996 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.48 44.96 7.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 119.383 0.992 . . . . 0.0 113.545 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -141.19 175.72 9.41 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.863 2.465 . . . . 0.0 108.021 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -114.41 149.3 36.42 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.765 1.621 . . . . 0.0 108.738 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.97 155.72 37.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 175.29 10.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.94 -178.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.864 0.84 . . . . 0.0 110.569 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.29 111.1 2.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.74 -1.124 . . . . 0.0 108.157 -179.69 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mtp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.4 mt -140.39 163.39 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -133.86 105.33 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 tp -95.64 147.89 23.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 123.09 49.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.82 140.26 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -139.34 121.8 16.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.358 0.981 . . . . 0.0 110.904 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.4 -112.46 0.51 Allowed Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 29.6 mmm -58.61 -54.79 43.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.156 1.382 . . . . 0.0 113.76 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 p 45.35 50.22 10.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.375 1.47 . . . . 0.0 109.193 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -92.85 168.36 11.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.984 0.897 . . . . 0.0 112.61 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -62.08 -43.1 99.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.157 0.983 . . . . 0.0 113.01 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -89.36 -38.87 13.82 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -52.01 -28.12 15.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.09 -37.75 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 119.605 1.093 . . . . 0.0 110.105 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.7 mmt -59.03 -44.44 91.75 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.374 -0.829 . . . . 0.0 110.343 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.3 68.89 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 108.882 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.26 -48.54 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.992 0.917 . . . . 0.0 109.595 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.4 m -58.79 -50.11 75.17 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.436 -0.79 . . . . 0.0 109.16 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -63.08 -34.66 78.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.304 0.956 . . . . 0.0 111.495 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.19 79.22 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -64.84 -48.05 75.73 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.458 -0.776 . . . . 0.0 110.033 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -63.5 -6.76 5.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 112.523 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -65.38 -20.04 66.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.262 1.392 . . . . 0.0 110.834 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.1 t -71.31 117.11 53.85 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -53.95 -66.1 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 118.387 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.76 -10.46 45.01 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -71.9 -57.37 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.868 2.334 . . . . 0.0 109.671 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 54.1 0.39 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.546 2.338 . . . . 0.0 116.549 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -131.19 106.93 8.65 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.494 1.518 . . . . 0.0 111.163 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.9 144.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.616 1.566 . . . . 0.0 107.224 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -137.35 117.32 13.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 t -114.62 125.64 71.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -75.5 129.87 37.97 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.79 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.91 -43.4 86.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.819 0.848 . . . . 0.0 109.955 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.18 -8.56 59.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.98 161.22 38.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 121.138 1.79 . . . . 0.0 110.904 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.09 46.01 3.49 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -115.02 134.58 55.06 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.113 1.457 . . . . 0.0 107.787 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.07 113.8 12.49 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.1 mt -94.1 143.55 26.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.01 141.09 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.424 0.631 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -114.74 104.42 11.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.43 168.89 23.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -89.32 12.67 15.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.992 1.717 . . . . 0.0 113.315 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.59 135.38 57.33 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.817 0.735 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.02 155.7 77.24 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 113.596 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -60.68 -66.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.941 3.094 . . . . 0.0 112.701 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -27.27 62.34 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.02 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.73 -52.95 63.28 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.442 1.019 . . . . 0.0 108.329 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.03 -47.66 79.36 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 117.716 -1.135 . . . . 0.0 110.465 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.1 t -52.16 -60.55 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 O-C-N 124.315 1.009 . . . . 0.0 109.017 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -40.26 76.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.923 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.64 88.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.991 1.268 . . . . 0.0 113.186 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 m -78.57 -32.8 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 0.0 109.465 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -61.36 -20.28 62.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.491 0.587 . . . . 0.0 110.036 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.65 -23.83 66.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.215 0.916 . . . . 0.0 109.847 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.46 -12.86 53.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.771 1.628 . . . . 0.0 110.727 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.94 -11.7 65.94 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.41 1.957 . . . . 0.0 113.786 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -76.36 144.98 39.78 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.36 1.08 . . . . 0.0 109.217 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -75.95 162.09 28.39 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.95 161.34 38.37 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.557 1.072 . . . . 0.0 111.067 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -147.88 123.66 10.56 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.961 0.904 . . . . 0.0 112.297 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.77 146.4 8.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.616 HD13 ' H ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -68.52 153.07 44.46 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.616 ' H ' HD13 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.431 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.555 ' C ' HD12 ' A' ' 2' ' ' LEU . 21.6 ptp . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.555 HD12 ' C ' ' A' ' 1' ' ' MET . 6.7 mp -140.46 159.62 41.79 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.072 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -100.9 115.79 31.23 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -104.4 143.3 33.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -125.69 128.95 48.61 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.59 152.49 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 125.892 1.677 . . . . 0.0 106.687 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -143.96 165.27 28.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.468 1.907 . . . . 0.0 108.697 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.26 -105.19 1.72 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.867 1.222 . . . . 0.0 111.755 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 85.6 mtp -84.94 -176.98 6.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.167 1.387 . . . . 0.0 110.295 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 p -153.12 105.52 2.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.441 1.096 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.6 t -163.45 148.76 11.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 121.07 1.759 . . . . 0.0 110.45 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -62.58 -41.95 99.26 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 124.304 1.041 . . . . 0.0 111.482 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -60.92 -14.88 25.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -30.67 71.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.573 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 m -58.41 -25.42 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 121.16 1.8 . . . . 0.0 111.421 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.7 mmm -69.61 -50.22 46.47 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.44 -52.44 53.15 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.791 0.836 . . . . 0.0 110.586 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.66 -55.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.645 1.578 . . . . 0.0 109.918 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 m -72.85 -25.45 61.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.811 1.187 . . . . 0.0 111.679 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -66.98 -55.99 12.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.549 1.522 . . . . 0.0 107.917 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.17 68.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.718 0.636 . . . . 0.0 110.166 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.4 -27.46 47.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 117.337 -1.316 . . . . 0.0 113.724 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -51.2 -21.8 2.25 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.975 1.716 . . . . 0.0 111.329 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 0.4 3.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.622 1.569 . . . . 0.0 113.21 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.91 143.11 23.94 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 120.796 1.635 . . . . 0.0 111.575 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.44 -81.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.349 3.366 . . . . 0.0 113.607 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.97 0.55 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.416 1.008 . . . . 0.0 110.619 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.68 -58.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.388 0.675 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 62.65 -14.95 0.06 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.907 1.683 . . . . 0.0 115.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -127.46 107.98 10.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.513 1.506 . . . . 0.0 111.657 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.12 119.3 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -119.19 143.54 47.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.861 2.064 . . . . 0.0 107.296 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.39 141.55 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.967 1.307 . . . . 0.0 108.081 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -88.03 118.65 27.74 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.78 -39.58 93.83 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.85 -9.1 59.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.549 1.068 . . . . 0.0 112.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -123.48 -168.91 1.85 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.226 1.41 . . . . 0.0 110.216 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.46 70.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 105.514 -3.034 . . . . 0.0 105.514 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -151.07 162.76 40.24 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 117.79 0.795 . . . . 0.0 109.468 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.86 154.73 40.81 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.274 1.03 . . . . 0.0 111.033 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -117.25 119.54 35.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 t -123.72 112.93 35.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 123.561 0.538 . . . . 0.0 110.194 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -104.72 105.78 16.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.743 0.817 . . . . 0.0 111.36 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.3 179.61 45.02 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.2 p -81.6 -12.08 58.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.041 0.936 . . . . 0.0 113.026 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.14 135.22 26.02 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.851 1.26 . . . . 0.0 112.692 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.82 143.17 98.43 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 125.895 1.678 . . . . 0.0 111.808 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.9 -32.24 36.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.827 1.685 . . . . 0.0 110.334 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -63.79 -48.93 74.92 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.689 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.34 67.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 123.846 0.716 . . . . 0.0 110.512 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -57.52 -52.78 64.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.768 0.827 . . . . 0.0 111.692 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.18 -46.85 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -31.71 71.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.97 -51.08 27.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.827 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.261 16.8 m -61.94 -32.9 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.442 1.019 . . . . 0.0 113.227 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.18 -20.05 50.49 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.96 -0.462 . . . . 0.0 111.58 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -73.87 -16.63 61.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.09 -52.07 5.14 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.341 1.428 . . . . 0.0 113.151 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.32 20.33 0.04 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.68 173.91 11.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.293 1.437 . . . . 0.0 108.243 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.4 163.67 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.354 -0.841 . . . . 0.0 108.794 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.79 165.82 34.83 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.629 0.728 . . . . 0.0 111.159 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -147.6 155.25 41.62 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.424 2.29 . . . . 0.0 105.762 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -128.02 137.8 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 O-C-N 121.224 -0.922 . . . . 0.0 111.28 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 tt -92.17 111.68 23.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.761 2.024 . . . . 0.0 105.743 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 125.579 1.552 . . . . 0.0 110.088 -179.738 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.7 mt -145.13 166.06 26.49 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 66' ' ' ALA . 33.3 mttm -127.94 124.88 38.42 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -109.06 115.68 30.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.681 1.192 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -88.48 124.35 33.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.74 131.67 69.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -138.92 156.82 46.97 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.374 1.07 . . . . 0.0 108.159 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.32 -74.17 0.26 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 108.081 -2.007 . . . . 0.0 108.081 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.2 tpp -149.29 142.66 25.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.04 116.72 22.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.2 m -144.72 117.17 8.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -59.66 -44.24 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.364 0.665 . . . . 0.0 109.837 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.85 -12.06 51.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.58 -33.21 72.38 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.946 1.248 . . . . 0.0 108.807 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.75 -31.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.519 1.127 . . . . 0.0 110.681 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.49 -51.11 60.24 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.73 97.56 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.892 0.877 . . . . 0.0 110.757 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.91 -51.99 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -63.07 -40.36 97.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.716 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -56.84 -55.38 35.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.353 0.979 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.8 85.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 122.522 0.329 . . . . 0.0 111.672 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -45.04 92.65 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -62.25 -8.46 5.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.971 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -60.89 -18.54 56.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.306 1.867 . . . . 0.0 110.749 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.24 127.13 23.19 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.51 126.93 13.34 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.679 2.919 . . . . 0.0 111.418 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.7 -17.1 8.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-O 116.758 -2.134 . . . . 0.0 113.974 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.91 2.53 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 121.176 2.488 . . . . 0.0 115.238 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -66.76 -1.64 4.09 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -95.77 104.22 16.14 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.44 139.19 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.5 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -123.08 116.54 23.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.45 131.84 53.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.91 1.684 . . . . 0.0 109.488 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 m -70.19 130.94 43.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.02 -48.62 34.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.95 0.405 . . . . 0.0 110.217 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.5 -52.25 7.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.611 1.164 . . . . 0.0 110.956 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -82.62 175.63 10.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.25 3.65 35.16 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.403 -1.221 . . . . 0.0 115.757 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -91.11 146.68 23.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.807 2.304 . . . . 0.0 109.151 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.58 138.75 44.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.766 1.627 . . . . 0.0 107.793 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.01 130.17 48.49 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -120.17 112.67 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.634 1.174 . . . . 0.0 108.8 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -90.4 114.91 27.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.93 41.67 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 118.775 0.716 . . . . 0.0 113.217 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 t -125.77 3.72 7.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.956 1.302 . . . . 0.0 112.916 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 156.7 32.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.542 0.687 . . . . 0.0 112.65 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.35 133.55 90.87 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 125.086 1.355 . . . . 0.0 109.104 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.65 -44.17 23.1 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.547 2.165 . . . . 0.0 110.151 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -56.51 -30.45 63.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.971 0.908 . . . . 0.0 112.05 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -39.69 79.21 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.635 0.652 . . . . 0.0 109.549 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.99 -45.12 74.98 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 123.717 0.807 . . . . 0.0 109.077 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -57.83 -58.5 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -60.72 -36.44 78.85 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.357 0.526 . . . . 0.0 112.063 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.28 99.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.952 0.797 . . . . 0.0 110.712 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.5 t -73.86 -33.14 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -60.62 -37.35 81.13 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.395 0.998 . . . . 0.0 110.284 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.65 -19.84 62.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.646 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -87.84 -3.41 58.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 112.225 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.53 37.12 6.25 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.058 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.54 172.96 11.82 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.401 1.101 . . . . 0.0 110.091 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -118.58 109.38 16.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.75 159.23 16.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.1 0.56 . . . . 0.0 111.552 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -158.3 159.26 35.73 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.0 2.52 . . . . 0.0 107.187 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.18 144.81 17.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.628 HD23 ' H ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -147.16 159.8 43.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.7 0.682 . . . . 0.0 110.718 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.628 ' H ' HD23 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.248 0.975 0 C-N-CA 125.861 1.665 . . . . 0.0 108.633 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.09 165.33 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -133.95 141.86 47.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.3 tp -122.65 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.521 1.529 . . . . 0.0 108.978 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -87.15 136.76 32.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.4 133.13 70.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 125.557 1.543 . . . . 0.0 107.236 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -145.13 163.77 33.32 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.48 -123.37 5.56 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.245 1.402 . . . . 0.0 113.949 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -68.0 83.03 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 129.658 3.183 . . . . 0.0 111.341 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.98 78.69 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.786 2.434 . . . . 0.0 111.06 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -137.79 161.83 35.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.981 1.712 . . . . 0.0 109.241 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.31 -57.83 4.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.995 1.718 . . . . 0.0 112.805 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -60.47 -19.1 55.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.7 m -63.26 -34.05 76.83 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.85 1.205 . . . . 0.0 109.667 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.23 -39.12 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.374 1.069 . . . . 0.0 109.734 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 48.6 tpp -62.16 -47.2 85.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.55 -52.32 66.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.52 -0.752 . . . . 0.0 110.124 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.47 -43.52 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.716 1.144 . . . . 0.0 113.092 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.9 t -60.68 -44.49 96.44 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.295 1.861 . . . . 0.0 110.002 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -69.23 -48.3 62.34 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.657 -0.652 . . . . 0.0 111.678 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.15 73.27 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.602 0.761 . . . . 0.0 111.288 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.567 HD22 ' HG ' ' A' ' 51' ' ' LEU . 19.6 mt -73.13 -52.13 15.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.708 0.686 . . . . 0.0 110.076 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -69.38 -3.7 15.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -53.56 -40.67 65.78 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.589 0.756 . . . . 0.0 111.039 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.22 136.52 37.89 Favored Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.44 115.06 3.15 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 N-CA-C 106.79 -2.042 . . . . 0.0 106.79 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.88 -92.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.759 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 t -64.75 -57.37 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 66.22 -31.6 0.16 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.278 2.231 . . . . 0.0 112.444 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -101.2 102.76 13.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.577 1.951 . . . . 0.0 106.374 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.36 127.12 37.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.548 1.139 . . . . 0.0 108.008 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.06 144.84 51.33 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.437 1.495 . . . . 0.0 111.911 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.12 143.04 42.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.729 1.612 . . . . 0.0 107.314 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -77.5 137.28 38.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 109.175 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.34 -48.09 44.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -80.76 -20.97 41.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.77 161.63 32.42 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 120.075 1.307 . . . . 0.0 109.485 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.21 36.16 3.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -104.26 141.62 35.97 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 120.372 -1.664 . . . . 0.0 107.583 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.22 146.06 51.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 108.562 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.93 144.31 50.73 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.015 1.726 . . . . 0.0 106.703 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.37 141.29 42.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.535 0.734 . . . . 0.0 110.909 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.13 104.19 8.39 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.446 1.117 . . . . 0.0 109.179 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.83 41.63 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 126.436 1.969 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -117.38 12.72 14.34 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.71 156.27 30.9 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.216 0.916 . . . . 0.0 110.436 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.31 154.93 81.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.235 1.414 . . . . 0.0 113.24 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.7 -51.63 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.14 2.56 . . . . 0.0 109.213 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -55.48 -40.33 71.52 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.128 -1.415 . . . . 0.0 111.074 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.24 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 120.136 1.335 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HG ' HD22 ' A' ' 22' ' ' LEU . 10.5 mp -70.01 -53.13 19.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.29 0.636 . . . . 0.0 110.666 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.8 t -52.51 -54.96 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.942 0.897 . . . . 0.0 109.942 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.32 -47.42 86.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.121 1.369 . . . . 0.0 110.421 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.75 -45.34 74.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.638 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.438 HG13 HD21 ' A' ' 22' ' ' LEU . 33.3 m -73.86 -32.71 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 119.06 0.845 . . . . 0.0 111.274 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -56.45 -39.16 72.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 112.227 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.83 -34.15 62.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -16.89 61.47 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.398 0.545 . . . . 0.0 112.218 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.29 0.16 47.26 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.544 1.068 . . . . 0.0 110.96 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -78.83 172.27 13.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.377 1.071 . . . . 0.0 109.519 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.35 149.19 39.74 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.57 170.01 23.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.493 1.139 . . . . 0.0 111.694 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -158.04 127.6 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.62 142.12 14.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -125.64 94.8 4.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 177.475 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptt? . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 118.126 -0.94 . . . . 0.0 113.278 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -91.92 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.716 1.143 . . . . 0.0 110.106 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -127.75 141.08 51.69 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.7 tp -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -86.75 133.98 33.61 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 100.639 -3.837 . . . . 0.0 100.639 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.43 118.85 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -127.58 145.66 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.94 -176.39 41.47 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.1 mtp -62.45 -22.8 66.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.905 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -123.18 154.64 38.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.116 1.366 . . . . 0.0 108.152 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 p -133.36 -5.51 2.97 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.664 1.186 . . . . 0.0 113.22 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -115.8 -67.92 0.96 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.406 1.082 . . . . 0.0 111.115 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 -20.54 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.818 -1.176 . . . . 0.0 113.447 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -59.75 -27.67 66.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.771 1.229 . . . . 0.0 112.049 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 m -52.5 -29.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 119.094 0.861 . . . . 0.0 112.865 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 9.9 tpt -67.57 -50.73 57.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.19 74.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.865 0.866 . . . . 0.0 110.374 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -56.27 -55.03 20.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 110.912 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.3 m -68.33 -36.33 79.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.471 1.032 . . . . 0.0 111.222 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -47.75 84.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.26 -49.53 75.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.516 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.38 -28.11 64.86 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.831 1.196 . . . . 0.0 112.303 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -58.27 -29.97 66.22 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.488 -0.758 . . . . 0.0 109.58 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -60.9 -16.95 47.79 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 117.258 -1.354 . . . . 0.0 112.83 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.46 92.07 1.7 Allowed Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 119.516 1.053 . . . . 0.0 108.817 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.67 117.16 4.99 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 105.878 -2.393 . . . . 0.0 105.878 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.27 -10.46 5.04 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 118.002 -1.443 . . . . 0.0 113.117 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.8 t -85.53 -56.93 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 120.166 1.983 . . . . 0.0 106.551 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 63.8 -19.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -130.04 114.49 15.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.829 2.104 . . . . 0.0 110.778 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.6 m -140.09 144.36 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.802 1.241 . . . . 0.0 109.737 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.01 144.75 32.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.957 1.303 . . . . 0.0 109.49 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.46 129.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -76.65 132.52 39.44 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.773 1.229 . . . . 0.0 111.243 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.2 mt -73.56 -48.61 31.57 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.2 1.0 . . . . 0.0 112.749 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.01 -31.61 69.37 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -135.68 161.62 35.03 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.632 1.106 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.59 43.22 1.33 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.236 1.398 . . . . 0.0 112.794 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -104.71 152.51 22.43 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.54 151.85 38.79 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.962 1.305 . . . . 0.0 108.387 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.41 144.6 47.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.091 1.756 . . . . 0.0 107.433 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -138.26 116.19 12.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.89 104.83 13.82 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.13 162.65 12.19 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 t -75.05 31.8 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.234 1.814 . . . . 0.0 112.321 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.71 149.77 8.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.946 1.298 . . . . 0.0 112.447 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.73 131.07 46.48 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.694 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -49.74 -61.81 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.605 2.87 . . . . 0.0 113.634 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -58.02 -23.16 53.05 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.868 -1.063 . . . . 0.0 112.633 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.76 -39.65 66.64 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.382 1.446 . . . . 0.0 109.334 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.09 -48.71 67.37 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.33 -55.86 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.068 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.51 -29.86 71.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.472 -0.775 . . . . 0.0 111.865 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.01 82.8 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.742 1.156 . . . . 0.0 108.726 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.17 -36.89 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.783 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.15 -36.43 72.99 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.234 1.014 . . . . 0.0 113.258 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.53 -15.3 49.92 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.233 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.31 8.71 29.92 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.087 1.312 . . . . 0.0 111.833 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.63 38.39 9.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.46 152.16 43.66 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.99 152.17 19.54 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.6 159.28 42.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.637 0.586 . . . . 0.0 110.867 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -153.59 117.19 4.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 m -80.04 168.3 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 124.398 1.079 . . . . 0.0 108.471 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -69.7 -176.05 0.98 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.721 0.808 . . . . 0.0 110.947 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.877 1.671 . . . . 0.0 108.925 -179.613 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 2' ' ' LEU . 3.5 mm? -114.7 165.33 12.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.893 0.854 . . . . 0.0 108.989 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -133.92 123.25 24.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 tp -97.13 111.76 23.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.663 1.185 . . . . 0.0 108.39 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 134.94 33.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.97 164.75 31.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -147.17 139.29 24.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.05 -152.11 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 mmt -63.57 157.68 23.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.027 0.442 . . . . 0.0 110.328 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -57.61 -80.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.714 2.005 . . . . 0.0 113.926 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 p -146.43 132.53 19.32 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.74 1.216 . . . . 0.0 110.148 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -172.15 -173.47 1.11 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.851 1.261 . . . . 0.0 109.61 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -56.67 -13.91 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.772 2.029 . . . . 0.0 113.111 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.0 m -52.94 -28.89 25.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.341 1.457 . . . . 0.0 110.958 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.34 -42.11 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.21 0.914 . . . . 0.0 109.089 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 89.3 mmm -63.01 -40.55 98.11 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.399 -0.813 . . . . 0.0 110.625 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HB1' ' CD ' ' A' ' 58' ' ' GLU . . . -66.08 -52.88 44.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.495 1.118 . . . . 0.0 110.416 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.7 m -67.18 -40.94 86.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-O 117.696 -1.145 . . . . 0.0 110.278 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.9 m -59.36 -43.57 92.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.808 1.64 . . . . 0.0 108.839 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -64.3 -37.9 89.14 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.907 -1.121 . . . . 0.0 110.757 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -44.97 68.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.508 0.723 . . . . 0.0 110.668 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -32.27 31.37 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.835 2.454 . . . . 0.0 109.635 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -53.08 -23.26 7.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.081 1.353 . . . . 0.0 112.715 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.29 -12.62 1.69 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.921 1.289 . . . . 0.0 114.472 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.5 m -53.78 152.54 9.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.828 0.74 . . . . 0.0 110.851 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -81.26 32.27 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.101 3.201 . . . . 0.0 111.514 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.91 91.66 1.61 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 p -112.89 -36.22 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.533 0.733 . . . . 0.0 111.328 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 67.15 -36.91 0.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.67 2.788 . . . . 0.0 113.733 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -104.86 106.61 17.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.1 144.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -143.72 140.76 30.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.52 141.64 45.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -89.08 131.7 35.12 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -72.32 -48.5 41.61 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.275 0.63 . . . . 0.0 110.947 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -82.49 -9.88 59.24 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -135.15 159.6 41.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.696 1.589 . . . . 0.0 111.734 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 59.84 4.74 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -148.12 138.6 22.88 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 118.566 1.183 . . . . 0.0 110.594 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.55 155.6 48.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.428 1.891 . . . . 0.0 110.268 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.16 142.73 46.65 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 126.553 1.941 . . . . 0.0 107.514 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.32 131.29 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.87 105.39 8.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.31 -155.39 26.16 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.699 -0.626 . . . . 0.0 111.8 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 t -89.3 -6.53 56.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.997 1.319 . . . . 0.0 114.066 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.66 123.7 10.64 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.447 1.021 . . . . 0.0 112.766 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.69 153.8 95.42 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 125.694 1.598 . . . . 0.0 108.737 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 -46.47 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.297 1.998 . . . . 0.0 109.944 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -58.45 -28.09 64.99 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.118 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.55 -51.19 64.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.21 -40.64 86.45 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.457 0.703 . . . . 0.0 111.18 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.36 -51.79 59.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -66.04 -30.46 70.99 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.167 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.99 77.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.893 0.77 . . . . 0.0 110.309 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -88.39 -32.57 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.211 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.85 -30.56 71.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.197 0.999 . . . . 0.0 110.882 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.61 -19.55 64.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.296 0.953 . . . . 0.0 108.864 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.52 ' CD ' ' HB1' ' A' ' 17' ' ' ALA . 75.6 mm-40 -97.63 3.5 50.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.581 1.553 . . . . 0.0 109.605 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.85 86.53 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.778 2.132 . . . . 0.0 114.293 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -74.07 166.35 23.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.241 2.021 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -117.72 129.26 55.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 116.403 -1.76 . . . . 0.0 107.752 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.57 160.38 42.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 121.835 2.107 . . . . 0.0 114.355 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.25 163.68 39.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.64 2.376 . . . . 0.0 107.394 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.5 154.76 16.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.781 -1.199 . . . . 0.0 109.228 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 65' ' ' LEU . 1.6 tm? -119.42 108.14 14.2 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 C-N-CA 124.534 1.134 . . . . 0.0 110.952 -178.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.84 165.51 12.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.387 1.475 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 118.0 22.55 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.079 1.752 . . . . 0.0 106.39 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tt -137.4 147.58 45.54 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.275 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -123.81 139.69 53.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.826 1.194 . . . . 0.0 110.42 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.95 138.0 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 124.576 1.151 . . . . 0.0 110.253 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -152.25 110.54 3.72 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.359 1.076 . . . . 0.0 111.413 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.0 -48.33 1.25 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 124.665 1.126 . . . . 0.0 113.077 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 7.3 tpt -160.78 159.56 30.15 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.559 1.18 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -82.51 79.0 9.07 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -149.95 138.17 20.45 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -60.42 -37.86 82.23 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -57.85 -26.98 62.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.996 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -60.01 -36.11 76.53 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.439 1.018 . . . . 0.0 110.745 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.75 -51.38 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 59.1 mtt -65.15 -40.82 94.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.881 -0.512 . . . . 0.0 110.982 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.17 -51.28 68.45 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.415 1.086 . . . . 0.0 111.206 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.09 -37.86 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 117.972 -1.013 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 m -60.13 -50.65 72.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.924 1.238 . . . . 0.0 108.122 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -54.14 -43.13 70.27 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.133 0.973 . . . . 0.0 111.13 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.96 59.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.069 0.948 . . . . 0.0 110.088 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 mt -56.67 -34.38 67.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.223 1.409 . . . . 0.0 112.047 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -63.55 -6.08 4.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.725 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -22.61 61.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 120.314 1.416 . . . . 0.0 111.706 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.11 95.75 13.67 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.03 45.27 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.095 3.196 . . . . 0.0 112.618 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.93 17.46 5.18 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.725 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 -57.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 119.402 1.601 . . . . 0.0 107.401 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 70.02 -53.26 0.63 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.089 2.155 . . . . 0.0 113.158 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -95.87 103.32 15.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.454 1.025 . . . . 0.0 109.073 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.78 134.09 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.507 1.123 . . . . 0.0 108.965 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -142.76 142.11 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.5 t -134.48 143.3 38.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 125.249 1.42 . . . . 0.0 109.391 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.45 145.0 35.29 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.0 -47.33 46.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.084 -1.01 . . . . 0.0 112.289 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -77.42 -24.18 50.45 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -133.23 147.86 51.99 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 119.891 1.223 . . . . 0.0 108.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.64 25.11 1.44 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.426 -1.208 . . . . 0.0 113.763 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -90.28 143.55 26.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.433 2.116 . . . . 0.0 108.237 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.05 162.69 34.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.3 1.04 . . . . 0.0 112.193 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.2 140.97 52.39 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.033 2.133 . . . . 0.0 106.445 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.57 146.33 27.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.134 0.968 . . . . 0.0 108.666 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -139.01 120.21 14.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.84 170.36 21.76 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 p -75.73 6.53 4.8 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.81 133.71 47.71 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.254 -0.904 . . . . 0.0 111.438 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.0 142.48 79.55 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.188 0.995 . . . . 0.0 111.165 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.2 -43.07 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.866 2.377 . . . . 0.0 113.889 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -56.65 -40.7 75.93 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.652 0.781 . . . . 0.0 111.235 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.3 95.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.941 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.08 -50.55 70.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.839 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.48 -48.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.691 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -65.93 -31.92 73.13 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.639 1.109 . . . . 0.0 111.291 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.4 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.568 0.622 . . . . 0.0 109.933 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 m -74.57 -33.18 31.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -56.55 -26.08 53.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.044 1.738 . . . . 0.0 114.627 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.56 -29.17 67.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.377 0.99 . . . . 0.0 112.398 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.07 4.37 17.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.857 -0.527 . . . . 0.0 111.707 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.1 45.24 83.93 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -123.68 150.72 43.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.525 1.53 . . . . 0.0 108.314 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 153.91 36.67 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.266 0.555 . . . . 0.0 110.36 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -157.53 153.11 26.45 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -152.89 158.14 41.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.97 152.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 120.865 -1.147 . . . . 0.0 109.03 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -137.95 85.53 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 pp -146.71 165.83 28.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.454 0.701 . . . . 0.0 110.679 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -112.07 104.56 12.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.578 1.18 . . . . 0.0 111.353 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 tt -98.88 148.32 24.06 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.869 2.068 . . . . 0.0 108.343 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -129.35 140.31 51.42 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.791 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.55 142.34 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.68 122.86 18.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.199 1.8 . . . . 0.0 110.234 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.33 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.2 mtt -142.48 132.57 24.56 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 m -74.82 81.57 2.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.787 0.835 . . . . 0.0 110.308 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -151.54 173.7 14.3 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.162 1.785 . . . . 0.0 108.134 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -67.36 -31.26 71.39 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.826 0.851 . . . . 0.0 112.244 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -61.08 -31.66 71.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.389 0.995 . . . . 0.0 111.686 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.3 t -62.49 -50.57 70.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -52.4 -50.13 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.245 1.418 . . . . 0.0 108.587 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 65.6 mtp -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.051 0.541 . . . . 0.0 110.219 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.53 64.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 m -64.05 -48.6 85.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.092 0.86 . . . . 0.0 111.182 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -63.38 -41.64 98.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.416 1.007 . . . . 0.0 110.118 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -64.33 -30.65 71.69 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.938 -1.727 . . . . 0.0 110.261 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.68 -51.43 41.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.034 0.834 . . . . 0.0 109.456 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.54 -33.82 76.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.892 0.477 . . . . 0.0 110.715 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -61.74 -7.23 3.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.109 0.964 . . . . 0.0 111.888 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HE3' ' CB ' ' A' ' 54' ' ' ALA . 0.6 OUTLIER -57.86 -33.23 68.47 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.589 1.54 . . . . 0.0 109.687 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.0 158.35 41.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.59 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.017 2.478 . . . . 0.0 111.371 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.49 74.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 105.633 -2.987 . . . . 0.0 105.633 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.16 -34.89 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.27 0.628 . . . . 0.0 110.605 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -176.41 -78.64 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.973 2.509 . . . . 0.0 106.416 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -155.72 151.41 27.31 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.082 1.31 . . . . 0.0 110.984 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.8 135.91 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 125.914 1.686 . . . . 0.0 106.799 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -143.27 140.7 30.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.78 131.48 42.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.49 1.116 . . . . 0.0 109.009 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 p -106.14 117.9 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.629 0.728 . . . . 0.0 110.931 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -18.37 61.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.077 0.951 . . . . 0.0 113.457 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -78.38 -15.53 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 112.958 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -137.26 -15.82 1.44 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.09 12.83 83.77 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.4 1.0 . . . . 0.0 112.749 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -93.29 146.74 23.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.868 1.334 . . . . 0.0 108.421 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.83 114.78 16.96 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.962 2.105 . . . . 0.0 109.168 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.89 134.2 34.34 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.25 131.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.798 1.285 . . . . 0.0 112.006 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -123.92 145.48 49.1 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 127.226 2.211 . . . . 0.0 108.581 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.6 177.17 15.44 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 126.246 1.879 . . . . 0.0 111.742 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.3 p -66.21 5.14 0.57 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.482 2.313 . . . . 0.0 113.595 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.54 140.45 56.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.929 -1.107 . . . . 0.0 108.315 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.94 129.53 39.45 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -58.34 -31.2 93.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.752 1.635 . . . . 0.0 112.268 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -57.06 -46.49 82.42 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.814 1.188 . . . . 0.0 110.487 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.86 76.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.619 0.768 . . . . 0.0 110.753 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 118.886 -0.578 . . . . 0.0 111.389 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.13 -52.95 52.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -60.67 -33.64 73.13 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.545 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.471 ' CB ' ' HE3' ' A' ' 24' ' ' LYS . . . -60.49 -50.89 71.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.428 1.467 . . . . 0.0 110.082 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.84 -32.45 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.34 -44.61 71.27 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.033 1.333 . . . . 0.0 109.879 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.38 -23.44 66.32 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.784 0.834 . . . . 0.0 109.802 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.67 -14.67 62.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.801 1.24 . . . . 0.0 108.921 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.57 30.0 5.73 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 128.01 2.719 . . . . 0.0 115.518 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.49 175.33 9.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.207 2.003 . . . . 0.0 112.574 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -100.06 134.88 42.32 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.32 160.9 33.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -149.41 164.64 34.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.54 158.53 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 121.582 -0.699 . . . . 0.0 111.065 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 tp -162.39 166.91 24.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.57 2.748 . . . . 0.0 106.045 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 178.352 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.94 166.45 14.41 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.571 0.748 . . . . 0.0 110.537 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -130.07 128.45 41.94 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.94 122.04 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -93.21 133.95 35.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.409 HG11 ' CG2' ' A' ' 18' ' ' VAL . 79.6 t -132.22 113.0 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -134.0 166.12 23.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.303 0.573 . . . . 0.0 109.833 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.0 170.63 43.39 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -83.68 0.6 46.34 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.047 -0.678 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 t -77.58 177.61 7.93 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.089 0.956 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -83.43 -164.68 0.94 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.421 1.888 . . . . 0.0 112.235 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.24 -2.15 0.91 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.287 1.835 . . . . 0.0 113.294 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -62.11 -13.63 28.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.531 -1.356 . . . . 0.0 111.904 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.03 -38.91 80.39 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 117.04 -1.457 . . . . 0.0 113.224 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.59 -52.06 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 120.571 1.532 . . . . 0.0 110.6 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.7 ttp -67.88 -47.03 69.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.163 -0.335 . . . . 0.0 111.326 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.71 63.64 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.478 0.711 . . . . 0.0 111.681 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.409 ' CG2' HG11 ' A' ' 6' ' ' VAL . 79.1 t -62.2 -39.89 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.0 m -61.7 -43.88 98.0 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.218 1.372 . . . . 0.0 109.329 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -56.31 -51.36 68.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.361 0.982 . . . . 0.0 109.091 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.47 69.76 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.89 0.744 . . . . 0.0 111.259 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.8 -30.51 70.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.221 1.408 . . . . 0.0 112.442 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -79.53 -4.28 50.67 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.86 -1.15 . . . . 0.0 112.02 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -36.99 85.79 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.33 1.423 . . . . 0.0 111.455 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.9 148.15 84.01 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.115 0.87 . . . . 0.0 109.4 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.02 -48.57 3.54 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.099 1.866 . . . . 0.0 112.916 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.55 69.92 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.4 -10.48 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.884 0.874 . . . . 0.0 111.938 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.14 163.87 28.26 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.837 -1.165 . . . . 0.0 112.327 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -103.62 134.69 46.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.76 144.18 37.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -144.24 143.13 30.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.251 1.02 . . . . 0.0 111.283 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.5 134.23 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 109.59 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.3 t -72.2 143.17 48.96 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 110.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.4 -28.84 62.22 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.367 -0.833 . . . . 0.0 110.534 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -81.67 -27.59 33.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.184 2.194 . . . . 0.0 115.621 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -145.87 160.22 42.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.698 0.799 . . . . 0.0 109.248 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.94 33.88 2.38 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.858 0.742 . . . . 0.0 111.871 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -90.73 125.67 35.76 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 125.014 1.326 . . . . 0.0 107.964 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.38 120.1 37.76 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.791 1.236 . . . . 0.0 109.559 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.13 134.77 34.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.29 132.39 66.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -136.13 105.5 6.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.673 1.189 . . . . 0.0 111.275 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.2 -148.08 11.78 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -121.3 7.87 10.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.844 1.258 . . . . 0.0 111.825 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.31 138.47 57.65 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.511 -0.743 . . . . 0.0 109.075 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -71.28 148.29 93.62 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.596 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.67 -44.56 10.52 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.591 1.527 . . . . 0.0 110.309 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -55.95 -29.65 60.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -48.44 48.58 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.385 0.993 . . . . 0.0 108.953 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.59 -47.75 68.84 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.258 1.023 . . . . 0.0 110.502 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.28 -52.07 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -60.2 -43.31 96.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 116.533 -1.698 . . . . 0.0 110.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.88 -46.56 67.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.59 1.086 . . . . 0.0 111.465 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 m -73.05 -32.4 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 O-C-N 121.43 -0.794 . . . . 0.0 111.13 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -68.32 -20.34 64.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.596 1.558 . . . . 0.0 112.544 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -63.49 -11.64 25.43 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.6 5.21 11.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.14 64.09 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 116.387 1.315 . . . . 0.0 116.387 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -74.32 175.96 7.15 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.655 1.728 . . . . 0.0 108.225 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -103.45 124.18 48.25 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.29 120.27 36.48 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.233 1.013 . . . . 0.0 110.183 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -135.64 106.93 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.631 0.772 . . . . 0.0 111.033 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.59 156.48 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.612 -0.68 . . . . 0.0 110.185 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.21 90.9 3.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.301 -1.333 . . . . 0.0 109.659 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 13.0 ptp . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.442 HD13 ' H ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -147.56 166.57 26.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.32 1.848 . . . . 0.0 109.139 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' H ' HD13 ' A' ' 2' ' ' LEU . 5.0 ptpt -122.81 115.19 21.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.655 1.582 . . . . 0.0 107.639 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.38 148.7 43.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.316 1.046 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -124.05 138.57 54.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.63 143.49 40.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.243 1.417 . . . . 0.0 107.776 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -151.38 161.55 42.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.31 -36.86 0.1 Allowed Glycine 0 CA--C 1.521 0.409 0 O-C-N 120.959 -1.088 . . . . 0.0 113.191 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.7 mmt -147.57 3.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.832 1.316 . . . . 0.0 114.201 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.0 p 57.43 5.57 0.31 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 m -73.07 147.58 44.85 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 120.354 -1.466 . . . . 0.0 111.941 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -63.18 -23.56 67.49 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.875 0.369 . . . . 0.0 111.978 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -81.08 -4.45 55.29 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.966 -1.084 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 p -57.0 -28.27 62.29 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.08 1.309 . . . . 0.0 111.822 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -54.28 -35.72 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.222 1.409 . . . . 0.0 111.093 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.59 -50.06 70.94 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.95 67.79 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.08 -49.17 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.967 0.803 . . . . 0.0 110.464 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -54.76 -53.94 48.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.413 1.006 . . . . 0.0 110.002 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -65.19 -33.15 75.33 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.796 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.19 -44.92 74.77 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.256 1.389 . . . . 0.0 108.936 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.68 -30.25 71.26 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.92 0.888 . . . . 0.0 109.137 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -70.44 -14.28 62.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -53.7 -46.52 70.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.646 1.566 . . . . 0.0 110.108 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.13 122.82 84.77 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.07 158.1 42.11 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.662 1.575 . . . . 0.0 109.42 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.31 -70.13 0.21 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-O 117.922 -1.488 . . . . 0.0 116.216 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.07 -57.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.181 1.491 . . . . 0.0 112.555 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 54.86 -26.6 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -96.28 104.63 16.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.026 1.731 . . . . 0.0 110.593 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.26 119.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -110.7 116.88 32.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.8 125.47 54.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.521 1.128 . . . . 0.0 110.405 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.7 t -71.9 132.9 45.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.775 0.798 . . . . 0.0 108.903 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.68 -38.61 64.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.381 1.072 . . . . 0.0 110.604 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -78.52 -46.33 19.8 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -107.81 171.37 7.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.09 0.556 . . . . 0.0 110.432 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.19 15.99 56.87 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.925 -0.931 . . . . 0.0 111.753 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.67 135.45 33.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 118.874 1.337 . . . . 0.0 110.189 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.73 114.7 17.64 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.997 2.119 . . . . 0.0 107.728 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -77.62 145.46 36.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.9 p -129.48 138.19 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -117.55 104.56 11.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.64 -166.51 37.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.698 2.094 . . . . 0.0 108.524 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -117.47 -2.18 11.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.11 1.764 . . . . 0.0 113.727 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.27 131.65 28.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.453 1.024 . . . . 0.0 112.014 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.56 126.74 31.11 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 126.527 1.931 . . . . 0.0 110.589 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.0 -33.49 98.8 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.491 1.46 . . . . 0.0 112.782 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -61.34 -30.34 70.46 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.134 1.334 . . . . 0.0 111.33 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.93 -44.8 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.48 0.712 . . . . 0.0 110.245 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.74 -53.96 38.96 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.6 t -54.37 -43.49 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.05 -42.32 89.68 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.073 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.69 -41.37 66.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -80.82 -33.66 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.971 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -69.39 -20.92 63.81 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.361 1.464 . . . . 0.0 111.898 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.86 -32.25 71.78 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.945 1.298 . . . . 0.0 108.911 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -75.94 -19.12 59.02 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.21 56.61 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.239 1.876 . . . . 0.0 112.313 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.5 155.66 33.6 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -88.27 150.23 23.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.963 -1.086 . . . . 0.0 109.146 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.75 158.12 43.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -145.7 150.38 36.18 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.675 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.4 147.58 22.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 121.259 -0.9 . . . . 0.0 109.86 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -146.88 170.73 16.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.182 1.793 . . . . 0.0 109.211 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.12 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.564 ' H1 ' ' CD ' ' A' ' 43' ' ' GLU . 18.0 ptt? . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.2 165.53 13.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.36 148.79 49.53 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.08 145.7 44.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -99.41 132.93 44.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.855 1.262 . . . . 0.0 107.678 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.8 t -126.76 102.11 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -119.74 168.39 11.12 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.112 0.869 . . . . 0.0 112.112 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.16 12.65 0.04 OUTLIER Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.134 2.302 . . . . 0.0 112.326 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.4 ttt 65.35 90.74 0.09 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.925 2.09 . . . . 0.0 109.608 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 m 57.11 80.49 0.16 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.145 1.778 . . . . 0.0 112.075 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 69.0 m -55.27 127.63 30.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.718 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -71.25 -175.82 1.31 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.676 1.19 . . . . 0.0 108.694 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -48.7 -23.14 0.93 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.594 1.558 . . . . 0.0 113.357 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 t -53.96 -28.26 36.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.071 1.348 . . . . 0.0 110.217 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.15 -36.22 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 119.041 0.837 . . . . 0.0 109.966 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.3 ttm -66.86 -43.31 83.94 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.808 -1.182 . . . . 0.0 109.703 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.95 -52.64 64.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.668 0.787 . . . . 0.0 110.037 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.33 -41.79 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -60.89 -48.7 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.915 -1.116 . . . . 0.0 110.083 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -64.22 -37.52 87.75 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 121.731 -0.606 . . . . 0.0 111.68 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.11 -47.53 67.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.346 1.058 . . . . 0.0 109.597 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.5 mt -57.48 -37.65 73.25 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.568 0.747 . . . . 0.0 109.181 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -68.91 -13.07 62.2 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.16 -0.963 . . . . 0.0 112.913 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -73.48 -21.08 60.52 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.538 1.517 . . . . 0.0 112.114 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.8 m -52.31 142.06 30.27 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.65 94.04 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.173 3.249 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.16 -74.02 0.37 Allowed Glycine 0 C--N 1.332 0.353 0 O-C-N 121.411 -0.805 . . . . 0.0 112.646 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.6 t -54.64 -58.9 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 117.253 0.527 . . . . 0.0 111.341 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 43.45 19.89 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -150.84 106.32 3.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.132 1.773 . . . . 0.0 109.335 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.0 138.91 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -141.35 118.36 11.22 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -110.79 142.93 21.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 t -90.67 146.34 24.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.81 -49.35 30.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.14 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -81.62 -57.94 3.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.799 0.439 . . . . 0.0 112.103 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.85 152.32 41.57 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.12 53.28 1.87 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -123.57 133.84 53.91 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.647 1.224 . . . . 0.0 110.863 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.97 115.04 19.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.256 2.622 . . . . 0.0 108.764 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.35 135.17 34.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.38 133.99 57.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.305 1.042 . . . . 0.0 109.888 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.564 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 16.0 tp10 -123.33 103.64 8.63 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.07 -170.22 41.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.661 1.124 . . . . 0.0 111.995 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -111.85 14.86 21.01 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.728 2.811 . . . . 0.0 115.585 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 142.06 57.63 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 120.302 -1.499 . . . . 0.0 109.496 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.01 151.1 81.5 Favored Pre-proline 0 C--O 1.237 0.429 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.301 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -55.32 -47.3 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.607 2.205 . . . . 0.0 111.519 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -55.1 -38.76 68.55 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.55 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.67 80.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.829 0.74 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.5 mt -68.21 -47.7 67.18 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.941 -0.474 . . . . 0.0 110.352 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.5 t -55.66 -56.37 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 124.413 1.085 . . . . 0.0 108.722 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -57.34 -50.22 73.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 117.589 -1.196 . . . . 0.0 110.036 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.11 64.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.303 0.956 . . . . 0.0 111.697 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -76.38 -43.18 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.087 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.7 -23.28 64.74 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.079 1.752 . . . . 0.0 110.914 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -62.46 -23.51 66.93 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.089 1.356 . . . . 0.0 110.532 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.29 39.5 mt-10 -104.36 16.43 26.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.836 0.854 . . . . 0.0 111.436 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.96 1.77 49.4 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 127.216 2.341 . . . . 0.0 116.129 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -74.92 151.24 38.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.137 1.469 . . . . 0.0 109.388 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -75.05 105.07 5.89 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.87 120.11 39.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.514 1.125 . . . . 0.0 109.125 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -141.58 114.05 8.27 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.82 167.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 pp -119.38 -173.09 2.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 108.597 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.685 1.594 . . . . 0.0 107.402 179.361 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtm . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.6 mt -132.14 166.06 22.64 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.336 1.454 . . . . 0.0 107.202 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -124.72 107.73 11.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.503 0.721 . . . . 0.0 111.063 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.01 137.65 36.06 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.383 -1.448 . . . . 0.0 108.028 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -109.17 137.72 46.63 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.7 143.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.554 1.07 . . . . 0.0 109.792 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -147.52 156.98 43.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.605 0.717 . . . . 0.0 109.748 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.01 -28.17 2.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.3 -1.278 . . . . 0.0 111.298 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 35.4 tpp -147.99 152.98 38.39 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.023 1.411 . . . . 0.0 110.339 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -141.46 78.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.9 m -150.42 150.39 31.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.967 2.107 . . . . 0.0 108.122 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -53.37 -31.84 46.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.661 1.985 . . . . 0.0 114.481 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -63.85 -22.31 66.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.328 -0.857 . . . . 0.0 112.356 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.2 t -52.83 -52.55 56.62 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.405 1.082 . . . . 0.0 108.242 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.1 t -52.56 -51.18 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.571 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -57.12 -49.96 74.28 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.79 0.836 . . . . 0.0 110.937 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.49 -38.54 90.05 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.199 0.999 . . . . 0.0 111.963 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.68 -54.75 30.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 108.987 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -65.61 -32.41 73.97 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.811 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -62.43 -42.59 99.56 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.565 -1.334 . . . . 0.0 111.106 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.52 -48.55 26.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.305 0.957 . . . . 0.0 111.97 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.43 -41.56 89.88 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.107 0.963 . . . . 0.0 113.33 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -49.8 -28.47 6.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -57.57 -27.1 62.38 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.48 1.036 . . . . 0.0 111.031 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.03 104.45 14.96 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 125.579 1.552 . . . . 0.0 108.527 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 168.84 23.77 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.452 1.435 . . . . 0.0 109.305 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.8 16.27 61.82 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 122.31 -0.244 . . . . 0.0 113.417 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.45 -58.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 39.45 2.84 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 131.37 3.868 . . . . 0.0 119.21 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -143.69 102.94 4.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.175 1.39 . . . . 0.0 107.59 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.32 142.41 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.98 116.96 11.64 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 t -90.72 143.16 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -89.52 132.99 34.79 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.84 -48.78 34.83 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.05 -0.5 . . . . 0.0 112.197 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -83.03 -12.68 56.99 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.024 1.33 . . . . 0.0 114.052 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HE3' ' OE1' ' A' ' 39' ' ' GLU . 21.2 mtpp -126.64 151.69 47.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.598 -0.689 . . . . 0.0 111.601 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.61 78.15 2.0 Allowed Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.441 ' OE1' ' HE3' ' A' ' 37' ' ' LYS . 8.6 pt-20 -165.9 158.39 14.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.353 0.661 . . . . 0.0 110.588 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.78 125.87 12.9 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.027 0.931 . . . . 0.0 109.554 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.7 mt -74.55 142.67 44.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.68 131.23 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 110.83 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -123.02 151.22 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.17 -157.47 15.01 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.83 29.62 7.82 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.905 1.282 . . . . 0.0 114.315 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.79 123.9 26.4 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.46 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.15 152.89 83.25 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.783 1.633 . . . . 0.0 112.127 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.56 -57.37 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.518 2.812 . . . . 0.0 113.565 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -56.65 -40.88 76.23 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 117.934 0.334 . . . . 0.0 110.549 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.5 88.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -54.69 35.25 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.233 0.613 . . . . 0.0 111.271 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.4 m -59.98 -35.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.037 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -71.42 -37.83 71.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.37 -0.831 . . . . 0.0 110.409 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.12 97.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.198 0.908 . . . . 0.0 109.281 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.32 -32.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.788 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.95 -23.39 45.14 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.56 1.144 . . . . 0.0 112.388 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.61 -29.06 69.8 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.953 0.797 . . . . 0.0 110.158 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -86.81 -13.71 44.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.471 1.508 . . . . 0.0 111.323 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.16 66.45 1.61 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.176 1.369 . . . . 0.0 115.365 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -139.83 170.14 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 108.479 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -106.54 105.09 14.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.635 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.1 149.62 35.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 119.09 0.859 . . . . 0.0 110.161 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -149.31 165.98 30.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.551 1.94 . . . . 0.0 108.502 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.1 154.56 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 121.348 -0.845 . . . . 0.0 111.212 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.7 tp -76.0 106.82 7.8 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.201 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.157 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.1 mt -116.69 151.15 36.95 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.633 1.173 . . . . 0.0 108.199 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -122.24 142.19 50.71 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.225 1.01 . . . . 0.0 110.797 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.0 tp -136.99 121.68 18.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.635 1.974 . . . . 0.0 110.278 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -87.95 137.9 31.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -126.94 91.01 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.614 1.566 . . . . 0.0 107.516 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.76 146.92 35.58 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.27 -165.16 25.21 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.1 ttt -95.92 -85.15 0.33 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.225 0.61 . . . . 0.0 109.446 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 12' ' ' ASN . 4.2 m -68.78 150.08 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.785 -0.572 . . . . 0.0 110.015 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.9 t -129.32 5.41 5.24 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.455 1.502 . . . . 0.0 111.094 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.494 ' H ' HG22 ' A' ' 10' ' ' THR . 29.1 m120 -86.49 -100.69 0.07 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.581 -1.324 . . . . 0.0 109.148 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -64.01 -11.19 26.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.92 -1.113 . . . . 0.0 112.908 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -28.56 69.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.809 1.244 . . . . 0.0 110.827 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -54.59 -35.47 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.088 0.858 . . . . 0.0 110.692 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.76 -45.65 77.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.701 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -52.43 65.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.22 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -58.91 -47.69 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.507 1.049 . . . . 0.0 110.866 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.5 p -63.43 -40.96 98.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -75.37 -40.89 57.6 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.608 0.763 . . . . 0.0 111.922 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.22 84.69 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.754 0.822 . . . . 0.0 110.191 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.0 mt -56.55 -28.24 59.59 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.9 0.48 . . . . 0.0 110.248 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -59.47 -11.9 5.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.047 0.939 . . . . 0.0 112.986 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -55.12 -16.36 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.289 1.404 . . . . 0.0 112.398 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.86 92.27 20.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.69 -4.34 15.09 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.016 2.477 . . . . 0.0 114.771 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.79 2.48 54.48 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 116.841 1.497 . . . . 0.0 116.841 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.549 HG21 ' CG1' ' A' ' 42' ' ' VAL . 5.9 p -113.9 -48.02 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 119.579 1.689 . . . . 0.0 112.164 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 59.43 -2.97 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.44 103.35 8.88 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.465 1.484 . . . . 0.0 107.198 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.0 m -141.27 138.29 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.279 1.032 . . . . 0.0 109.666 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.79 143.12 40.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.171 1.788 . . . . 0.0 108.284 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.6 t -136.88 143.24 35.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.101 1.76 . . . . 0.0 107.46 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.1 t -76.81 138.52 39.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.31 -36.04 66.18 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -81.59 -57.94 3.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.343 1.057 . . . . 0.0 112.198 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.54 177.29 6.4 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.963 1.305 . . . . 0.0 112.49 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.58 17.27 56.86 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -90.52 143.38 26.8 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.195 1.497 . . . . 0.0 108.302 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.43 163.13 33.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.942 1.297 . . . . 0.0 110.588 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.24 144.42 30.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.897 1.279 . . . . 0.0 110.211 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.549 ' CG1' HG21 ' A' ' 28' ' ' VAL . 79.9 t -130.42 143.25 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.551 1.94 . . . . 0.0 108.12 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -130.1 105.31 7.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.216 1.006 . . . . 0.0 109.951 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA3' HG23 ' A' ' 28' ' ' VAL . . . 167.09 -161.09 34.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.574 1.559 . . . . 0.0 110.225 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 p -96.15 0.54 51.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.735 1.268 . . . . 0.0 114.362 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.71 131.86 30.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.658 1.117 . . . . 0.0 111.019 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.36 142.44 98.35 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.35 -48.55 21.41 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.224 1.949 . . . . 0.0 112.348 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -62.02 -23.17 66.28 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.761 -1.114 . . . . 0.0 112.936 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.61 85.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.802 1.183 . . . . 0.0 108.348 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.65 -48.63 59.15 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.809 0.693 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.0 t -54.19 -59.41 2.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.969 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.1 -38.59 83.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.868 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.52 -44.69 69.36 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 117.156 -1.402 . . . . 0.0 110.22 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.25 -32.32 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.857 1.208 . . . . 0.0 112.041 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.79 -44.76 82.23 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.843 1.257 . . . . 0.0 108.844 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.37 -26.42 66.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.53 1.132 . . . . 0.0 111.422 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -69.99 -36.86 75.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.478 1.035 . . . . 0.0 108.65 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.37 30.59 1.16 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.567 1.556 . . . . 0.0 112.338 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -120.14 172.21 7.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.305 1.552 . . . . 0.0 109.255 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.93 99.63 6.48 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.331 0.969 . . . . 0.0 113.186 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.24 160.84 15.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.488 1.115 . . . . 0.0 112.161 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -154.46 130.13 9.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.876 1.27 . . . . 0.0 107.991 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.52 156.55 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.34 166.81 17.13 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.87 2.068 . . . . 0.0 106.901 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 125.065 1.346 . . . . 0.0 109.394 -179.383 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttm . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.03 166.46 10.82 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -130.41 146.53 51.99 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.884 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.3 tp -136.77 110.92 8.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -81.74 119.94 24.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.99 138.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -136.78 174.02 11.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 -102.2 0.96 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 34.1 tpp -113.48 114.56 26.71 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.571 1.186 . . . . 0.0 112.364 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.47 105.01 17.0 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.407 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 48.9 t -138.87 157.16 46.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 110.044 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.74 -28.95 67.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 110.618 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.88 -26.33 21.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.5 0.72 . . . . 0.0 111.071 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 79.5 m -61.49 -43.07 99.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.811 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.0 -33.39 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.773 1.17 . . . . 0.0 111.037 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.64 -45.44 75.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.27 65.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.364 0.665 . . . . 0.0 109.985 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -57.26 -49.54 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 124.634 1.174 . . . . 0.0 109.851 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -58.03 -53.56 56.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.159 0.891 . . . . 0.0 110.386 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -59.44 -47.32 85.94 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.461 -0.774 . . . . 0.0 112.152 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.46 92.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.99 0.916 . . . . 0.0 111.95 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.2 mt -64.66 -36.15 83.34 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.702 -1.249 . . . . 0.0 109.861 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.3 -19.07 64.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.953 0.901 . . . . 0.0 113.103 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -56.84 -36.18 69.7 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.113 1.524 . . . . 0.0 115.113 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.95 121.3 81.97 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 112.552 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.4 121.56 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.88 -14.96 2.4 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.273 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.38 -57.27 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 118.966 1.383 . . . . 0.0 108.809 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 63.36 -30.8 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.177 2.191 . . . . 0.0 115.25 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 122.94 35.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.8 2.091 . . . . 0.0 112.432 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 42' ' ' VAL . 22.8 m -141.25 144.43 26.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.16 1.384 . . . . 0.0 107.454 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -124.0 118.67 27.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.52 115.94 49.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.134 0.974 . . . . 0.0 108.404 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -93.02 118.11 30.81 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.61 -45.11 91.8 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.214 0.461 . . . . 0.0 111.205 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -55.46 -58.09 9.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 111.496 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -70.85 -49.94 40.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.234 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.88 2.56 52.28 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.68 1.61 . . . . 0.0 109.64 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.47 151.67 20.68 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.303 1.441 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.81 114.23 17.65 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.173 1.389 . . . . 0.0 109.776 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.62 113.47 20.34 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 31' ' ' VAL . 25.0 m -109.99 132.29 58.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 118.266 0.485 . . . . 0.0 110.65 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.26 105.56 14.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.84 158.52 11.36 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.42 -12.11 54.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.619 1.568 . . . . 0.0 112.773 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.55 155.24 2.25 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.57 136.4 85.96 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 125.432 1.493 . . . . 0.0 111.387 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.15 -25.3 37.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.441 2.094 . . . . 0.0 112.632 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -35.04 65.45 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.088 0.858 . . . . 0.0 110.725 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.47 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.96 -45.64 63.75 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.13 -47.36 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -62.2 -49.12 77.05 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.446 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.56 63.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.759 1.163 . . . . 0.0 113.164 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.4 t -81.49 -38.3 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.57 -36.0 82.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.26 -14.81 8.02 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.945 2.098 . . . . 0.0 112.36 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -115.67 -1.37 12.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.853 1.261 . . . . 0.0 111.275 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.97 42.22 9.0 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.382 0.992 . . . . 0.0 113.99 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -132.16 160.98 34.49 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.409 1.105 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -90.95 145.54 24.64 Favored 'General case' 0 CA--C 1.522 -0.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.1 143.43 47.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.866 1.266 . . . . 0.0 109.617 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -140.3 121.61 14.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 108.642 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -89.57 130.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.775 1.63 . . . . 0.0 109.993 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -133.92 126.42 30.34 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.83 1.652 . . . . 0.0 107.457 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.873 1.669 . . . . 0.0 110.092 178.867 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mmt . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.872 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.92 165.17 17.87 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.299 1.863 . . . . 0.0 110.974 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -142.55 147.66 36.29 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.49 1.916 . . . . 0.0 107.64 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.02 148.92 45.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.804 2.442 . . . . 0.0 108.547 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -97.03 138.55 34.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -122.11 128.39 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.229 2.212 . . . . 0.0 107.365 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -132.67 142.68 49.2 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.58 -179.9 24.88 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 125.371 1.462 . . . . 0.0 109.77 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.02 -46.33 88.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -173.14 -177.79 1.63 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.33 1.852 . . . . 0.0 107.421 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -72.97 139.19 46.54 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -152.53 170.23 20.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.898 1.279 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -57.37 -25.41 59.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.102 0.961 . . . . 0.0 109.464 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -27.57 17.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.321 2.249 . . . . 0.0 112.388 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.9 t -52.24 -46.03 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 120.353 1.433 . . . . 0.0 109.063 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -66.14 -43.4 87.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.272 -0.893 . . . . 0.0 108.648 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.43 67.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.735 0.814 . . . . 0.0 110.721 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.68 -35.4 75.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.4 m -57.53 -54.57 45.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.651 1.569 . . . . 0.0 109.439 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -64.13 -32.18 73.65 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -41.53 79.82 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.387 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.5 mt -57.11 -46.23 82.79 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -61.34 -4.33 1.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -57.99 -36.47 72.67 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 121.692 2.042 . . . . 0.0 114.413 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.07 119.78 29.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.217 1.007 . . . . 0.0 110.984 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.34 -21.99 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 113.46 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.41 4.04 66.55 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 117.696 -1.614 . . . . 0.0 115.381 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -113.43 -59.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.259 2.029 . . . . 0.0 109.288 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 57.77 0.82 0.12 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.161 2.584 . . . . 0.0 116.071 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.68 104.08 4.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.706 1.594 . . . . 0.0 110.772 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.18 140.06 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.122 0.969 . . . . 0.0 108.81 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -144.08 144.09 31.45 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.795 1.238 . . . . 0.0 108.958 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -124.58 143.81 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.569 1.947 . . . . 0.0 108.379 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 m -103.88 118.03 35.74 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.46 -30.09 69.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.033 1.288 . . . . 0.0 111.558 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.429 1.492 . . . . 0.0 110.313 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -83.24 -23.3 32.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.17 9.13 87.34 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 118.878 0.763 . . . . 0.0 112.113 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.6 160.79 14.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.187 1.994 . . . . 0.0 109.207 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.01 115.63 9.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.278 1.031 . . . . 0.0 109.762 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -91.07 140.13 30.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.465 1.106 . . . . 0.0 108.3 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.78 141.95 42.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 108.431 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -130.38 104.2 7.12 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.14 -176.97 40.76 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.855 1.693 . . . . 0.0 109.546 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 p -98.4 10.51 40.63 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.3 142.8 42.06 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.827 1.649 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.84 152.51 91.14 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.016 0.926 . . . . 0.0 109.972 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.84 -47.95 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.036 1.824 . . . . 0.0 110.421 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -38.78 72.83 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.485 0.314 . . . . 0.0 111.418 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.58 -53.87 44.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.962 0.905 . . . . 0.0 109.887 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.35 -52.89 62.9 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.531 0.732 . . . . 0.0 111.431 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.33 -57.84 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.833 0.853 . . . . 0.0 110.567 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -64.4 -35.88 82.35 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 119.005 0.82 . . . . 0.0 110.59 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.56 78.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.699 1.136 . . . . 0.0 110.337 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -77.97 -35.2 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.269 0.94 . . . . 0.0 109.535 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -61.61 -27.29 68.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.629 0.771 . . . . 0.0 110.955 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.99 -11.79 32.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.305 1.442 . . . . 0.0 111.562 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -109.49 -2.61 17.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.831 1.653 . . . . 0.0 111.125 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.55 -8.1 77.17 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.621 1.581 . . . . 0.0 113.768 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -78.98 157.91 28.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.756 1.278 . . . . 0.0 108.311 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -109.88 99.92 8.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.45 150.9 22.91 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.021 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -154.75 124.83 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 m -60.24 155.0 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.333 0.97 . . . . 0.0 109.928 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -56.9 132.15 51.73 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.884 1.273 . . . . 0.0 108.456 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.608 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.36 165.95 12.4 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.459 1.504 . . . . 0.0 107.799 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -150.4 104.05 3.2 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.413 -0.804 . . . . 0.0 108.848 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tp -79.17 147.9 32.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.817 0.847 . . . . 0.0 108.776 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -128.36 106.97 9.37 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.183 0.993 . . . . 0.0 109.497 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 t -74.95 153.07 6.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 126.13 1.772 . . . . 0.0 110.025 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -152.53 162.1 41.67 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 122.215 1.007 . . . . 0.0 111.855 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.27 -68.22 0.7 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 126.984 2.23 . . . . 0.0 113.416 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 mmt -84.37 162.78 19.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.899 0.85 . . . . 0.0 112.556 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -140.16 36.26 1.91 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.286 2.634 . . . . 0.0 106.772 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.97 179.46 2.72 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 119.949 -1.719 . . . . 0.0 109.504 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.94 -61.15 1.75 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.361 0.665 . . . . 0.0 110.008 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -56.72 -16.64 6.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.937 1.295 . . . . 0.0 114.05 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 p -59.58 -28.56 67.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.04 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.37 -46.49 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.529 1.513 . . . . 0.0 110.758 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.5 mtt -64.29 -49.81 70.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.334 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.42 -52.25 66.42 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.808 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.58 -52.02 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.305 1.442 . . . . 0.0 111.229 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 t -54.67 -43.97 72.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.184 1.357 . . . . 0.0 108.778 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -64.18 -50.69 67.13 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.626 -0.671 . . . . 0.0 111.342 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.06 -45.43 79.3 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.507 1.523 . . . . 0.0 112.117 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.15 -38.06 81.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.037 0.935 . . . . 0.0 110.425 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.28 -10.55 59.7 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -46.73 -57.33 4.95 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 m -66.52 118.65 56.03 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.562 1.528 . . . . 0.0 111.734 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.55 88.79 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.706 2.271 . . . . 0.0 108.522 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.69 -33.69 0.02 OUTLIER Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.452 -0.78 . . . . 0.0 111.419 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.29 -50.2 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 117.474 0.637 . . . . 0.0 109.504 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 67.58 -46.61 0.5 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.312 2.245 . . . . 0.0 112.64 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -101.45 109.85 21.75 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.523 1.51 . . . . 0.0 112.698 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.62 130.43 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -130.73 137.55 49.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.093 1.357 . . . . 0.0 107.465 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.75 138.04 44.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 119.301 0.955 . . . . 0.0 110.017 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.7 t -113.12 118.55 35.05 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.63 -24.33 66.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.406 0.682 . . . . 0.0 111.853 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.75 -13.75 61.39 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.746 1.618 . . . . 0.0 111.684 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -135.54 -15.74 1.85 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.79 18.46 72.35 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -100.19 145.5 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.49 114.56 9.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 122.9 0.48 . . . . 0.0 111.572 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.9 mp -77.55 144.42 37.61 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.965 1.706 . . . . 0.0 107.715 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.33 121.64 23.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.788 0.835 . . . . 0.0 109.298 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.05 104.99 9.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.46 177.51 21.14 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.697 1.618 . . . . 0.0 109.847 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -70.97 26.19 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.541 1.536 . . . . 0.0 113.991 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 106.11 1.19 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 142.07 98.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 123.323 0.649 . . . . 0.0 112.11 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.21 -48.14 12.75 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.457 2.105 . . . . 0.0 112.224 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -56.21 -37.26 69.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.468 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.64 63.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.309 0.644 . . . . 0.0 109.749 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -61.96 -50.07 73.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.289 1.035 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.59 -49.72 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -65.65 -42.01 91.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.836 0.744 . . . . 0.0 111.478 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.06 -31.23 70.89 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.656 1.182 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 62' ' ' ALA . 95.8 t -88.35 -41.75 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 118.656 0.662 . . . . 0.0 109.931 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.59 -42.35 82.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.839 0.856 . . . . 0.0 110.96 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.78 -12.74 50.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.785 -0.626 . . . . 0.0 112.03 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -97.83 -10.11 25.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 120.015 1.279 . . . . 0.0 113.338 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.23 9.27 60.68 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.238 -1.312 . . . . 0.0 114.576 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.69 145.64 30.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -88.2 152.14 22.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -149.21 147.37 28.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.561 0.618 . . . . 0.0 109.647 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -134.67 153.48 51.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.242 1.017 . . . . 0.0 108.263 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.18 173.97 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.99 85.5 3.51 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.6 mt -119.91 160.74 22.11 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.34 139.94 53.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.629 0.772 . . . . 0.0 110.109 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -122.29 111.54 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -88.95 127.15 35.65 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.22 141.54 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -141.45 98.57 3.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.33 -162.6 28.38 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.576 2.036 . . . . 0.0 109.761 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.2 ttt -124.47 8.08 8.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.175 1.79 . . . . 0.0 108.04 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.15 174.28 9.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 128.116 2.566 . . . . 0.0 107.465 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -140.0 -77.25 0.32 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -55.13 -28.6 53.87 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -93.1 -34.87 13.49 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 109.55 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 t -54.79 -54.3 43.89 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.929 1.292 . . . . 0.0 110.429 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.0 p -52.01 -38.29 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.128 0.971 . . . . 0.0 112.393 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.4 mmm -62.38 -49.8 74.08 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 110.088 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.82 -38.72 83.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.216 0.606 . . . . 0.0 110.185 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.23 -44.85 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.8 m -64.71 -40.02 94.64 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.904 1.229 . . . . 0.0 109.088 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -55.66 -49.76 72.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.109 0.964 . . . . 0.0 109.614 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.48 59.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.114 1.366 . . . . 0.0 110.246 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.6 mt -58.81 -28.11 65.7 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 124.355 1.062 . . . . 0.0 112.47 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -68.86 -21.01 64.29 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.098 -1.001 . . . . 0.0 111.63 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.21 -15.46 63.19 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.8 m -51.94 160.93 1.02 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.319 1.848 . . . . 0.0 113.313 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.65 -71.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.872 2.381 . . . . 0.0 111.757 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -156.75 51.95 0.42 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.709 0.671 . . . . 0.0 112.157 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.31 -36.48 74.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 118.01 0.905 . . . . 0.0 111.183 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.286 4.1 pt-20 58.38 -11.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.278 2.631 . . . . 0.0 116.362 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -135.18 104.07 5.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.076 2.15 . . . . 0.0 107.762 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -141.91 120.24 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -124.4 142.78 51.03 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.777 1.631 . . . . 0.0 108.956 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 t -137.01 143.21 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.079 0.552 . . . . 0.0 109.802 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -81.56 126.2 31.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.47 -48.57 48.36 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.052 0.941 . . . . 0.0 111.508 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.11 -13.59 59.65 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -118.75 -164.84 1.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.613 1.565 . . . . 0.0 108.463 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.87 66.54 0.57 Allowed Glycine 0 CA--C 1.52 0.344 0 N-CA-C 107.031 -2.428 . . . . 0.0 107.031 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -145.7 137.05 24.94 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.738 -1.448 . . . . 0.0 108.163 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.35 145.2 50.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.512 1.525 . . . . 0.0 109.406 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.16 138.98 54.28 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.65 139.75 42.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.701 0.801 . . . . 0.0 110.105 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -128.58 104.09 7.47 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.57 -169.13 27.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.0 p -59.56 6.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 130.976 3.711 . . . . 0.0 117.56 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.44 104.84 6.17 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.403 1.456 . . . . 0.0 110.376 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -66.1 132.91 94.62 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 123.862 0.865 . . . . 0.0 110.35 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.69 -38.55 91.29 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.464 2.109 . . . . 0.0 114.806 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.06 -38.27 85.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.867 2.122 . . . . 0.0 110.149 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.4 83.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 mt -67.38 -50.55 59.25 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.836 1.255 . . . . 0.0 109.375 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -52.84 -54.04 18.28 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 124.976 1.31 . . . . 0.0 108.156 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.67 -50.57 69.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.451 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.34 66.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.486 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.25 -32.88 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.216 0.916 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.76 -20.27 65.62 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.613 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.52 -28.2 69.14 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.484 1.493 . . . . 0.0 110.615 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -90.41 -7.86 52.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.064 1.346 . . . . 0.0 110.211 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.51 10.41 70.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.191 1.853 . . . . 0.0 115.399 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.89 156.35 37.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 120.394 2.097 . . . . 0.0 109.222 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -80.57 119.49 23.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.83 143.33 31.87 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.569 0.748 . . . . 0.0 109.159 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -147.02 149.82 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -106.13 148.47 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 123.766 0.826 . . . . 0.0 111.532 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.3 mt -148.2 150.45 33.78 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.32 1.448 . . . . 0.0 107.5 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.275 1.03 . . . . 0.0 110.452 179.695 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtt . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.6 mt -128.39 153.43 47.08 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -131.15 109.81 10.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.746 0.818 . . . . 0.0 109.408 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -101.51 111.46 23.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -90.05 138.5 31.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.88 152.48 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 119.104 0.866 . . . . 0.0 110.044 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -142.73 100.11 3.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.736 2.414 . . . . 0.0 108.258 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.41 -75.58 0.1 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -142.88 150.32 39.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.151 1.78 . . . . 0.0 107.473 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -143.74 -64.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.505 1.122 . . . . 0.0 108.264 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.5 m -75.48 64.36 1.59 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.898 1.279 . . . . 0.0 109.249 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -153.12 172.57 16.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.462 2.305 . . . . 0.0 106.477 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -66.14 -4.71 8.01 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.094 -1.004 . . . . 0.0 112.815 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -53.05 -26.71 16.75 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.373 1.469 . . . . 0.0 111.743 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.9 t -50.23 -49.3 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.924 1.29 . . . . 0.0 109.746 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -63.12 -31.1 72.17 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.94 -42.1 34.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.167 0.987 . . . . 0.0 109.752 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.54 -50.97 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.1 p -61.1 -50.65 72.38 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.09 -0.481 . . . . 0.0 109.835 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -53.83 -54.56 36.71 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.822 0.737 . . . . 0.0 111.881 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.03 -50.76 70.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.908 0.883 . . . . 0.0 111.082 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 mp -68.38 -29.33 68.01 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.169 -0.957 . . . . 0.0 112.84 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -86.95 -9.27 56.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.771 1.628 . . . . 0.0 113.258 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -56.22 -25.5 47.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.559 1.143 . . . . 0.0 113.511 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.65 141.77 29.5 Favored Pre-proline 0 N--CA 1.447 -0.576 0 C-N-CA 125.207 1.403 . . . . 0.0 107.318 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.09 177.2 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.719 2.28 . . . . 0.0 111.245 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.39 -61.51 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.0 t -75.55 -59.28 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 52.3 -17.37 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.588 2.355 . . . . 0.0 116.498 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.94 115.99 30.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 121.546 1.976 . . . . 0.0 110.514 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -147.98 119.15 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.143 1.777 . . . . 0.0 106.432 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -125.19 120.86 32.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 t -87.76 142.74 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.6 t -125.98 117.39 23.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.44 -48.51 49.07 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.451 1.5 . . . . 0.0 113.81 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -58.64 -19.04 35.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.777 1.231 . . . . 0.0 113.102 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 7.98 9.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.963 1.305 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 43.29 56.74 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 126.75 2.119 . . . . 0.0 110.427 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.62 179.94 7.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.9 115.23 10.4 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.776 2.43 . . . . 0.0 108.625 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.7 mt -81.95 123.95 29.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.48 146.22 26.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 118.765 0.711 . . . . 0.0 109.551 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -133.29 107.92 8.42 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.92 174.07 38.52 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 127.547 2.499 . . . . 0.0 108.484 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -88.33 3.6 49.15 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.263 1.425 . . . . 0.0 113.054 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 155.76 1.03 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 117.503 2.408 . . . . 0.0 117.503 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.69 137.09 62.88 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 127.137 2.175 . . . . 0.0 110.317 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.39 -42.94 30.8 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.197 1.932 . . . . 0.0 109.927 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.68 -45.18 95.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.143 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.52 -43.89 93.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 110.263 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -61.58 -54.49 42.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.688 0.795 . . . . 0.0 109.254 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.17 -46.85 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.427 1.091 . . . . 0.0 109.848 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -67.68 -39.01 84.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.171 -1.395 . . . . 0.0 111.33 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.65 -34.89 77.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.825 1.193 . . . . 0.0 110.268 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.81 -38.03 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.324 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.1 -40.3 86.89 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.165 -0.959 . . . . 0.0 111.944 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.11 -19.71 65.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.507 0.594 . . . . 0.0 111.28 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -88.97 -30.51 18.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.9 -1.048 . . . . 0.0 111.179 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 4.66 0.41 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 119.05 2.38 . . . . 0.0 119.05 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.17 138.98 26.92 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.593 3.196 . . . . 0.0 108.656 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -75.4 163.96 26.89 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 118.223 0.465 . . . . 0.0 109.909 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.73 161.04 43.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.65 0.738 . . . . 0.0 110.719 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -151.38 128.96 11.45 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.95 161.74 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.594 -0.691 . . . . 0.0 111.528 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.6 mt -118.51 169.34 9.86 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.684 1.594 . . . . 0.0 108.856 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.492 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.5 mt -134.48 163.08 30.49 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.834 -1.166 . . . . 0.0 109.187 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -120.54 133.1 55.43 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -136.84 148.71 47.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 109.426 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -122.32 138.36 54.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.24 128.57 21.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -139.53 159.27 42.56 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.495 1.118 . . . . 0.0 111.476 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.88 -100.39 0.53 Allowed Glycine 0 C--N 1.339 0.735 0 C-N-CA 124.907 1.242 . . . . 0.0 111.622 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.4 mtp -128.87 -17.0 4.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.091 0.946 . . . . 0.0 113.099 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.8 p -146.69 -178.31 6.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.902 2.081 . . . . 0.0 108.184 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.5 p -123.24 -17.54 6.58 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.008 0.923 . . . . 0.0 110.244 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -68.97 -79.13 0.06 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.983 0.811 . . . . 0.0 110.399 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -79.92 -14.49 58.58 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -52.46 -43.59 65.04 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.293 1.037 . . . . 0.0 110.531 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.61 -38.54 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.289 1.436 . . . . 0.0 110.741 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.62 -45.33 83.5 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.051 0.842 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.11 86.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.207 0.458 . . . . 0.0 109.888 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.22 -54.05 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.383 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -61.47 -38.65 88.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.174 1.352 . . . . 0.0 110.469 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -55.18 -50.55 69.04 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.306 0.642 . . . . 0.0 109.308 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.81 -51.63 38.72 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.52 -27.76 69.48 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -60.91 -9.6 4.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.488 1.04 . . . . 0.0 112.697 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.19 -29.64 58.31 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 114.027 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.95 156.63 91.77 Favored Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 121.446 -0.784 . . . . 0.0 112.248 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.7 -50.69 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.87 1.713 . . . . 0.0 109.77 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.32 34.04 0.02 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 121.207 -0.933 . . . . 0.0 112.231 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.11 -33.53 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 112.757 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.69 165.86 33.97 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -114.65 104.1 11.65 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.94 137.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.03 117.88 13.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.22 143.93 12.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -89.29 153.94 20.49 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.119 0.872 . . . . 0.0 108.925 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.51 -48.13 35.65 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.533 -1.354 . . . . 0.0 109.666 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -66.82 -22.56 66.0 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -145.48 145.97 31.29 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.748 1.158 . . . . 0.0 108.736 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.91 10.68 2.95 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.616 2.055 . . . . 0.0 114.414 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.62 163.94 14.37 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.2 162.5 39.34 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 126.256 1.822 . . . . 0.0 109.877 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.07 142.36 49.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.3 p -128.19 117.13 44.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.148 0.975 . . . . 0.0 108.8 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.93 104.95 12.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.903 2.081 . . . . 0.0 105.613 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.7 -176.27 39.03 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -95.18 7.52 45.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.569 1.148 . . . . 0.0 113.227 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.5 156.52 19.28 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.094 -1.003 . . . . 0.0 113.491 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.64 119.25 71.91 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -57.71 -41.03 74.58 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 121.901 1.734 . . . . 0.0 110.698 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -38.78 75.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.832 0.853 . . . . 0.0 110.648 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.8 82.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.76 0.709 . . . . 0.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.27 -46.53 73.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.14 -38.83 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.706 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -47.99 83.75 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.397 0.999 . . . . 0.0 109.776 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.21 87.17 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.256 1.022 . . . . 0.0 111.557 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.72 -34.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.128 0.571 . . . . 0.0 110.076 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -64.48 -51.68 61.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -67.81 -16.1 63.95 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -82.46 -9.13 59.56 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.29 -0.881 . . . . 0.0 108.941 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.35 52.81 3.63 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -141.08 175.26 9.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.981 1.712 . . . . 0.0 108.26 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -118.42 147.49 43.52 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.15 167.41 22.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -148.24 143.09 26.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -100.07 143.03 14.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -143.14 51.69 1.38 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 109.242 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.264 0 C-N-CA 128.54 2.736 . . . . 0.0 107.078 -178.487 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 ptm . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.85 157.39 16.41 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 120.995 -1.066 . . . . 0.0 108.395 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -115.12 124.21 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.64 148.35 38.28 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.03 1.332 . . . . 0.0 108.115 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -118.71 138.4 52.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.15 133.72 55.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -145.04 108.63 4.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.91 -97.54 1.57 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.8 mtt -143.6 -60.29 0.41 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -132.33 120.99 22.83 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -109.99 50.12 0.81 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.375 1.87 . . . . 0.0 112.147 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -111.21 -92.04 0.46 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -57.42 -31.23 65.65 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.645 1.111 . . . . 0.0 110.33 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 t -52.91 -37.24 60.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.351 2.26 . . . . 0.0 111.592 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -52.38 -41.99 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 119.181 0.901 . . . . 0.0 110.825 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 ttp -62.97 -47.58 82.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.829 0.286 . . . . 0.0 110.325 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 -52.08 62.55 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.354 1.062 . . . . 0.0 112.788 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.98 -44.65 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.463 -0.78 . . . . 0.0 109.223 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.6 m -60.73 -49.83 75.92 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.8 0.727 . . . . 0.0 109.538 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -51.11 -48.53 61.69 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.558 1.143 . . . . 0.0 110.323 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.06 52.72 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.444 0.465 . . . . 0.0 110.828 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.81 -29.11 62.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 112.563 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.56 -13.27 61.0 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.297 -0.877 . . . . 0.0 112.136 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -58.41 -56.04 27.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.567 1.076 . . . . 0.0 110.013 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.61 116.05 30.66 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.14 174.19 11.76 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.254 1.969 . . . . 0.0 110.642 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.53 12.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.226 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 71.3 t -114.76 -59.08 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 118.65 1.225 . . . . 0.0 109.434 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.304 74.4 mt-10 63.68 -44.58 0.25 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 128.286 2.635 . . . . 0.0 110.634 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -95.77 110.35 22.52 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.229 1.812 . . . . 0.0 110.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.16 144.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.063 1.345 . . . . 0.0 107.507 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.2 143.71 34.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.93 140.54 48.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.769 1.227 . . . . 0.0 108.669 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -115.72 115.29 26.09 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.8 -32.57 65.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -71.95 -9.21 58.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.738 0.815 . . . . 0.0 111.889 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 -14.31 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.28 60.12 Favored Glycine 0 N--CA 1.467 0.716 0 CA-C-N 120.723 1.601 . . . . 0.0 110.215 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.98 170.43 15.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.669 0.735 . . . . 0.0 112.169 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.91 157.71 43.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.372 1.869 . . . . 0.0 109.015 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.43 139.15 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.867 2.067 . . . . 0.0 106.443 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.45 121.6 31.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 123.287 0.635 . . . . 0.0 110.139 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -106.6 104.84 14.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . 175.24 -157.73 24.71 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.551 1.072 . . . . 0.0 111.208 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.8 p -113.48 16.94 18.7 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.431 2.292 . . . . 0.0 113.946 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.87 151.86 46.04 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.94 149.67 74.04 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.161 2.185 . . . . 0.0 109.564 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.92 -49.69 3.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 110.739 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -56.49 -49.3 75.1 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.036 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.54 -37.96 66.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 123.645 0.591 . . . . 0.0 111.866 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -73.87 -51.82 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.484 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -58.66 -36.28 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.096 0.862 . . . . 0.0 110.241 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -73.3 -40.55 64.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.943 0.897 . . . . 0.0 110.314 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.19 80.01 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.692 1.133 . . . . 0.0 108.6 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.266 17.6 m -71.58 -32.26 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.783 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.97 -28.77 62.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 120.054 1.297 . . . . 0.0 109.881 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -61.09 -18.72 59.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.414 1.007 . . . . 0.0 111.944 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.3 -6.5 58.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.516 1.053 . . . . 0.0 111.996 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.48 44.96 7.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 119.383 0.992 . . . . 0.0 113.545 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -141.19 175.72 9.41 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.863 2.465 . . . . 0.0 108.021 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -114.41 149.3 36.42 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.765 1.621 . . . . 0.0 108.738 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.97 155.72 37.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.18 175.29 10.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.94 -178.9 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.864 0.84 . . . . 0.0 110.569 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.29 111.1 2.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.74 -1.124 . . . . 0.0 108.157 -179.69 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mtp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.4 mt -140.39 163.39 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -133.86 105.33 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 tp -95.64 147.89 23.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 123.09 49.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.82 140.26 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -139.34 121.8 16.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.358 0.981 . . . . 0.0 110.904 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.4 -112.46 0.51 Allowed Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 29.6 mmm -58.61 -54.79 43.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.156 1.382 . . . . 0.0 113.76 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 p 45.35 50.22 10.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.375 1.47 . . . . 0.0 109.193 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -92.85 168.36 11.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.984 0.897 . . . . 0.0 112.61 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -62.08 -43.1 99.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.157 0.983 . . . . 0.0 113.01 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -89.36 -38.87 13.82 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.5 m -52.01 -28.12 15.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.09 -37.75 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 119.605 1.093 . . . . 0.0 110.105 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.7 mmt -59.03 -44.44 91.75 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.374 -0.829 . . . . 0.0 110.343 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.3 68.89 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.846 0.858 . . . . 0.0 108.882 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.26 -48.54 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.992 0.917 . . . . 0.0 109.595 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.4 m -58.79 -50.11 75.17 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.436 -0.79 . . . . 0.0 109.16 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -63.08 -34.66 78.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.304 0.956 . . . . 0.0 111.495 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.19 79.22 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -64.84 -48.05 75.73 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.458 -0.776 . . . . 0.0 110.033 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -63.5 -6.76 5.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 112.523 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -65.38 -20.04 66.21 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.262 1.392 . . . . 0.0 110.834 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.1 t -71.31 117.11 53.85 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -53.95 -66.1 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.037 2.491 . . . . 0.0 118.387 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.76 -10.46 45.01 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.4 t -71.9 -57.37 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.868 2.334 . . . . 0.0 109.671 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 54.1 0.39 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.546 2.338 . . . . 0.0 116.549 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -131.19 106.93 8.65 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.494 1.518 . . . . 0.0 111.163 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.9 144.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.616 1.566 . . . . 0.0 107.224 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -137.35 117.32 13.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 t -114.62 125.64 71.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -75.5 129.87 37.97 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.79 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.91 -43.4 86.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.819 0.848 . . . . 0.0 109.955 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.18 -8.56 59.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.98 161.22 38.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 121.138 1.79 . . . . 0.0 110.904 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.09 46.01 3.49 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -115.02 134.58 55.06 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.113 1.457 . . . . 0.0 107.787 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.07 113.8 12.49 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.1 mt -94.1 143.55 26.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.01 141.09 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.424 0.631 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -114.74 104.42 11.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.43 168.89 23.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -89.32 12.67 15.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.992 1.717 . . . . 0.0 113.315 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.59 135.38 57.33 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.817 0.735 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.02 155.7 77.24 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 113.596 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -60.68 -66.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.941 3.094 . . . . 0.0 112.701 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -27.27 62.34 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.02 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.73 -52.95 63.28 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.442 1.019 . . . . 0.0 108.329 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.03 -47.66 79.36 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 117.716 -1.135 . . . . 0.0 110.465 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.1 t -52.16 -60.55 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 O-C-N 124.315 1.009 . . . . 0.0 109.017 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -40.26 76.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.923 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.64 88.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.991 1.268 . . . . 0.0 113.186 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 m -78.57 -32.8 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 0.0 109.465 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -61.36 -20.28 62.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.491 0.587 . . . . 0.0 110.036 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.65 -23.83 66.32 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.215 0.916 . . . . 0.0 109.847 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.46 -12.86 53.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.771 1.628 . . . . 0.0 110.727 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.94 -11.7 65.94 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.41 1.957 . . . . 0.0 113.786 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -76.36 144.98 39.78 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.36 1.08 . . . . 0.0 109.217 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -75.95 162.09 28.39 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.95 161.34 38.37 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.557 1.072 . . . . 0.0 111.067 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -147.88 123.66 10.56 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.961 0.904 . . . . 0.0 112.297 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.77 146.4 8.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.616 HD13 ' H ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -68.52 153.07 44.46 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.616 ' H ' HD13 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.244 0.789 0 CA-C-O 116.786 -1.578 . . . . 0.0 110.431 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.555 ' C ' HD12 ' A' ' 2' ' ' LEU . 21.6 ptp . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.555 HD12 ' C ' ' A' ' 1' ' ' MET . 6.7 mp -140.46 159.62 41.79 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.072 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -100.9 115.79 31.23 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -104.4 143.3 33.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -125.69 128.95 48.61 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.59 152.49 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 125.892 1.677 . . . . 0.0 106.687 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -143.96 165.27 28.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.468 1.907 . . . . 0.0 108.697 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.26 -105.19 1.72 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.867 1.222 . . . . 0.0 111.755 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 85.6 mtp -84.94 -176.98 6.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.167 1.387 . . . . 0.0 110.295 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 p -153.12 105.52 2.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.441 1.096 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.6 t -163.45 148.76 11.23 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 121.07 1.759 . . . . 0.0 110.45 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -62.58 -41.95 99.26 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 124.304 1.041 . . . . 0.0 111.482 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -60.92 -14.88 25.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -30.67 71.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.573 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 m -58.41 -25.42 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 121.16 1.8 . . . . 0.0 111.421 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 96.7 mmm -69.61 -50.22 46.47 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.44 -52.44 53.15 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.791 0.836 . . . . 0.0 110.586 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.66 -55.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.645 1.578 . . . . 0.0 109.918 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 m -72.85 -25.45 61.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.811 1.187 . . . . 0.0 111.679 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -66.98 -55.99 12.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.549 1.522 . . . . 0.0 107.917 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.17 68.4 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.718 0.636 . . . . 0.0 110.166 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.4 -27.46 47.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 117.337 -1.316 . . . . 0.0 113.724 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -51.2 -21.8 2.25 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.975 1.716 . . . . 0.0 111.329 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 0.4 3.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.622 1.569 . . . . 0.0 113.21 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.91 143.11 23.94 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 120.796 1.635 . . . . 0.0 111.575 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.44 -81.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.349 3.366 . . . . 0.0 113.607 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.97 0.55 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.416 1.008 . . . . 0.0 110.619 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.68 -58.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.388 0.675 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 62.65 -14.95 0.06 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.907 1.683 . . . . 0.0 115.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -127.46 107.98 10.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.513 1.506 . . . . 0.0 111.657 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.12 119.3 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -119.19 143.54 47.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.861 2.064 . . . . 0.0 107.296 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.39 141.55 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.967 1.307 . . . . 0.0 108.081 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -88.03 118.65 27.74 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.78 -39.58 93.83 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -81.85 -9.1 59.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.549 1.068 . . . . 0.0 112.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -123.48 -168.91 1.85 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.226 1.41 . . . . 0.0 110.216 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.46 70.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 105.514 -3.034 . . . . 0.0 105.514 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -151.07 162.76 40.24 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 117.79 0.795 . . . . 0.0 109.468 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.86 154.73 40.81 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.274 1.03 . . . . 0.0 111.033 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -117.25 119.54 35.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 t -123.72 112.93 35.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 123.561 0.538 . . . . 0.0 110.194 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -104.72 105.78 16.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.743 0.817 . . . . 0.0 111.36 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.3 179.61 45.02 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.2 p -81.6 -12.08 58.88 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.041 0.936 . . . . 0.0 113.026 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.14 135.22 26.02 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.851 1.26 . . . . 0.0 112.692 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.82 143.17 98.43 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 125.895 1.678 . . . . 0.0 111.808 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.9 -32.24 36.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.827 1.685 . . . . 0.0 110.334 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -63.79 -48.93 74.92 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.689 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.34 67.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 123.846 0.716 . . . . 0.0 110.512 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -57.52 -52.78 64.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.768 0.827 . . . . 0.0 111.692 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.18 -46.85 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.079 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -31.71 71.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.97 -51.08 27.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.827 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.261 16.8 m -61.94 -32.9 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.442 1.019 . . . . 0.0 113.227 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -59.18 -20.05 50.49 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.96 -0.462 . . . . 0.0 111.58 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -73.87 -16.63 61.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.09 -52.07 5.14 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.341 1.428 . . . . 0.0 113.151 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.32 20.33 0.04 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.68 173.91 11.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.293 1.437 . . . . 0.0 108.243 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.4 163.67 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.354 -0.841 . . . . 0.0 108.794 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.79 165.82 34.83 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.629 0.728 . . . . 0.0 111.159 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -147.6 155.25 41.62 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.424 2.29 . . . . 0.0 105.762 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 2' ' ' LEU . 0.5 OUTLIER -128.02 137.8 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 O-C-N 121.224 -0.922 . . . . 0.0 111.28 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 tt -92.17 111.68 23.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.761 2.024 . . . . 0.0 105.743 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 125.579 1.552 . . . . 0.0 110.088 -179.738 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.7 mt -145.13 166.06 26.49 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 66' ' ' ALA . 33.3 mttm -127.94 124.88 38.42 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -109.06 115.68 30.53 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.681 1.192 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -88.48 124.35 33.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.74 131.67 69.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -138.92 156.82 46.97 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.374 1.07 . . . . 0.0 108.159 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.32 -74.17 0.26 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 108.081 -2.007 . . . . 0.0 108.081 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.2 tpp -149.29 142.66 25.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.04 116.72 22.41 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.2 m -144.72 117.17 8.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -59.66 -44.24 93.64 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.364 0.665 . . . . 0.0 109.837 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.85 -12.06 51.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.58 -33.21 72.38 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.946 1.248 . . . . 0.0 108.807 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.75 -31.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.519 1.127 . . . . 0.0 110.681 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.49 -51.11 60.24 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.73 97.56 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.892 0.877 . . . . 0.0 110.757 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.91 -51.99 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 m -63.07 -40.36 97.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.716 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -56.84 -55.38 35.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.353 0.979 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.8 85.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 122.522 0.329 . . . . 0.0 111.672 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -45.04 92.65 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -62.25 -8.46 5.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.971 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -60.89 -18.54 56.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.306 1.867 . . . . 0.0 110.749 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.24 127.13 23.19 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.51 126.93 13.34 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.679 2.919 . . . . 0.0 111.418 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.7 -17.1 8.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-O 116.758 -2.134 . . . . 0.0 113.974 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.91 2.53 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 121.176 2.488 . . . . 0.0 115.238 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -66.76 -1.64 4.09 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -95.77 104.22 16.14 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.44 139.19 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.5 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -123.08 116.54 23.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.45 131.84 53.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.91 1.684 . . . . 0.0 109.488 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.1 m -70.19 130.94 43.41 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.02 -48.62 34.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.95 0.405 . . . . 0.0 110.217 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.5 -52.25 7.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.611 1.164 . . . . 0.0 110.956 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -82.62 175.63 10.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.25 3.65 35.16 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.403 -1.221 . . . . 0.0 115.757 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -91.11 146.68 23.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.807 2.304 . . . . 0.0 109.151 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.58 138.75 44.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.766 1.627 . . . . 0.0 107.793 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.01 130.17 48.49 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -120.17 112.67 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.634 1.174 . . . . 0.0 108.8 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -90.4 114.91 27.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.48 -168.93 41.67 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 118.775 0.716 . . . . 0.0 113.217 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 t -125.77 3.72 7.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.956 1.302 . . . . 0.0 112.916 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 156.7 32.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.542 0.687 . . . . 0.0 112.65 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.35 133.55 90.87 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 125.086 1.355 . . . . 0.0 109.104 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.65 -44.17 23.1 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.547 2.165 . . . . 0.0 110.151 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -56.51 -30.45 63.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.971 0.908 . . . . 0.0 112.05 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -39.69 79.21 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.635 0.652 . . . . 0.0 109.549 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.99 -45.12 74.98 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 123.717 0.807 . . . . 0.0 109.077 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -57.83 -58.5 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -60.72 -36.44 78.85 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.357 0.526 . . . . 0.0 112.063 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.28 99.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.952 0.797 . . . . 0.0 110.712 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.5 t -73.86 -33.14 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -60.62 -37.35 81.13 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.395 0.998 . . . . 0.0 110.284 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.65 -19.84 62.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.646 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -87.84 -3.41 58.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 112.225 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.53 37.12 6.25 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.058 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.54 172.96 11.82 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.401 1.101 . . . . 0.0 110.091 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -118.58 109.38 16.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.75 159.23 16.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.1 0.56 . . . . 0.0 111.552 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -158.3 159.26 35.73 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.0 2.52 . . . . 0.0 107.187 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.18 144.81 17.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.628 HD23 ' H ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -147.16 159.8 43.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.7 0.682 . . . . 0.0 110.718 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.628 ' H ' HD23 ' A' ' 65' ' ' LEU . . . . . . . . 0 C--O 1.248 0.975 0 C-N-CA 125.861 1.665 . . . . 0.0 108.633 178.026 . . . . . . . . 1 1 . 1 stop_ save_